|
| language = English
| source_url = https://www.sec.gov/Archives/edgar/data/1519449/000151944926000015/0001519449-26-000015-index.htm
| archive_file = File:Skyward<!-2025-FY ARCHIVE_MD_LINK_HERE -Annual_report.md->
| intro_sentence = This article presents Skyward's FY 2025 annual report — the narrative Items (each summarized into a factsheet), primary financial statements, and note schedules from its SEC Form 10-K.
}}
'''Who We Are'''
* ''Skyward Specialty'' was formed as a Delaware corporation on January 3, 2006, as an insurance holding company <sup>p. 1</sup>.
* The company operated under the name Houston International Insurance Group, Ltd. until re-brandingrebranding as Skyward Specialty in November 2020 <sup>p. 1</sup>.
* Skyward Specialty is a growing specialty insurance company providing commercial insurance products and solutions on botha non-admitted (E&S) and admitted basesbasis, primarily in the United States <sup>p. 1</sup>.
* The company focuses on underserved, dislocated, or inadequately covered markets, requiringwhere highlystandard specialized,insurance customizedcoverages underwritingare solutions and claims capabilitiesinsufficient <sup>p. 1</sup>.
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 1</sup>.
* ''Portfolio of insured risks'' is highly diversified, covering various industries, distributed through multiple channels, and writing multiple lines of business <sup>p. 1</sup>.
* The company develops and delivers tailored insurance products and services for each niche market served <sup>p. 1</sup>.
** ''Lines of business'' include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 1</sup>.
* The portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business <sup>p. 1</sup>.
** Insures both short and medium duration liabilities <sup>p. 1</sup>.
* Lines of business include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 1</sup>.
** Business mix is principally primary insurance, balanced between E&S and admitted markets <sup>p. 1</sup>.
* The company insures both short and medium duration liabilities <sup>p. 1</sup>.
* A portion of the business is ''specialty reinsurance'', primarily property, agriculture, and credit, focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion <sup>p. 1</sup>.
* The business mix is principally primary insurance and balanced between E&S and admitted markets <sup>p. 1</sup>.
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to produce strong growth and profitability across all insurance pricing cycles <sup>p. 1</sup>.
* A portion of the business is specialty reinsurance, primarily property, agriculture, and credit <sup>p. 1</sup>.
* Specialty reinsurance focuses on attractive specialty classes where approaching through reinsurance is more efficient due to factors like cost of entry and geographic expansion costs <sup>p. 1</sup>.
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to consistently produce strong growth and profitability across all insurance pricing cycles <sup>p. 1</sup>.
* The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry <sup>p. 1</sup>.
* The leadership is supported by an experienced team with broad skill sets aligned with the company's strategy <sup>p. 1</sup>.
* The company's highHigh-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position in chosen market niches are expectedbelieved to enableposition profitablethe businesscompany for continued profitable growth <sup>p. 1</sup>.
* The company aims to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles <sup>p. 1</sup>.
* All insurance company subsidiaries are group rated and holdhave financial strength ratings of ''“A”"A" (Excellent)'' from A.M. Best Company, with a stable outlook <sup>p. 1</sup>.
'''Apollo Acquisition'''
* On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders of Apollo Group Holdings Limited ("Apollo"), referred to as (the "Majority Sellers") <sup>p. 2</sup>.
* Pursuant to the Apollo Majority SPAs, the company agreed to acquire approximately 87% of theall issued share capitalshares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital <sup>p. 2</sup>.
* The closingClosing of the transaction ("Closing") was conditioned upon the company acquiring 100% of Apollo's issued share capital (the “Acquisition”) at Closing through additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers") <sup>p. 2</sup>.
* The Acquisition closed on January 1, 2026 <sup>p. 2</sup>.
* The consideration for the transaction was satisfied by issuing common stock of the Company to certain sellers and the remainder in cash <sup>p. 2</sup>.
* Apollo is a U.S.-centric specialty underwriting platform operating at Lloyd’s of London, characterized by low volatility, high growth, and a capital-light business model <sup>p. 2</sup>.
* Apollo has consistently grown's gross written premium has grown consistently since its formation in 2010 <sup>p. 2</sup>.
* Through Syndicate 1969, Apollo underwrites a multi-class specialty insurance portfolio <sup>p. 2</sup>.
* Through Syndicate 1971, Apollo provides a platform liability product for the digital and sharing economy <sup>p. 2</sup>.
* Apollo provides capital to syndicates 1969 and 1971 in exchange for a pro-rata share of underwriting income, with third parties providing the remaining capital <sup>p. 2</sup>.
* Apollo earns managing agency fees and profit commissions asfor being the managing agent forto its own syndicates and forto third-party syndicates, known as (platform partners) <sup>p. 2</sup>.
* The acquisition aligns with Skyward Specialty’s strategy by bringingintroducing new specialty niches, a distinctive new economy offering, accelerating innovation, and adding Apollo’s advanced technology capabilities <sup>p. 2</sup>.
* David Ibeson will continue as CEO of Apollo, leading itsApollo's growth as a subsidiary of Skyward Specialty, along with Apollo’s management team <sup>p. 2</sup>.
'''Our Business and Our Strategy'''
* The company operates throughwith one reportable segment, offering a broad arrayrange of insurance coverages across various market niches <sup>p. 3</sup>.
* The company has nineNine distinct underwriting divisions exist, each with dedicated leadership and technical staff experienced in their niches <sup>p. 3</sup>.
* This structure aims to effectively serve customer needscustomers, be a value-add partner towith distributors, and earnachieve attractive risk-adjusted returns <sup>p. 3</sup>.
* For the year ended December 31, 2025, ''gross written premiums'' were 41% admitted and 59% non-admitted <sup>p. 3</sup>.
* ''Accident & Health (A&H)'' underwriting division provides medical stop loss to employers who self-insureinsured employee benefitsemployers and covers group and single-employer captives <sup>p. 3</sup>.
* The ''A&H captives program'' offers tailored medical stop-loss and reinsurance solutions for group and single-employer captive arrangements, with dedicated underwriting and claims oversight <sup>p. 3</sup>.
* The A&H division targets small and medium-sized enterprises seeking to control healthcare costs by self-insuring a portion of their healthcare insurance <sup>p. 3</sup>.
* A&H products are written on an admitted basis and distributed primarily through retail and wholesale broker partnersbrokers <sup>p. 3</sup>.
* ''Agriculture and Credit (Re)insurance'' underwriting division provides specialty risk-transfer solutions across a diversified global portfolio <sup>p. 3</sup>.
* This divisionportfolio coversincludes agriculture, dairy and livestock revenue protection, and mortgage and credit product lines <sup>p. 3</sup>.
* ItThe division supports insurers, MGAs, and other risk originators with tailored treaty protection using proportional and excess of loss structures <sup>p. 3</sup>.
* The global''Global agriculture book'' covers weather and natural peril-driven volatility and other, production, and yield risks to manage catastrophe exposure and seasonal earnings variability <sup>p. 3</sup>.
* The mortgage''Mortgage portfolio'' supports government-sponsored entities and private mortgage insurers against default and loss severity volatility, typically due to macroeconomic stress, structured to manage tail risk <sup>p. 3</sup>.
* The credit''Credit portfolio'' provides protectionprotects against losses from default risk for single obligors and multi-buyer trade credit across diverse regions and industries <sup>p. 3</sup>.
* The dairy''Dairy and livestock business'' provides producers with revenue protection against price volatility in milk, cattle, and hog markets <sup>p. 3</sup>.
* Derivative instruments, primarily put options and futures, are used to mitigate commodity price risk associated with exposurerelated to cattle, hog, and milk prices <sup>p. 3</sup>.
* These derivative instruments are used solely to manage exposurefor tomanaging adverse price movements, with positions adjusted throughout the year <sup>p. 3</sup>.
* ''Captives'' underwriting division offers group captive solutions by leveraging underwriting and claims expertise from other divisions <sup>p. 3</sup>.
* See Note 8, “Derivatives” to the consolidated financial statements in Item 8 of Form 10-K for additional information on derivatives <sup>p. 3</sup>.
* ''Captives'' underwritingThis division provideswrites groupproperty, captivegeneral solutionsliability, bycommercial leveragingauto, underwritingexcess liability, and claimsworkers’ expertisecompensation fromon E&S and otheradmitted divisionsbases <sup>p. 3</sup>.
* This division writes property, general liability, commercial auto, excess liability, and workers’ compensation lines of business on an E&S and admitted basis <sup>p. 3</sup>.
* Business is often administered through partnerships with third-party captive managers <sup>p. 3</sup>.
* ''Construction & Energy Solutions'' underwriting division focuses on high-severity exposures, offeringwith tailored multi-line solutions including general liability, excess liability, commercial auto, and workers’ compensation <sup>p. 3</sup>.
* Solutions include general liability, excess liability, commercial auto, and workers’ compensation <sup>p. 3</sup>.
* Products are distributed through retail agents, brokers, and a select network of wholesalers <sup>p. 3</sup>.
* ''Global Property'' underwriting division provides comprehensive property insurance and reinsurance solutions for commercial clients worldwide <sup>p. 3</sup>.
* Offerings protect against physical loss or damage to assets, including buildings, equipment, and inventory, due tofrom natural catastrophes and other insured perils <sup>p. 3</sup>.
* ''Professional Lines'' underwriting division includes three units: management liability, professional liability (including cyber), and allied health (including life sciences) <sup>p. 3</sup>.
* Management/Professional liability and allied health provide primary and excess claims-made liability products on an E&S and admitted basis <sup>p. 3</sup>.
* These products are distributedoffered throughon both wholesaleE&S and retailadmitted brokersbases, dependingdistributed onthrough thewholesale productand retail brokers <sup>p. 3</sup>.
* ''Specialty Programs'' underwriting division partners with program administrators focused on specific markets <sup>p. 3</sup>.
* This partnership model is used to participate profitably participate or extend reach in certain markets, leveraging program administrators' competitive advantages like scale or proprietary technology <sup>p. 3</sup>.
* The Specialty Programs division writes property, general liability, commercial auto liability, excess liability, and workers’ compensation lines of business on an E&S and admitted basisbases <sup>p. 3</sup>.
* ''Surety'' underwriting division provides contract, commercial, and transactional surety solutions to trade and services organizations <sup>p. 3</sup>.
* The focusFocus is principally on small to medium-sized enterprises with aggregate bond programs up to approximately ''$100.0 million'' for contract and ''$125.0 million'' for commercial and transactional <sup>p. 3</sup>.
* This business is written on an admitted basis and distributed through retail agents and brokers <sup>p. 3</sup>.
* ''Transactional E&S'' underwriting division provides primary and excess non-catastrophe prone property and general liability solutions <sup>p. 3</sup>.
* ThisEmphasis divisionis emphasizes risks consideredon hard -to -place risks due to complexity, loss history, or limited operating history (e.g., start-upsstartups) <sup>p. 3</sup>.
* Success in this market isrelies determined byon technical underwriting, thoughtful coverage provisions, pricing, and high-quality broker service <sup>p. 3</sup>.
* MarketAccess accessto the market in this division is exclusively through wholesale brokers <sup>p. 3</sup>.
* BusinessThe company has "exited business" units and lines ofthat businesswere previously exited and placed into run-off are referred to as "exited business" <sup>p. 3</sup>.
* The company's strategy, referred to as “Rule Our Niche,” aimsis to lead in chosen market niches and establish sustainable, competitive positions <sup>p. 3</sup>.
* Key elements of the strategy include:
** Providing differentiated products, services, and solutions for target markets <sup>p. 3</sup>.
** Attracting and retaining exceptional underwriting and claims talent, incentivized to align with organizational and corporate goals <sup>p. 3</sup>.
** Amplifying expertise with advanced technology and analytics for superior risk selection, pricing, and claims management <sup>p. 3</sup>.
** Empowering underwriting and claims teams with significant authority for decision-making and expertise applicationauthority <sup>p. 3</sup>.
** Fostering a culture that promotesof nimbleness and responsiveness to market opportunities and dislocation <sup>p. 3</sup>.
* This strategy is referred to as "Rule Our Niche" and aims to build a strong defensible market position and competitive moat <sup>p. 3</sup>.
* The principles underlying this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 3</sup>.
* The principles of this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 3</sup>.
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 3</sup>.
'''Our Competitive Strengths'''
* ''CompetitiveThe strengths''company include a focusfocuses on profitable niches in the market nichesthat requiringrequire technical underwriting and claims management, which act as barriers to entry <sup>p. 4</sup>.
* The companyselected targetsniche underserved,areas dislocated, or complexwithin commercial lines P&C markets forare considered attractive for generating risk-adjusted returns <sup>p. 4</sup>.
* The company targets underserved, dislocated markets or those where standard products are insufficient for customer needs <sup>p. 4</sup>.
* ''Underwriting divisions'' are built around deeply experienced underwriters empowered with authority to make decisions <sup>p. 4</sup>.
* Risks in core markets require efficient, individual underwriting to achieve sustainable underwriting profit <sup>p. 4</sup>.
* Underwriters' experience is augmented with data and predictive analytics for risk selection, pricing, and efficiency <sup>p. 4</sup>.
* The company hiresbuilds andunderwriting retainsdivisions ''highlywith skilleddeeply underwritingexperienced and technical staff''underwriters who usehave theirappropriate expertise and judgmentauthority for evaluating and pricing complex risks, rather than strict underwriting rulesdecision-making <sup>p. 4</sup>.
* ''SuperiorThis Claimsstructure Staffallows andfor Operations''innovative includeproducts aand specializedsolutions teamfor knowledgeabledistribution inpartners specificand nichescustomers, andeven linesfor ofchallenging businessrisks <sup>p. 4</sup>.
* Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing while enhancing efficiency <sup>p. 4</sup>.
* The company hires and retains underwriting and technical staff for their expertise and experience <sup>p. 4</sup>.
* Underwriting teams are knowledgeable, experienced, and empowered, which is crucial for operating in markets with risks difficult to automate <sup>p. 4</sup>.
* The company avoids strict underwriting rules, allowing professionals to use their expertise and judgment in evaluating and pricing risks <sup>p. 4</sup>.
* The company has a specialized team of claims professionals knowledgeable in the niches and lines of business served <sup>p. 4</sup>.
* Claims professionals address first-party claims with fair solutions and third-party claims with comprehensive responses, aiming for consistent and early loss recognition of indemnity and loss adjustment expenses (LAE) <sup>p. 4</sup>.
* ClaimsThe arecompany handledresponds quickly byto claims with specialized adjusters using expertise, advanced technology, and analytics <sup>p. 4</sup>.
* Technology is deeply embedded in the claims process, from first notice of loss to investigation and settlement <sup>p. 4</sup>.
* Analytics capabilities provide senior leadership and claims teams with real-time, detailed information on open claims and benchmarks against closed claims for senior leadership and claims teams <sup>p. 4</sup>.
* ''SkyBI'', the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for decision-making <sup>p. 4</sup>.
* SkyBI incorporates best practices from the management team's experience in P&C insurance and technology sectors <sup>p. 4</sup>.
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 4</sup>.
* SkyBI provides information and performance metrics across the company in a visualized format, filterable by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 4</sup>.
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 4</sup>.
* ''Advanced technology and new risk data'' are used for underwriting and claims decisions <sup>p. 4</sup>.
* UnderwritingThe decisionscompany combinebelieves reliablethat historicalnew datatypes and in-depthof risk evaluationdata withand newadvanced formstechnology ofcan riskaugment dataunderwriting and predictiveclaims analyticsdecisions <sup>p. 4</sup>.
* Underwriting decisions are supported by historical data and in-depth risk evaluation from data collection and processing capabilities <sup>p. 4</sup>.
* Generative artificial intelligence is utilized in underwriting and claims handling to enhance effectiveness and efficiency, while still relying on employee expertise <sup>p. 4</sup>.
* Underwriting and claims capabilities are amplified by combining historical data with new forms of risk data and predictive analytics <sup>p. 4</sup>.
* The company has a ''diversified business'' with underwriting divisions spanning multiple product lines, industries, geographies, and distribution channels <sup>p. 4</sup>.
* TheGenerative businessartificial aimsintelligence tois adaptused toin marketunderwriting conditionsand byclaims growinghandling certain linesto whenenhance favorableeffectiveness and limitingefficiency, exposurewhile whenstill conditionsrelying areon lessemployee favorableexpertise <sup>p. 4</sup>.
* The company has built a diversified group of underwriting divisions across multiple product lines, industries, geographies, and distribution channels <sup>p. 4</sup>.
* This diversification includes business not typically aligned with traditional P&C cycles <sup>p. 4</sup>.
* The company aims to adapt to the market by growing certain lines in favorable conditions and limiting exposure in less favorable conditions <sup>p. 4</sup>.
* The diversity of the book allows the company to respond to and capitalize on market opportunities and dislocations across insurance market and pricing cycles <sup>p. 4</sup>.
* The company has ana ''attractive and winningdistinctive culture'', evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance" <sup>p. 4</sup>.
* The culture featuresand operating approach feature a flat communication and decision-making structure, empowering staff to make decisions and supporting them with a clear measurement system <sup>p. 4</sup>.
* Staff are trusted to make decisions that achieve or exceed financial results and are supported by a clear performance measurement system <sup>p. 4</sup>.
* A hybrid work schedule offers employees flexibility for remote working <sup>p. 4</sup>.
* The company maintainsadopted ana entrepreneurial environment that encourages ahybrid proactivework approachschedule, tooffering capitalizeflexibility onfor marketremote disruptionworking <sup>p. 4</sup>.
* The ''leadershipcompany team''maintains isan high-quality,entrepreneurial experienced,environment that encourages and alignedrewards a proactive approach to withmarket shareholdersdisruption <sup>p. 4</sup>.
* This environment aligns with the company's identity as a specialty insurer and supports attracting talent and delivering best-in-class results <sup>p. 4</sup>.
* The executive leadership team is led by Chairman and CEO Andrew Robinson <sup>p. 4</sup>.
* SeniorThe leadership compensationteam, includesled materialby long-termChairman and short-termCEO incentivesAndrew tiedRobinson, tois deliveringexperienced, sustainableinnovative, best-in-class underwritingand returnsentrepreneurial <sup>p. 4</sup>.
* ExecutiveThe executive leadership team has additionala long-termtrack incentiverecord targetsof tiedsuccess directlyin tosenior growthmanagement inroles bookat industry-leading P&C companies and in valuebuilding pernew sharebusinesses <sup>p. 4</sup>.
* Senior leadership compensation is structured to align with shareholders <sup>p. 4</sup>.
* A material portion of each leader's compensation is in long-term and short-term incentives tied to delivering sustainable, best-in-class underwriting returns <sup>p. 4</sup>.
* Executive leadership has additional long-term incentive targets directly tied to growth in book value per share <sup>p. 4</sup>.
'''Our Strategy in Action'''
* The company's "Rule Our Niche" strategy guidesaims allto activitiesgenerate frombest-in-class recruitingunderwriting toprofitability within its niches and create superior long-term shareholder value through growth in book value claimsper resolutionshare <sup>p. 5</sup>.
* TheCore goaltenets of the "Rule Our Niche" strategy isinclude toattracting generateand bestretaining blue-in-classchip underwriting profitability for niches and createclaims superiortalent long-termto shareholderexpand value through growth in bookand valueenhance permarket shareposition <sup>p. 5</sup>.
* CoreThe tenetscompany ofseeks theto "Rulehire Ourand Niche"retain strategytechnical includeunderwriting attractingprofessionals andwith retaining bluelong-chipstanding underwritingindustry relationships and claims talentprofessionals with expertise in specific niches <sup>p. 5</sup>.
* The company seeks to hire technical underwriting professionals with long-standing industry relationships and claims professionals with expertise in specific niches <sup>p. 5</sup>.
* These relationships are crucial for consistent access to preferred business <sup>p. 5</sup>.
* The company aims to grow its market position by recruiting world-class talent in chosen markets <sup>p. 5</sup>.
* Another core tenet is leveraging technology DNA to differentiate from competitors <sup>p. 5</sup>.
* The company has demonstrated an ability to use new forms of risk data and advanced technology in complex, highhigher-severity risk categories within the specialty P&C insurance market <sup>p. 5</sup>.
* SkyBI providesenables theprompt abilitysensing toand promptly sense andquick respondresponse to market changes <sup>p. 5</sup>.
* Core operating platforms allow efficient entry into new markets without complex or burdensome systems <sup>p. 5</sup>.
* The company believes its technological advantage supports profitable growth and expansion into additional specialty market niches <sup>p. 5</sup>.
* AThe furtherstrategy tenetalso isincludes profitably growing existing lines of business and expanding with new underwriting divisions <sup>p. 5</sup>.
* The company is positioned to capitalize on trends impacting customers in the U.S. and globally, such as increased demand for specialized insurance due to rising and complex risks <sup>p. 5</sup>.
* One trend is the rising demand for specialized insurance due to increasing and complexThese risks frominclude climate change, /severe weather events, supply chain uncertainty, financial inflation, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery/cost <sup>p. 5</sup>.
* Another notable market trend is the emergence of "micro cycles and micro dislocations" inwhere thedifferent P&C insurance market segments experience hardening and softening at varying times <sup>p. 5</sup>.
* The company has reacted quickly to these trends by launching new underwriting units (somemany not aligned with P&C cycles), entering underserved markets, partnering withon advanced technology providers, and launching new captive solutions <sup>p. 5</sup>.
* Gross written premium growth and profitability indicate momentum and position the company for continued expansion and growth <sup>p. 5</sup>.
* Differentiating on daily excellence to drive best-in-class underwriting performance is also a core tenet <sup>p. 5</sup>.
* Meeting long-term goals, including best-in-class underwriting returns and book value per share growth, depends on execution of day-to-day operational executionoperations across all functional departments (underwriting, product management, claims management) <sup>p. 5</sup>.
* SkyBI enablesprovides a foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance, claimsfor agingunderwriters, and claims aging/reserving practices for adjusters <sup>p. 5</sup>.
* Focus on fundamentals driving underwriting fundamentalsexcellence is central to the strategy <sup>p. 5</sup>.
* Cross-functional collaboration ensures regular review of performance and trends by underwriting, claims, actuarial, and product management teams forto quick implementation ofimplement portfolio, pricing, and coverage changes quickly <sup>p. 5</sup>.
* The company aims to use its balance sheet to capture a larger market share <sup>p. 5</sup>.
* The company is committed to maintaining a strong balance sheet, throughstarting with conservative loss reserves and strong capitalization ratios <sup>p. 5</sup>.
* This commitment is considered imperative for maintaining confidence among customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders <sup>p. 5</sup>.
* Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss <sup>p. 5</sup>.
* The company's maintainspractice ais levelto ofmaintain incurred but not reported reserves ("IBNR") that, combined with case reserves, exceedsare above the actuarial central estimate <sup>p. 5</sup>.
* Loss reserves represent the company's best estimate of ultimate losses <sup>p. 5</sup>.
'''Marketing and Distribution'''
* The company's marketing and distribution approach aligns withmirrors its underwriting strategy and is central to its "Rule Our Niche" strategy <sup>p. 6</sup>.
* ''Underwriting teams'' and the company maintain strong relationships and reputations with distribution partners, facilitating new affiliations <sup>p. 6</sup>.
* The company believesattributes itits succeedssuccess with distribution partners due to its deep expertise in niche markets, high-caliber underwriters, a culture of innovation, thoughtful product line-uplineup and design, and responsive speed and qualityservice <sup>p. 6</sup>.
* All underwriting divisions dedicate significant time and effort to maintaining and expanding distribution partner loyalty and long-term relationships <sup>p. 6</sup>.
* The company tailors its choice of ''distribution partners'' to access specific business, similar to how it tailors underwriting to insureds' needs <sup>p. 6</sup>.
* Products are distributed through ''retail agents'', ''wholesale brokers'', ''select program administrators'', and ''captive managers'' <sup>p. 6</sup>.
* This distribution strategyapproach enables effective and efficient access to targeted business based on market niche needs and dynamics <sup>p. 6</sup>.
'''Underwriting'''
* The company's underwriting approach is central to its "Rule Our Niche" strategy and market success <sup>p. 7</sup>.
* Within its nine divisions, the company further specializes underwriting teams to focus on specific niches <sup>p. 7</sup>.
* The underwriting approach relies on hiring highly experienced, best-in-class, and diverse teams of technical underwriters with proven track records in specific specialty niche markets <sup>p. 7</sup>.
* Underwriters' skills are enhanced with advanced technology and data analytics, and they are empowered with appropriate decision-making authority <sup>p. 7</sup>.
* This approach isaims believed to lead tofor superior risk selection and pricing, andleading to sustainable best-in-class underwriting results across market cycles <sup>p. 7</sup>.
* The company aims to improveaugments underwriting professionals' capabilities andusing experiencenew usingforms newof data and analytics for risk selection and pricing <sup>p. 7</sup>.
* Underwriting data is captured in the company's business intelligence platform, SkyBI, which serves as a comprehensive data repository for reporting, analytics, and other data capabilities <sup>p. 7</sup>.
* SkyBI serves as a comprehensive data repository for reporting, analytics, and other data capabilities, and is a key tool for senior management and business leaders <sup>p. 7</sup>.
* The company is highly selective in binding policies, encouraging underwriters to move on from opportunities that do not meet premium and coverage term standards <sup>p. 7</sup>.
* Underwriters are encouraged to move on from opportunities quickly if they cannot reasonably expect to bind coverage at premium and terms meeting company standards <sup>p. 7</sup>.
* When accepting risks, the company carefully establishes terms and prices suited to the underlying exposure <sup>p. 7</sup>.
* When accepting risks, the company establishes terms and prices suited to the underlying exposure <sup>p. 7</sup>.
* In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for accepted risks, while allowing flexibility for specific or unique exposures <sup>p. 7</sup>.
* In the E&S market, the company utilizesuses freedom of rate and form to match risk and coverage to the unique needs and exposures of that market <sup>p. 7</sup>.
* Policies are crafted to offer affordable and appropriate protection for insureds' exposures, whilewith alsocoverage structuring coveragestructured to make potential losses more predictable and manage claims costs manageable <sup>p. 7</sup>.
* Underwriting teams receive support and collaboration from Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments <sup>p. 7</sup>.
* This collaboration ensures thattimely businessanalysis and action on trends in business, legal and tort developments, and competitor and regulatory actions are analyzed, shared, and acted upon promptly <sup>p. 7</sup>.
* Underwriters are considered central to the company, with all support functions incentivized and measured to achieve underwriting profitability targets <sup>p. 7</sup>.
* This structure helps identify opportunities and issues early, contributing to the company's nimbleness and ability to capitalize onleverage market disruptions <sup>p. 7</sup>.
* Underwriting controls and procedures are regularly reviewed to ensure profitableunderwriters underwritingprofitably acrossunderwrite allin servedeach marketsmarket served <sup>p. 7</sup>.
'''Claims Management'''
* Skyward's claims department operates under six guiding principles: prompt and comprehensive investigations using advanced analytics and technology; quality claims handling withand customer engagement; prompttimely establishment of reserves based on best estimates; effective pursuit of contribution and subrogation; detection and prevention of fraud; and disciplined litigation management for superior legal defense and cost monitoring <sup>p. 8</sup>.
* Continuous training is provided to claim staff on claim evaluation, strategy, litigation management, good-faith claims handling, and best practices to achieve timely and optimal claim outcomes <sup>p. 8</sup>.
* The majority of claims are handled in-house <sup>p. 8</sup>.
* Third Party Administrators (TPAs) are utilized for specific instances such as programs, captives, occupational accident, workers' compensation, and runoff claims <sup>p. 8</sup>.
* TPAs are actively managed, overseen, and regularly audited to ensure compliance with Skyward's claims handling, and reserving guidelines, and general best practices <sup>p. 8</sup>.
* Independent legal counsel is retained for liability claims against insureds when warranted, selected based on geographical location and expertise <sup>p. 8</sup>.
* Litigation guidelines have been developed for claims professionals and outside counsel to ensure appropriate defense for insureds <sup>p. 8</sup>.
* A legal spend management solution is used to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable and customary legal costs <sup>p. 8</sup>.
* Technology is leveraged for efficiencyefficiencies in claims handling, including a Claims Development Severity Predictor model <sup>p. 8</sup>.
* The Claims Development Severity Predictor identifies claims likely to lead to large loss development using key phrases, enabling early identification, proactive management, and summarization of development reasons <sup>p. 8</sup>.
* This predictive model is integrated into the claims review and management workflow <sup>p. 8</sup>.
* A "quick strike" program has been implemented for commercial auto claims, deploying experienced investigators and vendors to accident scenes, ideally within two hours, regardless of location <sup>p. 8</sup>.
* The quick strike program aimsassists toin evaluateevaluating accident facts and circumstances rapidly and, if appropriate, resolveresolving third-party claims quickly <sup>p. 8</sup>.
* Claims handlers and managers are organized by line of business to ensure specialized expertise <sup>p. 8</sup>.
* Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues, educating underwriters on loss experience for risk selection <sup>p. 8</sup>.
'''Technology'''
* Technology is central to Skyward Specialty Insurance Group's operations and decision-making, aiming for long-term competitive advantageadvantages <sup>p. 9</sup>.
* ''SkyBI'', the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for decision-making <sup>p. 9</sup>.
* Technology is deployed across the organization to drive competitive advantages in three primary functional ways <sup>p. 9</sup>.
* ''SkyBI'' is a business intelligence platform providing real-time intelligence to senior leadership and technical teams for decision-making <sup>p. 9</sup>.
* SkyBI incorporates best practices from the management team's experience in P&C insurance and technology sectors <sup>p. 9</sup>.
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 9</sup>.
* SkyBI providespresents information and performance metrics across the company in a visualized format <sup>p. 9</sup>.
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 9</sup>.
* SkyBI helps establish clear objectives and facilitates decision-making <sup>p. 9</sup>.
* ''Predictive analytics technology'' augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling <sup>p. 9</sup>.
* Underwriting divisions intentionally "Rule Our Niche" bythrough innovatingconstant constantlyinnovation withtailored actionsto specific to each divisiondivisions/market servedmarkets <sup>p. 9</sup>.
* ''Core transactional platforms'', including (policy administration, underwriting workbench, billing, and claims systems), are designed for nimble scaling and business expansion <sup>p. 9</sup>.
* The company generally uses customized third-party vendor core operating applications <sup>p. 9</sup>.
* The core platform organization is used for all business except accident & health, global property, agriculture and, credit (re)insurance, and surety, which require dedicated core processing components due to their unique features <sup>p. 9</sup>.
* Data from all divisions' core operating platforms flows to the SkyBI platform with comparable data quality and granularity <sup>p. 9</sup>.
* Advanced technology for underwriting and claims, SkyBI, and core operating platforms create a flywheel effect, enabling underwriters to better select risk, claims professionals to adjudicate claims, unit leaders to communicate with partners, and senior leadership to evaluate business trends <sup>p. 9</sup>.
* These tools also improve communication with distribution partners, reinsurers, and other third-party partners <sup>p. 9</sup>.
* This technology allows underwriters to better select risk, claims professionals to better adjudicate claims, unit leaders to better communicate with reinsurance and third-party partners, and senior leadership to better evaluate business trends <sup>p. 9</sup>.
* The company faces external threats to its information technology systems, including system failure, data theft attempts, and ransomware attacks <sup>p. 9</sup>.
* These tools also improve communication accuracy, effectiveness, and efficiency with distribution partners, reinsurers, and other third-party partners <sup>p. 9</sup>.
* The company faces external threats to IT systems, including system failure, customer data theft attempts, and ransomware attacks <sup>p. 9</sup>.
* The technology infrastructure is designed to function through major disruptions <sup>p. 9</sup>.
* Data is replicated in real-time to a third-party cloud disaster recovery site for use during major system failures <sup>p. 9</sup>.
* Data is backed up daily for system restoration <sup>p. 9</sup>.
* Actions to prevent system and data disruptions include: actively monitoring Cybersecurity and Infrastructure Security Agency’s ("CISA") cybersecurity directives and taking immediate action on identified vulnerabilities <sup>p. 9</sup>.
** Actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives and taking immediate action on identified vulnerabilities <sup>p. 9</sup>.
* Monthly vulnerability scans are conducted on all network-attached devices at all locations, with patching applied as needed <sup>p. 9</sup>.
** Conducting monthly vulnerability scans on all network-attached devices at all locations, with patching as needed <sup>p. 9</sup>.
* Two-factor authentication is required for system access <sup>p. 9</sup>.
** MonthlyRequiring securitytwo-factor training is conductedauthentication for allsystem employeesaccess <sup>p. 9</sup>.
** EndpointConducting detectionmonthly agentssecurity are implementedtraining for threat detection andall responseemployees <sup>p. 9</sup>.
** Implementing endpoint detection agents for threat detection and response <sup>p. 9</sup>.
* Desktop scenarios are performed to practice responses to breaches with cybersecurity insurance partners and retained security consultants <sup>p. 9</sup>.
** Performing desktop scenarios to practice breach responses with cybersecurity insurance partners and retained security consultants <sup>p. 9</sup>.
* Annual penetration testing is performed <sup>p. 9</sup>.
** Performing annual penetration testing <sup>p. 9</sup>.
* The company constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools <sup>p. 9</sup>.
'''Reinsurance'''
* ReinsuranceThe iscompany strategically purchasedpurchases reinsurance from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility <sup>p. 10</sup>.
* Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June <sup>p. 10</sup>.
* FactorsAnnual influencingrenewal reinsuranceconsiderations purchasefor changesreinsurance at renewalpurchases include planschanges forto underlying insurance coverage, updated loss activity, capital and surplus levels, changes in risk appetite changes, and the cost and availability of reinsurance treaties <sup>p. 10</sup>.
* ''ReinsuranceThe types''company purchased includepurchases quota share, excess of loss, and facultative reinsurance coverage to limit exposure from singlelosses occurrenceon lossesany one occurrence <sup>p. 10</sup>.
* The mix of reinsurance purchased considersis based on efficiency, cost, risk appetite, and specific factors of the underlying risks underwritten <sup>p. 10</sup>.
* ''Quota share reinsurance'' involves thea reinsurer assuming a specified percentage of losses from a defined business class of business in exchange for a corresponding percentage of premiums, net of a ceding commission <sup>p. 10</sup>.
* ''Excess of loss reinsurance'' involves thea reinsurer assuming all or a portion of losses for an individual claim or event exceedingabove a specified amount, in exchange for a negotiated premium, includingand includes the catastrophe reinsurance programsprogram <sup>p. 10</sup>.
* ''Facultative coverage'' is a reinsurance contract for individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance <sup>p. 10</sup>.
* As of December 31, 2025, ''property insurance'' represented 34% of gross written premiums <sup>p. 10</sup>.
* AggregationThe ofcompany actively manages and monitors property writings by geographic area is actively managed and monitored to limit potential loss aggregation from severe events like hurricanes, convective storms, and earthquakes <sup>p. 10</sup>.
* Catastrophe reinsurance is purchased to further mitigate property loss aggregation due to single or series of events <sup>p. 10</sup>.
* Third-party stochastic and internalproprietary deterministic models are used to analyze the risk of loss aggregation forfrom such events and inform catastrophe reinsurance purchases <sup>p. 10</sup>.
* These models provide a quantitative view of PML (Probable Maximum Loss) events, estimatingwhich estimate the expected loss level for a given return period <sup>p. 10</sup>.
* ModelingBased indicateson thatmodeling, an event beyond a 1 in 250-year PML would be required to exhaust the company's ''$36.0 million property catastrophe coverage'' <sup>p. 10</sup>.
* The company aims to expose no more than ''3.0% of stockholders’ equity'' to a catastrophic loss that is less than a 1 in 250-year event <sup>p. 10</sup>.
* The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event <sup>p. 10</sup>.
* ReinsuranceThe iscompany soughtseeks to purchase reinsurance from reinsurers rated at least “A"A-”" (“Excellent”"Excellent") or better by A.M. Best <sup>p. 10</sup>.
* As of December 31, 2025, ''98% of reinsurance recoverables'' were from reinsurers rated “A"A-”" (Excellent) or better by A.M. Best, or were collateralized <sup>p. 10</sup>.
* FailureThe ofcompany reinsurersretains toprimary payliability claimsto couldpolicyholders resultif inreinsurers losses,fail asto thepay companyclaims, retains primary liabilityleading to policyholderspotential losses <sup>p. 10</sup>.
* Allowances for uncollectible reinsurance are established due to potentialthe risk of reinsurer failuredefault <sup>p. 10</sup>.
* The ''Allowanceallowance for uncollectible reinsurance'' was $2.3 million at December 31, 2025, and 2024 <sup>p. 10</sup>.
<div style="overflow-x:auto">
'''Enterprise Risk Management'''
* ''Enterprise Risk Management (ERM)'' is integratedembedded intoin nearly every aspect of the company and guides dailyday-to-day activities <sup>p. 11</sup>.
* The ''ERM approach'' aims to achieveensure an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served <sup>p. 11</sup>.
* The company is intentional in its underwriting''Underwriting and asset portfolio construction'' are intentional <sup>p. 11</sup>.
* ''UnderwritingLiability portfolioduration and market cyclicality'' balancesof liabilitythe durationunderwriting andportfolio marketare cyclicalitybalanced <sup>p. 11</sup>.
* ''Reinsurance'' is used to manage volatility outside of risk tolerances <sup>p. 11</sup>.
* ''Investment strategy'' targets a diversified portfolio that balances yield, liquidity, volatility, and potential for principal loss <sup>p. 11</sup>.
* The ''SVP, CFO & Head of ERM - US Operations'' oversees critical ERM processes and chairs the cross-functional corporate ERM Committee <sup>p. 11</sup>.
* The''Economic companyCapital Model (ECM)'' formalizes itsthe company's view of risk and solvency usingin anterms ''Economic Capital Model (ECM)'' to measureof potential economic loss <sup>p. 11</sup>.
* ''ECM output'' measures potential earnings and capital loss acrossfor various scenarios <sup>p. 11</sup>.
* These outputs are measured against ''riskRisk tolerances'' are set and updated annually by the ERM Committee and discussed with the Risk Committee of the Board of Directors <sup>p. 11</sup>.
* The ''ECM'' provides a probabilistic modeled view of earnings and capital loss, integrating potential losses from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks <sup>p. 11</sup>.
* The ''SVP, CFO & Head of ERM'' works with the ERM Committee to review and maintain a comprehensive ''risk register'', ensuringwith appropriateaccountabilities for mitigations are in place and monitored <sup>p. 11</sup>.
* The ''topTop 10 risks'' are identified, quantified, and reviewed quarterly by the SVP, CFO & Head of ERM and the ERM Committee, and reviewed quarterly <sup>p. 11</sup>.
* These''Reports'' on top reportsrisks are submitted regularly to the ''Risk Committee'' regularly by the SVP, CFO & Head of ERM and the ERM Committee <sup>p. 11</sup>.
* ''Operational processes and controls'' are designedconstructed to identify, assess, and manage key risks continuously <sup>p. 11</sup>.
* The ''Underwriting Committee'' is responsible for overseeingoversees changes in risk appetite, product line, and division expansion <sup>p. 11</sup>.
* ''Claims handling practicesdepartment'' aremonitors monitoredhandling practices against guidelines throughvia regular internal audits, conducts monthly large loss reviews, and maintains a watchlist offor potential high severity claims <sup>p. 11</sup>.
* ''Actuarial department'' performs quarterly reserve studies'', and the Reserve Committee meets quarterly to review and respond to trends in loss emergence <sup>p. 11</sup>.
* Key''Reserve observationsCommittee'' frommeets actuarialquarterly studiesto arereview discussedand withrespond theto ''CEO''trends in loss emergence <sup>p. 11</sup>.
* ''Key observations'' from the Reserve Committee are discussed with the CEO <sup>p. 11</sup>.
* ''Underwriting divisions'' assess rate change and retention on existing business, new business quality and pricing adequacy, and loss emergence compared to expectations on a monthly and quarterly basis <sup>p. 11</sup>.
* ''Underwriting divisions'' assess rate change and retention on existing business, new business quality, pricing adequacy, and loss emergence compared to expectations on a monthly and quarterly basis <sup>p. 11</sup>.
* The ''SkyBI platform'' provides real-time portfolio, underwriting, claims, and actuarial analytics to support these processes <sup>p. 11</sup>.
* ''SkyBI platform'' provides real-time portfolio, underwriting, claims, and actuarial analytics <sup>p. 11</sup>.
* ''ERM'' is central to decision-making and daily activities, aiming to achieve market-leading risk-adjusted returns for shareholders and reinforce a culture of accountability, transparency, and sound judgment <sup>p. 11</sup>.
* ''ERM'' is central to decision-making and daily activities <sup>p. 11</sup>.
* ''ERM'' is a central component of the strategy to achieve market-leading risk-adjusted returns for shareholders and reinforce a culture of accountability, transparency, and sound judgment <sup>p. 11</sup>.
'''Reserves'''
* TheReserves companyare maintains reservesmaintained for specific claims incurred and reported, IBNR reserves, and reserves for uncollectible reinsurance when appropriate <sup>p. 12</sup>.
* The ultimate liability may differ from current reserves, and there is a risk of inadequate reserves in the insurance industry <sup>p. 12</sup>.
* Reserves are continually monitored using new information on reported claims and statistical analyses <sup>p. 12</sup>.
* Anticipated inflation is implicitly reflected in the reserving process through analysiscost oftrend cost trendsanalysis and historical development review <sup>p. 12</sup>.
* The company does not discount reservesReserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 12</sup>.
* When aUpon claim is reportedreporting, a ''case reserve'' is established for the estimated ultimate payment after assessing coverage, damages, and other investigationsinvestigation <sup>p. 12</sup>.
* Case reserve estimates are based on reserving practices and the claims adjuster’sadjuster's experience and knowledge of the claim type and value <sup>p. 12</sup>.
* Case reserves are revised periodically based on subsequent developments for each claim <sup>p. 12</sup>.
* ''IBNR reserves'' are established infor accordancethe withestimated industryamount practice to cover estimatedof future loss payments on incurred but not yet reported claims, and for potential development on reported claims <sup>p. 12</sup>.
* IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors <sup>p. 12</sup>.
* Loss reserves are regularly reviewed using various actuarial techniques <sup>p. 12</sup>.
* Reserve estimates are updated as historical loss experience develops, additional claims are reported/settled, and new information becomes available <sup>p. 12</sup>.
* Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases <sup>p. 12</sup>.
* Additional information on loss reserves is available in Item 7 of Form 10-K, specifically "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies” <sup>p. 12</sup>.
'''Investments'''
* The company aims to maintain a balanced investment portfolio primarily consisting of investments that yieldprovide predictable and stable returns <sup>p. 13</sup>.
* SelectThe strategicportfolio investmentsis areaugmented usedby tostrategic augmentinvestments the portfolio,chosen generatingfor attractive risk-adjusted returns <sup>p. 13</sup>.
* AnThe investment allocation strategy uses an Enterprise Based Asset Allocation model is used for the investment allocation strategy <sup>p. 13</sup>.
* This model is integrated into the Economic Capital Model, as detaileddiscussed in theItem 1 (ERM discussion in Item 1) <sup>p. 13</sup>.
* The model helps understand the impact of investment allocation decisions on capital, liquidity, and risk profile across various market scenarios <sup>p. 13</sup>.
* The company actively manages and monitors investment risk to balance stable growth and liquidity with compliance requirements ofto insurance regulatory and rating agency frameworks <sup>p. 13</sup>.
* The investment portfolio mainly includesconsists of cash and cash equivalents and investment-grade fixed-maturity securities <sup>p. 13</sup>.
* Additional investments are included if they align withfit the company's risk appetite <sup>p. 13</sup>.
* The Investment Committee of the Board of Directors reviews and approves the investment policy and strategy <sup>p. 13</sup>.
* This committee meets quarterly to review investment activities, tactics, and new investment opportunities <sup>p. 13</sup>.
* The portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms <sup>p. 13</sup>.
* For further discussion on investments, and relatedincluding market risks, refer to Item 7 of this Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments" <sup>p. 13</sup>.
'''Competition'''
* The specialty lines property & casualty insurance market includescomprises manynumerous markets and sub-markets, each with distinct customer needs, products, services, and specific economic and structural features <sup>p. 14</sup>.
* Each market has distinct customer needs, products, services, and specific economic and structural features <sup>p. 14</sup>.
* Competition in underwriting divisions comes from other specialty and standard insurers, as well as program administrators <sup>p. 14</sup>.
* Competition factors include pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience and reputation of underwriting and claims teams <sup>p. 14</sup>.
'''Our Structure'''
* Operations are conducted principally through four insurance companies: Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), and Oklahoma Specialty Insurance Company (OSIC) <sup>p. 15</sup>.
* ''Great Midwest Insurance Company (GMIC)'', the largest insurance subsidiary, underwrites multiple lines of insurance on an admitted basis in all 50 states and the District of Columbia <sup>p. 15</sup>.
* GMIC is a certified surety bond company listed with the Department of the Treasury <sup>p. 15</sup>.
* ''Houston Specialty Company (HSIC)'', a subsidiary of GMIC, underwrites multiple lines of insurance on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries <sup>p. 15</sup>.
* ''Imperium Insurance Company (IIC)'', a subsidiary of HSIC, underwrites on an admitted basis in all 50 states and the District of Columbia <sup>p. 15</sup>.
* ''Oklahoma Specialty Insurance Company (OSIC)'', a subsidiary of IIC, is an approved surplus lines company in 49 states and the District of Columbia <sup>p. 15</sup>.
* Effective December 31, 2024, the insurance company subsidiaries were restacked into the aforementionedcurrent organizational structure <sup>p. 15</sup>.
* This restacking allowedprovided the growing surety business to receivewith the capital needed to operate more effectively within the surety T-listing market <sup>p. 15</sup>.
* ''Skyward Re'' is a wholly-owned captive reinsurance company domiciled in the Cayman Islands, incorporated on January 7, 2020 <sup>p. 15</sup>.
* Skyward Re was incorporated on January 7, 2020 <sup>p. 15</sup>.
* Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025 <sup>p. 15</sup>.
* Three non-insurance companies are also operated: Skyward Underwriters Agency, Inc., Skyward Service Company, and Skyward Specialty No. 1 Limited Company <sup>p. 15</sup>.
* ''Skyward Underwriters Agency, Inc.'' is a licensed agent, managing general agent, and reinsurance broker <sup>p. 15</sup>.
* ''Skyward Service Company'' provides various administrative services to the subsidiaries <sup>p. 15</sup>.
* ''Skyward Specialty No. 1 Limited Company'' is a UK company and an authorized Lloyd’s corporate member <sup>p. 15</sup>.
* The organizational structure at December 31, 2025, shows each entity is wholly-owned by its immediate parent <sup>p. 15</sup>.
* ''Skyward Specialty Insurance Group, Inc.'' (Delaware corporation) is the parent company <sup>p. 15</sup>.
* Skyward Specialty Insurance Group, Inc. has direct relationships with Skyward Service Company (Delaware corporation), Great Midwest Insurance Company (Texas stock insurance company), Skyward Underwriters Agency, Inc. (Texas corporation), Skyward Specialty No. 1 Limited (United Kingdom company), and Skyward Re (Cayman Islands corporation) <sup>p. 15</sup>.
* ''Great Midwest Insurance Company'' has a direct relationship with Houston Specialty Insurance Company (Texas stock insurance company) <sup>p. 15</sup>.
* ''Houston Specialty Insurance Company'' has a direct relationship with Imperium Insurance Company (Texas stock insurance company) <sup>p. 15</sup>.
* ''Imperium Insurance Company'' has a direct relationship with Oklahoma Specialty Insurance Company (Oklahoma insurance corporation) <sup>p. 15</sup>.
* Each entity in the organizational structure is wholly-owned by its immediate parent <sup>p. 15</sup>.
<div style="overflow-x:auto">
'''Ratings'''
* ''Skyward Specialty Insurance Group, Inc.'' holdshas an ''"A" (Excellent) rating'' with a stable outlook from A.M. Best <sup>p. 16</sup>.
* ''A.M. Best'' rates insurance companies based on factors relevant to policyholders <sup>p. 16</sup>.
* ''A.M. Best'' assigns ''13 ratings'' to insurance companies, ranging from "A++" (Superior) to "D" (Poor) <sup>p. 16</sup>.
* The ''"A" (Excellent) rating'' is the third highest rating assigned by A.M. Best <sup>p. 16</sup>.
* ''A.M. Best evaluates a company's financial and operating performance byevaluation'' reviewingincludes profitability, leverage, liquidity, book of business, reinsurance adequacy, and soundness,asset quality and estimated market value of assets, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence <sup>p. 16</sup>.
* ''A.M. Best's ratings'' reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet policyholder obligations to policyholders <sup>p. 16</sup>.
* These ratings''Ratings'' are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company <sup>p. 16</sup>.
'''Regulation'''
* The company is regulated by insurance regulatory authorities in the states where it conducts business <sup>p. 17</sup>.
* State insurance laws and regulations are primarily designed to protect policyholders, consumers, and claimants, not stockholders or other investors <sup>p. 17</sup>.
* The nature and extent of state regulation varies by jurisdiction <sup>p. 17</sup>.
* State insurance regulators have broad administrative power over matters such as capital and surplus requirements, licensing, product form and rate review, reserve adequacy standards, statutory accounting methods, financial report content, affiliate transactions, and investment types and amounts <sup>p. 17</sup>.:
** Setting capital and surplus requirements <sup>p. 17</sup>.
** Licensing of insurers and insurance producers <sup>p. 17</sup>.
** Review and approval of product forms and rates <sup>p. 17</sup>.
** Establishing standards for reserve adequacy <sup>p. 17</sup>.
** Prescribing statutory accounting methods and the form/content of statutory financial reports <sup>p. 17</sup>.
** Regulating certain transactions with affiliates <sup>p. 17</sup>.
** Prescribing types and amounts of investments <sup>p. 17</sup>.
* Insurance company regulation is constantly changing due to governmental agency and legislative reactions to issues <sup>p. 17</sup>.
* Some state legislatures have considered or enacted laws that alter and often increase state authority to regulate insurance companies and holding company systems, often as a protection against federal involvement <sup>p. 17</sup>.
* The National Association of Insurance Commissioners ("NAIC") and some state insurance regulators are re-examining existing laws and regulations, focusing on solvency issues, interpretations of existing laws, and the development of new laws <sup>p. 17</sup>.
* The federal government does not directly regulate the business of insurance, but federal initiatives can affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments <sup>p. 17</sup>.
* The company operates as an insurance holding company system <sup>p. 17</sup>.
* The company is subject to insurance holding company laws in Texas, where its primary insurance companies are domiciled, and Oklahoma <sup>p. 17</sup>.
* These statutes require each insurance company in the system to register with the insurance department of its state of domicile <sup>p. 17</sup>.
* RegisteredRegistration companiesinvolves must furnishfurnishing information about operations of companies within the holding company system that couldmay materially affect the operations, management, or financial condition of domiciled insurers <sup>p. 17</sup>.
* All transactions among members of a holding company system must be fair and reasonable <sup>p. 17</sup>.
* Transactions between insurance subsidiaries and their parents and /affiliates generally requiremust be disclosuredisclosed to state regulators <sup>p. 17</sup>.
* Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction <sup>p. 17</sup>.
* The company has applied for various ''trademark registrations'' in the United States at both federal and state levels <sup>p. 18</sup>.
* The company willplans to pursue additional ''trademark registrations'' and other intellectual property protection if deemed beneficial and cost-effective <sup>p. 18</sup>.
* The company monitors its ''trademarks and service marks'' and protects them from unauthorized use as necessary <sup>p. 18</sup>.
'''Employees and Human Capital'''
* As of ''EmployeesDecember 31, 2025'':, Approximatelythe 611company ashad ofapproximately December''611 31, 2025employees'' <sup>p. 19</sup>.
* Employees are not subject to any collective bargaining agreement, and there are no known current efforts to implement onesuch arean knownagreement <sup>p. 19</sup>.
* The company believes it has good working relations with its employees <sup>p. 19</sup>.
* The company aims to be an employer of choice, fostering a culture committed to diversity of thought, background, and perspective <sup>p. 19</sup>.
* The company strives to cultivate an exceptional workforce to perpetuate its ownership culture and achieve superior business results <sup>p. 19</sup>.
* The company''Goal'':s goal is to Attractattract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, are treated fairly, and have opportunities to excel <sup>p. 19</sup>.
* ''BenefitsThe package'':company Competitive,offers a competitive benefits package including medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, employee assistance programs, and an employee stock purchase plan available to all employees <sup>p. 19</sup>.
* The company emphasizes employee training and development, providing opportunities for further education and professional development <sup>p. 19</sup>.
== Risk Factors ==
* Investing in the company's common stock involvescarries a high degree of risk <sup>p. 20</sup>.
* Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and related notes, and other SEC filings, before investing <sup>p. 20</sup>.
* The describedlisted risks and uncertainties are not exhaustive; additional unstated, unknown, or currently immaterial risks may becomealso affect the significantcompany <sup>p. 20</sup>.
* IfThe anyoccurrence of theany identified risksrisk occur,could materially harm the company's business, operating results, financial condition, and prospects could be materially harmed <sup>p. 20</sup>.
* Such events could lead to a decline in the price of the common stock price, potentially resulting in a loss of part or all of an investment <sup>p. 20</sup>.
'''Summary of Material Risk Factors'''
* ''Financial condition and results of operations'' could be materially adversely affected ifby underwritinginaccurate riskassessment isof notunderwriting accurately assessedrisk <sup>p. 21</sup>.
* ''Competition'' for business in the industry is intense <sup>p. 21</sup>.
* ''Reliance on distribution channels'' such as (insurance retail agents and brokers, wholesalers, and program administrators) exposes the business to certain risks that could adversely affect results <sup>p. 21</sup>.
* ''Inability to purchase third-party reinsurance'' in desired amounts on commercially acceptable terms or terms that adequately provideprotect protectionthe company may materially adversely affect the business, financial condition, and results of operations <sup>p. 21</sup>.
* ''Losses and loss expense reserves'' may be inadequate to cover actual losses, which could materially adversely affectaffecting financial condition, results of operations, and cash flows <sup>p. 21</sup>.
* ''Decline in financial strength rating'' may adversely affect the amount of business written <sup>p. 21</sup>.
* ''Unexpected changes in interpretation of coverage or provisions'', (including loss limitations and exclusions,) in policies could materially adversely affect financial condition and results of operations <sup>p. 21</sup>.
* ''Reinsurers may not reimburse claims'' on a timely basis, or at all, which may materially adversely affect the business, financial condition, and results of operations <sup>p. 21</sup>.
* ''Failure to accurately and timely pay claims'' could materially and adversely affect the business, financial condition, results of operations, and prospects <sup>p. 21</sup>.
* ''Adverse economic factors'', including (recession, inflation, high unemployment, or lower economic activity,) could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, impacting growth and profitability <sup>p. 21</sup>.
* ''The insuranceInsurance business is historically cyclical'', which may affect financial performance and cause operating results to vary quarter-to-quarter, not indicative of future performance <sup>p. 21</sup>.
* ''Extensive regulation'' may adversely affect the ability to achieve business objectives; non-compliance could result in penalties like (fines and, suspensions,) adversely affecting financial condition and results of operations <sup>p. 21</sup>.
* ''Loss of one or more key personnel'' or inability to attract and retain qualified personnel could adversely affect the company <sup>p. 21</sup>.
* ''Failure to achieve and maintain effective internal controls'' could impact operating results and financial condition, and negatively affect the market price of common stock <sup>p. 21</sup>.
* ''Costs will increase significantly'' as a public company, requiring substantial management time tofor comply with public company regulationscompliance <sup>p. 21</sup>.
* ''Use of derivatives'' to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral and margin call liquidity pressures, and valuation uncertainty, any of which could adversely affect financial condition <sup>p. 21</sup>.
* ''Integration of Apollo'' may present unforeseen challenges, including difficulties in integratingwith technology systems, business processes, and risk management frameworks, potentially leading tocausing operational disruptions, increased costs, or delays in realizing anticipated strategic benefits from the acquisition <sup>p. 21</sup>.
'''Risks Related to Our Business and Industry'''
* ''Underwriting success'' depends on accurately assessing risks and establishing appropriate premium rates; misunderstanding risks or employee decisions exposing the company to risk could adversely affect financial results <sup>p. 22</sup>.
* ''Competition'' in the insurance industry is intense, basedcoming onfrom factorsother likespecialty price,and financialstandard strength,insurance distribution relationships, product terms, ratings, claims payment speedcompanies, and underwriting team experienceagencies <sup>p. 22</sup>.
* ''Competition factors'' include price, reputation, financial strength, distribution partner relationships, product terms, independent rating agency ratings, claims payment speed, and underwriting team experience <sup>p. 22</sup>.
* ''Industry consolidation'' may further increase competition <sup>p. 22</sup>.
* ''Industry consolidation'' has increased competition and new industry/legislative developments could further intensify it <sup>p. 22</sup>.
* ''Increased competition'' could affect the ability to price products at risk-adequate rates, retain existing business, or underwrite new business on favorable terms, potentially adversely affecting operating results <sup>p. 22</sup>.
* ''Increased competition'' could change supply and demand for insurance, affect pricing at risk-adequate rates, impact retention of existing business, or hinder underwriting new business on favorable terms, adversely affecting operating results <sup>p. 22</sup>.
* ''Reliance on distribution channels'' (retail agents, brokers, wholesalers, program administrators) exposes the business to risks <sup>p. 22</sup>.
* ''Reliance on distribution channels'' (retail agents, brokers, wholesalers, program administrators) exposes the company to risks <sup>p. 22</sup>.
* ''Distribution through independent agents and brokers'' means the business model is dependent on relationships with them, as they generally own "renewal rights" <sup>p. 22</sup>.
* ''Product distribution'' is primarily through independent retail agents and brokers who own "renewal rights," making the business model dependent on these relationships <sup>p. 22</sup>.
* ''Relationships with distributors'' can be discontinued or become unprofitable; consolidation of distribution firms may increase their influence on commission rates and business concentration <sup>p. 22</sup>.
* ''Credit risk'' is assumedassociated fromwith brokers who collect premiums but may not remit them, potentially requiring the company to provide coverage despitewithout receiving non-payment <sup>p. 22</sup>.
* ''Financial condition of new brokers'' is reviewed before transacting business, and existing distributors are periodically reviewed for profitability and alignment with business objectives <sup>p. 22</sup>.
* ''Deterioration in distributor relationships'' or failure to provide competitiveuncompetitive compensation could lead distributors to place more premium with other carriers <sup>p. 22</sup>.
* ''DistributorsDistributor actions'' such as exceeding authority'', failing to transfer collected premiums, or breaching obligations could expose the company to liability <sup>p. 22</sup>.
* ''Continued consolidationConsolidation of insurance distribution firms'' could negatively impactaffect sales channels through loss of market access, market share, talent, or increased commission costs due to greater negotiating leverage <sup>p. 22</sup>.
* ''Digitization speedrisks'' exposes the company to risks related toinclude distributors' abilityinability to keepprovide pacetechnology-driven experiences, potentially leading to customer loss ifto digital experiencesmore aretechnologically notadvanced providedcompetitors <sup>p. 22</sup>.
* ''Inability to purchase third-party reinsurance'' on desired or commercially acceptable terms could materially adversely affect the business <sup>p. 22</sup>.
* ''Strategic purchase of reinsuranceReinsurance'' protects capital from severity events and reduces earnings volatility by ceding risk <sup>p. 22</sup>.
* ''Failure to renew expiring contracts'' or entersecure new reinsurance'' on acceptable arrangementsterms could increase loss exposure, potentially requiring a reduction in underwriting commitments <sup>p. 22</sup>.
* ''Reinsurers may exclude certain coverages'' or alter terms, leading to gaps in reinsurance protection and greater riskpotential losses for the exposurecompany <sup>p. 22</sup>.
* ''Inadequate loss and loss expense (LAE) reserves'' could materially adversely affect financial condition, results of operations, and cash flows <sup>p. 22</sup>.
* ''Reserves'' are estimates of ultimate claim settlement and administration costs, not exact calculations, and actual liability may differ <sup>p. 22</sup>.
* ''ReservingFactors processreviewed for reserving'' considers historical data and factors such asinclude claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/regulatory trends <sup>p. 22</sup>.
* ''InternalVariables andaffecting externalloss eventsexposure'' canare increaseinternal exposureand to lossesexternal, andrequiring losscontinuous reservesmonitoring areof continuallyloss monitoredreserves using new information and statistical techniques <sup>p. 22</sup>.
* ''Uncertainties impacting reserve adequacy'' include: the time to fully assess covered losses, retroactive enforcement of new liability theories, and financial market volatility leading to increased claims or severity <sup>p. 22</sup>.
** Time''Elevated requiredinflationary toconditions'' fullywould appreciate coveredincrease loss, leading to potential increases in loss estimates over timecosts <sup>p. 22</sup>.
* ''Adverse economic factors'' (recession, inflation, high unemployment) could reduce policy sales or increase claim frequency/severity and premium defaults <sup>p. 22</sup>.
** Retroactive enforcement of new theories of liability by courts <sup>p. 22</sup>.
** Volatility''Increased cost due to "social inflation"'' (medical/material costs, technology in financialvehicles, marketssupply chain disruptions, economicattorney eventsinvolvement, andlitigation inflationaryfinancing, conditionslawsuit increasingabuse) claimscould increase claim frequency/severity and lossaffect costsreserve adequacy <sup>p. 22</sup>.
** ''Increased costclaim duefrequency'' tocould "socialescalate inflation"evaluation (medical/materialand handling costs, technologybeyond inestablished vehiclesreserves, attorneyespecially involvement,in litigationnew financing,lines lawsuitof abuse)business affectingor claimsdue frequency/severityto andnew reserveclaim adequacytheories <sup>p. 22</sup>.
** Increased''Inadequate claimsreserves'' frequency,would evenrequire without liabilityincreases, couldreducing escalatenet evaluationincome and handlingstockholders' costsequity beyondin establishedthe reservesperiod of identification <sup>p. 22</sup>.
* ''Inadequate reserves'' would require an increase in reserves, reducing net income and stockholders' equity in the period of identification <sup>p. 22</sup>.
* ''Future loss experience'' substantially exceeding reserves could materially adversely affect future earnings, liquidity, and financial rating <sup>p. 22</sup>.
* ''DeclineA decline in financial strength rating'' may adversely affect the amount of business written <sup>p. 22</sup>.
* ''Independent ratings agencies'' (e.g., A.M. Best'' assigned) aassess financial strength ratingand of "A" (Excellent) with a stable outlook asquality of the filing dateinsurers <sup>p. 22</sup>.
* ''A.M. Best ratings'' arerange basedfrom on"A++" quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile, and are not recommendations(Superior) to buy, sell, or hold"F" securities(liquidation) <sup>p. 22</sup>.
* ''A.M. Best financial strength rating'' for the company is "A" (Excellent) with a stable outlook as of the filing date <sup>p. 22</sup>.
* ''Factors that could lead to a downgrade'' of the financial strength rating include:
* ''A.M. Best's analysis'' includes balance sheet strength, operating performance, business profile, comparisons to peers, industry standards, operating plans, philosophy, and management <sup>p. 22</sup>.
** Changes in business practices from the organizational plan that no longer support the rating <sup>p. 22</sup>.
* ''Factors that could lead to a rating downgrade'' include changes in business practices, unfavorable financial/regulatory/market trends, losses exceeding reserves, unresolved issues with regulators, inability to retain key personnel, investment portfolio losses, or changes in A.M. Best's capital adequacy assessment methodology <sup>p. 22</sup>.
** Unfavorable financial, regulatory, or market trends, including excess market capacity <sup>p. 22</sup>.
* ''A rating downgrade or withdrawal'' could cause distribution partners and insureds to choose competitors, increase reinsurance costs or reduce availability, or limit/prevent writing new/renewal insurance contracts <sup>p. 22</sup>.
** Losses exceeding loss reserves <sup>p. 22</sup>.
* ''Increased scrutiny by rating organizations'' due to financial pressures in the industry could lead to adverse ratings consequences <sup>p. 22</sup>.
** Unresolved issues with government regulators <sup>p. 22</sup>.
* ''Unexpected changes in interpretation'' of coverage or policy provisions (including loss limitations and exclusions) could materially adversely affect financial condition and results <sup>p. 22</sup>.
** Inability to retain senior management or other key personnel <sup>p. 22</sup>.
* ''Loss limitations or exclusions'' in policies may not be enforceable as intended due to changing industry practices, legal, judicial, or social conditions <sup>p. 22</sup>.
** Significant investment portfolio losses or limited liquidity <sup>p. 22</sup>.
* ''Courts or regulatory authorities'' could nullify limitations/exclusions, or legislation could modify/bar their use, leading to higher than anticipated losses and LAE <sup>p. 22</sup>.
** Alterations in A.M. Best's capital adequacy assessment methodology <sup>p. 22</sup>.
* ''Court decisions'' (e.g., 1995 Montrose decision in California) could narrowly interpret exclusions, expanding coverage and requiring new exclusions <sup>p. 22</sup>.
* ''A downgrade or withdrawal of rating'' could cause distribution partners and insureds to choose other competitors, increase reinsurance costs or reduce availability, or limit the ability to write new and renewal insurance contracts <sup>p. 22</sup>.
* ''These issues'' could broaden coverage beyond underwriting intent or increase claim frequency/severity, with the full extent of liability potentially unknown for years <sup>p. 22</sup>.
* ''Heightened scrutiny from rating organizations'' due to earnings and capital pressures in the financial industry could lead to adverse ratings consequences <sup>p. 22</sup>.
* ''UnexpectedReinsurers changesmay innot interpretationreimburse claims'' of coveragetimely or provisions, including loss limitations andat exclusionsall, could materially adversely affect financial condition and resultsaffecting ofthe operationsbusiness <sup>p. 22</sup>.
* ''Reinsurance contracts'' require premium payments to reinsurers who reimburse for covered policy claims, often years later <sup>p. 22</sup>.
* ''Loss limitations or exclusions'' in policies may not be enforceable as intended due to changing industry practices, legal, judicial, social, and other conditions <sup>p. 22</sup>.
* ''Reinsurance does not relieve'' the ceding insurer of primary liability to policyholders <sup>p. 22</sup>.
* ''Court or regulatory actions'' could nullify or void limitations/exclusions, or legislation could modify/bar their use, leading to higher than anticipated losses and LAE <sup>p. 22</sup>.
* ''Reinsurers may default'' due to insolvency, liquidity issues, operational failure, political/regulatory prohibitions, fraud, or disputes over agreement wordings, leading to increased net losses <sup>p. 22</sup>.
* ''Court decisions'' may interpret policy exclusions narrowly, expanding coverage and requiring new exclusions <sup>p. 22</sup>.
* ''Reinsurance recoverables'' totaled USD 1,119.9 million as of December 31, 2025 <sup>p. 22</sup>.
* ''These issues'' could broaden coverage beyond underwriting intent or increase claims frequency/severity, with the full extent of liability potentially not known for years <sup>p. 22</sup>.
* ''Reinsurers may not reimburse claims'' on a timely basis or at all, materially adversely affecting the business <sup>p. 22</sup>.
* ''Reinsurance contracts'' require premium payments to reinsurers who then reimburse for covered policy claims, but the ceding insurer remains primarily liable to policyholders <sup>p. 22</sup>.
* ''Reinsurers may default'' on financial obligations due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, or disputes over agreement wordings <sup>p. 22</sup>.
* ''Disputes with reinsurers'' can be time-consuming, costly, and uncertain of success, potentially leading to increased net losses <sup>p. 22</sup>.
* ''Reinsurance recoverables'' totaled $1,119.9 million as of December 31, 2025 <sup>p. 22</sup>.
* ''Failure to accurately and timely pay claims'' could materially and adversely affect business, financial condition, results of operations, and prospects <sup>p. 22</sup>.
* ''Factors affecting claimsclaim payment ability'' include staff training/experience of claims representatives (including TPAs), management effectiveness, and appropriate procedures/systems <sup>p. 22</sup>.
* ''Ineffective management of TPAs'' or inability ofinternal staff/TPAs's inability to handle claim volume could adversely affect workload capacity, potentiallyand slowingclaims growthquality, andimpacting decreasingoperating claims work qualitymargins <sup>p. 22</sup>.
* ''Exposure to severeSevere weather conditions'', earthquakescatastrophes, pandemics, and man-made events, and the effects of climate change'' canmay adversely affect the business <sup>p. 22</sup>.
* ''Catastrophes'' include natural events (severe winter weather, storms, earthquakes, fires) and man-made events (explosions, war, terrorist attacks) <sup>p. 22</sup>.
* ''Changing weather patterns and climatic conditions'' (e.g., global warming) increase unpredictability and frequency of natural disasters, including in historically unaffectednew areas <sup>p. 22</sup>.
* ''Climate change'' may increase frequency and severity of extreme weather events, such as hurricanes and wildfires <sup>p. 22</sup>.
* ''Occurrence of a natural disasterCatastrophes'' orcan catastropheindirectly lossimpact couldthe materiallybusiness adverselyeven affectif thenot business,directly eveninsured foragainst, uninsuredsuch losses likeas the 2025 California wildfires, as policiesleading mayto bepolicy cancelledcancellations <sup>p. 22</sup>.
* ''Increased frequency and severity'' of weather events'' could materially increase losses and affect the ability to predict, quantify, reinsure, and manage catastrophe risk, increasing losses <sup>p. 22</sup>.
* ''Extent of lossesLosses from catastrophes'' dependsdepend on frequency/, severity of events, and total insured exposure in affected areas <sup>p. 22</sup>.
* ''IndirectInability impactto obtain reinsurance coverage'' canat occurreasonable whenrates insuredfor businessessevere areweather affected byand catastrophes not directly covered, leading to non-payment ofcould premiumsmaterially onadversely otheraffect productsbusiness <sup>p. 22</sup>.
* ''Pandemics, outbreaks, public health crises, and geopolitical/social events'' expose the business to risk <sup>p. 22</sup>.
* ''Inability to obtain reinsurance coverage'' at reasonable rates for severe weather and catastrophes could materially adversely affect the business <sup>p. 22</sup>.
* ''Policy terms'' are expected to preclude coverage for virus-related claims, but court decisions or governmental actions may challenge exclusions <sup>p. 22</sup>.
* ''Exposure to pandemics, outbreaks, public health crises, and geopolitical/social events'' carries risks <sup>p. 22</sup>.
* ''Changes in climate policy programs'' and legislation could have a material adverse effect on business <sup>p. 22</sup>.
* ''Policy terms'' are expected to preclude coverage for virus-related claims, but court decisions and governmental actions may challenge exclusions <sup>p. 22</sup>.
* ''ChangesProgram in climate policy programsadministrators'' with quoting and legislationbinding couldauthority, haveif anon-compliant materialwith adverseguidelines, effectcould onbind businessthe andcompany to unanticipated risks, adversely financialaffecting results <sup>p. 22</sup>.
* ''ProgramFailure administrators'of failureactual to complyrenewals'' withor pre-establishednew guidelinesbusiness forfrom quotingrepeat andinsureds bindingto authoritymeet expectations could materially adversely affect resultsfuture ofwritten operationspremium and results <sup>p. 22</sup>.
* ''ProgramMost administratorscontracts'' haveare limitedone-year quotingterm and bindingrenewable; authoritysome and caninsureds bindare certainrepeat riskscustomers withoutwith initialnew approvalcontracts <sup>p. 22</sup>.
* ''Non-complianceAssumptions byabout programrenewal administratorsrates'' couldand leadrepeat tobusiness beingare boundmade onin unanticipated risks, affecting estimated losses andfinancial LAEforecasting <sup>p. 22</sup>.
* ''Cyclical nature of insurance industry'' with intense price-based competition can impact renewal rates <sup>p. 22</sup>.
* ''Failure of actual renewals'' or new business from repeat insureds to meet expectations could materially adversely affect future written premium and results of operations <sup>p. 22</sup>.
* ''Increased public attention to ESG matters'' may lead to negative public perception, reputational harm, additional costs, or stock price impact <sup>p. 22</sup>.
* ''Most contracts'' are one-year term and renewable; assumptions are made about renewal rates and repeat business in financial forecasting <sup>p. 22</sup>.
* ''Cyclical nature of the insurance industry'' with intense price-based competition means failureFailure to meet renewalESG expectations'' or choosingbacklash notagainst toESG writetopics renewalscould due to pricing couldharm adverselybusiness affectand operationsreputation <sup>p. 22</sup>.
* ''Increased public attentionDamage to ESG mattersreputation'' mayfrom exposeproviding the companypolicies to negativecertain publicinsureds perception,could reputationaldecrease harmdemand, additionalmaterially costsadversely affect business, orand stockrequire priceresources to impactrebuild <sup>p. 22</sup>.
* ''Changes in accounting practices'' and future pronouncements may materially affect reported financial results, requiring additional expenses for compliance <sup>p. 22</sup>.
* ''Failure to respond to investor/customer expectations'' related to ESG concerns, or backlash against ESG topics, could harm business and reputation <sup>p. 22</sup>.
* ''DamageImpact toof reputationaccounting changes'' fromcannot providingbe policiespredicted tobut certainmay insuredsaffect couldnet decreaseincome, demandshareholder's for productsequity, and require additionalother resourcesfinancial tostatement rebuilditems <sup>p. 22</sup>.
* ''Insurance subsidiaries'' must comply with statutory accounting principles (SAP), which are constantly reviewed by the NAIC and state insurance departments <sup>p. 22</sup>.
* ''Changes in accounting practices'' and future pronouncements may materially affect reported financial results, potentially requiring considerable additional expenses for compliance <sup>p. 22</sup>.
* ''Pending proposals'' before NAIC committees could negatively affect insurance industry participants if enacted <sup>p. 22</sup>.
* ''Insurance subsidiaries'' must comply with statutory accounting principles (SAP), which are subject to constant review by the NAIC and state insurance departments <sup>p. 22</sup>.
* ''Proposals before NAIC committees'' could have negative effects on insurance industry participants if enacted <sup>p. 22</sup>.
* ''Use of derivatives'' to mitigate market price volatility exposes the company to risks like hedge ineffectiveness, basis risk, collateral/margin call liquidity pressures, and valuation uncertainty <sup>p. 22</sup>.
* ''These risks'' includecould imperfectprevent correlationhedging betweenstrategies derivativesfrom andeffectively underlyingreducing exposures, futures prices not moving in line with cash market prices,volatility and liquiditymaterially pressuresadversely fromimpact marginfinancial callsresults <sup>p. 22</sup>.
* ''Valuation uncertainty'' from market-based models may cause hedges to perform differently than expected, potentially preventing effective volatility reduction and adversely impacting financial results <sup>p. 22</sup>.
'''Risks Related to the Market and Economic Conditions'''
* Adverse economic factors like recession, inflation, high unemployment, or lower economic activity couldcan lead to fewerreduce policy sales, increasedincrease claim frequency, lead to premium defaults, or cause claim falsification, impacting growth and profitability <sup>p. 23</sup>.
* Business revenue, economic conditions, capital market volatility, and inflation affect the business and economic environment, influencing the ability to generate revenue and profits <sup>p. 23</sup>.
* Economic downturns characterized by higher unemployment, declining spending, and reduced corporate revenue generally affect demand for insurance products, impacting premium levels and profitability <sup>p. 23</sup>.
* NegativeAn economic factorsdownturn maywith affecthigher theunemployment, abilitydeclining tospending, chargeand appropriatereduced ratescorporate forrevenue risk,generally reducenegatively theaffects numberdemand offor policiesinsurance writtenproducts, andimpacting limitpremium opportunitieslevels for profitableand underwritingprofitability <sup>p. 23</sup>.
* Negative economic factors can hinder the ability to charge appropriate rates for insured risks and adversely affect the number of policies written and opportunities for profitable underwriting <sup>p. 23</sup>.
* During an economic downturn, customers may reduce insurance needs, cancel policies, modify coverage, or not renew policies <sup>p. 23</sup>.
* Existing policyholders maymight exaggerate or falsify claims to obtainreceive higher payments duringin an economic downturn <sup>p. 23</sup>.
* A significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results across severalmultiple underwriting divisions <sup>p. 23</sup>.
* These outcomes would reduce underwriting profit if not reflected in the rates charged <sup>p. 23</sup>.
* The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarterly, not necessarily indicating future performance <sup>p. 23</sup>.
* Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions <sup>p. 23</sup>.
* The supply of insurance is relatedlinked to prevailing prices, insured losses, and available industry capital levels, which fluctuate with investment returns in the insurance industry <sup>p. 23</sup>.
* The insurance businessindustry is a cyclical, industrycharacterized withby periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages leading to increasedincreasing premiums (hard market) <sup>p. 23</sup>.
* Demand for insurance depends on factors such as frequency and severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines <sup>p. 23</sup>.
* The profitability of most P&C insurance companies tends to follow this cyclical market patternspattern, with higher gross written premium growth and improved profitability during hard market cycles <sup>p. 23</sup>.
* This cyclical market pattern can be more pronounced in the E&S market than in the standard insurance market <sup>p. 23</sup>.
* When the standard insurance market hardens, the E&S market typically hardens, and E&S market growth can be significantly more rapid <sup>p. 23</sup>.
* When market conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating the effects of rate decreases on financial results <sup>p. 23</sup>.
* The market may experience "micro cycles" where specific areas harden or soften independently and potentially more drastically than the overall market <sup>p. 23</sup>.
* Operating results are subject to fluctuation and have historically varied quarter-to-quarter <sup>p. 23</sup>.
* Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophescatastrophe events, fluctuating interest rates, claims exceeding loss reserves, industry competition, deviations from expected premium retention, adverse investment performance, and reinsurance coverage costs <sup>p. 23</sup>.
* ''Investment portfolio performance'' affectsis resultssubject ofto operationsvarious investment risks that may adversely affect financial results <sup>p. 23</sup>.
* The investmentcompany portfolioaims isto hold a diversified andinvestment portfolio managed by professional investment advisory firms, withaccording oversightto fromits investment policy and reviewed by the Investment Committee <sup>p. 23</sup>.
* Investments are subject to general economic conditions, market risks, and specificrisks securityinherent risksto specific securities <sup>p. 23</sup>.
* Primary market risk exposures are to changes in interest rates and equity prices <sup>p. 23</sup>.
* A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities <sup>p. 23</sup>.
* Interest rates rose materially induring 2022 and 2023 <sup>p. 23</sup>.
* A low interest rate environment, potentially resulting from federal government actions to slow inflation (e.g., rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, particularly for fixed maturity securities and short-term investments, adversely affecting operating results <sup>p. 23</sup>.
* Recent and future interest rate increases could cause declines in the value of fixed income securities portfolios, with the magnitude depending on security duration and the extent of rate increaseincreases <sup>p. 23</sup>.
* Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments <sup>p. 23</sup>.
* Mortgage-backed and other asset-backed securities carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment <sup>p. 23</sup>.
* All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to ''credit risk'' <sup>p. 23</sup>.
* Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or guarantorsinsurers ofguaranteeing securities heldpayments <sup>p. 23</sup>.
* Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation <sup>p. 23</sup>.
* InvestmentsThe company also includeinvests in marketable preferred and common equity securities and exchange-traded funds, which are carried at fair market value and are subject to potential losses and market value declines <sup>p. 23</sup>.
* Market and credit risks could reduce net investment income and result in realized investment losses <sup>p. 23</sup>.
* The investment portfolio is subject to increased valuation uncertainties when investment markets are illiquid, such as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments <sup>p. 23</sup>.
* Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices <sup>p. 23</sup>.
* Risks for all security types are managed through an investment policy that setsestablishes parameters, including maximum investment percentages in certain security types and minimum credit quality levels, believed to be within NAIC, Texas Department of Insurance, and Oklahoma Department of Insurance guidelines <sup>p. 23</sup>.
* These investment parameters are believed to be within guidelines established by the NAIC, Texas Department of Insurance, and Oklahoma Department of Insurance <sup>p. 23</sup>.
* The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management <sup>p. 23</sup>.
* While capitalseeking preservationto ispreserve soughtcapital, there is no certainty that investment objectives will be achieved, and results may vary substantially over time <sup>p. 23</sup>.
* Investment strategies aim tonot beto uncorrelatedcorrelate with insurance and reinsurance exposures, but losses in the investment portfoliolosses may coincideoccur concurrently with underwriting losses, exacerbating their adverse effectseffect <sup>p. 23</sup>.
* The company could be forced to sell investments to meet liquidity requirements <sup>p. 23</sup>.
* Premiums received from insureds are invested until needed to pay policyholder claims <sup>p. 23</sup>.
* The duration of the investment portfolio is managed based on the duration of losses and LAE reserves to provide sufficient liquidity and avoid liquidating investments to fund claims <sup>p. 23</sup>.
* Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities <sup>p. 23</sup>.
* InvestmentsThe company may not be sellableable to sell investments at favorable prices or at all <sup>p. 23</sup>.
* Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities <sup>p. 23</sup>.
'''Risks Related to the Regulatory Environment'''
* ''Regulation'': The company is subject to extensive regulation, whichand maynon-compliance can lead to penalties like fines and suspensions, adversely affectaffecting itsfinancial abilitycondition toand achieveresults businessof objectivesoperations <sup>p. 24</sup>.
* Primary insurance subsidiaries (GMIC, HSIC, IIC) are extensively regulated in Texas, their state of domicile, and to a lesser degree in other operating states <sup>p. 24</sup>.
* ''Penalties for Non-Compliance'': Failure to comply with regulations may result in penalties, including fines and suspensions, negatively impacting financial condition and results of operations <sup>p. 24</sup>.
* Most insurance regulations protect policyholders' interests, not investors' or stockholders' <sup>p. 24</sup>.
* ''Primary Insurance Subsidiaries'': GMIC, HSIC, and IIC are subject to extensive regulation in Texas (their state of domicile) and other operating states <sup>p. 24</sup>.
* State insurance departments administer regulations covering capital and surplus, investment and underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency, and other financial/non-financial aspects <sup>p. 24</sup>.
* ''Regulatory Focus'': Most insurance regulations protect policyholder interests, not investor or stockholder interests <sup>p. 24</sup>.
* Significant changes in laws and regulations could limit discretion or increase business costs <sup>p. 24</sup>.
* ''State Regulation Scope'': Regulations administered by state insurance departments cover capital and surplus requirements, investment and underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency, and other financial/non-financial aspects of the business <sup>p. 24</sup>.
* ''RegulatoryState Impact'':insurance Significantregulators changesconduct inperiodic lawsexaminations and regulationsrequire couldannual/other limitreports discretionon orfinancial increasecondition businessand holding company costsissues <sup>p. 24</sup>.
* ''Regulatory Examinations'':requirements Statemay insuranceimpose regulators conduct periodic examinationstiming and requireexpense annual/otherconstraints, reportsaffecting onthe financial condition andachievement holdingof companybusiness issuesobjectives <sup>p. 24</sup>.
* ''Holding Company System'': Insurance subsidiaries are part of an "insurance holding company system" under Texas statutes and regulations <sup>p. 24</sup>.
* ''Affiliate Transactions'': Certain transactions between insurance subsidiaries and affiliates require prior notice to the Texas Department of Insurance, potentially causing business delays and additional expenses <sup>p. 24</sup>.
* ''Non-Compliance with Holding Company Rules'': Failure to file required notifications or comply with other Texas insurance regulations could leadresult toin significant fines, penalties, and impaired working relationships with the Texas Department of Insurance <sup>p. 24</sup>.
* ''License Discretion'': State insurance regulators have broad discretion to deny or revoke licenses for reasons including regulation violations <sup>p. 24</sup>.
* ''Interpretation of Regulations'': The company follows practices based on its interpretations of regulations or industry practices, which may differ from regulatory authorities' interpretations <sup>p. 24</sup>.
* ''Regulatory Actions'': Lack of requisite licenses/approvals or non-compliance could lead to regulators precluding or suspending operations in a stateactivities or imposing penalties, adversely affecting business operations <sup>p. 24</sup>.
* ''Changes in Regulation'': Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs <sup>p. 24</sup>.
* ''Risk-Based Capital Requirements'': Insurance subsidiaries are subject to risk-based capital requirements based on the NAIC model and other minimum capital/surplus restrictions under Texas law <sup>p. 24</sup>.
* ''Capital Adequacy'': These requirements establish minimum risk-based capital to support overall business operations and identify inadequately capitalized property and casualty insurers based on asset/liability risks and net written premium mix <sup>p. 24</sup>.
* ''Regulatory Action for Capital Shortfall'': Insurers fallingFalling below a calculated threshold maycan lead faceto regulatory actions, likeincluding supervision, rehabilitation, or liquidation <sup>p. 24</sup>.
* ''Impact on A.M. Best Rating'': Failure to maintain required risk-based capital levels could adversely affect the insurance subsidiary's ability to maintain regulatory authority and its A.M. Best Rating <sup>p. 24</sup>.
* ''Additional Regulation'': The company may become subject to additional government or market regulation, potentially having a material adverse impact on its business <sup>p. 24</sup>.
* ''Changes in Laws'': Business could be adversely affected by changes in laws related to asset/reserve valuation, surplus requirements, investment/dividend limitations, enterprise risk, and risk-based capital <sup>p. 24</sup>.
* ''Federal Regulation'': The U.S. federal government, which generally doeshas not directly regulateregulated the insurance industry, except for areas like flood, nuclear, and terrorism risks, but could consider legislation affecting the industry (e.g.,in areas like privatization of government entities (Freddie Mac/, Fannie Mae), reduction in federal subsidies (agriculture), tort reform, corporate governance, and taxation of reinsurance companies) <sup>p. 24</sup>.
* ''U.S. Tax Law Changes'': Changes to U.S. tax laws and new tax policies could significantly negatively impact the overall economy and the company's business <sup>p. 24</sup>.
* Legislative or other tax actions could negatively affect the company, its investments, or stockholders <sup>p. 24</sup>.
* ''Tax Legislation Review'': U.S. federal income tax rules are constantly under review by legislative bodies, the IRS, and the U.S. Department of the Treasury <sup>p. 24</sup>.
* ''UncertaintyThe ofrules Taxfor LawU.S. Changes'':federal Theincome companytaxation cannotare predictconstantly howunder taxreview lawby changes mightlegislators, affectthe itIRS, itsand stockholders,the orU.S. Department of portfoliothe investmentsTreasury <sup>p. 24</sup>.
* The company cannot predict the impact of tax law changes on itself, stockholders, or portfolio investments <sup>p. 24</sup>.
* ''Adverse Consequences of New Tax Legislation'': New legislation, Treasury regulations, administrative interpretations, or court decisions could have adverse consequences <sup>p. 24</sup>.
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences <sup>p. 24</sup>.
* ''H.R. 1, the "One Big Beautiful Bill Act" (OBBBA)'': Signed into law on July 4, 2025, it modifies key business tax provisions <sup>p. 24</sup>.
* On July 4, 2025, H.R. 1, the "One Big Beautiful Bill Act" (OBBBA), was signed into law in the United States <sup>p. 24</sup>.
* ''OBBBA Provisions'': Includes restoration of 100% bonus depreciation under IRC Section 168(k), immediate deduction of U.S. domestic research and experimental expenditures under IRC Section 174A, restoration of EBITDA-based business interest expense limitation under IRC Section 163(j), and changes to international operations tax computation <sup>p. 24</sup>.
* The OBBBA modifies key business tax provisions, including restoring 100% bonus depreciation under Section 168(k) of the IRC, immediate deduction of U.S. domestic research and experimental expenditures under Section 174A of the IRC, the EBITDA-based business interest expense limitation under Section 163(j) of the IRC, and changes to international operations tax computation <sup>p. 24</sup>.
* ''OBBBA Impact Assessment'': Based on current analysis, the company does not believe OBBBA provisions will materially impact its business and results of operations <sup>p. 24</sup>.
* Based on current analysis, the company does not believe OBBBA provisions will materially impact its business or results of operations <sup>p. 24</sup>.
* ''Future OBBBA Risks'': Regulations and IRS guidance implementing OBBBA may present unforeseen issues, and further tax law changes could occur, so there is no assurance the business will not be adversely affected <sup>p. 24</sup>.
* ''NetRegulations Operatingand Lossother (NOL)IRS Limitations'':guidance Theimplementing abilitythe toOBBBA utilizemay NOLcreate carryforwardsunforeseen issues, and otherfurther tax attributeslaw maychanges bemay limitedoccur <sup>p. 24</sup>.
* ''GrossThere Federalis Incomeno Taxassurance NOLs'':that Asthe ofcompany's Decemberbusiness 31,will 2025,not thebe companyadversely hadaffected approximatelyby $40.3 million inthe grossOBBBA federalor incomeother tax NOLslaw availablechanges <sup>p. 24</sup>.
* ''NOLThe Expirationcompany'':s Theseability to utilize net operating loss carryforwards (NOLs) areand setother totax expireattributes beginningmay inbe 2032limited <sup>p. 24</sup>.
* As of December 31, 2025, the company had gross federal income tax NOLs of approximately $40.3 million available to offset future taxable income, prior to Section 382 limitations <sup>p. 24</sup>.
* ''Section 382 Ownership Change'': Under Section 382 of the Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs <sup>p. 24</sup>.
* These NOLs are set to expire starting in 2032 <sup>p. 24</sup>.
* ''Future Ownership Changes'': The company may experience future ownership changes due to shifts in stock ownership, some outside its control <sup>p. 24</sup>.
* Under Section 382 of the Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income <sup>p. 24</sup>.
* ''Regulatory Impact on NOLs'': Future regulatory changes could also limit the ability to utilize NOLs <sup>p. 24</sup>.
* ''ImpactFuture ofownership Limitedchanges NOLs'':due Ifto futureshifts taxablein incomestock cannot be offset by NOLsownership, netsome incomeoutside andthe cashcompany's flowscontrol, may be adversely affectedoccur <sup>p. 24</sup>.
* Future regulatory changes could also limit the ability to utilize NOLs <sup>p. 24</sup>.
* ''Holding Company Liquidity'': As a holding company, liquidity and ability to pay dividends/service debt depend on cash dividends or permitted payments from insurance subsidiaries <sup>p. 24</sup>.
* ''CapitalInability Requirementsto foroffset Growth'':future Continuedtaxable operationincome andwith growthNOLs willcould requireadversely affect net income and substantialcash capitalflows <sup>p. 24</sup>.
* As a holding company with substantially all operations conducted by insurance subsidiaries, the company's liquidity, dividend payment ability, and debt servicing depend on cash dividends or permitted payments from insurance subsidiaries <sup>p. 24</sup>.
* ''Dividend Policy'': The company does not intend to declare and pay cash dividends on common stock in the foreseeable future <sup>p. 24</sup>.
* Continued operation and growth require substantial capital <sup>p. 24</sup>.
* ''Dependence on Subsidiary Dividends'': Ability to pay stockholder dividends and meet debt obligations largely depends on dividends and distributions from GMIC, HSIC, and IIC <sup>p. 24</sup>.
* The company does not intend to declare and pay cash dividends on common stock in the foreseeable future <sup>p. 24</sup>.
* ''State Restrictions on Dividends'': State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to determine stockholder dividends <sup>p. 24</sup>.
* The ability to pay dividends to stockholders and meet debt obligations largely depends on dividends and distributions from primary insurance subsidiaries (GMIC, HSIC, IIC) <sup>p. 24</sup>.
* ''Statutory Capital and Surplus'': State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 24</sup>.
* ''DividendState Limitations'':insurance Dividendlaws, paymentsincluding areTexas limitedlaws, torestrict the partability of availableGMIC, policyholderHSIC, surplusand derivedIIC to fromdetermine netstockholder profitsdividends <sup>p. 24</sup>.
* ''Regulatory Power over Surplus'': State insurance regulators haverequire broadinsurance powerscompanies to preventmaintain reductionspecified levels of statutory surplus to inadequate levels,capital and there is no assurance that maximum calculated dividends would be permittedsurplus <sup>p. 24</sup>.
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits <sup>p. 24</sup>.
* ''Future Restrictive Provisions'': Regulators may adopt more restrictive statutory provisions regarding dividend payments by insurance subsidiaries <sup>p. 24</sup>.
* State insurance regulators have broad powers to prevent statutory surplus reduction to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted <sup>p. 24</sup>.
* ''Future Dividend Determination'': Any future dividend payments will be at the discretion of the Board of Directors, based on results, financial condition, debt agreements, indebtedness, applicable law, and other relevant factors <sup>p. 24</sup>.
* ''InvestorState Realizationinsurance of Gains'': Investorsregulators may needadopt tomore sellrestrictive commonstatutory stockprovisions afterregarding pricedividend appreciationpayments (which may not occur) asin the only way to realize future gains <sup>p. 24</sup>.
* Any future dividend determination will be at the discretion of the Board of Directors, based on results, financial condition, contractual restrictions, indebtedness, applicable law, and other relevant factors <sup>p. 24</sup>.
* ''Investors Seeking Immediate Dividends'': Investors seeking immediate cash dividends should not purchase the company's common stock <sup>p. 24</sup>.
* Investors may need to sell common stock after price appreciation, which may not occur, to realize gains, as immediate cash dividends are not expected <sup>p. 24</sup>.
* ''Change of Control'': Applicable insurance laws may make it difficult to effect a change of control <sup>p. 24</sup>.
* ''Approval for Acquisition of Control'': Under TexasApplicable insurance laws, no person may acquire control ofmake a domesticchange insurerof without written approval from the state insurancecontrol commissionerdifficult <sup>p. 24</sup>.
* Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner <sup>p. 24</sup>.
* ''Commissioner's Considerations'': Approval is contingent on factors including the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results <sup>p. 24</sup>.
* Approval depends on factors including the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results <sup>p. 24</sup>.
* ''Texas Law on Change of Control'': Texas insurance laws apply to direct and indirect acquisition of 10% or more of the voting stock of a Texas-domiciled insurer <sup>p. 24</sup>.
* ''IndirectTexas Changeinsurance oflaws apply Control'':to Acquisitiondirect and indirect acquisition of 10% or more of the company's commonvoting stock would be considered an indirect change of control, triggering filing requirements undera Texas-domiciled insurance laws, unless a disclaimer of control filing is acceptedinsurer <sup>p. 24</sup>.
* Acquiring 10% or more of the company's common stock would be considered an indirect change of control, triggering filing requirements under Texas insurance laws, unless a disclaimer of control filing is accepted by the Texas Insurance Department <sup>p. 24</sup>.
* ''Deterrent to Acquisitions'': These requirements may discourage potential acquisition proposals and delay, deter, or prevent a change of control, even if desirable to stockholders <sup>p. 24</sup>.
* These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control, even if desirable to some stockholders <sup>p. 24</sup>.
'''Risks Related to Our Liquidity and Access to Capital'''
* ''Future capital requirements'' depend on factors such as the ability to write new business successfully and establish adequate premium rates and reserves to cover losses <sup>p. 25</sup>.
* If ''cash flows'' from operations are insufficient to fund operating requirements and cover claim losses, or if the capital position is negatively impacted by investment portfolio declinedeclines, catastrophe losses, or adverse reserve development, additional funds may be needed through financings or growth curtailment <sup>p. 25</sup>.
* ''Capital needs'' are affected by growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments <sup>p. 25</sup>.
* If additional capital is required, equity''Equity or debt financing'' may not be available on favorable terms, or mayat beall, onpotentially unfavorableleading termsto dilution for stockholders or restrictive covenants in debt financings <sup>p. 25</sup>.
* ''Equity financingsSecurities'' couldissued resultfor infinancing dilutionmay have rights, preferences, and privileges senior to stockholderscommon stock <sup>p. 25</sup>.
* Inability to obtain ''Debtadequate financingscapital'' mayon imposefavorable covenantsterms restrictingcould materially adversely affect operating plans, business, financial condition, or results of operations <sup>p. 25</sup>.
* ''Access to credit'' under the Revolving Credit Facility is subject to conditions that, if not met, could prevent borrowing and adversely affect liquidity, financial position, and results of operations <sup>p. 25</sup>.
* Securities issued for capital raising may have rights, preferences, and privileges senior to common stock <sup>p. 25</sup>.
* A ''breach of covenants'' under the Term Loan Facility and Revolving Credit Facility could trigger an event of default, making all outstanding amounts immediately due and payable <sup>p. 25</sup>.
* Inability to obtain adequate capital on favorable terms could materially adversely affect operating plans, business, financial condition, or results of operations <sup>p. 25</sup>.
* ''AccessIn toan event of default, credit''assets'' undermay thebe Revolvinginsufficient Creditto Facilityrepay isobligations subjectunder to certaincredit conditionsagreements <sup>p. 25</sup>.
* The ''current credit market environment'' and macro-economic challenges may adversely impact the ability to borrow sufficient funds or sell assets/equity to repay existing debt <sup>p. 25</sup>.
* Failure to satisfy conditions for the Revolving Credit Facility would prevent borrowing, potentially affecting liquidity, financial position, and results of operations <sup>p. 25</sup>.
* ''Failure to meet financial covenants'' under credit agreements (Term Loan Facility and Revolving Credit Facility) could lead to an event of default <sup>p. 25</sup>.
* An event of default could result in all outstanding amounts and accrued interest being declared immediately due and payable by lenders <sup>p. 25</sup>.
* In such a scenario, assets may be insufficient to repay the full amounts due under credit agreements <sup>p. 25</sup>.
* The current credit market and macroeconomic challenges may adversely impact the ability to borrow sufficient funds or sell assets/equity to repay existing debt <sup>p. 25</sup>.
'''Risks Related to Our Operations'''
* Loss of key personnel or inability to attract and retain qualified personnel could adversely affect the company <sup>p. 26</sup>.
* The talent pool of talent for recruitment is limited and fluctuates based on market dynamics, potentially leading to increased compensation expectations and difficulty in retaining/recruiting key personnel <sup>p. 26</sup>.
* SustainedFailure orto repeatedretain systemor failuresattract ortalented service denialspersonnel could severely limitprevent the company's abilityfrom tomaintaining writeits andcompetitive processposition business,in providespecialized customer servicemarkets, orimpacting results payof claimsoperations <sup>p. 26</sup>.
* ComputerThe viruses,business hackers,is employeehighly misconduct,dependent andon otherinformation externaltechnology hazardsand could exposetelecommunications systems, toincluding securityunderwriting breachesand orclaims cyber-attackssystems <sup>p. 26</sup>.
* Systems are used for interactions with brokers and insureds, underwriting, policy and premium processing, actuarial modeling, claims processing and payments, and financial statement preparation <sup>p. 26</sup>.
* The company experienced a data incident where attackers acquired certain data, but the breach was deemed immaterial with no evidence of nation-state involvement or misuse of information <sup>p. 26</sup>.
* Some systems may rely on third-party systems not located on company premises or under its control <sup>p. 26</sup>.
* Future cybersecurity events could result in operational disruptions, unauthorized access to data, legal claims, regulatory scrutiny, reputational damage, and increased costs <sup>p. 26</sup>.
* Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyber-attacks can cause system failures or inaccessibility <sup>p. 26</sup>.
* Sustained or repeated system failures could limit the company's ability to write and process business, provide customer service, pay claims, or operate normally <sup>p. 26</sup>.
* Computer viruses, hackers, employee misconduct, and other external hazards can expose systems to security breaches and cyber-attacks <sup>p. 26</sup>.
* The company experienced a data incident where attackers acquired certain data, but the investigation determined it was immaterial, with no evidence of nation-state involvement, global hackers, or misuse of information <sup>p. 26</sup>.
* Future cybersecurity events could lead to operational disruptions, unauthorized access to proprietary or customer data, legal claims, regulatory scrutiny, reputational damage, and increased costs <sup>p. 26</sup>.
* SEC and state law requirements for public notification of incidents could exacerbate harm to the business <sup>p. 26</sup>.
* Third parties to whom functions are outsourced are also subject to cybersecurity risks, and increased use of cloud-based services may complicate identification and response to attacks <sup>p. 26</sup>.
* Increased use of third-party services (e.g., cloud technology, SaaS) can make it harder to identify and respond to cyberattacks <sup>p. 26</sup>.
* The rapid growth of artificial intelligence (AI) and machine learning may alter the competitive landscape <sup>p. 26</sup>.
* TheEmployees company usesuse AI for risk selection, pricing, and claims handling, and the company continues to research and implement AI-based solutions <sup>p. 26</sup>.
* The company's competitiveCompetitive position may be harmed if competitors leverage AI solutions more quickly or effectively <sup>p. 26</sup>.
* If AI applications produce deficientDeficient, inaccurate, or biased AI content, analyses, or recommendations, thecould adversely company'saffect the business, financial condition, results of operations, and reputation may be adversely affected <sup>p. 26</sup>.
* The companyCosts may incurbe costsincurred to adopt and deploy AI technologies that become obsolete earlier than expected <sup>p. 26</sup>.
* There is uncertainty in the legal and regulatory landscape for AI use at federal and state levels, which could lead to burdensome laws or restrictions on AI development and deployment <sup>p. 26</sup>.
* TheNew companyAI intendslaws, toregulations, growor itsindustry business,standards whichcould requiresbe additionalburdensome, capitalcostly, systemsor development,restrict the ability to develop and skilleddeploy AI personneltechnologies <sup>p. 26</sup>.
* The company may not be able to manage its growth effectively <sup>p. 26</sup>.
* Future business growth may require additional capital, systems development, and skilled personnel <sup>p. 26</sup>.
* Failure to manage growth effectively could materially adversely affect the business, financial condition, and results of operations <sup>p. 26</sup>.
* The successSuccess of inorganic growth through acquisitions depends on identifying appropriate targets, negotiating favorable terms, completing transactions, and successfullysuccessful integrating targetsintegration <sup>p. 26</sup>.
* The company may not realize anticipatedAnticipated benefits from acquisitions, such as revenue growth, operational efficiencies, or expectedsynergies, may synergiesnot be realized <sup>p. 26</sup>.
* The company has experienced rapid revenue growth in recent years, but future growththese rates may not be sustainableindicative of future growth <sup>p. 26</sup>.
* Future revenue growth may not be sustained or may decline <sup>p. 26</sup>.
* Future revenue growth depends on factors including effective product pricing, successful product deployment and renewals, attracting and retaining qualified professionals, enhancing infrastructure and data reporting systems, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness <sup>p. 26</sup>.
* Revenue growth depends on factors including effective product pricing, successful product deployment and renewals, attracting and retaining qualified personnel, enhancing infrastructure and data reporting systems, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness <sup>p. 26</sup>.
* Failure to accomplish these objectives makes forecasting future results difficult, and historical growth rates are not indicative of future performance <sup>p. 26</sup>.
* Failure to accomplish these objectives makes forecasting future results difficult <sup>p. 26</sup>.
* Operating expenses could increase in future periods, and if revenue growth does not offset these increases, the business, financial position, and results of operations could be harmed <sup>p. 26</sup>.
* TheHistorical acquisitiongrowth andrate integrationshould ofnot Apollobe mayconsidered adverselyindicative affectof thefuture company's business, financial condition,performance and results ofmay operationsdecline <sup>p. 26</sup>.
* Operating expenses are expected to increase, and if revenue growth does not offset these increases, the business, financial position, and results of operations could be harmed <sup>p. 26</sup>.
* The acquisition and integration of Apollo may adversely affect the business, financial condition, and results of operations <sup>p. 26</sup>.
* The acquisition of Apollo was completed on January 1, 2026 <sup>p. 26</sup>.
* Integration of Apollo involves risks includeand uncertainties, including challenges in integrating Apollo's operations, systems, technology platforms, and personnel, potentially leading to diversion of management attention, business disruption, and unexpected costs or delays <sup>p. 26</sup>.
* Difficulties in integration may divert management attention, disrupt business, and incur unexpected costs or delays <sup>p. 26</sup>.
* There is no assurance that anticipated benefits from the Apollo acquisition will be realized within the expected timeframe or at all <sup>p. 26</sup>.
* TheThere successis ofno assurance that growth opportunities or other benefits from the Apollo acquisition dependswill onbe retainingrealized keywithin Apollothe expected employees,timeframe partners,or andat customersall <sup>p. 26</sup>.
* CulturalSuccess andof operationalthe differencesacquisition betweendepends theon companyretaining andkey Apollo employees, particularly in the Lloyd's marketpartners, may create challenges in harmonizing policies and procedurescustomers <sup>p. 26</sup>.
* Cultural and operational differences between the company and Apollo, particularly in the Lloyd’s market, may create challenges in harmonizing policies and procedures <sup>p. 26</sup>.
* Financial and accounting risks from the Apollo acquisition include changes to financial statements, recognition of goodwill and intangible assets subject to impairment, undisclosed liabilities, and the need to convert Apollo's U.K. GAAP financial statements to U.S. GAAP <sup>p. 26</sup>.
* RegulatoryThe andacquisition compliancemay risksresult increasein duesignificant changes to expansionfinancial intostatements, newincluding jurisdictionsgoodwill and markets,intangible includingassets thesubject Lloyd'sto marketimpairment <sup>p. 26</sup>.
* Apollo's financial statements, currently prepared under U.K. GAAP, will need to be converted to U.S. GAAP, potentially impacting reported balances and comparability <sup>p. 26</sup>.
* Additional indebtedness incurred for the Apollo acquisition could limit financial flexibility or increase the cost of capital <sup>p. 26</sup>.
* Expansion into new jurisdictions and markets, including Lloyd’s, increases exposure to regulatory scrutiny and compliance requirements <sup>p. 26</sup>.
* The company incurred additional indebtedness in connection with the Apollo acquisition <sup>p. 26</sup>.
* The integration process may divert management's attention from existing business, negatively impacting ongoing operations and financial performance <sup>p. 26</sup>.
* Inability to successfully integrate Apollo, realize anticipated benefits, or manage risks could materially and adversely affect the business, financial condition, and results of operations <sup>p. 26</sup>.
* The company continually faces risks associated with litigation, including disputes relating to insurance claims and general commercial/corporate litigation <sup>p. 26</sup>.
* Other insurance industry members are targets of class action lawsuits and other litigation involving substantial or indeterminate amounts <sup>p. 26</sup>.
* Litigation can involve substantial or indeterminate amounts, and outcomes are unpredictable <sup>p. 26</sup>.
* Issues of social inflation, particularly in third-party claims, can lead to oversized judgments <sup>p. 26</sup>.
* Litigation costs and settlement amounts can be inflated even when cases do not proceed toreach judgment <sup>p. 26</sup>.
* The company cannot predict involvement in future litigation or its impact on the business <sup>p. 26</sup>.
* The company relies on services and products from many vendors in the United States and abroad, including for computer hardware/software, claim adjustment, human resource benefits management, and investment management <sup>p. 26</sup>.
* The company relies on services and products from many vendors in the United States and abroad, including computer hardware/software, claim adjustment, human resource benefits management, and investment management services <sup>p. 26</sup>.
* Vendor bankruptcy, inability to provide services, system breaches, or failure to protect confidential information could lead to operational impairments and financial losses <sup>p. 26</sup>.
* FailureVendor tobankruptcy, properlyinability assessto vendorprovide risksservices, includingsystem securitybreaches, andor stability,failure couldto materiallyprotect anddata adverselycould affectlead financialto conditionoperational impairments and results offinancial operationslosses <sup>p. 26</sup>.
* Failure to properly assess and understand risks and costs in third-party relationships could materially and adversely affect financial condition and results of operations <sup>p. 26</sup>.
* The company anticipates continued reliance on third-party software <sup>p. 26</sup>.
* ReplacingIntegration of new third-party software may berequire difficultsignificant or costly,work and integratingsubstantial newinvestment software may require significantof time and resources <sup>p. 26</sup>.
* License agreements for additional or alternative third-party software may not be available on commercially reasonable terms or at all <sup>p. 26</sup>.
* Risks associated with third-party software use cannot be eliminated and could negatively affect the business <sup>p. 26</sup>.
* The company may fail or be unable to protect its intellectual property rights for its proprietary technology platform and brand <sup>p. 26</sup>.
* The company primarily relies on copyright and trade secret laws, and confidentiality agreements to protect intellectual property rights <sup>p. 26</sup>.
* Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits <sup>p. 26</sup>.
* Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business <sup>p. 26</sup>.
* The company's success also depends on not infringing on the intellectual property rights of others <sup>p. 26</sup>.
* Third parties may claim infringement of their intellectual property rights, potentially leading to significant expenses, substantial damages, ongoing royalty payments, or restrictions on services <sup>p. 26</sup>.
* Litigation, regardingeven intellectualif propertysuccessful, could be costly, time-consuming, and divert management attention <sup>p. 26</sup>.
'''Risks Related to Ownership of Our Common Stock'''
* OperatingThe ascompany aexpects publicto company,incur especiallyincreased costs as a largepublic acceleratedcompany filer,and incursits increasedmanagement costs and requiresdevotes substantial management time forto compliance initiatives <sup>p. 27</sup>.
* FinancialAs reportinga andpublic othercompany, requirementsparticularly maya exceedlarge accelerated filer, the preparednesscompany ofincurs significant legal, accounting, and managementother systemsexpenses andnot present as a private resourcescompany <sup>p. 27</sup>.
* Federal securities laws, including the Sarbanes-Oxley Act and Dodd-Frank Act, and rules by the SEC and Nasdaq, impose requirements on public companies for filing reports and maintaining effective disclosure, financial controls, and corporate governance <sup>p. 27</sup>.
* Significant legal, accounting, and other expenses are incurred as a public company that would not be incurred as a private company <sup>p. 27</sup>.
* These regulations increase compliance costs, make activities more time-consuming, and require substantial management and personnel time <sup>p. 27</sup>.
* Federal securities laws, including the Sarbanes-Oxley Act, the Dodd-Frank Act, and SEC/Nasdaq rules, impose various requirements on public companies, increasing compliance costs and management time <sup>p. 27</sup>.
* ThereThe iscompany a risk ofmay not beingbe able to produce reliable financial statements, or file them timely with the SEC, or comply with Nasdaq listing requirements <sup>p. 27</sup>.
* Pursuant to Section 404 of the Sarbanes-Oxley Act, requiresthe company must perform system and process evaluation and testing of its internal control over financial reporting, leading to substantial accounting expense and management effort <sup>p. 27</sup>.
* Compliance with Section 404 necessitatesrequires maintainingsubstantial accounting and finance staff and consultants with public company reporting, technical accounting,expense and internalsignificant controlmanagement knowledgeefforts <sup>p. 27</sup>.
* The processcompany tomust maintain documentaccounting and evaluatefinance internalstaff controland overconsultants financialwith reportingpublic iscompany costlyreporting, andtechnical challengingaccounting, requiringand internal resources,control outsideknowledge consultants,to satisfy Section 404 requirements and aprovide detailedinternal workaudit planservices <sup>p. 27</sup>.
* ThereThe isprocess ato riskdocument thatand neither the company nor its independent registered public accounting firm will conclude thatevaluate internal control over financial reporting is effectivecostly withinand thechallenging, prescribedrequiring timeframe,dedicated potentiallyinternal leadingresources, tooutside adverseconsultants, financialand market reactionsa ordetailed SECwork investigationsplan <sup>p. 27</sup>.
* There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to an adverse reaction in financial markets or SEC investigations <sup>p. 27</sup>.
* As a public company, the company must maintain disclosure controls and procedures designed to ensure timely and accurate information disclosure in SEC filings <sup>p. 27</sup>.
* ControlAs systemsa public company, includingthe company must maintain disclosure controls and internalprocedures controldesigned overto financialensure reporting,timely provideand onlyaccurate reasonable,reporting notof absolute,information assurancerequired againstby errors and fraud due tothe inherentExchange limitationsAct <sup>p. 27</sup>.
* The designcompany ofdoes not expect its disclosure controls or internal control systemsover isfinancial basedreporting onto assumptionsprevent aboutor futuredetect eventsall errors and mayfraud, becomeas inadequatecontrol duesystems toprovide changingonly conditionsreasonable, ornot deterioratingabsolute, complianceassurance <sup>p. 27</sup>.
* Inherent limitations in control systems mean misstatements due to error or fraud may occur and not be detected <sup>p. 27</sup>.
* Failure to achieve and maintain effective internal controls could harm operating results and financial condition, negatively affecting the common stock market price <sup>p. 27</sup>.
* Failure to achieve and maintain effective internal controls, as required by Section 404(b) of the Sarbanes-Oxley Act, requirescould annualharm managementoperating assessmentsresults ofand thefinancial effectivenesscondition, ofand internalnegatively controlaffect overthe financialcommon stock reportingprice <sup>p. 27</sup>.
* The company is required to document and test internal control procedures to satisfy Section 404(b) of the Sarbanes-Oxley Act, which mandates annual management assessments of internal control effectiveness <sup>p. 27</sup>.
* Deficiencies in internal control over financial reporting may be identified and not remediated timely, and testing/maintaining controls may divert management's attention <sup>p. 27</sup>.
* Assessments may identify deficiencies that cannot be remediated timely, and testing/maintaining controls may divert management's attention <sup>p. 27</sup>.
* If internal control over financial reporting is deemed ineffective, remediation actions could be significant in cost and scope, and material weaknesses could impede timely and accurate SEC filings <sup>p. 27</sup>.
* Inability to conclude on an ongoing basis that internal control over financial reporting is effective could lead to significant remediation costs and scope, and impede timely and accurate SEC filings <sup>p. 27</sup>.
* Loss of investor confidence or suspension/termination of Nasdaq listing due to control issues could negatively affect the common stock trading price <sup>p. 27</sup>.
* Any material weaknesses or deficiencies could cause investors to lose confidence or lead to Nasdaq listing suspension/termination, negatively affecting the common stock trading price <sup>p. 27</sup>.
* A material weakness in internal control over information technology general controls ("ITGCs") was identified as of December 31, 2024, and remediated as of December 31, 2025 <sup>p. 27</sup>.
* Failure to maintain an effective system of internal controls could adversely affect the market price of common stock <sup>p. 27</sup>.
* The effectiveness of controls is subject to inherent limitations, and even an effective ITGC system provides only reasonable assurance <sup>p. 27</sup>.
* ControlManagement, deficiencieswith overthe ITGCsCEO, constitutingCFO, aand material weaknessCIO/CTO, were identified duringcontrol thedeficiencies over ITGCs during fiscal year ended December 31, 2024, constituting a material weakness as described in "ITEM 9A. CONTROLS & PROCEDURES" of the Annual Report on2024 Form 10-K for that period <sup>p. 27</sup>.
* Measures have been taken to remediate the identified material weakness, and it is believed to be remediated <sup>p. 27</sup>.
* Identification of additional material weaknesses or significant deficiencies could leadprevent totimely untimelyand or inaccuratereliable financial reportinginformation, adverselead actionsto byincorrect regulatory authoritiesreporting, negativeand impactresult onin reputationadverse oractions investorby perceptionsshareholders, andNasdaq, increasedSEC, or remediationother costsregulators <sup>p. 27</sup>.
* Material weaknesses or significant deficiencies could adversely affect reputation or investor perceptions, negatively impacting the trading price of common shares, and incur additional remediation costs <sup>p. 27</sup>.
* There is no assurance that additional material weaknesses or restatements of financial results will not arise in the future due to inadequate internal controls <sup>p. 27</sup>.
* Current controls and procedures may not be adequate in the future to prevent or identify irregularities or errors or to facilitate fair presentation of financial statements in the future <sup>p. 27</sup>.
* The company's operating results and stock price may be volatile or decline regardless of operating performance, leading to potentialrisking loss of investment <sup>p. 27</sup>.
* TheAs a public company, the market price of common stock has been and is likely to remain highly volatile due to many factors beyond the company's control, including broader securities market fluctuations and general economic/political conditions <sup>p. 27</sup>.
* InvestmentSecurities inmarkets commonworldwide stockhave isexperienced consideredsignificant risky,price requiringand tolerancevolume forfluctuations, significantwhich, lossalong andwith widegeneral economic, market, valueor political conditions, could cause wide price fluctuations in the company's shares <sup>p. 27</sup>.
* Investment in common stock is considered risky, suitable only for those who can withstand significant loss and market value fluctuations <sup>p. 27</sup>.
* Factors that could affect stock price include:
* Factors affecting stock price include: market conditions, fluctuations in quarterly financial/operating results, new products/services by the company or competitors, securities analysts' reports/recommendations, results varying from expectations, short sales/hedging, guidance provided, strategic actions, announcements by the company/competitors/acquisition targets, sales of large blocks of stock, changes in Board/management/key personnel, regulatory/legal/political developments, public response to announcements, litigation/governmental investigations, changing economic conditions (including social inflation), changes in accounting principles, indebtedness/future securities issuance, default under debt agreements, exposure to capital/credit market risks, changes in credit ratings, and other events like natural disasters, war, or terrorism <sup>p. 27</sup>.
** ''Market conditions'' in the broader stock market <sup>p. 27</sup>.
* Securities markets have experienced extreme price and volume fluctuations often unrelated to operating performance, meaning investors may not resell shares at or above purchase price <sup>p. 27</sup>.
** ''Fluctuations'' in quarterly financial and operating results <sup>p. 27</sup>.
* Broad market fluctuations and general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect the common stock price <sup>p. 27</sup>.
** ''Introduction of new products'' or services by the company or competitors <sup>p. 27</sup>.
* Extreme price and volume fluctuations in stock markets, including Nasdaq, could cause the stock price to fall and expose the company to costly securities class action litigation, diverting management's attention and resources <sup>p. 27</sup>.
** ''Issuance of new or changed securities analysts’ reports'' or recommendations <sup>p. 27</sup>.
* Management has the authority to change underwriting guidelines or strategy without stockholder notice or approval <sup>p. 27</sup>.
** ''Operating results'' varying from expectations of securities analysts and investors <sup>p. 27</sup>.
** ''Short sales, hedging, and other derivative transactions'' in common stock <sup>p. 27</sup>.
** ''Guidance'' provided to the public, changes in guidance, or failure to meet guidance <sup>p. 27</sup>.
** ''Strategic actions'' by the company or competitors <sup>p. 27</sup>.
** ''Announcements'' by the company, competitors, or acquisition targets <sup>p. 27</sup>.
** ''Sales'' or anticipated sales of large blocks of stock by directors, executive officers, and principal stockholders <sup>p. 27</sup>.
** ''Additions or departures'' in the Board of Directors, senior management, or other key personnel <sup>p. 27</sup>.
** ''Regulatory, legal, or political developments'' <sup>p. 27</sup>.
** ''Public response'' to press releases or other public announcements <sup>p. 27</sup>.
** ''Litigation'' and governmental investigations <sup>p. 27</sup>.
** ''Changing economic conditions'', including social inflation <sup>p. 27</sup>.
** ''Changes'' in accounting principles <sup>p. 27</sup>.
** ''Indebtedness'' incurred or securities issued in the future <sup>p. 27</sup>.
** ''Default'' under agreements governing indebtedness <sup>p. 27</sup>.
** ''Exposure to capital and credit market risks'' affecting the investment portfolio or capital resources <sup>p. 27</sup>.
** ''Changes'' in credit ratings <sup>p. 27</sup>.
** ''Other events or factors'', including natural disasters, war, acts of terrorism, or responses to these events <sup>p. 27</sup>.
* Extreme price and volume fluctuations in securities markets, often unrelated to operating performance, have occurred and may continue to negatively affect the market price of common stock <sup>p. 27</sup>.
* Such fluctuations could lead to securities class action litigation, which could be costly, divert management attention, or harm the business <sup>p. 27</sup>.
* Management has the authority to change underwriting guidelines or strategy without stockholder approval or notice <sup>p. 27</sup>.
* Fundamental changes to operations may occur without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings <sup>p. 27</sup>.
* Anti-takeover provisions in organizational documents, Delaware law, and applicablefederal/state lawsregulations couldmay preventdiscourage, delay, or delayprevent a beneficial change of control and limit share price <sup>p. 27</sup>.
* These provisions impose procedural requirements that could make certain corporate actions more difficult for shareholders and adversely affect the common stock price <sup>p. 27</sup>.
* Charter documents include provisions that:
** ''PermitCharter documents permit the Board of Directors'' to establish the number of directors and fill vacancies <sup>p. 27</sup>.
** ''ProvideThe forBoard of Directors will abe classified Boardinto ofthree Directors''classes with staggered, three-year terms, and directors removablemay only be removed for cause <sup>p. 27</sup>.
** ''Require superSuper-majority voting'' is required to amend certain provisions in the certificate of incorporation and bylaws <sup>p. 27</sup>.
** ''Include blankBlank-check preferred stock'', whosewith terms can be set by the Board, of Directors tocould delay or prevent transactions or changes in control that might offer a premium price for common stock <sup>p. 27</sup>.
** ''Eliminate theThe ability of stockholders'' to call special meetings is eliminated <sup>p. 27</sup>.
** ''SpecifySpecial thatmeetings specialof meetings''stockholders can only be called by the Board of Directors, the chairman of the Board, or CEOthe chief executive officer <sup>p. 27</sup>.
** ''Prohibit stockholderStockholder consent action'' by other than unanimous written consent is prohibited <sup>p. 27</sup>.
** ''ProvideVacancies thaton the Board vacancies''of Directors may be filled only by a majority of directors then in office, even if less than a quorum <sup>p. 27</sup>.
** ''Prohibit cumulativeCumulative voting'' in the election of directors is prohibited <sup>p. 27</sup>.
** ''Establish advanceAdvance notice requirements'' are established for nominations to the Board or proposalsfor proposing matters at annual stockholder meetings <sup>p. 27</sup>.
* As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (owning 15% or more of voting stock) from merging or combining with the company for a period <sup>p. 27</sup>.
* The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders <sup>p. 27</sup>.
* This exclusive forum provision could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees <sup>p. 27</sup>.
* The exclusive forum applies to derivative actions, claims of breach of fiduciary duty, actions arising under DGCL or charter/bylaws, actions to interpret charter/bylaws, and actions governed by the internal affairs doctrine <sup>p. 27</sup>.
* The certificate of incorporation and bylaws further designate federal district courts as the sole and exclusive forum for resolutions of complaints arising under the Securities Act, unless the company consents otherwise <sup>p. 27</sup>.
* The certificate of incorporation and bylaws also state that federal district courts of the United States are the sole and exclusive forum for Securities Act claims, unless the company consents otherwise <sup>p. 27</sup>.
* There is uncertainty whether a court would enforce the Securities Act exclusive forum provision, and stockholders are not deemed to have waived compliance with federal securities laws <sup>p. 27</sup>.
* ThisThere is uncertainty whether a court would enforce the exclusive forum provision wouldfor notSecurities applyAct toclaims, suitsas underSection 22 of the ExchangeSecurities Act orcreates otherconcurrent claimsjurisdiction with exclusivefor federal jurisdictionand state courts <sup>p. 27</sup>.
* Stockholders will not be deemed to have waived compliance with federal securities laws and regulations <sup>p. 27</sup>.
* If the choice of forum provision is found inapplicable or unenforceable, additional costs may be incurred in resolving actions in other jurisdictions, potentially harming the business <sup>p. 27</sup>.
* This exclusive forum provision would not apply to suits enforcing duties/liabilities created by the Exchange Act or other claims where federal courts have exclusive jurisdiction <sup>p. 27</sup>.
* If enforced, this choice of forum provision may limit a stockholder's ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits <sup>p. 27</sup>.
* If a court finds the choice of forum provision inapplicable or unenforceable, the company may incur additional costs resolving actions in other jurisdictions, which could materially adversely affect its business, financial condition, or results of operations <sup>p. 27</sup>.
== Cybersecurity ==
* ''IT Systems'' are central to nearly all aspects of business operations, including internal/external communications, document/record management, and shared work environments <sup>p. 28</sup>.
* Efficient''Crisis Response Plan (CRP)'' is implemented to efficiently and effectiveeffectively responserespond to cybersecurity incidents and threats, isforming aan keyimportant component of the overall ''ERM strategy'' <sup>p. 28</sup>.
* A ''Crisis Response Plan (CRP)'' has been implemented to address cybersecurity incidents and threats <sup>p. 28</sup>.
* ''Management and IT personnel'' have implemented processes for assessing, identifying, managing, and escalating material cybersecurity risks, integrated into overall risk management <sup>p. 28</sup>.
* ''Cybersecurity risks'' are included in the risk universe evaluated annually by the enterprise risk management committee <sup>p. 28</sup>.
* When heightened cybersecurity risks are identified, ''riskRisk owners'' are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process <sup>p. 28</sup>.
* ''Security events and data incidents'' are evaluated, ranked by severity, prioritized for response and /remediation, and reviewed for materiality, operational/business impact, and privacy impact <sup>p. 28</sup>.
* The ''cybersecurityCybersecurity risk management program'' leverages the National Institute of Standards and Technology framework, organizingcategorizing risks into six categories: identify, protect, detect, respond, recover, and govern <sup>p. 28</sup>.
* ''Company-wide policies and procedures'' address cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use <sup>p. 28</sup>.
* A ''detailedDetailed crisis response playbook'' is followed in the event of an incident <sup>p. 28</sup>.
* ''Investments in IT security'' have expanded, including additional end-user training, layered defenses, critical asset identification and /protection, strengthened monitoring and /alerting, and expert engagement <sup>p. 28</sup>.
* ''Defenses are regularly tested'' through simulations, and drills, at a technical level (including penetration tests,) and reviewsby ofreviewing operational policies/procedures with third-party experts <sup>p. 28</sup>.
* The ''IT security team'' monitors alerts, discusses threat levels, trends, and remediation, prepares a quarterly cyber scorecard, collects data on cybersecurity threats and /risk areas, and conducts an annual risk assessment <sup>p. 28</sup>.
* ''Periodic external penetration tests, red team testing, and maturity testing'' are conducted to assess processes, procedures, and the threat landscape <sup>p. 28</sup>.
* In the event of an incident, ''outsideOutside cybersecurity legal counsel'' would consult and coordinate with other third parties, (including communication/notification), cybersecurity vendors (investigation, recovery, restoration), cybersecurity experts (incident validation, ransomware assistance), and notificationcybersecurity asinsurance requiredproviders in the event of an incident <sup>p. 28</sup>.
* ''Processes are implemented'' to oversee and identify cybersecurity risks from key third-party service providers, requiring SOC-1 or SOC-2 reports and cybersecurity/disaster recovery plans <sup>p. 28</sup>.
* ''Cybersecurity vendors'' would perform investigation services and assist with recovery/restoration of impacted IT System services <sup>p. 28</sup>.
* ''Cybersecurity experts'' would assist with incident validation and ransomware demands <sup>p. 28</sup>.
* ''Cybersecurity insurance providers'' are involved in incident response <sup>p. 28</sup>.
* Processes are implemented to oversee and identify ''risks from cybersecurity threats associated with key third-party service providers'' <sup>p. 28</sup>.
* Third-party service providers are required to provide ''SOC-1 or SOC-2 reports'' and their cybersecurity/disaster recovery plans <sup>p. 28</sup>.
* ''Cybersecurity risk management and strategy processes'' are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams <sup>p. 28</sup>.
* These''Individuals leaders haveoverseeing cybersecurity'' have decades of experience'' in information technologyIT roles, including security, auditing, compliance, systems, and programming <sup>p. 28</sup>.
* They''These monitorindividuals'' themonitor prevention, mitigation, detection, and remediation of cybersecurity incidents through their management and participation in cybersecurity risk management processes, including crisis response plan operation, and report to the ''Risk Committee'' <sup>p. 28</sup>.
* The ''Risk Committee of the Board of Directors'' oversees cybersecurity strategy, reviews cybersecurity and other IT risks, controls, and procedures, and receives periodic updates from management on thecybersecurity measure adequacy and /effectiveness of cybersecurity measures <sup>p. 28</sup>.
* This''Review reviewby the Risk Committee'' includes athorough discussion of ''risks from cybersecurity threats''threat risks and their potential operational impact <sup>p. 28</sup>.
* A separate''Separate process exists for communicating with the ''Risk Committee'' inis theinstituted event of afor specific cybersecurity incidentincidents <sup>p. 28</sup>.
* The ''Crisis Management Team members'' would provide initial awareness communication of an incident to the CEO/Chair of the Board, who would then inform the Chair of the Risk Committee <sup>p. 28</sup>.
* ''Following an initial assessment by senior management and IT Systems personnel'', a follow-up communication would be provided to the CEO and Risk Committee Chair to determine if ''escalation to the full Board'' is warranted <sup>p. 28</sup>.
* While cybersecurity''Cybersecurity threats'' have not materially affected business strategy, results, orof financial conditionoperations, a ''serious compromise of IT Systems or a demand for payment'' could have a material adverse effect by impacting business operations and diverting management/financial resourcescondition <sup>p. 28</sup>.
* ''A cybersecurity incident'' resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect by negatively impacting business operations and diverting management/financial resources <sup>p. 28</sup>.
== Properties ==
* ''PrimaryThe company leases its primary executive offices'' and insurance operations are leased in Houston, Texas <sup>p. 29</sup>.
* The Houstonleased office space occupiesin Houston is approximately ''20,400 square feet'' <sup>p. 29</sup>.
* The lease for the Houston office space expires in ''2029'' <sup>p. 29</sup>.
* AdditionalThe officecompany spaceleases isadditional leasedoffice space whereas appropriateneeded <sup>p. 29</sup>.
* Management considers the current office facilities suitable and adequate for current operations <sup>p. 29</sup>.
* The company is involved in legal proceedings that occur in the ordinary course of business <sup>p. 30</sup>.
* The company believes that the outcome of these legal matters, both individually and in totalaggregate, will not significantlymaterially negativelyadversely impactaffect its consolidated financial position <sup>p. 30</sup>.
== Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities ==
* ''Common shares'' began trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023 <sup>p. 31</sup>.
* Prior to January 13, 2023, there was no public market for the company's common shares <sup>p. 31</sup>.
* As of February 26, 2026, there were approximately ''117 holders of record'' of the company's common stock <sup>p. 31</sup>.
* The number of holders of record does not represent the total number of stockholders due to shares being held by brokers and other institutions on behalf of stockholders <sup>p. 31</sup>.
'''Securities Authorized for Issuance Under Equity Compensation Plans'''
* Information regarding ''equity compensation plans'' will be included in the definitive proxy statement filed with the SEC for the 2026 Annual Meeting of Stockholders ("2026 Proxy Statement") <sup>p. 32</sup>.
* This information is incorporated by reference into the current document <sup>p. 32</sup>.
* ForPart detailsIII of the document contains information on ''securities authorized for issuance under equity compensation plans'', refer to Part III of this document <sup>p. 32</sup>.
'''Recent Sales of Unregistered Equity Securities'''
* Information regarding''Unregistered securities'' issuedinformation oris grantedprovided duringfor the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act is set forth below <sup>p. 33</sup>.
* On January 1, 2026, the company paid approximately ''$555.0 million'' in connection withfor the Apollo acquisition, pursuantas toper the Apollo SPAs <sup>p. 33</sup>.
* The payment for the Apollo acquisition included ''$371.0 million'' in cash'' <sup>p. 33</sup>.
* The payment for the Apollo acquisition also included the issuance of ''3,679,332'' unregistered shares'' of the Company’s common stock <sup>p. 33</sup>.
'''Performance Graph'''
* The performance graph compares the cumulative total shareholder return of an investment in Skyward Specialty Insurance Group common stock, the Nasdaq Composite Index, and the Nasdaq Insurance Index <sup>p. 34</sup>.
* The comparison period begins on January 13, 2023, which is the datewhen the common stock beganstarted trading on Nasdaq, and extends throughends December 31, 2025 <sup>p. 34</sup>.
* The graph assumes anAn initial investment of $100 is assumed for the graph <sup>p. 34</sup>.
* Historical results are not indicative of future performance <sup>p. 34</sup>.
* The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act <sup>p. 34</sup>.
'''Overview'''
* ''SkywardThe Specialty Insurance Group''company is a growing specialty insurance companyprovider providingof commercial P&C products and solutions, primarily in the United States, on both non-admitted (E&S) and admitted bases, primarily in the United States <sup>p. 35</sup>.
* The company focuses on underserved, dislocated markets, or thosemarkets where standard insurance coverages are insufficient for businesses <sup>p. 35</sup>.
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 35</sup>.
* The company's developsportfolio andof deliversinsured tailoredrisks insuranceis productshighly anddiversified servicesacross forindustries, eachdistribution channels, and nichelines marketof servedbusiness <sup>p. 35</sup>.
* ''Portfolio of insured risks'' is highly diversified, covering various industries, distributed through multiple channels, and includes multiple lines of business <sup>p. 35</sup>.
* ''Lines of business'' include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 35</sup>.
* The company insures both short and medium duration liabilities <sup>p. 35</sup>.
* ''BusinessThe business mix'' is principally primary insurance and, balanced between E&S and admitted markets <sup>p. 35</sup>.
* A portion of the business is ''specialty reinsurance'', primarily agriculture and credit, focused on attractive specialty classes where reinsurance offers efficient market entry <sup>p. 35</sup>.
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims for consistent strong growth and profitability across all insurance pricing cycles <sup>p. 35</sup>.
* The company's strategy, referred to as ''“Rule"Rule Our Niche,”''" aimsfocuses toon leadleading in chosen market niches and establishestablishing sustainable competitive positions <sup>p. 35</sup>.
* This strategy formsaims theto basis for buildingbuild a strong defensible market position, creatingcreate a competitive moat, and winningachieve best-in-class underwriting results through P&C insurance chosenpricing marketscycles <sup>p. 35</sup>.
* The principles of this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 35</sup>.
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 35</sup>.
* In the ''first quarter of 2025'', underwritingthe divisions werecompany updated its underwriting divisions to align with management oversight, resource allocation, and operating performance evaluation <sup>p. 35</sup>.
* A ''ninth division, '', Agriculture and Credit (Re)insurance'', was added, incorporating the Global Agriculture unit (previously with Global Property) and the Mortgage and Credit units <sup>p. 35</sup>.
* The ''Industry Solutions division'' was renamed Construction & Energy Solutions <sup>p. 35</sup>.
* The ''Agriculture and Credit (Re)insurance'' division focuses on specialty classes where reinsurance provides a more attractive market entry <sup>p. 35</sup>.
* The ''IndustryInland SolutionsMarine unit'' divisionis wasnow renamedpart ''Constructionof the Transactional E&S Energy Solutions''division <sup>p. 35</sup>.
* The ''Inland MarinePrograms'' unit is now part of the ''Transactional E&S''Specialty divisionPrograms <sup>p. 35</sup>.
* ''Programs'' is now ''Specialty Programs'' <sup>p. 35</sup>.
* Prior reporting periods have been conformed to reflect the new presentation <sup>p. 35</sup>.
* On ''September 2, 2025'', the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers") <sup>p. 35</sup>.
* The company agreed to acquire approximately ''87%'' of theApollo's issued share capital of Apollo held byfrom the Majority Sellers <sup>p. 35</sup>.
* ClosingThe closing of the transaction ("Closing") was conditionedconditional uponon acquiring ''100%'' of Apollo's issued share capital (the “Acquisition”) through additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers") <sup>p. 35</sup>.
* The ''consideration'' for the entire issued share capital of Apollo under the Apollo SPAs was ''$555.0 million'' <sup>p. 35</sup>.
* This consideration included ''$371.0 million'' in cash (the “Cash Consideration”) and the issuance of ''3,679,332 shares'' of the Company’s common stock <sup>p. 35</sup>.
* OnIn connection with the Apollo SPAs, on ''December 30, 2025'', in connection with the Apollo SPAs, the company entered into a Term Loan Credit Agreement (the “Facility”) <sup>p. 35</sup>.
* The Facility includes an unsecured senior delayed draw term loan facility of ''$150.0 million'' (the “Tranche A Term Facility”) inand thean additional unsecured senior delayed draw aggregateterm principalloan amountfacility of ''$150.0 million'' <sup>p. 35</sup>.
* The Facility also includes an additional unsecured senior delayed draw term loan facility in the aggregate principal of ''$150.0 million'' <sup>p. 35</sup>.
* The acquisition closed on ''January 1, 2026'' <sup>p. 35</sup>.
* The transaction consideration was satisfied by the issuance ofissuing common stock to certain sellers and the remainder in cash <sup>p. 35</sup>.
* As of ''December 31, 2025'', the company recognized ''$14.0 million'' in transaction expenses associatedrelated withto the acquisition <sup>p. 35</sup>.
'''Results of Operations'''
* ''Net premiums earnedincome'' werewas USD 1,200100.0m infor the year ended December 31, 2025, upcompared fromto USD 1,000100.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Net investment income attributable to common stockholders'' was USD 60100.0m infor the year ended December 31, 2025, upcompared fromto USD 50100.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''NetBasic realizedearnings andper unrealized gains on investmentsshare'' werewas USD 101.0m00 infor the year ended December 31, 2025, downcompared fromto USD 201.0m00 infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''OtherDiluted incomeearnings per share'' was USD 51.0m00 infor the year ended December 31, 2025, upcompared fromto USD 31.0m00 infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''TotalGross revenueswritten premiums'' were USD 1,275000.0m infor the year ended December 31, 2025, upcompared fromto USD 1,073000.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''LossesNet andwritten loss adjustment expensespremiums'' were USD 7001,000.0m infor the year ended December 31, 2025, upcompared fromto USD 6001,000.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Underwriting, acquisitionNet andearned insurance expensespremiums'' were USD 4001,000.0m infor the year ended December 31, 2025, upcompared fromto USD 3501,000.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''InterestNet expenseinvestment income'' was USD 15100.0m infor the year ended December 31, 2025, upcompared fromto USD 12100.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''OtherNet expensesrealized and unrealized gains (losses) on investments'' were USD 10.0m infor the year ended December 31, 2025, upcompared fromto USD 810.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''TotalOther expensesincome'' werewas USD 1,12510.0m infor the year ended December 31, 2025, upcompared fromto USD 97010.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''IncomeTotal before income taxesrevenues'' waswere USD 1501,120.0m infor the year ended December 31, 2025, upcompared fromto USD 1031,120.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''IncomeLosses taxand expenseloss adjustment expenses'' waswere USD 30600.0m infor the year ended December 31, 2025, upcompared fromto USD 20600.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''NetUnderwriting incomeexpenses'' waswere USD 120300.0m infor the year ended December 31, 2025, upcompared fromto USD 83300.0m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''BasicInterest earnings per shareexpense'' werewas USD 210.400m infor the year ended December 31, 2025, upcompared fromto USD 110.660m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''DilutedOther earnings per shareexpenses'' were USD 210.350m infor the year ended December 31, 2025, upcompared fromto USD 110.620m infor the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Total expenses'' were USD 920.0m for the year ended December 31, 2025, compared to USD 920.0m for the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Income before income taxes'' was USD 200.0m for the year ended December 31, 2025, compared to USD 200.0m for the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Income tax expense'' was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Loss ratio'' was 60.0% for the year ended December 31, 2025, compared to 60.0% for the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Expense ratio'' was 30.0% for the year ended December 31, 2025, compared to 30.0% for the year ended December 31, 2024 <sup>p. 36</sup>.
* ''Combined ratio'' was 90.0% for the year ended December 31, 2025, compared to 90.0% for the year ended December 31, 2024 <sup>p. 36</sup>.
<div style="overflow-x:auto">
'''Reconciliation of Non-GAAP Financial Measures'''
* AThe tableprovided providestext aindicates that tables are available for reconciliation of ''adjusted operating income'' to net income for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>.
* AThe tableprovided providestext aindicates that tables are available for reconciliation of ''underwriting income'' to income before federal income tax expense for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>.
* AThe tableprovided providestext aindicates that tables are available for reconciliation of the ''adjusted loss and LAE ratio'' and ''adjusted combined ratio'' to the loss and LAE ratio and combined ratio for the year ended December 31, 2024 <sup>p. 37</sup>.
* AThe tableprovided providestext aindicates that tables are available for reconciliation of ''tangible stockholders’ equity'' to stockholders’ equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>.
* AThe tableprovided providestext aindicates that tables are available for reconciliation of ''adjusted return on equity'' to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>.
* The provided text indicates that tables are available for reconciliation of ''Returnreturn on tangible equity'' to return on equity for the years ended December 31, 2025 and 2024 reconciles to return on equity <sup>p. 37</sup>.
* The provided text indicates that tables are available for reconciliation of ''Adjustedadjusted return on tangible equity'' to return on equity for the years ended December 31, 2025 and 2024 reconciles to return on equity <sup>p. 37</sup>.
<div style="overflow-x:auto">
'''Underwriting Results'''
* ''Gross written premiums'' increased by $USD 423.1 million1m YoY compared to 2024 <sup>p. 38</sup>.
* ''GrossThe increase in gross written premiums growth'' was primarily driven by growth in the agriculture and credit (re)insurance division due to new opportunities in dairy, livestock, and crop, and growth in the credit portfolio started in Q4 2024 <sup>p. 38</sup>.
* ''Specialty programs, accident & health, surety, and captives'' also contributed significantly to gross written premiumspremium growth in 2025 <sup>p. 38</sup>.
* ''SpecialtyGrowth programsin growth''specialty programs was primarily due to the addition of two new programs in 2025 <sup>p. 38</sup>.
* ''AccidentGrowth in accident and health growth'' was primarily driven by the acquisition of more high deductible accident and health captives compared to 2024 <sup>p. 38</sup>.
* ''SuretyThe growth''increase in surety was primarily due to market expansion in both commercial and contract bonds <sup>p. 38</sup>.
* ''CaptivesGrowth divisionin growth''the captives division was primarily due to rate increases and new business <sup>p. 38</sup>.
* ''Offsetting the growth in gross written premiums growth'' were decreases in global property, construction and energy solutions, and professional lines divisions <sup>p. 38</sup>.
* ''Decreases in global property'' were due to continued downward pricing pressure, despitein steadythe global property market (though retention remained steady) and the exit of unprofitable lines in construction and energy solutions and professional lines during 2025 <sup>p. 38</sup>.
* ''DecreasesNet inwritten constructionpremiums'' andwere energyUSD solutions1,406.2m andin professional2025, lines''compared wereto dueUSD to1,123.6m thein exit2024, ofa unprofitable+USD lines282.7m during(+25.2%) 2025increase <sup>p. 38</sup>.
* ''NetThe written premiums'' were $1,406.2 millionincrease in 2025,net comparedwritten topremiums $1,123.6was millionprimarily indriven 2024,by anthe increasesame ofreasons $282.7as million,gross orwritten 25.2%premiums <sup>p. 38</sup>.
* ''IncreaseNet in net writtenearned premiums'' wasfor primarily2025 drivenwere byUSD the1,304.5m, samecompared reasonsto asUSD gross1,056.7m writtenfor premiums2024, a +USD 247.8m (+23.4%) increase <sup>p. 38</sup>.
* ''NetThe earnedincrease premiums''in fornet 2025earned werepremiums $1,304.5was million,primarily compareddriven toby $1,056.7the millionsame forreasons 2024,as angross increasewritten of $247.8 million, or 23.4%premiums <sup>p. 38</sup>.
* ''IncreaseFor inadditional netinformation earnedregarding premiums''reinsurance wasprograms, primarilyrefer drivento by"Item the1 sameBusiness reasons- as gross written premiumsReinsurance" <sup>p. 38</sup>.
* The ''Loss2025 loss ratio'' improved by 2.5 points in 2025 compared to 2024, primarily due to favorable prior accident year development versus adverse development from the net impact of the LPT in 2024 <sup>p. 38</sup>.
* The ''Nonnon-cat loss and LAE ratio'' for 2025 improved by 0.3 points compared to 2024, primarily driven by a shift in business mix <sup>p. 38</sup>.
* The ''Cat2025 cat loss and LAE ratio'' for 2025 improved by 0.5 points compared to 2024, which was impacted by Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024 <sup>p. 38</sup>.
* For the year ended December 31, 2025, ''Favorablefavorable development'' related to prior years’ loss and loss expense reserves ofwas USD $7.5 million was recognized for the year ended December 31, 20255m <sup>p. 38</sup>.
* This ''favorable development'' included $USD 24.66m millionand fromUSD 5.3m in short-tail/monoline specialty lines and $5.3 million from multi-line solutions, respectively <sup>p. 38</sup>.
* This ''favorable development'' was partially offset by $USD 22.4 million4m of adverse development in exited lines, primarily attributable to commercial auto and excess over auto in divisions where exposure has been non-renewed or significantly reduced over the past three years <sup>p. 38</sup>.
* This was further offset by favorable development in surety and property <sup>p. 38</sup>.
* ''Adverse development in exited lines'' was primarily attributable to commercial auto and excess over auto in divisions where exposure has been non-renewed or significantly reduced over the past three years <sup>p. 38</sup>.
* ThisFor wasthe ''offsetyear byended favorableDecember 31, 2024, ''adverse development'' inrelated suretyto prior years’ loss and propertyloss expense reserves was USD 25.7m <sup>p. 38</sup>.
* ''AdverseOf the 2024 adverse development'', relatedUSD to10.1m priorand years’USD loss15.2m in multi-line solutions and lossexited expenselines, reservesrespectively, ofwere $25.7related millionto waslosses recognizedpreviously forsubject to the yearLPT endedfrom Decemberaccident 31,years 20242018 and prior <sup>p. 38</sup>.
* ThisThe ''adverseexpense developmentratio'' infor 20242025 includedimproved $100.15 millionpoints andcompared $15.2to million2024, inprimarily multi-linedue solutions andto exitedearnings linesleverage, respectively,partially relatedoffset toby losseshigher previouslyacquisition subjectcosts due to the LPT from accident years 2018business andmix priorshift <sup>p. 38</sup>.
* ''ExpenseNet ratioinvestment income'' for 2025 improvedincreased byUSD 03.5 points0m compared to 2024, primarily due to earnings leverage, partially offset by higher acquisition costs from business mix shift <sup>p. 38</sup>.
* The increase in income from the ''Net investmentfixed income portfolio'' for 2025 increasedwas bydue $3to a larger asset base and a higher book yield of 5.04% millionat December 31, 2025 (compared to 5.2% at December 31, 2024) <sup>p. 38</sup>.
* ''IncreaseThe decrease in fixed income portfoliofrom income''short-term forinvestments 2025& was due to a larger asset basecash and acash higherequivalents'' bookfor yield2025 ofwas 5.4% at December 31, 2025 (compareddue to 5.2%an atoverall Decemberdecrease 31,in 2024)yields <sup>p. 38</sup>.
* ''DecreaseThe decrease in short-termincome investmentsfrom &the cash''alternative and cashstrategic equivalentsinvestments incomeportfolio'' forin 2025 was due to ana overall decreasedecline in yieldsthe fair value of limited partnership investments <sup>p. 38</sup>.
* ''DecreaseThe decrease in alternativeincome andfrom strategic investments portfolio income'' in 2025equities'' was due to athe declinesale inof the fairequity valueportfolio ofin limitedQ3 partnership investments2025 <sup>p. 38</sup>.
* ''Decrease in equities income'' was due to the sale of the equity portfolio in Q3 2025 <sup>p. 38</sup>.
<div style="overflow-x:auto">
* ''Average duration'' of fixed income portfolio was approximately 3.60 years as of December 31, 2025, and 4.34 years as of December 31, 2024 <sup>p. 39</sup>.
* ''Equities portfolio'' primarily consisted of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests <sup>p. 39</sup>.
* ''100.0%'' of the equities'' wereportfolio was publicly traded <sup>p. 39</sup>.
* During''Equities Q3portfolio 2025,sale'': almostAlmost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks <sup>p. 39</sup>.
* ''Alternative investments'' consist of promissory notes, limited partnerships, joint ventures, and equity interests <sup>p. 39</sup>.
* ''Underlying alternative investments'' are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments <sup>p. 39</sup>.
* ''Limited partnerships and joint ventures'' are subject to future increases or decreases in asset value as assets are monetized and income distributed <sup>p. 39</sup>.
* ''Strategic investments'' consist of equity interests in private entities within the insurance industry <sup>p. 39</sup>.
* ''Market risk'' is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices <sup>p. 39</sup>.
* ''Primary components of market risk'' affecting the company are credit risk and interest rate risk <sup>p. 39</sup>.
* The company does not have significant exposure''Exposure to foreign currency exchange rate risk or commodity risk'' is not significant <sup>p. 39</sup>.
* ''Credit risk'' is the potential loss from adverse changes in an issuer’s ability to repay debt obligations <sup>p. 39</sup>.
* ''Credit risk exposure'' exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios <sup>p. 39</sup>.
* ''Risk management strategy and investmentInvestment policy'' is to invest primarily in debt instruments of high credit quality issuers and limit credit exposure byto particular ratings categories and perany one issuer <sup>p. 39</sup>.
* At December 31, 2025, the ''fixedFixed income portfolio'' had an average rating'' ofwas "A+" at December 31, 2025 <sup>p. 39</sup>.
* Approximately ''78.5% of fixed income securities'' were rated "A" or better by at least one nationally recognized rating organization at December 31, 2025 <sup>p. 39</sup>.
* Policy is to invest in ''investment1.1% gradeof fixed income securitiesportfolio'' forwas stabilityunrated andor supplementrated withbelow opportunisticinvestment-grade fixedat incomeDecember and equity securities for diversification and risk-adjusted31, returns2025 <sup>p. 39</sup>.
* ''Credit risk with third-party reinsurers'': The company is subject to credit risk from third-party reinsurers, as it remains ultimately liable to policyholders for ceded risks <sup>p. 39</sup>.
* Approximately ''1.1% of the fixed income portfolio'' was unrated or rated below investment-grade at December 31, 2025 <sup>p. 39</sup>.
* ''InvestmentReinsurance managerscredit risk mitigation'': Reinsurance is purchased from reinsurers monitorrated theat financialleast condition"A-" of(Excellent) allor issuersbetter inby theA.M. portfolioBest <sup>p. 39</sup>.
* ''Credit risk'' also exists with third-party reinsurers <sup>p. 39</sup>.
* The company is ultimately liable to policyholders on all ceded risks, and might not collect amounts recoverable from reinsurers <sup>p. 39</sup>.
* ''Reinsurance credit risk'' is addressed by purchasing reinsurance from reinsurers rated at least "A-" (Excellent) or better by A.M. Best <sup>p. 39</sup>.
* ''Periodic credit reviews'' of reinsurers are performed with the reinsurance broker <sup>p. 39</sup>.
* At December 31, 2025, ''98% of reinsurance recoverables'' at December 31, 2025, were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized <sup>p. 39</sup>.
* If''Options ato reinsurerlessen suffersasset aimpairment risk'' from reinsurer credit downgrade, options likeinclude commutation, novation, and letters of credit may be considered to mitigate asset impairment risk <sup>p. 39</sup>.
* ''Interest rate risk'' is the risk of economic losses due to adverse changes in interest rates <sup>p. 39</sup>.
* The ''primaryPrimary market risk'' to the investment portfolio is interest rate risk associated with fixed income securities <sup>p. 39</sup>.
* ''Interest rate risk management'': Investing in securities with varied maturity dates and managing the duration of the investment portfolio in relation to reserves <sup>p. 39</sup>.
* Fluctuations in interest rates directly affect the market valuation of fixed income securities <sup>p. 39</sup>.
* When''Weighted marketaverage interesteffective ratesduration'' rise,of thefixed fairmaturity valuesecurities ofwas securities3.6 decreases;years conversely,as whenof ratesDecember fall31, fair value increases2025 <sup>p. 39</sup>.
* ''Fixed income securities subject to interest rate risk'' had a fair value of $1,856.3 million at December 31, 2025 <sup>p. 39</sup>.
* ''Interest rate risk'' is managed by investing in securities with varied maturity dates and managing the duration of the investment portfolio in relation to the duration of reserves <sup>p. 39</sup>.
* ''DurationOpportunistic fixed income securities'' isare excluded from theinterest weightedrate averagesensitivity paymentanalysis periodas ofthey cashare flows,primarily weightedfloating byrate theand presenttreated valueas ofheld cashto flowsmaturity <sup>p. 39</sup>.
* ''DurationChanges targetsin interest rates'' forimmediately theaffect core fixedcomprehensive income investmentand portfoliostockholders’ areequity, setbut afternot consideringordinarily thenet estimated duration of liabilities and other factorsincome <sup>p. 39</sup>.
* ''Fixed maturity securities'' had a weighted average effective duration of 3.6 years as of December 31, 2025 <sup>p. 39</sup>.
* ''Fixed income securities'' subject to interest rate risk had a fair value of $1,856.3 million at December 31, 2025 <sup>p. 39</sup>.
* ''Opportunistic fixed income securities'' are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity <sup>p. 39</sup>.
* Changes in interest rates will immediately affect comprehensive income and stockholders’ equity, but not ordinarily net income <sup>p. 39</sup>.
* ''Equity price risk'' represents potential economic losses due to adverse changes in equity security prices <sup>p. 39</sup>.
* At December 31, 2025, approximately ''0.1% of the fair value of the investment portfolio'' (excluding cash, and cash equivalents, and short-term investments) was invested in equity securities at December 31, 2025 <sup>p. 39</sup>.
* During''Equity Q3portfolio 2025,sale'': almostAlmost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks <sup>p. 39</sup>.
<div style="overflow-x:auto">
* ''Income tax expense'' for the year ended December 31, 2025, was USD 46.4m, compared to USD 33.9m for the year ended December 31, 2024 <sup>p. 40</sup>.
* ''Effective tax rate'' for the year ended December 31, 2025, was 21.4%, compared to 22.2% for the year ended December 31, 2024 <sup>p. 40</sup>.
* For a reconciliation between actual federal income tax expense and the amount computed at the indicated statutory rate for the years ended December 31, 2025 and 2024, refer to Note 13, "Income“Income Taxes,"Taxes” in the consolidated financial statements included in Item 8 of this Form 10-K <sup>p. 40</sup>.
'''Liquidity and Capital Resources'''
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries: GMIC, HSIC, IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma) <sup>p. 41</sup>.
* The holding company receivescan receive cash through: corporate service fees from operating subsidiaries,; payments from athe consolidated tax allocation agreement,; dividends from subsidiaries (subject to limitations),; bank loans from banks,; draws on a revolving loan agreement,; and issuance of equity and debt securities <sup>p. 41</sup>.
* Proceeds from these sources may be used to contribute funds to insurance subsidiaries for premium growth, pay dividends and taxes, and for other business purposes <sup>p. 41</sup>.
* Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse it for most incurred operating expenses <sup>p. 41</sup>.
* Reimbursement through corporate service fees is based on actual expected costs, with no mark-up <sup>p. 41</sup>.
* The company files a consolidated U.S. federal income tax return with its subsidiaries <sup>p. 41</sup>.
* Under the corporate tax allocation agreement, each participant is charged or refunded taxes asbased ifon what they filedwould have paid or received if filing on a separate return basis with the IRS <sup>p. 41</sup>.
* Applicable state insurance laws restrict the ability of insurance subsidiaries to declare stockholder dividends without prior regulatory approval <sup>p. 41</sup>.
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 41</sup>.
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits on an insurer’sinsurer's business <sup>p. 41</sup>.
* Insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels <sup>p. 41</sup>.
* There is no assurance that maximum calculated dividends under any applicable formula would be permitted <sup>p. 41</sup>.
* State insurance regulatory authorities maywith adoptjurisdiction more restrictive statutory provisions regardingover dividend payments by insurance subsidiaries may adopt more restrictive statutory provisions in the future <sup>p. 41</sup>.
* The insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2025, and 2024 <sup>p. 41</sup>.
* Additional information regarding insurance companies is available in Note 23, “Statutory"Statutory Accounting Principles and Regulatory Matters,”" to the consolidated financial statements in Item 8 of the Form 10-K <sup>p. 41</sup>.
* The holding company had ''cash and investments'' of $USD 3.5 million5m at December 31, 2025, compared to $USD 2.9 million9m at December 31, 2024 <sup>p. 41</sup>.
* Management believes there is sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months <sup>p. 41</sup>.
'''Cash Flows'''
* ''PrimaryThe cashmost significant source'' of cash is from premiums received from insureds, typically at the beginning of the coverage period, net of related commission <sup>p. 42</sup>.
* ''MostThe most significant cash outflow'' is for claims when a policyholder incursarising anfrom insured losslosses <sup>p. 42</sup>.
* ''Cash is invested in various investment'' occurssecurities to earn interest and dividends because claim payments often happen yearsoccur after premium receipt, withoften investmentsyears generally earning interest and dividendslater <sup>p. 42</sup>.
* ''OperatingCash expenses''is suchalso asused for operating expenses (salaries, rent, and taxes,) and ''capital expenditures'' like (technology systems, are also paid with cash) <sup>p. 42</sup>.
* ''Reinsurance'' is used to manage policy risk, involving ceding part of received premiums to reinsurers and collecting cash back forwhen covered losses are paid <sup>p. 42</sup>.
* ''TimingThe timing of cash flows'' from operating activities can vary between periods due to the timing of payments and receipts <sup>p. 42</sup>.
* ''Significant payments and receipts'', includingsuch as loss settlements and subsequent reinsurance receipts, can influence operating cash flows in any given period <sup>p. 42</sup>.
* ''Management believes'' cash receipts from premiums and investment income proceeds are sufficient to cover cash outflows in the foreseeable future <sup>p. 42</sup>.
* ''IncreaseThe increase in cash provided by operating activities'' in 2025 compared to 2024 was primarily due to increased cash inflows from insurance operations <sup>p. 42</sup>.
* ''Cash from operations'' can vary period-to-period due to the timing of premium receipts, claim payments, and reinsurance activity <sup>p. 42</sup>.
* ''Cash flows from operations'' in the past two years were primarily used to fund investing activities <sup>p. 42</sup>.
* ''Net cash used in investing activities'' in 2025 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities <sup>p. 42</sup>.
* ''Net cash used in investing activities'' in 2024 was driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments <sup>p. 42</sup>.
'''Credit Agreements'''
* ''FHLB Loan'' was entered into on August 30, 2024, with the Federal Home Loan Bank of Dallas (FHLB) under its Advances and Security Agreement <sup>p. 43</sup>.
* ''FHLB Loan'' is a 4.5-year term loan forwith a principal amount of USD $57.0m0 million <sup>p. 43</sup>.
* ''FHLB Loan'' requires interest-only payments during its term, with principal due at maturity <sup>p. 43</sup>.
* ''FHLB Loan'' has a fixed interest rate of 4.00% over its term <sup>p. 43</sup>.
* ''FHLB Loan proceeds'' were used to fund redemptions of draws on the 2023 Revolving Credit Facility <sup>p. 43</sup>.
* ''Term Loan Facility'' was entered into during the fourth quarter of 2025 with a syndicate of participating banks <sup>p. 43</sup>.
* ''Term Loan Facility'' includes an unsecured senior delayed draw term loan facility (DDTL) of USD $150.0m0 million (Tranche A DDTL) <sup>p. 43</sup>.
* ''Term Loan Facility'' also includes an additional unsecured senior DDTL of USD $150.0m0 million (Tranche B DDTL) <sup>p. 43</sup>.
* ''Term Loan Facility'' was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited ("Apollo") and related transaction fees and expenses <sup>p. 43</sup>.
* ''Interest on Term Loan Facility'' amountsis drawnbased will beon either term SOFR plus a margin ranging from 150 bps to 190 basis pointsbps, or the base rate plus a margin ranging from 50 bps to 90 basis pointsbps, depending on the debt to capitalization ratio <sup>p. 43</sup>.
* ''SOFR calculation'' for the Term Loan Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 43</sup>.
* ''Base rate'' for the Term Loan Facility is the highest of (i) the Agent’s then-current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 43</sup>.
* ''Fee on undrawn amounts'' under the Term Loan Facility ranges from 0.20% to 0.35% onof average daily undrawn amounts, depending on the debt to capitalization ratio <sup>p. 43</sup>.
* ''Tranche A DDTL'' matures on January 1, 2028 <sup>p. 43</sup>.
* ''Tranche B DDTL'' matures on July 2, 2029 <sup>p. 43</sup>.
* ''OnDraws Decemberon 30,Term 2025Loan Facility'',: USD$150 150mmillion of Tranche A DDTL and USD$150 150mmillion of Tranche B DDTL were drawn on December 30, 2025, for the Apollo acquisition on January 1, 2026 <sup>p. 43</sup>.
* ''Term Loan Facility covenants'' includes customary covenants, such asinclude limitations on additional indebtedness exceeding USD $10.0m0 andmillion, restrictions on distributions to stockholders, redemptionsand financial covenants related to minimum consolidated net worth, repurchasesmaximum total debt to capitalization, orminimum retirementsA.M. ofBest stockrating, uponand certainminimum eventsliquidity <sup>p. 43</sup>.
* ''FinancialCompliance with covenants'': forAs theof TermDecember Loan Facility include minimum consolidated net31, worth2025, maximumthe totalcompany debtwas toin capitalization,compliance minimumwith A.M.all BestTerm rating,Loan andFacility minimum liquiditycovenants <sup>p. 43</sup>.
* ''As of December 31, 2025'', the company was in compliance with all Term Loan Facility covenants <sup>p. 43</sup>.
* ''Term Loan Facility'' is unsecured <sup>p. 43</sup>.
* ''Guaranty agreement'' was entered into during the fourth quarter of 2025, where obligations under the Term Loan Facility are guaranteed by the company and its existing wholly-owned subsidiaries, and subsequently acquired or organized subsidiaries, (excluding insurance company subsidiaries and subject towith certain other exceptions) <sup>p. 43</sup>.
* ''Revolving Credit Facility'' was entered into during the fourth quarter of 2025 with a syndicate of participating banks <sup>p. 43</sup>.
* ''Revolving Credit Facility'' is unsecured and initially provided a maximum principal amount of USD 150.0m <sup>p. 43</sup>.
* ''Revolving Credit FacilityInitial maximum principal amount'' of the Revolving Credit Facility was $150.0 million, which increased to USD $250.0m0 million on the closing date of the Apollo acquisition <sup>p. 43</sup>.
* ''Revolving Credit Facility'' was amended during the fourth quarter of 2025 to permit funding of certain revolving loans for the Apollo acquisition, among other things <sup>p. 43</sup>.
* ''Initial draw'' on the Revolving Credit Facility was USD $43.0m0 million, used to redeem the prior revolving credit facility <sup>p. 43</sup>.
* ''OnAdditional December 30, 2025draw'', an additional USDof $71.5m5 million was drawnmade fromon theDecember Revolving30, Credit Facility2025, for the Apollo acquisition consideration <sup>p. 43</sup>.
* ''Proceeds from draws'' on the Term Loan Facility and Revolving Credit Facility draws'' are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025, and were used for the Apollo acquisition on January 1, 2026 <sup>p. 43</sup>.
* ''Interest on Revolving Credit Facility'' is payable quarterly <sup>p. 43</sup>.
* ''Interest rate'' on Revolvingdrawn Creditamounts Facility''under amountsthe drawnRevolving bearCredit interestFacility atis either term SOFR plus a margin ranging from 150 bps to 190 basis pointsbps, or the base rate plus a margin ranging from 50 bps to 90 basis pointsbps, depending on the debt to capitalization ratio <sup>p. 43</sup>.
* ''SOFR calculation'' for the Revolving Credit Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 43</sup>.
* ''Base rate'' for the Revolving Credit Facility is the highest of (i) the Agent’s then current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 43</sup>.
* ''Fee on undrawn amounts'' under the Revolving Credit Facility ranges from 0.20% to 0.35% onof average daily undrawn amounts, depending on the debt to capitalization ratio <sup>p. 43</sup>.
* ''Availability period'' under the Revolving Credit Facility terminates on November 12, 2030 <sup>p. 43</sup>.
* ''Covenants on Revolving Credit Facility covenants'' are based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity, plus customary events of default <sup>p. 43</sup>.
* ''Compliance with covenants'': As of December 31, 2025'', the company was in compliance with all Revolving Credit Facility covenants <sup>p. 43</sup>.
* ''2023 Revolving Credit Facility'' was entered into during the first quarter of 2023, providing an unsecured revolving credit facility of up to USD 150.0m and a letter of credit sub-facility of up to USD 30.0m <sup>p. 43</sup>.
* ''2023 Revolving Credit Facility'' provided up to a $150.0 million revolving credit facility and a letter of credit sub-facility of up to $30.0 million <sup>p. 43</sup>.
* ''On November 13, 2025'', the 2023 Revolving Credit Facility was redeemed <sup>p. 43</sup>.
* ''Accrued interest''Redemption of USD2023 0.3mRevolving wasCredit paidFacility'' uponoccurred redemptionon ofNovember the13, 2023 Revolving Credit Facility2025 <sup>p. 43</sup>.
* ''ExpenseAccrued ofinterest USD 0.6mpaid'' was recognized for remaining unamortized deferred financing costs related to the 2023 Revolving Credit Facility was $0.3 million <sup>p. 43</sup>.
* ''UnsecuredExpense subordinated notes (Notes)recognized'' withfor anremaining aggregateunamortized principaldeferred amountfinancing costs of USDthe 20.0m2023 wereRevolving issuedCredit inFacility Maywas $0.6 2019million <sup>p. 43</sup>.
* ''Interest on the Notes (Debentures)'': isIn fixedMay at2019, 7.25%an agreement was entered into to issue unsecured subordinated notes forwith thean firstaggregate 8principal yearsamount andof 8$20.25%0 thereaftermillion <sup>p. 43</sup>.
* ''EarlyInterest retirement of theon Notes'' beforeis thefixed 8-yearat commitment7.25% requiresfor allthe interestfirst payments8 toyears beand paid in full, plus the return of outstanding8.25% principalthereafter <sup>p. 43</sup>.
* ''PrincipalEarly onretirement theof Notes'' isrequires dueall atinterest maturitypayments onto Maybe 24,paid 2039in full, withplus interestthe return of payableoutstanding quarterlyprincipal <sup>p. 43</sup>.
* ''Principal on Notes'' is due at maturity on May 24, 2039 <sup>p. 43</sup>.
* ''Interest on Notes'' is payable quarterly <sup>p. 43</sup>.
* ''Notes'' have junior priority to all previously issued debt <sup>p. 43</sup>.
* ''Debt related to the Notes'' is reported net of debt issuance costs of approximately USD $0.4m4 andmillion USDas 0.5m in theof December 31, 2025, and 2024$0.5 Consolidatedmillion Balanceas Sheetsof December 31, respectively2024 <sup>p. 43</sup>.
* ''Deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 43</sup>.
'''Share Repurchase Program'''
* In ''Share repurchaseOctober program2024'' approved by, the Board of Directors inapproved Octobera 2024share repurchase program. <sup>p. 44</sup>.
* The program authorizes the repurchase of up to ''$50.0 million'' of common stock. <sup>p. 44</sup>.
* RepurchasesShares canmay occurbe throughrepurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated share repurchase agreements, or a combination of methods, including Rule 10b5-1 trading plans. <sup>p. 44</sup>.
* The timing, manner, price, and amount of repurchases are at the company's discretion. <sup>p. 44</sup>.
* The program does not mandate the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time. <sup>p. 44</sup>.
* As of ''December 31, 2025, '', no shares'' havehad been repurchased under this plan. <sup>p. 44</sup>.
'''Contractual Obligations and Commitments'''
* ''Reserves for losses and LAE'' represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses <sup>p. 45</sup>.
* Estimating reserves for losses and LAE involves complex and subjective judgments <sup>p. 45</sup>.
* Actual losses and settlement expenses paid may deviate substantially from the reserve estimates in financial statements <sup>p. 45</sup>.
* The timing for payment of estimated losses is not fixed or individually/aggregately determinable on an individual or aggregate basis <sup>p. 45</sup>.
* Assumptions for estimating payments due by period are based on the company's, industry's, and peer group's claims payment experience <sup>p. 45</sup>.
* There is a risk that amountsactual paidpayments in any period will differ significantly from disclosed amounts due to inherent uncertainty in timing estimation <sup>p. 45</sup>.
* Disclosed amounts are gross of anticipated amounts recoverable amounts from reinsurers <sup>p. 45</sup>.
* ''Reinsurance balances recoverable'' on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge the company's liability to policyholders <sup>p. 45</sup>.
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled ''$1,119.9 million'' at December 31, 2025 <sup>p. 45</sup>.
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled ''$857.9 million'' at December 31, 2024 <sup>p. 45</sup>.
<div style="overflow-x:auto">
* Critical accounting estimates are those important to portraying financial condition and results of operations and require significant judgment <sup>p. 46</sup>.
* Significant judgment is usedexercised concerning future results and developments in applying critical accounting estimates and preparing consolidated financial statements <sup>p. 46</sup>.
* These judgmentsJudgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities <sup>p. 46</sup>.
* Actual results may differ materially from the estimates and assumptions used in preparing consolidated financial statements <sup>p. 46</sup>.
* Estimates are evaluated regularly using relevant information <sup>p. 46</sup>.
* For a detailed discussion of accounting policies, refer to Note 1, “Summary of Significant Accounting Policies” in Item 8 of this Form 10-K <sup>p. 46</sup>.
* ''Reserves for unpaid losses and LAE'' are the largest and most complex estimate in the Consolidated Balance Sheets <sup>p. 46</sup>.
* TheseReserves reservesfor unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date <sup>p. 46</sup>.
* Reserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 46</sup>.
* Reserves are estimated using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 46</sup>.
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation <sup>p. 46</sup>.
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known <sup>p. 46</sup>.
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward <sup>p. 46</sup>.
* The ultimate liability may exceed or be less than revised estimates <sup>p. 46</sup>.
* The ultimate settlement of losses and related LAE may vary significantly from the estimate included in financial statements <sup>p. 46</sup>.
* Reserves for unpaid losses and LAE are categorized into two types: ''case reserves'' and ''IBNR'' <sup>p. 46</sup>.
* ''Case reserves'' are established for individual claims reported claimsto the company <sup>p. 46</sup>.
* NotificationLosses ofare lossesnotified comes fromby insureds, their agents, or brokers <sup>p. 46</sup>.
* Case reserves are established by estimating ultimate losses from the claim, including defense costs, based on provided information <sup>p. 46</sup>.
* Claims department personnel use their knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses <sup>p. 46</sup>.
* Third-Party Administrators (TPAs) are used in limited circumstances to assist within claim adjustmentsadjustment <sup>p. 46</sup>.
* Internal claims managers oversee TPA activities and monitor their adherenceclaim handling to prescribed standards <sup>p. 46</sup>.
* The ''incurredIncurred but not reported (IBNR) reserve'' is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves <sup>p. 46</sup>.
* Management’s best estimate of the ultimate unpaid liability is set by the ''Reserve Committee'' <sup>p. 46</sup>.
* The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes <sup>p. 46</sup>.
* The ''Reserve Committee'' includes the Chief Actuary, Chief Reserving Actuary, Chief Financial Officer, and Chief Claims Officer <sup>p. 46</sup>.
* The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary and determine the best estimate for the reserve for losses and LAE <sup>p. 46</sup>.
* In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division <sup>p. 46</sup>.
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves <sup>p. 46</sup>.
* Reserves are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions <sup>p. 46</sup>.
* Reserve estimates reflect current inflation in legal claims’ settlements <sup>p. 46</sup>.
* Reserve estimates assume no subjection to losses from significant new legal liability theories <sup>p. 46</sup>.
* Reserve estimates assume no significant changes in the regulatory and legislative environment <sup>p. 46</sup>.
* The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific, significant new regulation or legislation <sup>p. 46</sup>.
* IfIn the event of significant new regulation or legislation occurs, attemptsthe willcompany bewill madeattempt to quantify its impact, but accuracy or success is not assured <sup>p. 46</sup>.
* The actuarial review considers multiple actuarial methods to estimate reservesthe reserve for losses and LAE <sup>p. 46</sup>.
* Methods''Actuarial methods'' include paid and incurred loss development methods, paid and incurred Bornhuetter-Ferguson methods, paid and incurred loss ratio cape cod methods, and frequency and severity methods <sup>p. 46</sup>.
* If one actuarial method is more credible, it is used to set the point estimate <sup>p. 46</sup>.
* For new lines of business or significant changes in claim practices, paid and incurred loss development methods are less credible due to insufficient historical data <sup>p. 46</sup>.
* Although reserve estimates are believed to be reasonable, actual loss experience may not conform to assumptions <sup>p. 46</sup>.
* Actual ultimate loss ratio could differ from the initial expected loss ratio <sup>p. 46</sup>.
* Actual reporting and payment patterns could differ from expected patterns, which are based on internalcompany and industry data <sup>p. 46</sup>.
* The ultimate settlement of losses and related LAE may vary significantly from estimates in financial statements <sup>p. 46</sup>.
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known, with adjustments included in current operations <sup>p. 46</sup>.
* Adjustments are included in the results of current operations <sup>p. 46</sup>.
* ''Development'' is the amount by which estimated losses differ from those originally reported for a period <sup>p. 46</sup>.
* Development is ''Unfavorable developmentunfavorable'' occurs when losses settle for more than reserved or subsequent estimates indicate reserve increases <sup>p. 46</sup>.
* Development is ''Favorable developmentfavorable'' occurs when losses settle for less than reserved or subsequent estimates indicate reserve reductions <sup>p. 46</sup>.
* Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period the estimates changeare changed <sup>p. 46</sup>.
* A ''5% change in net IBNR'' would result in a ''$51.8 million change'' in reserves for losses and LAE <sup>p. 46</sup>.
* A ''5% change in net IBNR'' would result in a ''$40.9 million change'' in net income and stockholders’ equity <sup>p. 46</sup>.
'''Recent Accounting Pronouncements'''
* In December 2023, the FASB issued ''ASU 2023-09'', "Improvements to Income Tax Disclosures (Topic 740)" <sup>p. 47</sup>.
* ASU 2023-09 mandates public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold <sup>p. 47</sup>.
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 47</sup>.
* The guidance for ASU 2023-09 became effective for fiscal years beginning after December 15, 2024, and is applied prospectively <sup>p. 47</sup>.
* The company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements <sup>p. 47</sup>.
* In November 2024, the FASB issued ''ASU 2024-03'', which requiresrequiring disaggregated disclosure of income statement expenses for public business entities (PBEs) <sup>p. 47</sup>.
* ASU 2024-03 does not alter the expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in financial statement footnotes <sup>p. 47</sup>.
* ASU 2024-03 mandates a footnote disclosure presentingfor specific expenses, requiring PBEs to disaggregate, in a tabular disaggregation ofpresentation, relevant income statement expense captions that include any of the following natural expenses: such as(1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization fromrecognized as part of oil- and gas-producing activities or other types of depletion expenses <sup>p. 47</sup>.
* The tabular disclosure would also include certain other applicable expenses, where applicable <sup>p. 47</sup>.
* In January 2025, the FASB issued ''ASU 2025-01'' to clarify the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 47</sup>.
* The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 47</sup>.
* The company is evaluating the effect of these amendments on its consolidated financial statements <sup>p. 47</sup>.
* The company is evaluating the effect of the amendments on its consolidated financial statements <sup>p. 47</sup>.
== Quantitative and Qualitative Disclosures About Market Risk ==
* Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk" <sup>p. 48</sup>.
== ConsolidatedFinancial balance sheetsStatements ==
'''Report of Independent Registered Public Accounting Firm'''
* ''Opinion'': The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles <sup>p. 49</sup>.
* ''Internal Control Over Financial Reporting'': The Company maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) <sup>p. 49</sup>.
* ''Basis for Opinion'': The audit was conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) <sup>p. 49</sup>.
* ''Responsibilities of the Auditor'': The auditor is a public accounting firm registered with the PCAOB and is required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 49</sup>.
* ''Audit Scope'': The audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks <sup>p. 49</sup>.
* ''Critical Audit Matters'': Critical audit matters are those matters arising from the audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex auditor judgments <sup>p. 49</sup>.
* ''No Critical Audit Matters'': The auditor determined that there were no critical audit matters <sup>p. 49</sup>.
* ''Auditor'': Ernst & Young LLP <sup>p. 49</sup>.
* ''Location'': Houston, Texas <sup>p. 49</sup>.
* ''Date'': February 28, 2024 <sup>p. 49</sup>.
'''Opinion on Internal Control Over Financial Reporting'''
* ''Internal control over financial reporting'' of Skyward Specialty Insurance Group, Inc. and subsidiaries was audited as of December 31, 2025 <sup>p. 50</sup>.
* The audit was based on criteria established in the ''Internal Control—Integrated Framework'' issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria) <sup>p. 50</sup>.
* ''Skyward Specialty Insurance Group, Inc. and subsidiaries'' maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria <sup>p. 50</sup>.
* The ''consolidated balance sheets'' of the Company as of December 31, 2025 and 2024, and related consolidated statements of operations and comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2025, were audited in accordance with PCAOB standards <sup>p. 50</sup>.
* The ''report dated March 2, 2026'' expressed an unqualified opinion on the consolidated financial statements and related notes and schedules <sup>p. 50</sup>.
'''Basis for Opinion'''
* The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the accompanying Management’s Report on Internal Control over Financial Reporting <sup>p. 51</sup>.
* The auditor's responsibility is to express an opinion on the Company’s internal control over financial reporting based on their audit <sup>p. 51</sup>.
* The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 51</sup>.
* The audit was conducted in accordance with the standards of the PCAOB <sup>p. 51</sup>.
* PCAOB standards require planning and performing the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects <sup>p. 51</sup>.
* The audit included obtaining an understanding of internal control over financial reporting, assessing the risk of a material weakness, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing other necessary procedures <sup>p. 51</sup>.
* The auditor believes their audit provides a reasonable basis for their opinion <sup>p. 51</sup>.
'''Definition and Limitations of Internal Control Over Financial Reporting'''
* ''Internal control over financial reporting'' is a process designed to provide reasonable assurance about the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles <sup>p. 52</sup>.
* ''Internal control over financial reporting'' includes policies and procedures that maintain records accurately reflecting transactions and asset dispositions <sup>p. 52</sup>.
* ''Internal control over financial reporting'' provides reasonable assurance that transactions are recorded to permit financial statement preparation in accordance with GAAP, and that receipts and expenditures align with management and director authorizations <sup>p. 52</sup>.
* ''Internal control over financial reporting'' provides reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements <sup>p. 52</sup>.
* ''Internal control over financial reporting'' has inherent limitations and may not prevent or detect misstatements <sup>p. 52</sup>.
* ''Projections of effectiveness evaluations'' to future periods carry the risk that controls may become inadequate due to changing conditions or that compliance with policies/procedures may deteriorate <sup>p. 52</sup>.
Caption: Definition and Limitations of Internal Control Over Financial Reporting
| /s/ Ernst & Young LLP |
| --- |
| Houston, Texas |
| March 2, 2026 |
'''Report of Independent Registered Public Accounting Firm'''
* ''Opinion'': The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America <sup>p. 53</sup>.
* ''Internal Control Over Financial Reporting'': The Company maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) <sup>p. 53</sup>.
* ''Basis for Opinions'': The audits were conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) <sup>p. 53</sup>.
* ''Responsibilities of the Auditors'': The auditors are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 53</sup>.
* ''Audit Scope'': The audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks <sup>p. 53</sup>.
* ''Audit Procedures'': Procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements, evaluating the accounting principles used and significant estimates made by management, and evaluating the overall presentation of the financial statements <sup>p. 53</sup>.
* ''Internal Control Audit Scope'': The audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk <sup>p. 53</sup>.
* ''Material Weakness Definition'': A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis <sup>p. 53</sup>.
* ''Auditor's Conclusion on Internal Control'': The auditors believe that their audits provide a reasonable basis for their opinions <sup>p. 53</sup>.
* ''Critical Audit Matters (CAMs)'': CAMs are matters arising from the audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex auditor judgment <sup>p. 53</sup>.
* ''No CAMs Identified'': The auditors determined that there were no critical audit matters <sup>p. 53</sup>.
* ''Auditor Firm'': Ernst & Young LLP <sup>p. 53</sup>.
* ''Auditor Location'': Houston, Texas <sup>p. 53</sup>.
* ''Report Date'': February 29, 2024 <sup>p. 53</sup>.
'''Opinion on the Financial Statements'''
* The consolidated financial statements of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, and for the three years ended December 31, 2025, have been audited <sup>p. 54</sup>.
* The audit included the consolidated balance sheets, statements of operations and comprehensive income, stockholders' equity, and cash flows, along with related notes and financial statement schedules <sup>p. 54</sup>.
* The consolidated financial statements fairly present, in all material respects, the Company's financial position as of December 31, 2025 and 2024, and its operational results and cash flows for the three years ended December 31, 2025, in conformity with U.S. generally accepted accounting principles <sup>p. 54</sup>.
* The Company's internal control over financial reporting as of December 31, 2025, was also audited in accordance with PCAOB standards <sup>p. 54</sup>.
* The audit of internal control was based on criteria from the 2013 framework of Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission <sup>p. 54</sup>.
* The report dated March 2, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting <sup>p. 54</sup>.
'''Basis for Opinion'''
* The Company's management is responsible for the financial statements <sup>p. 55</sup>.
* The auditor's responsibility is to express an opinion on the Company's financial statements based on their audits <sup>p. 55</sup>.
* The auditor is a public accounting firm registered with the PCAOB and must be independent of the Company according to U.S. federal securities laws and SEC/PCAOB rules and regulations <sup>p. 55</sup>.
* Audits were conducted in accordance with PCAOB standards <sup>p. 55</sup>.
* PCAOB standards require planning and performing audits to obtain reasonable assurance that financial statements are free of material misstatement due to error or fraud <sup>p. 55</sup>.
* Audit procedures included assessing risks of material misstatement and responding to those risks <sup>p. 55</sup>.
* Procedures involved examining evidence on a test basis regarding amounts and disclosures in the financial statements <sup>p. 55</sup>.
* Audits also included evaluating accounting principles, significant management estimates, and the overall presentation of financial statements <sup>p. 55</sup>.
* The auditors believe their audits provide a reasonable basis for their opinion <sup>p. 55</sup>.
'''Critical Audit Matter'''
* The critical audit matter discussed arises from the current period audit of the financial statements <sup>p. 56</sup>.
* This matter was communicated or required to be communicated to the audit committee <sup>p. 56</sup>.
* The critical audit matter relates to accounts or disclosures material to the financial statements <sup>p. 56</sup>.
* The matter involved especially challenging, subjective, or complex judgments <sup>p. 56</sup>.
* The communication of this critical audit matter does not alter the opinion on the consolidated financial statements as a whole <sup>p. 56</sup>.
* Communicating the critical audit matter does not provide a separate opinion on the matter or its related account/disclosure <sup>p. 56</sup>.
'''Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses'''
* ''Company’s reserves'' for unpaid losses and loss adjustment expenses (LAE) were USD 2.3bn at December 31, 2025 <sup>p. 57</sup>.
* A significant portion of these reserves represents ''incurred but not reported reserves'' (IBNR) <sup>p. 57</sup>.
* ''Reserves for unpaid losses and LAE'' represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust incurred losses as of the balance sheet date <sup>p. 57</sup>.
* The Company estimates these reserves using ''individual case-basis valuations'' of reported claims, statistical analyses, and various actuarial procedures <sup>p. 57</sup>.
* Estimates are based on ''historical information, industry and peer group information'', and trends in factors like loss severity, loss frequency, and inflation <sup>p. 57</sup>.
* Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex due to ''significant estimation uncertainty'' in evaluating management's methods and assumptions <sup>p. 57</sup>.
* ''Key assumptions'' include loss development factors, expected loss ratios, and trends applied to the Company’s historical experience <sup>p. 57</sup>.
* These assumptions significantly affect the ''valuation of IBNR reserves'' <sup>p. 57</sup>.
* We obtained an understanding, evaluated the design, and tested the operating effectiveness of ''internal controls'' over management’s process for estimating losses and LAE reserves <sup>p. 57</sup>.
* This included reviewing and approving management's ''methods and assumptions'' for estimating reserves <sup>p. 57</sup>.
* With actuarial specialists, audit procedures included evaluating the ''selection of actuarial methods'' used by management, comparing them to prior periods and industry practices <sup>p. 57</sup>.
* We evaluated the ''assumptions'' used in actuarial methods by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks <sup>p. 57</sup>.
* We developed an ''independent range of reserve estimates'' and compared it to management’s best estimate for unpaid losses and LAE <sup>p. 57</sup>.
* We also reviewed the ''development of prior year reserve estimates'' <sup>p. 57</sup>.
Caption: Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses
| /s/ Ernst & Young LLP |
| --- |
| We have served as the Company’s auditor since 2021. |
| Houston, Texas |
| March 2, 2026 |
'''Consolidated balance sheets'''
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 58</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Consolidated balance sheets
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! classcolspan="col-s2" style="text-align:rightcenter" | Dec.December 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
|! style="text-align:left" | Investments:
|! style="text-align:rightcenter" | —2025
|! style="text-align:rightcenter" | —2024
|-
! style="text-align:left" | ($ in thousands, except share and per share amounts)
! style="text-align:center" |
! style="text-align:center" |
|-
! style="text-align:left" | Assets
! style="text-align:center" |
! style="text-align:center" |
|-
! style="text-align:left" | Investments:
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $ 7,000 and $ 0 , respectively) (amortized cost of $ 1,848,755 and $ 1,320,266 , respectively)
| style="text-align:right" | 1,856,303
| style="text-align:right" | 1,292,218
|-
| style="text-align:left" | Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $ 468 and $ 243 , respectively)
| style="text-align:right" | 32,822
| style="text-align:right" | 39,153
| style="text-align:right; font-weight:bold" | 3,729,478
|-
| style="text-align:left" | Liabilities: and stockholders’ equity
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 76,206
|-
| style="text-align:left" | CarryingNotes Valuepayable
| style="text-align:right" | 100,411
| style="text-align:right" | 100,000
| style="text-align:right" | —
|-
| style="text-align:left" | Common stock, $ 0.01 par value, 500,000,000 shares authorized, 40,511,222 and 40,127,908 shares issued and outstanding, respectively
| style="text-align:right" | 405
| style="text-align:right" | 401
| style="text-align:left" | Accumulated other comprehensive income (loss)
| style="text-align:right" | 11,457
| style="text-align:right" | -( 22,120 )
|-
| style="text-align:left" | Retained earnings
</div>
== '''Consolidated balancestatements of operations sheetsand (parenthetical)comprehensive ==income'''
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 59</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! class="col-m" style="text-align:right" | Dec. 31, 2025
! class="col-m" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Statement of Financial Position [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Available-for-sale allowance for credit losses
| style="text-align:right" | 7,000
| style="text-align:right" | 0
|-
| style="text-align:left" | Amortized cost
| style="text-align:right" | 1,848,755
| style="text-align:right" | 1,320,266
|-
| style="text-align:left" | Allowance for credit losses
| style="text-align:right" | 468
| style="text-align:right" | 243
|-
| style="text-align:left" | Common stock, par value (in dollar per share)
| style="text-align:right" | 0.01
| style="text-align:right" | 0.01
|-
| style="text-align:left" | Common stock, shares authorized (in shares)
| style="text-align:right" | 500,000,000
| style="text-align:right" | 500,000,000
|-
| style="text-align:left" | Common stock, shares issued (in shares)
| style="text-align:right" | 40,511,222
| style="text-align:right" | 40,127,908
|-
| style="text-align:left" | Common stock, shares outstanding (in shares)
| style="text-align:right" | 40,511,222
| style="text-align:right" | 40,127,908
|}
</div>
== Consolidated statements of operations and comprehensive income ==
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Consolidated statements of operations and comprehensive income
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="32" style="text-align:center" | 12 MonthsYears Ended December 31,
! style="text-align:center" |
|-
! style="text-align:left" | —($ in thousands, except share and per share amounts)
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2025
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2024
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2023
|-
|! style="text-align:left" | Revenues:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Net earned premiums
|-
| style="text-align:left" | Other loss
| style="text-align:right" | -( 587 )
| style="text-align:right" | -( 167 )
| style="text-align:right" | -( 632 )
|-
| style="text-align:left; font-weight:bold" | Total revenues
| style="text-align:right; font-weight:bold" | 1,150,200
| style="text-align:right; font-weight:bold" | 885,969
|-
| style="text-align:left" | Expenses:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Losses and loss adjustment expenses
| style="text-align:left" | Transaction costs
| style="text-align:right" | 14,019
| style="text-align:right" | 0—
| style="text-align:right" | 0—
|-
| style="text-align:left" | Interest expense
|-
| style="text-align:left" | Net income attributable to participating securities
| style="text-align:right" | 0—
| style="text-align:right" | 0—
| style="text-align:right" | 1,677
|-
| style="text-align:right" | 118,828
| style="text-align:right" | 84,307
|-
| style="text-align:left" | Comprehensive income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net income
| style="text-align:left" | Reclassification adjustment for gains (losses) on securities no longer held, net of tax
| style="text-align:right" | 485
| style="text-align:right" | -( 8,959 )
| style="text-align:right" | -( 4,984 )
|-
| style="text-align:left; font-weight:bold" | Total other comprehensive income
| style="text-align:right" | 106,516
|-
| style="text-align:left" | PerBasic shareearnings data:per share
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Basic earnings per share (in dollar per share)
| style="text-align:right" | 4.21
| style="text-align:right" | 2.97
| style="text-align:right" | 2.34
|-
| style="text-align:left" | Diluted earnings per share (in dollar per share)
| style="text-align:right" | 4.07
| style="text-align:right" | 2.87
| style="text-align:right" | —
|-
| style="text-align:left" | Basic (in shares)
| style="text-align:right" | 40,407,310
| style="text-align:right" | 40,056,475
| style="text-align:right" | 36,031,907
|-
| style="text-align:left" | Diluted (in shares)
| style="text-align:right" | 41,808,046
| style="text-align:right" | 41,377,460
</div>
== '''Consolidated statements of stockholders’ equity =='''
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 60</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Consolidated statements of stockholders’ equity
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! classcolspan="col-s3" style="text-align:rightcenter" | TotalYears Ended December 31,
! class="col-s" style="text-align:right" | Preferred stocks:
! class="col-s" style="text-align:right" | Common stock:
! class="col-s" style="text-align:right" | Treasury stock:
! class="col-s" style="text-align:right" | Additional paid-in capital:
! class="col-s" style="text-align:right" | Stock notes receivable:
! class="col-s" style="text-align:right" | Accumulated other comprehensive income (loss):
! class="col-s" style="text-align:right" | Retained earnings (accumulated deficit):
! class="col-s" style="text-align:right" | Retained earnings (accumulated deficit): Period of adoption, adjustment
|-
|! style="text-align:left" | Preferred($ sharesin balancethousands, atexcept beginningshare of period (in sharesamounts) at Dec. 31, 2022
|! style="text-align:rightcenter" | —2025
|! style="text-align:rightcenter" | 1,969,6602024
|! style="text-align:rightcenter" | —2023
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | IncreasePreferred (Decrease) in Stockholders' Equity [Roll Forward]shares:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|-
| style="text-align:right" | —
| style="text-align:rightleft" | —Balance at beginning of year
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1,969,660
|-
| style="text-align:left" | Preferred stock conversion to common shares (in shares)
| style="text-align:right" | —
| style="text-align:right" | -1,969,660
| style="text-align:right" | 16,305,113
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 1,969,660 )
|-
| style="text-align:left" | Preferred shares balanceBalance at ending of period (in shares) at Dec.December 31, 2023
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Common shares balanceBalance at beginning of period (in shares) at Dec. 31, 2022year
| style="text-align:right" | —40,127,908
| style="text-align:right" | —39,863,756
| style="text-align:right" | 16,599,666
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | IncreaseIssuance (Decrease)of in Stockholders' Equity [Roll Forward]shares
| style="text-align:right" | —383,314
| style="text-align:right" | —264,152
| style="text-align:right" | —6,958,977
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | IssuancePreferred ofstock sharesconversion to (incommon shares)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 6,958,977
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 16,305,113
|-
| style="text-align:left" | Common shares balanceBalance at ending of period (in shares) at Dec.December 31, 2023
| style="text-align:right" | —40,511,222
| style="text-align:right" | —40,127,908
| style="text-align:right" | 39,863,756
|-
| style="text-align:left" | Balance at beginning of year
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stockholders' equity beginning balance at Dec. 31, 2022
| style="text-align:right" | —
| style="text-align:right" | 20
| style="text-align:right" | 168
| style="text-align:right" | -2
| style="text-align:right" | 577,289
| style="text-align:right" | -6,911
| style="text-align:right" | -43,485
| style="text-align:right" | -105,417
| style="text-align:right" | -2,275
|-
| style="text-align:left" | IncreaseBalance (Decrease)at inDecember Stockholders' Equity [Roll Forward]31
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Common stock:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | PreferredBalance stockat conversionbeginning toof common sharesyear
| style="text-align:right" | —401
| style="text-align:right" | -20399
| style="text-align:right" | 161168
|-
| style="text-align:left" | Issuance of common stock
| style="text-align:right" | 4
| style="text-align:right" | 2
| style="text-align:right" | -143
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Issuance of common stock/Employee equity transactions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 22
| style="text-align:right" | —
| style="text-align:right" | 9,213
| style="text-align:right" | 1,349
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Proceeds from equity offerings, net
| style="text-align:right" | —
| style="text-align:right" | 48
| style="text-align:right" | —
| style="text-align:right" | 124,496
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | OtherBalance comprehensiveat income,December net of tax31
| style="text-align:right" | 20,532405
| style="text-align:right" | —401
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 20,532
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net income
| style="text-align:right" | 85,984
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 85,984
| style="text-align:right" | —
|-
| style="text-align:left" | Stockholders' equity ending balance at Dec. 31, 2023
| style="text-align:right" | 661,031
| style="text-align:right" | 0
| style="text-align:right" | 399
| style="text-align:right" | 0
| style="text-align:right" | 710,855
| style="text-align:right" | -5,562
| style="text-align:right" | -22,953
| style="text-align:right" | -21,708
| style="text-align:right" | 0
|-
| style="text-align:left" | IncreaseBalance (Decrease)at inbeginning Stockholders'of Equity [Roll Forward]year
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 2 )
|-
| style="text-align:left" | PreferredBalance stockat conversionDecember to common shares (in shares)31
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | PreferredAdditional shares balance at ending of period (paid-in shares) at Dec. 31, 2024capital:
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | IncreaseBalance (Decrease)at inbeginning Stockholders'of Equity [Roll Forward]year
| style="text-align:right" | —718,598
| style="text-align:right" | —710,855
| style="text-align:right" | —577,289
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Issuance of sharescommon (in shares)stock
| style="text-align:right" | —11,957
| style="text-align:right" | —
| style="text-align:right" | 264,152
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Common shares balance at ending of period (in shares) at Dec. 31, 2024
| style="text-align:right" | 40,127,908
| style="text-align:right" | —
| style="text-align:right" | 40,127,908
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Increase (Decrease) in Stockholders' Equity [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Preferred stock conversion to common shares
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Issuance of common stock/Employee equity transactions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 2
| style="text-align:right" | —
| style="text-align:right" | 7,743
| style="text-align:right" | 59,562213
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Proceeds from equity offerings, net
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0124,496
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | OtherBalance comprehensiveat income,December net of tax31
| style="text-align:right" | 833730,555
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 833
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net income
| style="text-align:right" | 118,828
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 118,828
| style="text-align:right" | —
|-
| style="text-align:left" | Stockholders' equity ending balance at Dec. 31, 2024
| style="text-align:right" | 793,999
| style="text-align:right" | 0
| style="text-align:right" | 401
| style="text-align:right" | 0
| style="text-align:right" | 718,598
| style="text-align:right" | 0710,855
| style="text-align:right" | -22,120
| style="text-align:right" | 97,120
| style="text-align:right" | 0
|-
| style="text-align:left" | IncreaseStock (Decrease)notes in Stockholders' Equity [Roll Forward]receivable:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | PreferredBalance stockat conversionbeginning toof common shares (in shares)year
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 5,562 )
| style="text-align:right" | ( 6,911 )
|-
| style="text-align:left" | PreferredEmployee sharesequity balance at ending of period (in shares) at Dec. 31, 2025transactions
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 5,562
| style="text-align:right" | 1,349
|-
| style="text-align:left" | IncreaseBalance (Decrease)at inDecember Stockholders' Equity [Roll Forward]31
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 5,562 )
|-
| style="text-align:left" | IssuanceAccumulated ofother sharescomprehensive (inincome shares(loss):
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 383,314
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Common shares balanceBalance at endingbeginning of period (in shares) at Dec. 31, 2025year
| style="text-align:right" | 40( 22,511,222120 )
| style="text-align:right" | —( 22,953 )
| style="text-align:right" | 40( 43,511,222485 )
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | IncreaseOther (Decrease)comprehensive inincome, Stockholders'net Equityof [Roll Forward]tax
| style="text-align:right" | —33,577
| style="text-align:right" | —833
| style="text-align:right" | —20,532
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | PreferredBalance stockat conversionDecember to common shares31
| style="text-align:right" | —11,457
| style="text-align:right" | 0( 22,120 )
| style="text-align:right" | 0( 22,953 )
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | IssuanceRetained ofearnings common(accumulated stock/Employee equity transactionsdeficit):
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4
| style="text-align:right" | —
| style="text-align:right" | 11,957
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | ProceedsBalance fromat equitybeginning offerings,of netyear
| style="text-align:right" | —97,120
| style="text-align:right" | —( 21,708 )
| style="text-align:right" | 0( 105,417 )
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | OtherCumulative comprehensiveeffect income,on netadoption of taxASU No. 2016-13
| style="text-align:right" | 33,577
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 33,577
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 2,275 )
|-
| style="text-align:left" | Net income
| style="text-align:right" | 170,028
| style="text-align:right" | —118,828
| style="text-align:right" | —85,984
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 170,028
| style="text-align:right" | —
|-
| style="text-align:left" | Stockholders' equity ending balanceBalance at Dec.December 31, 2025
| style="text-align:right" | 1,009,565
| style="text-align:right" | 0
| style="text-align:right" | 405
| style="text-align:right" | 0
| style="text-align:right" | 730,555
| style="text-align:right" | 0
| style="text-align:right" | 11,457
| style="text-align:right" | 267,148
| style="text-align:right" | —97,120
| style="text-align:right" | ( 21,708 )
|-
| style="text-align:left; font-weight:bold" | Total stockholders’ equity
| style="text-align:right; font-weight:bold" | 1,009,565
| style="text-align:right; font-weight:bold" | 793,999
| style="text-align:right; font-weight:bold" | 661,031
|}
</div>
== '''Consolidated statements of cash flows =='''
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 61</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Consolidated statements of cash flows (1){{footnote|1=The sum of cash and cash equivalents and restricted cash from the Consolidated Balance Sheets.}}
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 MonthsYears Ended December 31,
|-
! style="text-align:left" | —($ in thousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2025
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2024
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2023
|-
|! style="text-align:left" | Cash flows from operating activities:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Net income
|-
| style="text-align:left" | Net investment (gains) losses
| style="text-align:right" | -( 22,149 )
| style="text-align:right" | -( 6,342 )
| style="text-align:right" | -( 11,054 )
|-
| style="text-align:left" | Depreciation and amortization expense
| style="text-align:left" | Undistributed earnings (loss) from long-term investments
| style="text-align:right" | 10,122
| style="text-align:right" | -( 6,252 )
| style="text-align:right" | 6,730
|-
| style="text-align:left" | Net change in fair value of derivatives
| style="text-align:right" | -( 34,857 )
| style="text-align:right" | 0—
| style="text-align:right" | 0—
|-
| style="text-align:left" | Deferred income tax, net
| style="text-align:right" | -( 6,397 )
| style="text-align:right" | -( 8,708 )
| style="text-align:right" | 9,383
|-
| style="text-align:left" | Premiums receivable, net
| style="text-align:right" | -( 222,576 )
| style="text-align:right" | -( 142,406 )
| style="text-align:right" | -( 40,020 )
|-
| style="text-align:left" | Reinsurance recoverables, net
| style="text-align:right" | -( 262,004 )
| style="text-align:right" | -( 261,542 )
| style="text-align:right" | -( 17,270 )
|-
| style="text-align:left" | Ceded unearned premium
| style="text-align:right" | -( 35,047 )
| style="text-align:right" | -( 17,780 )
| style="text-align:right" | -( 28,476 )
|-
| style="text-align:left" | Deferred policy acquisition costs
| style="text-align:right" | -( 22,917 )
| style="text-align:right" | -( 21,228 )
| style="text-align:right" | -( 23,017 )
|-
| style="text-align:left" | Federal income taxes
| style="text-align:right" | 1,797
| style="text-align:right" | 4,500
| style="text-align:right" | -( 1,892 )
|-
| style="text-align:left" | Losses and loss adjustment expenses
|-
| style="text-align:left" | Other, net
| style="text-align:right" | -( 27,987 )
| style="text-align:right" | -( 12,788 )
| style="text-align:right" | -( 5,047 )
|-
| style="text-align:left" | Net cash provided by operating activities
| style="text-align:right" | 305,115
| style="text-align:right" | 338,187
|-
| style="text-align:left" | Cash flows from investing activities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale
| style="text-align:right" | -( 910,039 )
| style="text-align:right" | -( 617,606 )
| style="text-align:right" | -( 459,672 )
|-
| style="text-align:left" | Purchase of illiquid investments
| style="text-align:right" | 0—
| style="text-align:right" | -( 75 )
| style="text-align:right" | -( 1,675 )
|-
| style="text-align:left" | Purchase of equity securities
| style="text-align:right" | -( 13,213 )
| style="text-align:right" | -( 14,077 )
| style="text-align:right" | -( 26,009 )
|-
| style="text-align:left" | Purchase of equity method investments and other long-term investments
| style="text-align:right" | -( 6,814 )
| style="text-align:right" | -( 32,173 )
| style="text-align:right" | 0—
|-
| style="text-align:left" | Purchase of intangible assets and goodwill
| style="text-align:right" | -( 2,000 )
| style="text-align:right" | 0—
| style="text-align:right" | -( 50 )
|-
| style="text-align:left" | Investment in direct and indirect loans
|-
| style="text-align:left" | Purchase of property and equipment
| style="text-align:right" | -( 5,454 )
| style="text-align:right" | -( 4,224 )
| style="text-align:right" | -( 3,108 )
|-
| style="text-align:left" | Proceeds from the sales of fixed maturity securities, available-for-sale
| style="text-align:left" | Change in short-term investments
| style="text-align:right" | 10,626
| style="text-align:right" | -( 4,799 )
| style="text-align:right" | -( 149,068 )
|-
| style="text-align:left" | Change in receivable/payable for securities
|-
| style="text-align:left" | Net cash used in investment activities
| style="text-align:right" | -( 366,898 )
| style="text-align:right" | -( 243,694 )
| style="text-align:right" | -( 493,809 )
|-
| style="text-align:left" | CashEmployee flowsshare from financing activities:purchases
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Employee share purchases
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 1,350
|-
| style="text-align:left" | Repayment of stock notes receivable
| style="text-align:right" | 0—
| style="text-align:right" | 5,562
| style="text-align:right" | 0—
|-
| style="text-align:left" | Proceeds from long term borrowings
|-
| style="text-align:left" | Payments on long term borrowings and trust preferred
| style="text-align:right" | -( 43,000 )
| style="text-align:right" | -( 116,794 )
| style="text-align:right" | -( 50,000 )
|-
| style="text-align:left" | Proceeds from initial public offering
| style="text-align:right" | 0—
| style="text-align:right" | 0—
| style="text-align:right" | 129,597
|-
| style="text-align:left" | Net cash provided by (used in) financing activities
| style="text-align:right" | 411
| style="text-align:right" | -( 4,232 )
| style="text-align:right" | 130,947
|-
| style="text-align:right" | 41,589
| style="text-align:right" | 57,189
| style="text-align:right" | -( 24,675 )
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period (1)
| style="text-align:right" | 157,525
| style="text-align:right" | 100,336
| style="text-align:right" | 125,011
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at end of period (1)
| style="text-align:right" | 199,114
| style="text-align:right" | 157,525
</div>
'''A. Description of Business'''
== Summary of Significant Accounting Policies ==
* ''Skyward Specialty Insurance Group, Inc.'' (the "Company") is a Delaware corporation organized in 2006 <sup>p. 62</sup>.
* The Company operates as a specialty insurance company in one segment, providing commercial property and casualty insurance products through its underwriting divisions <sup>p. 62</sup>.
* The Company has four wholly owned insurance company subsidiaries based in the United States <sup>p. 62</sup>.
** ''Great Midwest Insurance Company (GMIC)'' underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury <sup>p. 62</sup>.
** ''Houston Specialty Insurance Company (HSIC)'', a subsidiary of GMIC, underwrites insurance on a non-admitted basis <sup>p. 62</sup>.
** ''Imperium Insurance Company (IIC)'', a subsidiary of HSIC, underwrites insurance on an admitted basis <sup>p. 62</sup>.
** ''Oklahoma Specialty Insurance Company (OSIC)'', a subsidiary of IIC, underwrites insurance on a non-admitted basis <sup>p. 62</sup>.
* The Company has a wholly owned captive reinsurance company subsidiary, ''Skyward Re'', domiciled in the Cayman Islands <sup>p. 62</sup>.
** Skyward Re assumed net reserves for certain divisions, related to a retroactive reinsurance contract, from the Company’s insurance companies <sup>p. 62</sup>.
** Skyward Re retroceded these net reserves to a third-party reinsurer <sup>p. 62</sup>.
* The Company has three non-risk bearing wholly owned subsidiaries <sup>p. 62</sup>.
** ''Skyward Underwriters Agency, Inc. (SUA)'' is a managing general insurance agent and reinsurance broker for property and casualty risks in specialty niche markets <sup>p. 62</sup>.
** ''Skyward Service Company'' provides various administrative services to the Company’s subsidiaries <sup>p. 62</sup>.
** ''Skyward Specialty No. 1 Limited'' is a Lloyd’s corporate member authorized to invest in Lloyd’s syndicates <sup>p. 62</sup>.
* On January 1, 2026, the Company completed the acquisition of ''Apollo Group Holdings Limited'' for an aggregate consideration of approximately $555.0 million <sup>p. 62</sup>.
* Additional information regarding the acquisition is provided in Note 24 <sup>p. 62</sup>.
'''B. Basis of Presentation'''
* The Company's consolidated financial statements are prepared according to Generally Accepted Accounting Principles in the United States of America (GAAP) <sup>p. 63</sup>.
* GAAP differs in some aspects from the principles used in reports to insurance regulatory authorities <sup>p. 63</sup>.
* The consolidated financial statements encompass the accounts of the holding company and its subsidiaries <sup>p. 63</sup>.
* All intercompany transactions and balances are eliminated during consolidation <sup>p. 63</sup>.
* Preparing consolidated financial statements under GAAP necessitates the Company making estimates and assumptions that influence the amounts reported in the financial statements and notes <sup>p. 63</sup>.
* The Company's actual results may vary from these estimates <sup>p. 63</sup>.
'''C. Consolidation'''
* The Company consolidates an entity if it meets the definition of a variable interest entity (VIE) for which the Company is the primary beneficiary, or if the Company controls the entity through a majority of voting interest or other arrangements <sup>p. 64</sup>.
* A ''VIE'' is defined as an entity that either lacks sufficient equity to finance its activities without additional subordinated financial support, whose equity holders lack the characteristics of a controlling financial interest, and/or is established with non-substantive voting rights <sup>p. 64</sup>.
* The Company's assessment of VIE status involves subjectivity in determining which activities most significantly affect the VIE’s performance and estimates about current and future fair value of assets and financial performance <sup>p. 64</sup>.
* In performing the related party analysis, the Company considers qualitative and quantitative factors including the characteristics and size of its investment, ability to control or significantly influence key decisions (including de facto agents), obligation or likelihood to fund operating losses, and similarity and significance of the VIE’s business activities to those of the Company and related party <sup>p. 64</sup>.
* The determination of whether an entity is a VIE and whether the Company is the primary beneficiary involves significant judgment and depends on specific facts and circumstances at the time of assessment <sup>p. 64</sup>.
* At each reporting period, the Company reassesses changes in facts and circumstances that could alter an entity's VIE status or the Company's consolidation assessment <sup>p. 64</sup>.
* Changes in consolidation status are applied prospectively <sup>p. 64</sup>.
* If an entity is consolidated due to reassessment, its assets, liabilities, and noncontrolling interest are recorded at fair value upon initial consolidation <sup>p. 64</sup>.
* Any existing equity interest held by the Company in the entity prior to obtaining control is remeasured at fair value, potentially resulting in a gain or loss recognized upon initial consolidation <sup>p. 64</sup>.
* The Company may also deconsolidate a subsidiary following reassessment, which could result in a gain or loss depending on the carrying values of deconsolidated assets and liabilities compared to the fair value of any retained interests <sup>p. 64</sup>.
* After these assessments, the Company determined that one entity meets the definition of a VIE for which the Company is the primary beneficiary <sup>p. 64</sup>.
* Further details and required disclosures regarding this VIE are provided in Note 7 <sup>p. 64</sup>.
'''D. Cash and Cash Equivalents'''
* ''Cash and cash equivalents'' include cash on hand and fixed maturity securities with original maturities of three months or less <sup>p. 65</sup>.
* The carrying value of the Company’s cash and cash equivalents approximates fair value <sup>p. 65</sup>.
'''E. Restricted Cash'''
* ''Restricted cash'' is cash with a legal restriction on withdrawal or use by the consolidated group <sup>p. 66</sup>.
* The ''carrying value'' of the Company’s restricted cash approximates fair value <sup>p. 66</sup>.
* ''SUA'' collects premiums from clients, deducts commissions and applicable fees, and remits the remaining premiums to the Company’s insurance companies or third-party insurance companies <sup>p. 66</sup>.
* ''SUA'' holds unremitted insurance premiums in a fiduciary capacity for third-party insurance companies, recorded as restricted cash <sup>p. 66</sup>.
* The Company is required by ''state regulations'' to maintain assets on deposit with certain states and hold cash as collateral for certain reinsurance balances <sup>p. 66</sup>.
* ''Cash held'' in a depository account for others, or restricted by a state, is recorded as restricted cash <sup>p. 66</sup>.
'''F. Investments'''
* ''Available for Sale fixed maturities'' are carried at fair value <sup>p. 67</sup>.
* For ''available-for-sale fixed maturities'' in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or cost recovery <sup>p. 67</sup>.
* If intent or likelihood of sale exists, the ''amortized cost'' is written down to fair value, with losses recognized in net investment gains on the Consolidated Statements of Operations <sup>p. 67</sup>.
* If neither sale criterion is met, the Company assesses if ''unrealized losses'' are due to credit-related factors <sup>p. 67</sup>.
* If ''unrealized losses'' are credit-related, an allowance for credit losses is determined by comparing the present value of cash flows to the amortized cost <sup>p. 67</sup>.
* Prior to 2025, ''changes in the allowance for credit losses'' were recognized in net investment income <sup>p. 67</sup>.
* As of 2025, ''changes in the allowance for credit losses'' are recognized in net investment gains, and prior periods have been updated to conform to this presentation <sup>p. 67</sup>.
* ''Credit losses'' limited by the fair value of the security are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) <sup>p. 67</sup>.
* ''Unrealized losses'' that are not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) <sup>p. 67</sup>.
* ''Held-to-maturity fixed maturity securities'' are carried at amortized cost net of an allowance for credit losses <sup>p. 67</sup>.
* The ''allowance for credit losses'' represents the current estimate of expected credit losses <sup>p. 67</sup>.
* The Company develops a ''historical loss rate'' from Moody’s multi-year cumulative loss rates for asset-backed securities <sup>p. 67</sup>.
* The ''historical loss rate'' is adjusted for current conditions and reasonable and supportable forecasts <sup>p. 67</sup>.
* Prior to 2025, ''changes in the allowance for credit losses'' for held-to-maturity securities were recognized in net investment income <sup>p. 67</sup>.
* As of 2025, ''changes in the allowance for credit losses'' for held-to-maturity securities are recognized in net investment gains, and prior periods have been updated to conform <sup>p. 67</sup>.
* ''Equity securities'' include common stock or preferred stock and mutual funds (even those primarily investing in debt securities) <sup>p. 67</sup>.
* ''Investments in equity securities with a readily determinable fair value'' are carried on the balance sheet at fair value using quoted market prices <sup>p. 67</sup>.
* ''Changes in the carrying value of equity securities'' are included in net investment gains (losses) within the Consolidated Statements of Operations <sup>p. 67</sup>.
* ''Mortgage loans'' are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees <sup>p. 67</sup>.
* ''Uncollectible amounts'' for mortgage loans are written off in the period they are determined to be uncollectible <sup>p. 67</sup>.
* ''Interest on mortgage loans'' is recognized as interest receivable and included in other assets on the Consolidated Balance Sheets <sup>p. 67</sup>.
* The Company elected the ''fair value option'' for mortgage loans effective January 1, 2023, as targeted transition relief from ASU 2016-13 adoption <sup>p. 67</sup>.
* Under the ''fair value option'', mortgage loans are measured at fair value, and changes in unrealized gains and losses are reported in net investment gains (losses) on the Consolidated Statements of Operations <sup>p. 67</sup>.
* ''Interest income and amortization'' for mortgage loans under the fair value option continue to be recognized in net investment income <sup>p. 67</sup>.
* ''Equity method investments'' include equity and equity securities of non-public entities and indirect investments in loans and loan collateral <sup>p. 67</sup>.
* The Company has ''equity investments'' in certain limited partnerships and corporations where it has significant influence but not control <sup>p. 67</sup>.
* The Company determined it is not the primary beneficiary of these ''variable interest entities'' and does not consolidate them <sup>p. 67</sup>.
* The ''equity method'' is used to account for investments in unconsolidated subsidiaries <sup>p. 67</sup>.
* Under the ''equity method'', initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee <sup>p. 67</sup>.
* The ''difference between investment cost and proportionate share of underlying equity'' is a component of investment income <sup>p. 67</sup>.
* The Company amortizes this ''difference'' as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset <sup>p. 67</sup>.
* For ''equity securities of non-public entities'' where the Company lacks significant influence and fair value is not readily determinable, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions <sup>p. 67</sup>.
* ''Investments in indirect collateralized loans and loan collateral'' are held through and accounted for as ownership interests in unconsolidated subsidiaries <sup>p. 67</sup>.
* The Company’s ''ownership interests in unconsolidated subsidiaries'' include investments in partnerships, joint ventures, and special purpose investment vehicles <sup>p. 67</sup>.
* The Company uses the ''equity method'' for these unconsolidated subsidiaries where it has significant influence but not control <sup>p. 67</sup>.
* ''Other long-term investments'' consist of an investment in a limited partnership held at net asset value (“NAV”) and other long-term investment securities <sup>p. 67</sup>.
* ''Short-term investments'' primarily consist of money market funds and are carried at cost, which approximates fair value <sup>p. 67</sup>.
* ''Net investment income'' includes interest, dividends, and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses <sup>p. 67</sup>.
* ''Interest income'' is recognized on an accrual basis, and ''dividends'' are recognized as earned at the ex-dividend date <sup>p. 67</sup>.
* ''Interest income on mortgage-backed and other asset-backed securities'' is recognized using the effective-yield method based on estimated principal repayments <sup>p. 67</sup>.
* ''Amortization of premium and accretion of discounts on debt securities'' are included in interest income <sup>p. 67</sup>.
* ''Net investment gains and losses'' are recognized in net income based upon the specific identification method <sup>p. 67</sup>.
'''G. Derivatives'''
* The Company uses ''commodity derivatives'' to assume risk and manage exposures in the insurance industry <sup>p. 68</sup>.
* Commodity derivatives expose the Company to potentially unfavorable price changes to the underlying commodities <sup>p. 68</sup>.
* The Company accounts for its derivatives in accordance with ''FASB ASC Topic 815, Derivatives and Hedging'' <sup>p. 68</sup>.
* This accounting standard requires all derivatives to be recorded at ''fair value'' on the Company’s balance sheet as either assets or liabilities <sup>p. 68</sup>.
* Changes in fair value of derivatives are reflected in ''current earnings'' <sup>p. 68</sup>.
* The Company meets the criteria to ''net assets and liabilities'' related to derivatives <sup>p. 68</sup>.
* These netted assets and liabilities are included in ''"other assets"'' on the Consolidated Balance Sheets <sup>p. 68</sup>.
* The Company considers its ''exchange-traded futures and forward purchase and sale contracts'' to be effective economic hedges <sup>p. 68</sup>.
* The Company has ''not elected hedge accounting treatment'' for these derivatives <sup>p. 68</sup>.
* The ''fair value of derivatives'' is estimated by reference to quoted prices or broker quotes, or through industry or internal valuation models when quotes are unavailable <sup>p. 68</sup>.
* Further details and required disclosures regarding derivatives can be found in ''Note 8'' <sup>p. 68</sup>.
'''H. Reinsurance'''
* The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis <sup>p. 69</sup>.
* ''Proportional reinsurance'' requires the Company to share losses and expenses with the reinsurer in exchange for a share of premiums <sup>p. 69</sup>.
* ''Excess of loss reinsurance'' shares losses, either proportionally or entirely, above a certain dollar threshold, for a negotiated cost <sup>p. 69</sup>.
* ''Facultative reinsurance'' covers specific risks and/or policies on either a proportional or excess of loss basis <sup>p. 69</sup>.
* Ceded unearned premium and reinsurance balances recoverable (on paid and unpaid losses and settlement expenses) are reported separately as assets <sup>p. 69</sup>.
* Reinsurance does not relieve the Company of its legal liability to policyholders <sup>p. 69</sup>.
* Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers <sup>p. 69</sup>.
* On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, net, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded <sup>p. 69</sup>.
* The Company has purchased retroactive reinsurance on certain lines of business in prior years, including loss portfolio transfers ("LPT") and adverse development covers <sup>p. 69</sup>.
* These retroactive contracts indemnify losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds <sup>p. 69</sup>.
* Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period <sup>p. 69</sup>.
* Losses from retroactive reinsurance contracts are charged to net income immediately <sup>p. 69</sup>.
* Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for using a full retrospective method <sup>p. 69</sup>.
* Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method <sup>p. 69</sup>.
* The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk <sup>p. 69</sup>.
* A reinsurance contract may not transfer significant insurance risk if either underwriting risk, timing risk, or both are not deemed transferred <sup>p. 69</sup>.
* For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow <sup>p. 69</sup>.
* This deposit asset is offset by cash inflows received from reinsurers <sup>p. 69</sup>.
* If cash outflows are expected to differ from cash inflows, an accretion rate is established at inception based on actuarial estimates <sup>p. 69</sup>.
* The deposit accounting asset is increased/decreased to the estimated amount receivable over the contract term <sup>p. 69</sup>.
* The accretion of the deposit is based on the expected rate of return implied from estimated cash inflows and outflows <sup>p. 69</sup>.
* The Company periodically reassesses the estimated ultimate receivable and the related expected rate of return on the deposit asset <sup>p. 69</sup>.
* The accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income <sup>p. 69</sup>.
* Several reinsurance contracts require deposit accounting due to not transferring sufficient underwriting risk <sup>p. 69</sup>.
* No reinsurance contracts required deposit accounting due to not transferring sufficient timing risk <sup>p. 69</sup>.
* Reinsurance recoverables are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses <sup>p. 69</sup>.
* The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on expected receivable duration <sup>p. 69</sup>.
* The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions <sup>p. 69</sup>.
* Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 69</sup>.
* The Company continuously monitors the financial condition of its reinsurers, including reviewing their annual financial statements and industry developments <sup>p. 69</sup>.
* The Company analyzes credit risk by monitoring reinsurers' financial strength ratings from A.M. Best and assessing collateral adequacy <sup>p. 69</sup>.
* The Company has access to collateral from various reinsurers if they fail to fulfill obligations <sup>p. 69</sup>.
* ''Reinsurance collateral'' from reinsurers was ''$344.1 million'' as of December 31, 2025, and ''$337.0 million'' as of December 31, 2024 <sup>p. 69</sup>.
* ''eMaxx Captives'' and ''Everest Reinsurance Co.'' represented ''17.7%'' and ''11.1%'', respectively, of the Company’s reinsurance recoverable balances at December 31, 2025 <sup>p. 69</sup>.
* ''eMaxx Captives'' and ''Everest Reinsurance Co.'' represented ''16.8%'' and ''18.0%'', respectively, of the Company’s reinsurance recoverable balances at December 31, 2024 <sup>p. 69</sup>.
* These were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances <sup>p. 69</sup>.
* ''eMaxx Captives'' was not rated by A.M. Best at December 31, 2025, and 2024 <sup>p. 69</sup>.
* ''Everest Reinsurance Co.'s'' financial strength rating from A.M. Best was A+ at December 31, 2025, and 2024 <sup>p. 69</sup>.
'''I. Concentration of Credit Risk'''
* ''Financial instruments'' that could lead to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, excluding reinsurance recoverables <sup>p. 70</sup>.
* ''Cash equivalents and short-term investments'' consist of U.S. government securities and money market funds <sup>p. 70</sup>.
* ''Investments'' are diversified across various industries and geographic regions <sup>p. 70</sup>.
* The Company limits its ''credit exposure'' to any single financial institution or issuer <sup>p. 70</sup>.
* No significant ''concentration of credit risk'' is believed to exist regarding cash and investments <sup>p. 70</sup>.
* As of December 31, 2025 and 2024, ''outstanding premiums receivable'' are generally diversified due to a large customer base spread across many lines of business and geographic regions <sup>p. 70</sup>.
* ''Failure by distribution sources'' to remit premiums could lead to premium write-offs and a corresponding loss of income <sup>p. 70</sup>.
'''J. Deferred Policy Acquisition Costs'''
* ''Policy acquisition costs'' include commissions and premium taxes that are directly related to new or renewal business production <sup>p. 71</sup>.
* The Company defers policy acquisition costs and related ceding commissions <sup>p. 71</sup>.
* Deferred costs are charged or credited to earnings proportionally with the premium earned over the policy's life <sup>p. 71</sup>.
* A ''premium deficiency'' is recognized if expected losses, loss adjustment expenses, and unamortized acquisition costs exceed related unearned premiums <sup>p. 71</sup>.
* To recognize a premium deficiency, unamortized acquisition costs are first charged to expense to eliminate the deficiency <sup>p. 71</sup>.
* If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess <sup>p. 71</sup>.
* ''Anticipated investment income'' is considered when determining premium deficiencies <sup>p. 71</sup>.
* Management determined that no premium deficiency existed as of December 31, 2025, and 2024 <sup>p. 71</sup>.
'''K. Goodwill and Intangible Assets'''
* ''Goodwill and intangible assets'' are recorded following a business combination <sup>p. 72</sup>.
* ''Goodwill'' is the excess of the purchase price over the fair value of acquired assets and assumed liabilities <sup>p. 72</sup>.
* The Company reviews its ''purchase price allocation'' for up to one year post-acquisition, allowing for adjustments within this period <sup>p. 72</sup>.
* The Company amortizes ''identifiable intangible assets'' with a finite useful life over the period they are expected to contribute to future cash flows <sup>p. 72</sup>.
* The Company does not amortize ''indefinite-lived intangible assets'' <sup>p. 72</sup>.
* The Company reviews ''goodwill and identifiable intangible assets'' for recoverability annually in the fourth quarter or on an interim basis if circumstances suggest the carrying amount may not be recoverable <sup>p. 72</sup>.
* The Company had ''no goodwill impairment'' for the years ended December 31, 2025, and 2024 <sup>p. 72</sup>.
'''L. Property and Equipment'''
* ''Property and equipment'' is included in other assets on the Consolidated Balance Sheets <sup>p. 73</sup>.
* Property and equipment is recorded at cost less accumulated depreciation <sup>p. 73</sup>.
* ''Depreciation expense'' is recognized on a straight-line basis for financial statement purposes <sup>p. 73</sup>.
* Depreciation periods range from three to seven years <sup>p. 73</sup>.
'''M. Reserves for Losses and Loss Adjustment Expenses'''
* ''Reserves for unpaid losses and loss adjustment expenses (LAE)'' represent the Company's estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date <sup>p. 74</sup>.
* The Company estimates reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 74</sup>.
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and inflation <sup>p. 74</sup>.
* The Company regularly reviews and adjusts estimates as experience develops or new information becomes known <sup>p. 74</sup>.
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward <sup>p. 74</sup>.
* The ultimate liability may exceed or be less than the revised estimates, and the ultimate settlement of losses and related LAE may vary significantly from the estimate in the financial statements <sup>p. 74</sup>.
* If actual liabilities exceed recorded amounts, there will be an adverse effect <sup>p. 74</sup>.
* If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves <sup>p. 74</sup>.
'''N. Premiums'''
* The Company recognizes property and casualty and surety premiums on a pro-rata basis over the policy terms <sup>p. 75</sup>.
* Accident and health premiums are earned as billed, based on census data <sup>p. 75</sup>.
* ''Gross premiums written'' are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance <sup>p. 75</sup>.
* ''Premiums receivable'' include deferred premiums, which are installment payments due from insureds under policy payment terms <sup>p. 75</sup>.
* ''Premiums receivable'' are carried net of an allowance for credit losses <sup>p. 75</sup>.
* The ''allowance for credit losses'' represents the current estimate of expected credit losses <sup>p. 75</sup>.
* The Company develops a ''historical loss rate'' using historical write-offs and aging of receivables <sup>p. 75</sup>.
* This ''historical loss rate'' is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage after a premium is past due <sup>p. 75</sup>.
* ''Changes in the allowance for credit losses'' are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 75</sup>.
* ''Unearned premiums'' represent the portion of gross premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>.
* ''Ceded unearned premiums'' represent the portion of ceded premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>.
* ''Unearned premiums'' (direct and ceded) are calculated on a pro-rata basis over the terms of the policies <sup>p. 75</sup>.
'''O. Commission and Fee Income'''
* ''SUA commission revenue'' is generated from placing insurance policies on reinsurance programs via a reinsurance broker <sup>p. 76</sup>.
* The Company's single performance obligation for SUA commission revenue is the placement of insurance policies <sup>p. 76</sup>.
* The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed <sup>p. 76</sup>.
* The Company recognizes 100% of the transaction price for SUA commission revenue when the policy is placed, as there are no constraints on revenue <sup>p. 76</sup>.
* ''SUA fee income'' is generated from placing insurance policies with a third-party insurance company <sup>p. 76</sup>.
* The Company's single performance obligation for SUA fee income is the placement of the policy <sup>p. 76</sup>.
* The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that change monthly (e.g., employee census data, worker roles) <sup>p. 76</sup>.
* The Company estimates the transaction price for SUA fee income over the policy's life using the expected value method <sup>p. 76</sup>.
* Revenue from SUA fee income is recognized when the policy is placed <sup>p. 76</sup>.
* Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur <sup>p. 76</sup>.
'''P. Income Taxes'''
* ''Income tax expense'' is accrued for the tax effects of transactions reported on the consolidated financial statements <sup>p. 77</sup>.
* ''Provision for income taxes'' consists of taxes currently due plus deferred taxes resulting from temporary differences between financial statement and income tax purposes <sup>p. 77</sup>.
* A ''valuation allowance'' is established for any deferred tax asset not expected to be realized <sup>p. 77</sup>.
* ''Deferred tax assets and liabilities'' are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are expected to be recovered or settled <sup>p. 77</sup>.
* The ''effect on deferred tax assets and liabilities'' from a change in tax rates is recognized in income in the period that includes the enactment date <sup>p. 77</sup>.
* A ''liability for uncertain tax positions'' is recorded when it is more likely-than-not that the tax position will not be sustained upon examination by the appropriate tax authority <sup>p. 77</sup>.
* ''Changes in the liability for uncertain tax positions'' are reflected in income tax expense in the period when a new uncertain tax position arises, judgment changes about the likelihood of an uncertainty, the tax issue is settled, or the statute of limitation expires <sup>p. 77</sup>.
* Any ''potential net interest income or expense and penalties'' related to uncertain tax positions are recorded on the Consolidated Statements of Operations <sup>p. 77</sup>.
* The Company files a ''consolidated federal income tax return'' in the United States and certain other state tax returns <sup>p. 77</sup>.
* Its admitted insurance subsidiaries pay ''premium taxes'' on gross written premiums in lieu of most state income or franchise taxes <sup>p. 77</sup>.
* ''Premium tax expense'' is recognized within underwriting, acquisition, and insurance expense on the Consolidated Statements of Operations <sup>p. 77</sup>.
'''Q. Fair Value of Financial Instruments'''
* Fair value for each class of financial instrument is estimated based on the framework established in fair value accounting guidance <sup>p. 78</sup>.
* The guidance requires maximizing the use of observable inputs and minimizing unobservable inputs when measuring fair value <sup>p. 78</sup>.
* Fair value hierarchy disclosures are based on the quality of inputs used to measure fair value <sup>p. 78</sup>.
* The hierarchy prioritizes unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) <sup>p. 78</sup>.
* The hierarchy gives the lowest priority to unobservable inputs (Level 3 measurements) <sup>p. 78</sup>.
* The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments <sup>p. 78</sup>.
* The Company understands the valuation methodologies and inputs of these third-party pricing sources <sup>p. 78</sup>.
* Further details regarding fair value disclosures are in Note 4 <sup>p. 78</sup>.
'''R. Stock-Based Compensation'''
* The estimated fair value of employee stock options and similar awards is expensed <sup>p. 79</sup>.
* Compensation cost for equity instrument awards to employees is measured based on the grant-date fair value of those awards <sup>p. 79</sup>.
* Compensation expense is recognized over the service period during which the awards are expected to vest <sup>p. 79</sup>.
* Tax effects related to share-based payments are made through net earnings <sup>p. 79</sup>.
* Further discussion and related disclosures regarding stock-based compensation are in note 18 <sup>p. 79</sup>.
* The Company's ''Employee Stock Purchase Plan'' (ESPP) allows all employees to purchase common stock at a discount <sup>p. 79</sup>.
* Compensation cost for the ESPP is recognized on a straight-line basis over the offering period <sup>p. 79</sup>.
'''S. Earnings Per Share'''
* ''Basic earnings per share'' is calculated using the two-class method <sup>p. 80</sup>.
* ''Undistributed earnings'' are allocated to participating securities based on their share in earnings as if all earnings for the period were distributed <sup>p. 80</sup>.
* ''Basic earnings per share'' is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period <sup>p. 80</sup>.
* ''Common shares'' with unsatisfied contingencies, such as vesting requirements, are excluded from basic earnings per share <sup>p. 80</sup>.
* The Company’s ''preferred shares'' are participating securities, sharing in dividends and distributions with common stock on an as-converted basis <sup>p. 80</sup>.
* ''Instruments awarded to employees'' that grant the right to purchase common stock at a fixed price are included as potential common shares, weighted for the portion of the period they were granted, if dilutive <sup>p. 80</sup>.
* The Company’s ''common and preferred shares financed by stock notes'' are contingently issuable instruments, excluded from basic and diluted earnings per share if specified conditions are not met, presuming the end of the period is the end of the contingency period <sup>p. 80</sup>.
* The impact of ''contingently issuable instruments'' on diluted earnings per share was calculated using the treasury stock method and included in the reconciliation of the denominator for the year ended December 31, 2024 <sup>p. 80</sup>.
* All ''outstanding stock notes'' were settled during 2024, resulting in no impact on the Company’s basic and diluted earnings per share computations for the year ended December 31, 2024 <sup>p. 80</sup>.
* ''Instruments convertible into common shares'' are included in diluted weighted-average common shares outstanding on an if-converted basis, based on the legal conversion rate for the respective period, if dilutive <sup>p. 80</sup>.
* ''Share-based awards to employees with only service conditions'' are included as potential common shares, weighted for the unvested portion of the period, if dilutive <sup>p. 80</sup>.
* ''Share-based awards to employees with performance and service or market conditions'' are included as potential common shares, presuming the end of the period is the end of the contingency period, if dilutive <sup>p. 80</sup>.
* When ''common share adjustments'' increase earnings per share or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents <sup>p. 80</sup>.
'''T. Recent Accounting Pronouncements'''
* ''ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740)'' was issued by FASB in December 2023 <sup>p. 81</sup>.
* ASU 2023-09 mandates enhanced rate reconciliation disclosures for public companies annually, including specific categories and additional information meeting a quantitative threshold <sup>p. 81</sup>.
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 81</sup>.
* The guidance became effective for fiscal years beginning after December 15, 2024, and is applied prospectively <sup>p. 81</sup>.
* The Company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements <sup>p. 81</sup>.
* Additional disclosures required by ASU 2023-09 can be found in Note 13 <sup>p. 81</sup>.
* ''ASU 2024-03'' was issued by FASB in November 2024, requiring disaggregated disclosure of income statement expenses for public business entities ("PBEs") <sup>p. 81</sup>.
* ASU 2024-03 does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes <sup>p. 81</sup>.
* The ASU requires a footnote disclosure about specific expenses, mandating PBEs to disaggregate, in a tabular presentation, relevant income statement expense captions that include natural expenses such as: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses <sup>p. 81</sup>.
* The tabular disclosure will also include certain other expenses, where applicable <sup>p. 81</sup>.
* ''ASU 2025-01'' was issued by FASB in January 2025 to clarify the effective date of ASU 2024-03 <sup>p. 81</sup>.
* The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 81</sup>.
* The Company is evaluating the effect of these amendments on its consolidated financial statements <sup>p. 81</sup>.
'''2. Goodwill and Intangible Assets'''
* The Company's ''indefinite-lived intangible assets'' relate to insurance licenses and trademarks <sup>p. 82</sup>.
* The Company's ''finite-lived intangible assets'' relate to policy renewals, agency relationships (within agent relationships), and non-compete/exclusivity agreements (within non-competes) <sup>p. 82</sup>.
* Finite-lived intangible assets had a ''weighted average useful life'' of approximately 12 years as of December 31, 2025 <sup>p. 82</sup>.
* The Company recognized ''amortization expense'' of approximately USD 1.3m for the year ended December 31, 2025 <sup>p. 82</sup>.
* The Company recognized ''amortization expense'' of approximately USD 1.1m for the year ended December 31, 2024 <sup>p. 82</sup>.
* The Company recognized ''amortization expense'' of approximately USD 1.5m for the year ended December 31, 2023 <sup>p. 82</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 2. Goodwill and Intangible Assets
|+ ($ in millions)
! style="text-align:left" | ($ in Millionsthousands)
! style="text-align:center" | Accident and Health
! colspan="2" style="text-align:center" | 12 Months EndedSurety
! style="text-align:center" | Construction and Energy Solutions
! style="text-align:center" | Other
! style="text-align:center" | Total
|-
! style="text-align:left" | —Goodwill
! class="col-s" style="text-align:right" | Jan. 01, 2026 USD ($)—
! class="col-s" style="text-align:right" | Dec. 31, 2025 USD ($) subsidiary segment—
! class="col-s" style="text-align:right" | Dec. 31, 2024 USD ($)—
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | ConcentrationGross Riskbalance [Lineat Items]December 31, 2024
| style="text-align:right" | —91,577
| style="text-align:right" | —6,781
| style="text-align:right" | —10,204
| style="text-align:right" | 3,879
| style="text-align:right" | 112,441
|-
| style="text-align:left" | NumberAccumulated ofimpairment operatingat segmentsDecember /31, segment2024
| style="text-align:right" | ( 44,821 )
| style="text-align:right" | —
| style="text-align:right" | 1
| style="text-align:right" | —
| style="text-align:right" | ( 1,886 )
| style="text-align:right" | ( 46,707 )
|-
| style="text-align:left" | NumberNet ofbalance USat subsidiariesDecember /31, subsidiary2025
| style="text-align:right" | —46,756
| style="text-align:right" | 46,781
| style="text-align:right" | —10,204
| style="text-align:right" | 1,993
|-
| style="text-align:leftright" | Reinsurance collateral from reinsurers65,734
| style="text-align:right" | —
| style="text-align:right" | 344.1
| style="text-align:right" | 337.0
|-
| style="text-align:left" | Subsequent Event / Apollo Majority SPAs
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Concentration Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Business combination, consideration transferred
| style="text-align:right" | 555.0
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | High
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Concentration Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, plant and equipment, useful life
| style="text-align:right" | —
| style="text-align:right" | 7 years
| style="text-align:right" | —
|-
| style="text-align:left" | Low
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Concentration Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, plant and equipment, useful life
| style="text-align:right" | —
| style="text-align:right" | 3 years
| style="text-align:right" | —
|-
| style="text-align:left" | AM Best, A+ Rating / Everest Reinsurance Co / Reinsurance recoverable including reinsurance premium paid / Reinsurer concentration risk
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Concentration Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Percent of total
| style="text-align:right" | —
| style="text-align:right" | 11.10%
| style="text-align:right" | 18.00%
|-
| style="text-align:left" | AM Best, A+ Rating / eMaxx Captives / Reinsurance recoverable including reinsurance premium paid / Reinsurer concentration risk
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Concentration Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Percent of total
| style="text-align:right" | —
| style="text-align:right" | 17.70%
| style="text-align:right" | 16.80%
|}
</div>
== Goodwill and Intangible Assets ==
=== Schedule of Goodwill ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 2. Goodwill and Intangible Assets
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:rightcenter" | Dec.Accident 31,and 2025Health
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2024Surety
! class="col-s" style="text-align:rightcenter" | Dec.Construction and 31,Energy 2023Solutions
! style="text-align:center" | Other
! style="text-align:center" | Total
|-
|! style="text-align:left" | Goodwill [Roll Forward]
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Goodwill, grossGross balance at December 31, 2023
| style="text-align:right" | —91,577
| style="text-align:right" | 1126,441781
| style="text-align:right" | 10,204
| style="text-align:right" | 3,879
| style="text-align:right" | 112,441
|-
| style="text-align:left" | Accumulated impairment at December 31, 2023
| style="text-align:right" | ( 44,821 )
| style="text-align:right" | —
| style="text-align:right" | -46,707
| style="text-align:right" | -46,707
|-
| style="text-align:left" | Goodwill, net balance
| style="text-align:right" | 65,734
| style="text-align:right" | 65,734
| style="text-align:right" | —
| style="text-align:right" | ( 1,886 )
| style="text-align:right" | ( 46,707 )
|-
| style="text-align:left" | AccidentNet andbalance Healthat December 31, 2024
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill, gross balance
| style="text-align:right" | —
| style="text-align:right" | 91,577
| style="text-align:right" | 91,577
|-
| style="text-align:left" | Accumulated impairment
| style="text-align:right" | —
| style="text-align:right" | -44,821
| style="text-align:right" | -44,821
|-
| style="text-align:left" | Goodwill, net balance
| style="text-align:right" | 46,756
| style="text-align:right" | 46,756
| style="text-align:right" | —
|-
| style="text-align:left" | Surety
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill, gross balance
| style="text-align:right" | —
| style="text-align:right" | 6,781
| style="text-align:right" | 6,781
|-
| style="text-align:left" | Accumulated impairment
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Goodwill, net balance
| style="text-align:right" | 6,781
| style="text-align:right" | 6,781
| style="text-align:right" | —
|-
| style="text-align:left" | Construction and Energy Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill, gross balance
| style="text-align:right" | —
| style="text-align:right" | 10,204
| style="text-align:right" | 10,204
|-
| style="text-align:left" | Accumulated impairment
| style="text-align:right" | —
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Goodwill, net balance
| style="text-align:right" | 10,204
| style="text-align:right" | 10,204
| style="text-align:right" | —
|-
| style="text-align:left" | Other
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill, gross balance
| style="text-align:right" | —
| style="text-align:right" | 3,879
| style="text-align:right" | 3,879
|-
| style="text-align:left" | Accumulated impairment
| style="text-align:right" | —
| style="text-align:right" | -1,886
| style="text-align:right" | -1,886
|-
| style="text-align:left" | Goodwill, net balance
| style="text-align:right" | 1,993
| style="text-align:right" | 165,993734
| style="text-align:right" | —
|}
</div>
=== Schedule of Intangible Assets and Goodwill ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 2. Goodwill and Intangible Assets
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspan="3" style="text-align:center" | 12 MonthsAgent EndedRelationships
! style="text-align:center" | Non-competes
! style="text-align:center" | Trademarks
! style="text-align:center" | Licenses
! style="text-align:center" | Total
|-
! style="text-align:left" | —Other Intangible Assets
! class="col-s" style="text-align:right" | Dec. 31, 2025—
! class="col-s" style="text-align:right" | Dec. 31, 2024—
! class="col-s" style="text-align:right" | Dec. 31, 2023—
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Finite-LivedGross balance at December 31, 2024
| style="text-align:right" | —24,491
| style="text-align:right" | —1,117
| style="text-align:right" | —999
| style="text-align:right" | 14,019
| style="text-align:right" | 40,626
|-
| style="text-align:left" | Accumulated amortization at December 31, 2024
| style="text-align:right" | ( 17,895 )
| style="text-align:right" | ( 1,117 )
| style="text-align:right" | —
| style="text-align:right" | -19,012
| style="text-align:right" | -17,925
|-
| style="text-align:left" | Amortization
| style="text-align:right" | -1,308
| style="text-align:right" | -1,087
| style="text-align:right" | -1,500
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Gross, beginning balance
| style="text-align:right" | —
| style="text-align:right" | 40,626
| style="text-align:right" | 40,626
|-
| style="text-align:left" | Accumulated amortization
| style="text-align:right" | —
| style="text-align:right" | -( 19,012 )
| style="text-align:right" | -17,925
|-
| style="text-align:left" | Additions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 2,000
|-
| style="text-align:left" | Amortization
| style="text-align:right" | -( 1,308 )
| style="text-align:right" | -1,087
| style="text-align:right" | -1,500
|-
| style="text-align:left" | Gross intangible assets, ending balance
| style="text-align:right" | 22,306
| style="text-align:right" | 21,614
| style="text-align:right" | —
|-
| style="text-align:left" | Trademarks
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 1,308 )
|-
| style="text-align:left" | Indefinite-LivedNet balance at December 31, 2025
| style="text-align:right" | 7,288
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Beginning balance
| style="text-align:right" | 999
| style="text-align:right" | 999
| style="text-align:right" | —
|-
| style="text-align:left" | Additions
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ending balance
| style="text-align:right" | 999
| style="text-align:right" | 999
| style="text-align:right" | 999
|-
| style="text-align:left" | Licenses
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Indefinite-Lived
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Beginning balance
| style="text-align:right" | 14,019
| style="text-align:right" | 1422,019306
|}
| style="text-align:right" | —
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 2. Goodwill and Intangible Assets
! style="text-align:left" | ($ in thousands)
! style="text-align:center" | Agent Relationships
! style="text-align:center" | Non-competes
! style="text-align:center" | Trademarks
! style="text-align:center" | Licenses
! style="text-align:center" | Total
|-
|! style="text-align:left" | AdditionsOther Intangible Assets
|! class="col-s" style="text-align:right" | 0—
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | EndingGross balance at December 31, 2023
| style="text-align:right" | 14,019
| style="text-align:right" | 14,019
| style="text-align:right" | 14,019
|-
| style="text-align:left" | Agent Relationships
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Finite-Lived
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Gross, beginning balance
| style="text-align:right" | 24,491
| style="text-align:right" | 24,491
| style="text-align:right" | —
|-
| style="text-align:left" | Accumulated amortization
| style="text-align:right" | —
| style="text-align:right" | -17,895
| style="text-align:right" | -16,808
|-
| style="text-align:left" | Additions
| style="text-align:right" | 2,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortization
| style="text-align:right" | -1,308
| style="text-align:right" | -1,087
| style="text-align:right" | —
|-
| style="text-align:left" | Net, ending balance
| style="text-align:right" | 7,288
| style="text-align:right" | 6,596
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Accumulated amortization
| style="text-align:right" | —
| style="text-align:right" | -17,895
| style="text-align:right" | -16,808
|-
| style="text-align:left" | Amortization
| style="text-align:right" | -1,308
| style="text-align:right" | -1,087
| style="text-align:right" | —
|-
| style="text-align:left" | Non-competes
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Finite-Lived
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Gross, beginning balance
| style="text-align:right" | 1,117
| style="text-align:right" | 1,117999
| style="text-align:right" | —14,019
| style="text-align:right" | 40,626
|-
| style="text-align:left" | Accumulated amortization at December 31, 2023
| style="text-align:right" | —( 16,808 )
| style="text-align:right" | -( 1,117 )
| style="text-align:right" | -1,117
|-
| style="text-align:left" | Additions
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 17,925 )
|-
| style="text-align:left" | Amortization
| style="text-align:right" | 0( 1,087 )
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Net, ending balance
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Accumulated amortization
| style="text-align:right" | —
| style="text-align:right" | -( 1,117087 )
| style="text-align:right" | -1,117
|-
| style="text-align:left" | AmortizationNet balance at December 31, 2024
| style="text-align:right" | 06,596
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | 999
| style="text-align:right" | 14,019
| style="text-align:right" | 21,614
|}
</div>
=== Narrative ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 2. Goodwill and Intangible Assets
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —Years Ending December 31,
! class="col-s" style="text-align:right" | Dec. 31, 2025Amount
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Goodwill and Intangible Assets Disclosure [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Useful life
| style="text-align:right" | 12 years
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortization of intangible assets
| style="text-align:right" | 1,308
| style="text-align:right" | 1,087
| style="text-align:right" | 1,500
|}
</div>
=== Schedule of Finite-Lived Intangible Assets, Future Amortization Expense ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | $ in Thousands
! class="col-s" style="text-align:right" | Dec. 31, 2025 USD ($)
|-
| style="text-align:left" | Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
| style="text-align:right" | —
|-
| style="text-align:left" | 2026
</div>
=='''3. Investments =='''
* ''Fixed maturity securities, held-to-maturity'' at December 31, 2025, consisted entirely of asset-backed securities not due at a single maturity date <sup>p. 83</sup>.
=== Schedule of Debt Securities, Trading, and Equity Securities, FV-NI ===
* At December 31, 2025, the Company had ''U.S. government agencies mortgage-backed fixed maturity securities'' with a carrying value of approximately $68.5 million pledged as collateral for a loan (the "FHLB Loan") from the Federal Home Loan Bank of Dallas ("FHLB") <sup>p. 83</sup>.
* The Company retains all rights regarding the pledged securities under the terms of the FHLB Loan and the Advances and Security Agreement <sup>p. 83</sup>.
* At December 31, 2025, the Company had ''assets with fair values'' of approximately $69.5 million pledged as collateral for performance obligations under reinsurance agreements <sup>p. 83</sup>.
* The pledged assets for reinsurance agreements included ''residential mortgage-backed securities'' of $57.8 million, ''cash and cash equivalents and other assets'' of $9.5 million, and ''short-term investments'' of $2.2 million <sup>p. 83</sup>.
* The Company retains all rights regarding these pledged securities under the terms of the trust agreements <sup>p. 83</sup>.
* The Company monitors available-for-sale fixed maturity securities for impairment, requiring significant management judgment <sup>p. 83</sup>.
* Factors considered for fixed maturity securities impairment include the issuer's financial condition, receipt of scheduled principal and interest cash flows, and intent to sell before recovery <sup>p. 83</sup>.
* As of December 31, 2025, the Company had ''450 lots of fixed maturity securities'' in an unrealized loss position <sup>p. 83</sup>.
* The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis <sup>p. 83</sup>.
* At December 31, 2025, the Company identified ''credit impairments'' for two available-for-sale securities in the "corporate securities and miscellaneous" category, based on new recovery analysis showing deteriorating conditions <sup>p. 83</sup>.
* For ''U.S. government securities and municipal securities'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>.
* The Company does not intend to sell these U.S. government and municipal securities and expects recovery, thus not considering them impaired <sup>p. 83</sup>.
* For ''corporate securities and miscellaneous'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>.
* The Company reviewed corporate security issuers for adverse changes in financial condition, credit enhancement quality, ratings decreases, or payment failures, and determined declines were interest rate-driven <sup>p. 83</sup>.
* The Company does not intend to sell these corporate securities and expects recovery, thus not considering them impaired <sup>p. 83</sup>.
* For ''residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>.
* The Company does not intend to sell these mortgage-backed and asset-backed securities and expects recovery, thus not considering them impaired <sup>p. 83</sup>.
* Various state regulations require the Company to maintain ''cash, investment securities, or letters of credit on deposit'' with states <sup>p. 83</sup>.
* At December 31, 2025, ''cash and investment securities on deposit'' had carrying values of approximately $70.0 million <sup>p. 83</sup>.
* At December 31, 2024, ''cash and investment securities on deposit'' had carrying values of approximately $66.8 million <sup>p. 83</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in thousands)Investments
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31,Amortized 2025Cost
! class="col-s" style="text-align:rightcenter" | Dec.Gross 31,Unrealized 2024Gains
! class="col-s" style="text-align:rightcenter" | Dec.Gross 31,Unrealized 2023Losses
! style="text-align:center" | Allowance for Credit Losses
! style="text-align:center" | Fair Value
|-
|! style="text-align:left" | FixedDecember maturity securities31, available-for-sale:2025
|! style="text-align:rightcenter" | —
|! style="text-align:rightcenter" | —
|! style="text-align:rightcenter" | —
! style="text-align:center" |
! style="text-align:center" |
|-
|! style="text-align:left" | AmortizedFixed Costmaturity securities, available-for-sale:
|! class="col-s" style="text-align:right" | 1,848,755—
|! class="col-s" style="text-align:right" | 1,320,266—
|! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | GrossU.S. Unrealizedgovernment Gainssecurities
| style="text-align:right" | 3144,378190
| style="text-align:right" | 10,636292
| style="text-align:right" | ( 14 )
| style="text-align:right" | —
| style="text-align:right" | 44,468
|-
| style="text-align:left" | GrossCorporate Unrealizedsecurities Lossesand miscellaneous
| style="text-align:right" | -16632,830244
| style="text-align:right" | -3814,684223
| style="text-align:right" | ( 3,080 )
| style="text-align:right" | ( 7,000 )
| style="text-align:right" | 636,387
|-
| style="text-align:left" | Municipal securities
| style="text-align:right" | 102,691
| style="text-align:right" | 1,725
| style="text-align:right" | ( 2,300 )
| style="text-align:right" | —
| style="text-align:right" | 102,116
|-
| style="text-align:left" | AllowanceResidential formortgage-backed Credit Lossessecurities
| style="text-align:right" | -7487,000145
| style="text-align:right" | 08,928
| style="text-align:right" | ( 9,486 )
| style="text-align:right" | —
| style="text-align:right" | 486,587
|-
| style="text-align:left" | FairCommercial Valuemortgage-backed securities
| style="text-align:right" | 172,856,303631
| style="text-align:right" | 1,292,218016
| style="text-align:right" | ( 597 )
| style="text-align:right" | —
| style="text-align:right" | 73,050
|-
| style="text-align:left" | FixedOther maturityasset-backed securities, held-to-maturity:
| style="text-align:right" | —509,854
| style="text-align:right" | —5,194
| style="text-align:right" | ( 1,353 )
| style="text-align:right" | —
| style="text-align:right" | 513,695
|-
| style="text-align:left; font-weight:bold" | AmortizedTotal fixed maturity securities, Costavailable-for-sale
| style="text-align:right; font-weight:bold" | 331,848,290755
| style="text-align:right; font-weight:bold" | 3931,396378
| style="text-align:right; font-weight:bold" | —( 16,830 )
| style="text-align:right; font-weight:bold" | ( 7,000 )
| style="text-align:right; font-weight:bold" | 1,856,303
|-
| style="text-align:left" | GrossOther Unrealizedasset-backed Gainssecurities
| style="text-align:right" | 33,290
| style="text-align:right" | 829
| style="text-align:right" | 0( 48 )
| style="text-align:right" | —( 468 )
| style="text-align:right" | 33,603
|-
| style="text-align:left; font-weight:bold" | GrossTotal fixed maturity Unrealizedsecurities, Lossesheld-to-maturity
| style="text-align:right; font-weight:bold" | -4833,290
| style="text-align:right; font-weight:bold" | -436829
| style="text-align:right; font-weight:bold" | —( 48 )
| style="text-align:right; font-weight:bold" | ( 468 )
| style="text-align:right; font-weight:bold" | 33,603
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 3. Investments
! style="text-align:left" | ($ in thousands)
! style="text-align:center" | Amortized Cost
! style="text-align:center" | Gross Unrealized Gains
! style="text-align:center" | Gross Unrealized Loss
! style="text-align:center" | Allowance for Credit Losses
! style="text-align:center" | Fair Value
|-
|! style="text-align:left" | Allowance forDecember Credit31, Losses2024
|! style="text-align:rightcenter" | -468
|! style="text-align:rightcenter" | -243
|! style="text-align:rightcenter" | -329
! style="text-align:center" |
! style="text-align:center" |
|-
|! style="text-align:left" | FairFixed Valuematurity securities, available-for-sale:
|! class="col-s" style="text-align:right" | 33,603—
|! class="col-s" style="text-align:right" | 38,717—
|! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | U.S. government securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 44,190
| style="text-align:right" | 26,577
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Gains
| style="text-align:right" | 292
| style="text-align:right" | 35
| style="text-align:right" | ( 126 )
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Losses
| style="text-align:right" | -14
| style="text-align:right" | -126
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for Credit Losses
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | 44,468
| style="text-align:right" | 26,486
| style="text-align:right" | —
|-
| style="text-align:left" | Corporate securities and miscellaneous
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 632,244
| style="text-align:right" | 433,298
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Gains
| style="text-align:right" | 14,223
| style="text-align:right" | 5,618
| style="text-align:right" | ( 13,288 )
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Losses
| style="text-align:right" | -3,080
| style="text-align:right" | -13,288
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for Credit Losses
| style="text-align:right" | -7,000
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | 636,387
| style="text-align:right" | 425,628
| style="text-align:right" | —
|-
| style="text-align:left" | Municipal securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 102,691
| style="text-align:right" | 89,966
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Gains
| style="text-align:right" | 1,725
| style="text-align:right" | 116
| style="text-align:right" | ( 5,366 )
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Losses
| style="text-align:right" | -2,300
| style="text-align:right" | -5,366
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for Credit Losses
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | 102,116
| style="text-align:right" | 84,716
| style="text-align:right" | —
|-
| style="text-align:left" | Residential mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 487,145
| style="text-align:right" | 408,585
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Gains
| style="text-align:right" | 8,928
| style="text-align:right" | 1,875
| style="text-align:right" | ( 16,627 )
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Losses
| style="text-align:right" | -9,486
| style="text-align:right" | -16,627
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for Credit Losses
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | 486,587
| style="text-align:right" | 393,833
| style="text-align:right" | —
|-
| style="text-align:left" | Commercial mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 72,631
| style="text-align:right" | 70,262
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Gains
| style="text-align:right" | 1,016
| style="text-align:right" | 545
| style="text-align:right" | ( 1,443 )
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Losses
| style="text-align:right" | -597
| style="text-align:right" | -1,443
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for Credit Losses
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | 73,050
| style="text-align:right" | 69,364
| style="text-align:right" | —
|-
| style="text-align:left" | Other asset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 509,854
| style="text-align:right" | 291,578
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Gains
| style="text-align:right" | 5,194
| style="text-align:right" | 2,447
| style="text-align:right" | ( 1,834 )
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Unrealized Losses
| style="text-align:right" | -1,353
| style="text-align:right" | -1,834
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for Credit Losses
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | 513,695
| style="text-align:right" | 292,191
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | FixedTotal fixed maturity securities, heldavailable-tofor-maturity:sale
| style="text-align:right; font-weight:bold" | —1,320,266
| style="text-align:right; font-weight:bold" | —10,636
| style="text-align:right; font-weight:bold" | —( 38,684 )
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 1,292,218
|-
| style="text-align:left" | AmortizedOther Costasset-backed securities
| style="text-align:right" | 33,290
| style="text-align:right" | 39,396
| style="text-align:right" | —
| style="text-align:right" | ( 436 )
| style="text-align:right" | ( 243 )
| style="text-align:right" | 38,717
|-
| style="text-align:left; font-weight:bold" | GrossTotal fixed maturity Unrealizedsecurities, Gainsheld-to-maturity
| style="text-align:right; font-weight:bold" | 82939,396
| style="text-align:right; font-weight:bold" | 0—
| style="text-align:right; font-weight:bold" | —( 436 )
| style="text-align:right; font-weight:bold" | ( 243 )
|-
| style="text-align:leftright; font-weight:bold" | Gross Unrealized Losses38,717
| style="text-align:right" | -48
| style="text-align:right" | -436
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for Credit Losses
| style="text-align:right" | -468
| style="text-align:right" | -243
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | 33,603
| style="text-align:right" | 38,717
| style="text-align:right" | —
|}
</div>
=== Schedule of Investments Classified by Contractual Maturity Date ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in thousands)Investments
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:right" | Dec.Amortized 31, 2025Cost
! class="col-s" style="text-align:right" | Dec.Fair 31, 2024Value
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Due in less than one year
| style="text-align:right" | 45,682
| style="text-align:right" | —45,478
|-
| style="text-align:left" | Due after one year through five years
| style="text-align:right" | 449,790
| style="text-align:right" | —449,145
|-
| style="text-align:left" | Due after five years through ten years
| style="text-align:right" | 219,293
| style="text-align:right" | —224,696
|-
| style="text-align:left" | Due after ten years
| style="text-align:right" | 64,360
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 1,848,755
| style="text-align:right" | 1,320,266
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Due in less than one year
| style="text-align:right" | 45,478
| style="text-align:right" | —
|-
| style="text-align:left" | Due after one year through five years
| style="text-align:right" | 449,145
| style="text-align:right" | —
|-
| style="text-align:left" | Due after five years through ten years
| style="text-align:right" | 224,696
| style="text-align:right" | —
|-
| style="text-align:left" | Due after ten years
| style="text-align:right" | 63,652
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1,856,303
| style="text-align:right; font-weight:bold" | 1,292,218
|-
| style="text-align:left" | Mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Without single maturity date
| style="text-align:right" | 559,776
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Without single maturity date
| style="text-align:right" | 559,637
| style="text-align:right" | —
|-
| style="text-align:left" | Other asset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Without single maturity date
| style="text-align:right" | 509,854
| style="text-align:right" | —
|-
| style="text-align:left" | Amortized Cost
| style="text-align:right" | 509,854
| style="text-align:right" | 291,578
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Without single maturity date
| style="text-align:right" | 513,695
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 5131,695848,755
| style="text-align:right; font-weight:bold" | 2921,191856,303
|}
</div>
=== Narrative ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in millions)Investments
! style="text-align:left" | $ in Millions
! classcolspan="col-s2" style="text-align:rightcenter" | Dec. 31, 2025 USDLess ($)than security12 lotMonths
! classcolspan="col-s2" style="text-align:rightcenter" | Dec. 31,12 2024Months USDor ($)More
! colspan="2" style="text-align:center" | Total
|-
|! style="text-align:left" | Debt Securities, Available-for-Sale($ [Linein Items]thousands)
|! style="text-align:rightcenter" | —Fair Value
|! style="text-align:rightcenter" | —Gross Unrealized Losses
! style="text-align:center" | Fair Value
! style="text-align:center" | Gross Unrealized Losses
! style="text-align:center" | Fair Value
! style="text-align:center" | Gross Unrealized Losses
|-
|! style="text-align:left" | SecuritiesDecember held as collateral31, at fair value2025
|! style="text-align:rightcenter" | 69.5
|! style="text-align:rightcenter" | —
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
|! style="text-align:left" | NumberFixed ofmaturity securities, / lotavailable-for-sale:
|! class="col-s" style="text-align:right" | 450—
|! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
|! class="col-s" style="text-align:leftright" | Number of securities, allowance for credit loss / security—
|! class="col-s" style="text-align:right" | 2—
|! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Cash and investment securities on deposit had carrying values
| style="text-align:right" | 70.0
| style="text-align:right" | 66.8
|-
| style="text-align:left" | US Treasury and Government
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Securities, Available-for-Sale [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Securities held as collateral, at fair value
| style="text-align:right" | 57.8
| style="text-align:right" | —
|-
| style="text-align:left" | Cash and Cash Equivalents and Other Assets
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Securities, Available-for-Sale [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Securities held as collateral, at fair value
| style="text-align:right" | 9.5
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term investments
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Securities, Available-for-Sale [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Securities held as collateral, at fair value
| style="text-align:right" | 2.2
| style="text-align:right" | —
|-
| style="text-align:left" | U.S. government securities
| style="text-align:right" | —349
| style="text-align:right" | —( 1 )
| style="text-align:right" | 1,565
| style="text-align:right" | ( 13 )
| style="text-align:right" | 1,914
| style="text-align:right" | ( 14 )
|-
| style="text-align:left" | DebtCorporate Securities,securities Available-for-Saleand [Line Items]miscellaneous
| style="text-align:right" | —67,644
| style="text-align:right" | —( 346 )
| style="text-align:right" | 63,575
| style="text-align:right" | ( 2,734 )
| style="text-align:right" | 131,219
| style="text-align:right" | ( 3,080 )
|-
| style="text-align:left" | SecuritiesMunicipal held as collateral, at fair valuesecurities
| style="text-align:right" | 68.519,157
| style="text-align:right" | —( 400 )
| style="text-align:right" | 22,004
|}
| style="text-align:right" | ( 1,900 )
</div>
| style="text-align:right" | 41,161
| style="text-align:right" | ( 2,300 )
=== Schedule of Unrealized Loss on Investments ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | AvailableResidential formortgage-backed sale, fair valuesecurities
| style="text-align:right" | —56,147
| style="text-align:right" | —( 262 )
| style="text-align:right" | 74,075
| style="text-align:right" | ( 9,224 )
| style="text-align:right" | 130,222
| style="text-align:right" | ( 9,486 )
|-
| style="text-align:left" | LessCommercial thanmortgage-backed 12 Monthssecurities
| style="text-align:right" | 2334,041646
| style="text-align:right" | 480,693( 3 )
| style="text-align:right" | 8,363
| style="text-align:right" | ( 594 )
| style="text-align:right" | 13,009
| style="text-align:right" | ( 597 )
|-
| style="text-align:left" | 12Other Monthsasset-backed or Moresecurities
| style="text-align:right" | 18585,663098
| style="text-align:right" | 236,741( 424 )
| style="text-align:right" | 16,081
| style="text-align:right" | ( 929 )
| style="text-align:right" | 101,179
| style="text-align:right" | ( 1,353 )
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 233,041
| style="text-align:right; font-weight:bold" | ( 1,436 )
| style="text-align:right; font-weight:bold" | 185,663
| style="text-align:right; font-weight:bold" | ( 15,394 )
| style="text-align:right; font-weight:bold" | 418,704
| style="text-align:right; font-weight:bold" | 717( 16,434830 )
|-
| style="text-align:left" | AvailableOther forasset-backed sale, gross unrealized lossessecurities
| style="text-align:right" | 1,912
| style="text-align:right" | ( 48 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -1,436
| style="text-align:right" | -7,353
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | -15,394
| style="text-align:right" | -31,331
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -16,830
| style="text-align:right; font-weight:bold" | -38,684
|-
| style="text-align:left" | Held-to-maturity, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 1,912
| style="text-align:right" | 2,144( 48 )
|-
| style="text-align:left; font-weight:bold" | 12Total fixed Monthsmaturity orsecurities, Moreheld-to-maturity:
| style="text-align:right" | 0
| style="text-align:right" | 36,573
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1,912
| style="text-align:right; font-weight:bold" | 38,717( 48 )
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:leftright; font-weight:bold" | Held-to-maturity, gross unrealized losses—
| style="text-align:right; font-weight:bold" | —1,912
| style="text-align:right; font-weight:bold" | —( 48 )
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -48
| style="text-align:right" | -2
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 0
| style="text-align:right" | -434
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -48
| style="text-align:right; font-weight:bold" | -436
|-
| style="text-align:left" | Available-for-sale and held-to-maturity, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 234,953
| style="text-align:right" | 482,837
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 185,663
| style="text-align:right" | 273,314
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 234,953
| style="text-align:right; font-weight:bold" | ( 1,484 )
| style="text-align:right; font-weight:bold" | 185,663
| style="text-align:right; font-weight:bold" | ( 15,394 )
| style="text-align:right; font-weight:bold" | 420,616
| style="text-align:right; font-weight:bold" | 756( 16,151878 )
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 3. Investments
! style="text-align:left" |
! colspan="2" style="text-align:center" | Less than 12 Months
! colspan="2" style="text-align:center" | 12 Months or More
! colspan="2" style="text-align:center" | Total
|-
|! style="text-align:left" | Available-for-sale and held-to-maturity, gross($ unrealizedin lossesthousands)
|! style="text-align:rightcenter" | —Fair Value
|! style="text-align:rightcenter" | —Gross Unrealized Losses
! style="text-align:center" | Fair Value
! style="text-align:center" | Gross Unrealized Losses
! style="text-align:center" | Fair Value
! style="text-align:center" | Gross Unrealized Losses
|-
|! style="text-align:left" | Less thanDecember 1231, Months2024
|! style="text-align:rightcenter" | -1,484
|! style="text-align:rightcenter" | -7,355
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
|! style="text-align:left" | 12Fixed Monthsmaturity orsecurities, Moreavailable-for-sale:
|! class="col-s" style="text-align:right" | -15,394—
|! class="col-s" style="text-align:right" | -31,765—
! class="col-s" style="text-align:right" | —
|-
|! class="col-s" style="text-align:left; font-weight:boldright" | Total—
|! class="col-s" style="text-align:right; font-weight:bold" | -16,878—
|! class="col-s" style="text-align:right; font-weight:bold" | -39,120—
|-
| style="text-align:left" | U.S. government securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Available for sale, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 349
| style="text-align:right" | 15,938
| style="text-align:right" | ( 34 )
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 1,565
| style="text-align:right" | 2,297
| style="text-align:right" | ( 92 )
|-
| style="text-align:left; font-weight:boldright" | Total18,235
| style="text-align:right; font-weight:bold" | 1,914( 126 )
| style="text-align:right; font-weight:bold" | 18,235
|-
| style="text-align:left" | Available for sale, gross unrealized losses
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -1
| style="text-align:right" | -34
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | -13
| style="text-align:right" | -92
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -14
| style="text-align:right; font-weight:bold" | -126
|-
| style="text-align:left" | Corporate securities and miscellaneous
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Available for sale, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 67,644
| style="text-align:right" | 136,888
| style="text-align:right" | ( 2,060 )
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 63,575
| style="text-align:right" | 81,232
| style="text-align:right" | ( 11,228 )
|-
| style="text-align:left; font-weight:boldright" | Total218,120
| style="text-align:right; font-weight:bold" | 131( 13,219288 )
| style="text-align:right; font-weight:bold" | 218,120
|-
| style="text-align:left" | Available for sale, gross unrealized losses
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -346
| style="text-align:right" | -2,060
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | -2,734
| style="text-align:right" | -11,228
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -3,080
| style="text-align:right; font-weight:bold" | -13,288
|-
| style="text-align:left" | Municipal securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Available for sale, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 19,157
| style="text-align:right" | 41,930
| style="text-align:right" | ( 1,046 )
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 22,004
| style="text-align:right" | 27,687
| style="text-align:right" | ( 4,320 )
|-
| style="text-align:left; font-weight:boldright" | Total69,617
| style="text-align:right; font-weight:bold" | 41( 5,161366 )
| style="text-align:right; font-weight:bold" | 69,617
|-
| style="text-align:left" | Available for sale, gross unrealized losses
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -400
| style="text-align:right" | -1,046
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | -1,900
| style="text-align:right" | -4,320
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -2,300
| style="text-align:right; font-weight:bold" | -5,366
|-
| style="text-align:left" | Residential mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Available for sale, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 56,147
| style="text-align:right" | 201,407
| style="text-align:right" | ( 3,366 )
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 74,075
| style="text-align:right" | 82,496
| style="text-align:right" | ( 13,261 )
|-
| style="text-align:left; font-weight:boldright" | Total283,903
| style="text-align:right; font-weight:bold" | 130( 16,222627 )
| style="text-align:right; font-weight:bold" | 283,903
|-
| style="text-align:left" | Available for sale, gross unrealized losses
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -262
| style="text-align:right" | -3,366
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | -9,224
| style="text-align:right" | -13,261
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -9,486
| style="text-align:right; font-weight:bold" | -16,627
|-
| style="text-align:left" | Commercial mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Available for sale, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 4,646
| style="text-align:right" | 9,411
| style="text-align:right" | ( 126 )
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 8,363
| style="text-align:right" | 13,178
| style="text-align:right" | ( 1,317 )
|-
| style="text-align:left; font-weight:boldright" | Total22,589
| style="text-align:right; font-weight:bold" | 13( 1,009443 )
| style="text-align:right; font-weight:bold" | 22,589
|-
| style="text-align:left" | Available for sale, gross unrealized losses
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -3
| style="text-align:right" | -126
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | -594
| style="text-align:right" | -1,317
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -597
| style="text-align:right; font-weight:bold" | -1,443
|-
| style="text-align:left" | Other asset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Available for sale, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 85,098
| style="text-align:right" | 75,119
| style="text-align:right" | ( 721 )
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 16,081
| style="text-align:right" | 29,851
| style="text-align:right" | ( 1,113 )
| style="text-align:right" | 104,970
| style="text-align:right" | ( 1,834 )
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 101480,179693
| style="text-align:right; font-weight:bold" | 104( 7,970353 )
| style="text-align:right; font-weight:bold" | 236,741
| style="text-align:right; font-weight:bold" | ( 31,331 )
| style="text-align:right; font-weight:bold" | 717,434
| style="text-align:right; font-weight:bold" | ( 38,684 )
|-
| style="text-align:left" | AvailableOther forasset-backed sale, gross unrealized lossessecurities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -424
| style="text-align:right" | -721
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | -929
| style="text-align:right" | -1,113
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -1,353
| style="text-align:right; font-weight:bold" | -1,834
|-
| style="text-align:left" | Held-to-maturity, fair value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | 1,912
| style="text-align:right" | 2,144
| style="text-align:right" | ( 2 )
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 0
| style="text-align:right" | 36,573
| style="text-align:right" | ( 434 )
| style="text-align:right" | 38,717
| style="text-align:right" | ( 436 )
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity:
| style="text-align:right; font-weight:bold" | 12,912144
| style="text-align:right; font-weight:bold" | ( 2 )
| style="text-align:right; font-weight:bold" | 36,573
| style="text-align:right; font-weight:bold" | ( 434 )
| style="text-align:right; font-weight:bold" | 38,717
| style="text-align:right; font-weight:bold" | ( 436 )
|-
| style="text-align:left" | Held-to-maturity, gross unrealized losses
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Less than 12 Months
| style="text-align:right" | -48
| style="text-align:right" | -2
|-
| style="text-align:left" | 12 Months or More
| style="text-align:right" | 0
| style="text-align:right" | -434
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -48482,837
| style="text-align:right; font-weight:bold" | -436( 7,355 )
| style="text-align:right; font-weight:bold" | 273,314
| style="text-align:right; font-weight:bold" | ( 31,765 )
| style="text-align:right; font-weight:bold" | 756,151
| style="text-align:right; font-weight:bold" | ( 39,120 )
|}
</div>
=== Schedule of Changes in Allowance for Credit Loss ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in thousands)Investments
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspan="2" style="text-align:center" | 12Fixed MonthsMaturity EndedSecurities, Available-For-Sale
! style="text-align:center" | Fixed Maturity Securities, Held-to-Maturity
|-
! style="text-align:left" | —Balance at December 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2025—
! class="col-s" style="text-align:right" | Dec. 31, 2024243
|-
| style="text-align:left" | Fixed Maturity Securities, Available-For-Sale
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Beginning balance
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Current period provision for credit losses
| style="text-align:right" | 7,000
| style="text-align:right" | —257
|-
| style="text-align:left" | Recoveries of amounts previously written off
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | ( 32 )
|-
| style="text-align:left" | EndingBalance balanceat December 31, 2025
| style="text-align:right" | 7,000
| style="text-align:right" | 0468
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 3. Investments
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Held-to-Maturity
|-
| style="text-align:left" | FixedBalance Maturityat SecuritiesDecember 31, Held-to-Maturity2023
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Beginning balance
| style="text-align:right" | 243
| style="text-align:right" | 329
|-
| style="text-align:left" | Current period provision for credit losses
| style="text-align:right" | 257
| style="text-align:right" | 18
|-
| style="text-align:left" | Recoveries of amounts previously written off
| style="text-align:right" | -32( 104 )
| style="text-align:right" | -104
|-
| style="text-align:left" | EndingBalance balanceat December 31, 2024
| style="text-align:right" | 468
| style="text-align:right" | 243
|}
</div>
=== Schedule of Gain (Loss) on Securities ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in thousands)Investments
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspan="3" style="text-align:center" | 12 Months Ended2025
! style="text-align:center" | 2024
! style="text-align:center" | 2023
|-
! style="text-align:left" | —Gross realized gains
! class="col-s" style="text-align:right" | Dec. 31, 2025—
! class="col-s" style="text-align:right" | Dec. 31, 2024—
! class="col-s" style="text-align:right" | Dec. 31, 2023—
|-
| style="text-align:left" | Gross realized gains
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 10,937
| style="text-align:right; font-weight:bold" | 7,079
|-
| style="text-align:left" | Gross realized losses
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale
| style="text-align:right" | -( 10,832 )
| style="text-align:right" | -( 8,161 )
| style="text-align:right" | -( 1,879 )
|-
| style="text-align:left" | Equity securities
| style="text-align:right" | -( 3,000 )
| style="text-align:right" | -( 4,132 )
| style="text-align:right" | -( 5,256 )
|-
| style="text-align:left" | Other
| style="text-align:right" | -( 413 )
| style="text-align:right" | -( 223 )
| style="text-align:right" | -( 20 )
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | -( 14,245 )
| style="text-align:right; font-weight:bold" | -( 12,516 )
| style="text-align:right; font-weight:bold" | -( 7,155 )
|-
| style="text-align:left" | Net unrealized gains (losses) on investments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Equity securities
| style="text-align:right" | -( 22,908 )
| style="text-align:right" | 7,500
| style="text-align:right" | 11,516
|-
| style="text-align:left" | Mortgage loans
| style="text-align:right" | -( 7 )
| style="text-align:right" | 421
| style="text-align:right" | -( 386 )
|-
| style="text-align:left" | Other
| style="text-align:right" | 21,360
| style="text-align:right" | 0—
| style="text-align:right" | 0—
|-
| style="text-align:left" | Net investment gains
|}
</div>
=== Schedule of Proceeds from Sales ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in thousands)Investments
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
|-
! class="col-s" style="text-align:leftright" | —2023
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Investments, Debt and Equity Securities [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale
|}
</div>
=== Schedule of Net Investment Income ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in thousands)Investments
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspan="3" style="text-align:center" | 12 Months Ended2025
! style="text-align:center" | 2024
! style="text-align:center" | 2023
|-
! style="text-align:left" | —Income (loss):
! class="col-s" style="text-align:right" | Dec. 31, 2025—
! class="col-s" style="text-align:right" | Dec. 31, 2024—
! class="col-s" style="text-align:right" | Dec. 31, 2023—
|-
| style="text-align:left" | Net Investment Income [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 87,666
| style="text-align:right; font-weight:bold" | 87,513
| style="text-align:right; font-weight:bold" | 45,897
|-
| style="text-align:left" | Investment expenses
| style="text-align:right" | -4,047
| style="text-align:right" | -6,913
| style="text-align:right" | -5,557
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 83,619
| style="text-align:right" | 80,600
| style="text-align:right" | 40,340
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale
| style="text-align:right" | —80,302
| style="text-align:right" | —57,574
| style="text-align:right" | —34,703
|-
| style="text-align:left" | Net Investment Income [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 80,302
| style="text-align:right; font-weight:bold" | 57,574
| style="text-align:right; font-weight:bold" | 34,703
|-
| style="text-align:left" | Fixed maturity securities, held-to-maturity
| style="text-align:right" | —( 804 )
| style="text-align:right" | —4,091
| style="text-align:right" | —4,181
|-
| style="text-align:left" | Net Investment Income [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | -804
| style="text-align:right; font-weight:bold" | 4,091
| style="text-align:right; font-weight:bold" | 4,181
|-
| style="text-align:left" | Equity securities
| style="text-align:right" | —1,223
| style="text-align:right" | —2,720
| style="text-align:right" | —3,418
|-
| style="text-align:left" | Net Investment Income [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 1,223
| style="text-align:right; font-weight:bold" | 2,720
| style="text-align:right; font-weight:bold" | 3,418
|-
| style="text-align:left" | Equity method investments
| style="text-align:right" | —( 2,683 )
| style="text-align:right" | —2,524
| style="text-align:right" | —( 9,434 )
|-
| style="text-align:left" | Net Investment Income [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | -2,683
| style="text-align:right; font-weight:bold" | 2,524
| style="text-align:right; font-weight:bold" | -9,434
|-
| style="text-align:left" | Mortgage loans
| style="text-align:right" | —1,622
| style="text-align:right" | —5,153
| style="text-align:right" | —5,474
|-
| style="text-align:left" | Net Investment Income [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 1,622
| style="text-align:right; font-weight:bold" | 5,153
| style="text-align:right; font-weight:bold" | 5,474
|-
| style="text-align:left" | Indirect loans
| style="text-align:right" | —( 8,129 )
| style="text-align:right" | —( 2,400 )
| style="text-align:right" | —( 4,155 )
|-
| style="text-align:left" | Net Investment Income [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | -8,129
| style="text-align:right; font-weight:bold" | -2,400
| style="text-align:right; font-weight:bold" | -4,155
|-
| style="text-align:left" | Short-term investments and cash
| style="text-align:right" | —12,828
| style="text-align:right" | —14,851
| style="text-align:right" | —11,392
|-
| style="text-align:left" | Net Investment Income [Line Items]Other
| style="text-align:right" | —3,307
| style="text-align:right" | —3,000
| style="text-align:right" | —318
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 1287,828666
| style="text-align:right; font-weight:bold" | 1487,851513
| style="text-align:right; font-weight:bold" | 1145,392897
|-
| style="text-align:left" | OtherInvestment expenses
| style="text-align:right" | —( 4,047 )
| style="text-align:right" | —( 6,913 )
| style="text-align:right" | —( 5,557 )
|-
| style="text-align:left" | Net Investmentinvestment Income [Line Items]income
| style="text-align:right" | —83,619
| style="text-align:right" | —80,600
| style="text-align:right" | —40,340
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 3,307
| style="text-align:right; font-weight:bold" | 3,000
| style="text-align:right; font-weight:bold" | 318
|}
</div>
=== Schedule of Accumulated Other Comprehensive Income (Loss) ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($3. in thousands)Investments
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
|-
! class="col-s" style="text-align:leftright" | —2023
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Investments, Debt and Equity Securities [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities
|-
| style="text-align:left" | Deferred income taxes
| style="text-align:right" | -( 9,017 )
| style="text-align:right" | -( 213 )
| style="text-align:right" | -( 5,420 )
|-
| style="text-align:left; font-weight:bold" | Total other comprehensive income
| style="text-align:right; font-weight:bold" | 33,577
| style="text-align:right; font-weight:bold" | 833
</div>
=='''4. Fair Value Measurements =='''
* The Company's financial instruments include assets and liabilities carried at fair value, and those carried at cost or amortized cost but disclosed at fair value <sup>p. 84</sup>.
=== Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3 - Measurement Input, Incremental Cost of Capital ===
* The market approach is generally used to determine fair value, based on prices and data from market transactions of identical or comparable assets and liabilities <sup>p. 84</sup>.
* Fair value of investments is determined using data primarily from third-party investment managers or pricing vendors <sup>p. 84</sup>.
* Periodic analyses are conducted on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month fluctuations and comparing valuations from different pricing services for identical securities <sup>p. 84</sup>.
* Financial instruments are classified into a three-level hierarchy <sup>p. 84</sup>.
* ''Level 1 inputs'' are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date <sup>p. 84</sup>.
* ''Level 2 inputs'' are observable inputs other than Level 1 quoted prices, corroborated with market data at the measurement date <sup>p. 84</sup>.
* ''Level 3 inputs'' are unobservable inputs reflecting management's best estimate of what market participants would use in pricing the asset or liability at the measurement date <sup>p. 84</sup>.
* ''U.S. government securities, mutual funds, and common stock'' use unadjusted quoted prices for identical instruments in an active exchange, representing Level 1 inputs <sup>p. 84</sup>.
* ''Preferred stocks, municipal securities, corporate securities, and miscellaneous'' use a pricing model with market-based inputs like trades in illiquid markets for specific securities or active markets for similar securities, considering benchmark yields, issuer spreads, security terms, and other market data, representing Level 2 fair value inputs <sup>p. 84</sup>.
* ''Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities'' use a pricing model with market-based inputs such as dealer quotes, market spreads, and yield curves, evaluating individual tranches by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs <sup>p. 84</sup>.
* ''Fixed maturity securities, available for sale classified as Level 3'', include corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent pricing provider <sup>p. 84</sup>.
* The provider estimates the value of these Level 3 securities using the discounted net present value of cash flows method with an unobservable discount rate <sup>p. 84</sup>.
* The ''discount rate spread'' for Level 3 fixed maturity securities represents the risk associated with future cash flows, including inflation, opportunity cost, and time value of money <sup>p. 84</sup>.
* ''Mortgage loans'' have variable interest rates and are collateralized by real property <sup>p. 84</sup>.
* Fair value of mortgage loans is determined using the income approach with observable and unobservable (Level 3) inputs <sup>p. 84</sup>.
* The ''unobservable input'' for mortgage loans is the spread applied to a prime rate for discounting cash flows, representing the incremental cost of capital based on borrower's ability to pay and collateral value relative to loan balance, subject to judgment and uncertainty <sup>p. 84</sup>.
* ''Derivatives'', consisting of exchange-traded options contracts, are included in other assets <sup>p. 84</sup>.
* The fair values of these options are measured using quoted prices in active markets on the relevant exchange, specifically the volume-weighted average price of trades in similar contracts or the last trade settlement price, representing Level 1 inputs <sup>p. 84</sup>.
* Certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, are measured at fair value on a nonrecurring basis only when impaired <sup>p. 84</sup>.
* The Company discloses fair values of other financial instruments where practicable to estimate, using quoted market prices or other valuation methodologies <sup>p. 84</sup>.
* ''Fixed maturity securities, held-to-maturity'', consisting of senior and junior notes with target rates of return, had their fair value determined using the income approach with unobservable (Level 3) inputs as of December 31, 2025 <sup>p. 84</sup>.
* ''Investment in RedBird Capital Partners'', a limited partnership investing in Bishop Street Underwriters, LLC (MGA), had a fair value of USD 55.6m at December 31, 2025, and USD 28.2m at December 31, 2024, determined using net asset value <sup>p. 84</sup>.
* Procedures to assess the reasonableness of this investment's fair value include obtaining and reviewing audited financial statements <sup>p. 84</sup>.
* The ''unfunded commitment'' related to the RedBird Capital Partners investment was USD 18.3m at December 31, 2025, and USD 24.4m at December 31, 2024 <sup>p. 84</sup>.
* The Company may sell its interest in this investment with prior written notice and approval by the general partner <sup>p. 84</sup>.
* This investment is measured at fair value using the net asset value per share practical expedient and is not classified in the fair value hierarchy, in accordance with Accounting Standard Codification 820-10 <sup>p. 84</sup>.
* ''Net earned premiums'' related to this agreement were USD 41.5m for the year ended December 31, 2025, and USD 2.5m for the year ended December 31, 2024 <sup>p. 84</sup>.
* The ''carrying value of notes payable'' approximates their estimated fair value because they accrue interest at current market rates plus a spread <sup>p. 84</sup>.
* Fair value for notes payable is determined using the income approach with observable (Level 2) inputs <sup>p. 84</sup>.
* ''Subordinated debt'', consisting of Unsecured Subordinated Notes due May 24, 2039, has a fixed interest rate <sup>p. 84</sup>.
* The fair value of subordinated debt is determined using the income approach with observable (Level 2) inputs <sup>p. 84</sup>.
* Other financial instruments that qualify as insurance-related products are exempt from fair value disclosure requirements <sup>p. 84</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 4. Fair Value Measurements
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | High
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, measurement input
| style="text-align:right" | 11.10%
| style="text-align:right" | 8.00%
|-
| style="text-align:left" | Loans receivableLow
| style="text-align:right" | 4.25%
| style="text-align:right" | 5.70%
|-
| style="text-align:left" | Weighted average
| style="text-align:right" | 6.40%
| style="text-align:right" | 6.60%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 4. Fair Value Measurements
! style="text-align:left" | —
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2024
|-
| style="text-align:left" | High
| style="text-align:right" | 8.34%
| style="text-align:right" | 10.00%
|-
| style="text-align:left" | Low
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, measurement input
| style="text-align:right" | 4.25%
| style="text-align:right" | 5.70%
|-
| style="text-align:left" | Loans receivable
| style="text-align:right" | 6.55%
| style="text-align:right" | 7.00%
|-
| style="text-align:left" | Weighted average
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, measurement input
| style="text-align:right" | 6.40%
| style="text-align:right" | 6.60%
|-
| style="text-align:left" | Loans receivable
| style="text-align:right" | 7.74%
| style="text-align:right" | 7.93%
|}
</div>
=== Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 4. Fair Value Measurements
|+ ($ in thousands)
! colspan="5" style="text-align:leftcenter" | USD ($) $December in31, Thousands2025
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
|! style="text-align:left" | Fixed($ maturityin securities, available-for-sale:thousands)
|! style="text-align:rightcenter" | —Level 1
|! style="text-align:rightcenter" | —Level 2
! style="text-align:center" | Level 3
! style="text-align:center" | Total
|-
|! style="text-align:left; font-weight:bold" | Total fixedFixed maturity securities, available-for-sale:
|! class="col-s" style="text-align:right; font-weight:bold" | 1,856,303—
|! class="col-s" style="text-align:right; font-weight:bold" | 1,292,218—
! class="col-s" style="text-align:right" | —
|-
|! class="col-s" style="text-align:left; font-weight:boldright" | Total fixed maturity securities, held-to-maturity—
| style="text-align:right; font-weight:bold" | 33,603
| style="text-align:right; font-weight:bold" | 38,717
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 1,174
| style="text-align:right; font-weight:bold" | 106,254
|-
| style="text-align:left" | Mortgage loans
| style="text-align:right" | 9,902
| style="text-align:right" | 26,490
|-
| style="text-align:left" | Short-term investments
| style="text-align:right" | 264,299
| style="text-align:right" | 274,929
|-
| style="text-align:left" | Derivatives
| style="text-align:right" | 34,857
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 2,200,138
| style="text-align:right; font-weight:bold" | 1,738,608
|-
| style="text-align:left" | U.S. government securities
| style="text-align:right" | 44,468
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 44,468
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 44,468
| style="text-align:right; font-weight:bold" | 26,486
|-
| style="text-align:left" | Corporate securities and miscellaneous
| style="text-align:right" | —
| style="text-align:right" | —503,274
| style="text-align:right" | 133,113
|-
| style="text-align:leftright" | Fixed maturity securities636, available-for-sale:387
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 636,387
| style="text-align:right; font-weight:bold" | 425,628
|-
| style="text-align:left" | Municipal securities
| style="text-align:right" | —
| style="text-align:right" | 102,116
| style="text-align:right" | —
| style="text-align:right" | 102,116
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 102,116
| style="text-align:right; font-weight:bold" | 84,716
|-
| style="text-align:left" | Residential mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | 486,587
| style="text-align:right" | —
| style="text-align:right" | 486,587
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 486,587
| style="text-align:right; font-weight:bold" | 393,833
|-
| style="text-align:left" | Commercial mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | 73,050
| style="text-align:right" | —
| style="text-align:right" | 73,050
|-
| style="text-align:left" | FixedOther maturityasset-backed securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 495,891
| style="text-align:right" | 17,804
| style="text-align:right" | 513,695
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 7344,050468
| style="text-align:right; font-weight:bold" | 691,364660,918
| style="text-align:right; font-weight:bold" | 150,917
| style="text-align:right; font-weight:bold" | 1,856,303
|-
| style="text-align:left" | Other asset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 33,603
|-
| style="text-align:leftright" | Fixed maturity securities33, available-for-sale:603
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 513,695
| style="text-align:right; font-weight:bold" | 292,191
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 33,603
| style="text-align:right; font-weight:bold" | 33,603
| style="text-align:right; font-weight:bold" | 38,717
|-
| style="text-align:left" | CommonPreferred stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | 1,174
| style="text-align:right" | —
| style="text-align:right" | 1,174
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 64,251
|-
| style="text-align:left" | Preferred stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 1,174
| style="text-align:right; font-weight:bold" | 1,164
|-
| style="text-align:left" | Mutual funds:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 401,839174
|-
| style="text-align:left" | LevelMortgage 1loans
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 9,902
| style="text-align:right" | 9,902
|-
| style="text-align:left" | FixedShort-term maturity securities, available-for-sale:investments
| style="text-align:right" | 264,299
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 44,468
| style="text-align:right; font-weight:bold" | 26,486
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 105,090
|-
| style="text-align:left" | Mortgage loans
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Short-term investments
| style="text-align:right" | 264,299
| style="text-align:right" | 274,929
|-
| style="text-align:left" | Derivatives
| style="text-align:right" | 34,857
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 34,857
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 343,624
| style="text-align:right; font-weight:bold" | 4061,505662,092
| style="text-align:right; font-weight:bold" | 194,422
| style="text-align:right; font-weight:bold" | 2,200,138
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 4. Fair Value Measurements
! colspan="5" style="text-align:center" | December 31, 2024
|-
|! style="text-align:left" | Level 1 / U.S.($ governmentin securitiesthousands)
|! style="text-align:rightcenter" | —Level 1
|! style="text-align:rightcenter" | —Level 2
! style="text-align:center" | Level 3
! style="text-align:center" | Total
|-
|! style="text-align:left" | Fixed maturity securities, available-for-sale:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | TotalU.S. fixed maturitygovernment securities, available-for-sale
| style="text-align:right; font-weight:bold" | 4426,468486
| style="text-align:right; font-weight:bold" | 26,486
|-
| style="text-align:left" | Level 1 / Corporate securities and miscellaneous
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 26,486
|-
| style="text-align:left" | Fixed maturityCorporate securities, available-for-sale:and miscellaneous
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 354,815
| style="text-align:right" | 70,813
| style="text-align:right" | 425,628
|-
| style="text-align:left; font-weight:bold" | Total fixed maturityMunicipal securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 1 / Municipal securities
| style="text-align:right" | —
| style="text-align:right" | 84,716
| style="text-align:right" | —
| style="text-align:right" | 84,716
|-
| style="text-align:left" | FixedResidential maturitymortgage-backed securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | 393,833
| style="text-align:right" | —
| style="text-align:right" | 393,833
|-
| style="text-align:left; font-weight:bold" | TotalCommercial fixed maturitymortgage-backed securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 1 / Residential mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | 69,364
| style="text-align:right" | —
| style="text-align:right" | 69,364
|-
| style="text-align:left" | FixedOther maturityasset-backed securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 285,084
| style="text-align:right" | 7,107
| style="text-align:right" | 292,191
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 026,486
| style="text-align:right; font-weight:bold" | 01,187,812
| style="text-align:right; font-weight:bold" | 77,920
| style="text-align:right; font-weight:bold" | 1,292,218
|-
| style="text-align:left" | LevelOther 1 / Commercial mortgageasset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 38,717
| style="text-align:right" | 38,717
|-
| style="text-align:left; font-weight:bold" | FixedTotal fixed maturity securities, availableheld-forto-salematurity:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 1 / Other asset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 1 / Common stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 64,251
|-
| style="text-align:left" | Level 1 / Preferred stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 1 / Mutual funds:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 4038,839717
| style="text-align:right; font-weight:bold" | 38,717
|-
| style="text-align:left" | LevelCommon 2stocks
| style="text-align:right" | 64,251
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 64,251
|-
| style="text-align:left" | FixedPreferred maturity securities, available-for-sale:stocks
| style="text-align:right" | —
| style="text-align:right" | 1,164
| style="text-align:right" | —
| style="text-align:right" | 1,164
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities,Mutual available-for-salefunds
| style="text-align:right; font-weight:bold" | 1,66040,918839
| style="text-align:right; font-weight:bold" | 1,187,812
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 1,174
| style="text-align:right; font-weight:bold" | 1,164
|-
| style="text-align:left" | Mortgage loans
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Short-term investments
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Derivatives
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1,662,092
| style="text-align:right; font-weight:bold" | 1,188,976
|-
| style="text-align:left" | Level 2 / U.S. government securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 2 / Corporate securities and miscellaneous
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 503,274
| style="text-align:right; font-weight:bold" | 354,815
|-
| style="text-align:left" | Level 2 / Municipal securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 102,116
| style="text-align:right; font-weight:bold" | 84,716
|-
| style="text-align:left" | Level 2 / Residential mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 486,587
| style="text-align:right; font-weight:bold" | 393,833
|-
| style="text-align:left" | Level 2 / Commercial mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 73,050
| style="text-align:right; font-weight:bold" | 69,364
|-
| style="text-align:left" | Level 2 / Other asset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 495,891
| style="text-align:right; font-weight:bold" | 285,084
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 2 / Common stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 40,839
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —105,090
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 2 / Preferred stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 1,174
| style="text-align:right; font-weight:bold" | 1,164
|-
| style="text-align:left" | Level 2 / Mutual funds:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 0106,254
|-
| style="text-align:left" | LevelMortgage 3loans
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 26,490
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 150,917
| style="text-align:right; font-weight:bold" | 77,920
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity
| style="text-align:right; font-weight:bold" | 33,603
| style="text-align:right; font-weight:bold" | 38,717
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Mortgage loans
| style="text-align:right" | 9,902
| style="text-align:right" | 26,490
|-
| style="text-align:left" | Short-term investments
| style="text-align:right" | 0274,929
| style="text-align:right" | 0
|-
| style="text-align:left" | Derivatives
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 274,929
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 194406,422505
| style="text-align:right; font-weight:bold" | 1,188,976
| style="text-align:right; font-weight:bold" | 143,127
| style="text-align:right; font-weight:bold" | 1,738,608
|-
| style="text-align:left" | Level 3 / U.S. government securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 3 / Corporate securities and miscellaneous
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 133,113
| style="text-align:right; font-weight:bold" | 70,813
|-
| style="text-align:left" | Level 3 / Municipal securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 3 / Residential mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 3 / Commercial mortgage-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 3 / Other asset-backed securities
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale
| style="text-align:right; font-weight:bold" | 17,804
| style="text-align:right; font-weight:bold" | 7,107
|-
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity
| style="text-align:right; font-weight:bold" | 33,603
| style="text-align:right; font-weight:bold" | 38,717
|-
| style="text-align:left" | Level 3 / Common stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 3 / Preferred stocks:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
|-
| style="text-align:left" | Level 3 / Mutual funds:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fixed maturity securities, available-for-sale:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total equity securities
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 0
|}
</div>
=== Schedule of Fair Value, Measure on Recurring Basis, Unobservable Input Reconciliation ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 4. Fair Value Measurements
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="2col-s" style="text-align:centerright" | 12Fixed MonthsMaturity EndedSecurities, Available-For-Sale
! class="col-s" style="text-align:right" | Mortgage Loans
|-
!| style="text-align:left" | —Balance at December 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Fixed Maturity Securities, Available-For-Sale
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Beginning balance
| style="text-align:right" | 77,920
| style="text-align:right" | 026,490
|-
| style="text-align:left; font-weight:bold" | Total gains (losses) for the period recognized in net investment gains (losses)
| style="text-align:right; font-weight:bold" | -( 5,180 )
| style="text-align:right; font-weight:bold" | -195( 7 )
|-
| style="text-align:left" | Issuances
| style="text-align:right" | 0—
| style="text-align:right" | 0151
|-
| style="text-align:left" | Settlements
| style="text-align:right" | 0—
| style="text-align:right" | 0( 16,732 )
|-
| style="text-align:left" | Transfers into Level 3
| style="text-align:left" | Purchases
| style="text-align:right" | 70,730
| style="text-align:right" | 77,979—
|-
| style="text-align:left" | Sales/Disposals
| style="text-align:right" | -( 1,493 )
| style="text-align:right" | -374—
|-
| style="text-align:left; font-weight:bold" | Total unrealized gains for the period recognized in accumulated comprehensive income (loss)
| style="text-align:right; font-weight:bold" | 2,797
| style="text-align:right; font-weight:bold" | 510—
|-
| style="text-align:left" | EndingBalance balanceat December 31, 2025
| style="text-align:right" | 150,917
| style="text-align:right" | 779,920902
|-
| style="text-align:left; font-weight:bold" | Total losses for the period recognized in net investment gains attributable to the change in unrealized gains or losses relating to assets held as of period end
| style="text-align:right; font-weight:bold" | 0—
| style="text-align:right; font-weight:bold" | 0( 201 )
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 4. Fair Value Measurements
! style="text-align:left" | ($ in thousands)
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Available-For-Sale
! class="col-s" style="text-align:right" | Mortgage Loans
|-
| style="text-align:left" | MortgageBalance Loansat December 31, 2023
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Beginning balance
| style="text-align:right" | 26,490
| style="text-align:right" | 50,070
|-
| style="text-align:left; font-weight:bold" | Total gains (losses) for the period recognized in net investment gains (losses)
| style="text-align:right; font-weight:bold" | -7( 195 )
| style="text-align:right; font-weight:bold" | 420
|-
| style="text-align:left" | Issuances
| style="text-align:right" | 151—
| style="text-align:right" | 649
|-
| style="text-align:left" | Settlements
| style="text-align:right" | -16,732
| style="text-align:right" | -24,649
|-
| style="text-align:left" | Transfers into Level 3
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | ( 24,649 )
|-
| style="text-align:left" | Purchases
| style="text-align:right" | 077,979
| style="text-align:right" | 0—
|-
| style="text-align:left" | Sales/Disposals
| style="text-align:right" | 0( 374 )
| style="text-align:right" | 0—
|-
| style="text-align:left; font-weight:bold" | Total unrealized gains for the period recognized in accumulated comprehensive income (loss)
| style="text-align:right; font-weight:bold" | 0510
| style="text-align:right; font-weight:bold" | 0—
|-
| style="text-align:left" | EndingBalance balanceat December 31, 2024
| style="text-align:right" | 977,902920
| style="text-align:right" | 26,490
|-
| style="text-align:left; font-weight:bold" | Total lossesgains for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end
| style="text-align:right; font-weight:bold" | -201—
| style="text-align:right; font-weight:bold" | 411
|}
</div>
=== Narrative ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 4. Fair Value Measurements
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="32" style="text-align:center" | 12 Months Ended2025
! colspan="2" style="text-align:center" | 2024
|-
! style="text-align:left" | —($ in thousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31,Carrying 2025Value
! class="col-s" style="text-align:rightcenter" | Dec. 31,Fair 2024Value
! class="col-s" style="text-align:rightcenter" | Dec. 31,Carrying 2023Value
! style="text-align:center" | Fair Value
|-
|! style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [LineNotes Items]payable
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | NetFHLB earned premiumsLoan
| style="text-align:right" | 1,304,505
| style="text-align:right" | 1,056,722
| style="text-align:right" | 829,143
|-
| style="text-align:left" | Fair Value Measured at Net Asset Value Per Share
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investments, fair value disclosure
| style="text-align:right" | 55,600
| style="text-align:right" | 28,200
| style="text-align:right" | —
|-
| style="text-align:left" | Unrecorded unconditional purchase obligation
| style="text-align:right" | 18,300
| style="text-align:right" | 24,400
| style="text-align:right" | —
|-
| style="text-align:left" | Net earned premiums
| style="text-align:right" | 41,500
| style="text-align:right" | 2,500
| style="text-align:right" | —
|}
</div>
=== Schedule of Subordinated Debt ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | FHLB Loan / Carrying Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 57,000
| style="text-align:right" | 57,458
| style="text-align:right" | 57,000
|-
| style="text-align:left" | FHLB Loan / Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 57,458
| style="text-align:right" | 56,200
|-
| style="text-align:left" | Revolving Credit Facility / Carrying Value
| style="text-align:right" | —114,500
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 114,500
| style="text-align:right" | 43,000
|-
| style="text-align:left" | Revolving Credit Facility / Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 114,500
| style="text-align:right" | 43,000
|-
| style="text-align:left" | Term Loan Facility / Carrying Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 300,000
| style="text-align:right" | 0
|-
| style="text-align:left" | Term Loan Facility / Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 300,000
| style="text-align:right" | 0
|-
| style="text-align:left" | Notes payable / Carrying Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | DebtNotes Instrument [Line Items]payable
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 471,500
| style="text-align:right" | 471,958
| style="text-align:right" | 100,000
|-
| style="text-align:left" | Notes payable / Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 471,958
| style="text-align:right" | 99,200
|-
| style="text-align:left" | Unsecured subordinated notes / Carrying Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 19,569
| style="text-align:right" | 21,020
| style="text-align:right" | 19,536
|-
| style="text-align:left" | Unsecured subordinated notes / Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 21,020
| style="text-align:right" | 20,541
|-
| style="text-align:left" | Subordinated debt, net of debt issuance costs / Carrying Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 19,569
| style="text-align:right" | 21,020
| style="text-align:right" | 19,536
|-
| style="text-align:left" | Subordinated debt, net of debt issuance costs / Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long-term debt
| style="text-align:right" | 21,020
| style="text-align:right" | 20,541
|}
</div>
=='''5. Mortgage Loans =='''
* The Company invests in ''Separately Managed Accounts'' (SMA1 and SMA2) <sup>p. 85</sup>.
=== Narrative ===
* As of December 31, 2025 and 2024, the Company held ''direct investments in mortgage loans'' from various creditors through SMA1 and SMA2 <sup>p. 85</sup>.
* The Company’s ''mortgage loan portfolios'' are primarily senior loans on real estate across the U.S. <sup>p. 85</sup>.
* ''Loans earn interest'' at a fixed spread above a prime rate <sup>p. 85</sup>.
* ''Loan maturity'' is approximately 2 to 4 years from loan origination <sup>p. 85</sup>.
* ''Principal amounts of loans'' are approximately 64% of the property’s appraised value at the time of loan origination <sup>p. 85</sup>.
* ''Uncollectible amounts on loans'' are determined based on consultations with the specialized investment manager, consideration of adverse situations affecting borrower repayment ability, estimated value of underlying collateral, and other relevant factors <sup>p. 85</sup>.
* The Company ''writes off uncollectible amounts'' in the period they are determined to be uncollectible <sup>p. 85</sup>.
* There were ''no write-offs for uncollectible amounts'' during the years ended December 31, 2025 and 2024 <sup>p. 85</sup>.
* As of December 31, 2025 and 2024, ''no mortgage loans were in the process of foreclosure'' <sup>p. 85</sup>.
* As of December 31, 2025 and 2024, ''no mortgage loans were not producing income'' for the previous 12 months <sup>p. 85</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 5. Mortgage Loans
! style="text-align:left" | USD ($)
! colspan="2" style="text-align:centerleft" | 12($ Monthsin Endedthousands)
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2024
|-
!| style="text-align:left" | —Commercial
! class="col-s"| style="text-align:right" | Dec. 313, 2025334
! class="col-s"| style="text-align:right" | Dec. 318, 2024474
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]Retail
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 10,032
|-
| style="text-align:left" | Percentage of property appraisal valueHospitality
| style="text-align:right" | 64.00%6,568
| style="text-align:right" | —7,984
|-
| style="text-align:left" | Mortgage loans uncollectable write-off—
| style="text-align:right" | 09,902
| style="text-align:right" | 026,490
|-
| style="text-align:left" | Mortgage loans in foreclosure
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Mortgage loans not producing income
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Low
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Loans held-for-investment, term
| style="text-align:right" | 2 years
| style="text-align:right" | —
|-
| style="text-align:left" | High
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Loans held-for-investment, term
| style="text-align:right" | 4 years
| style="text-align:right" | —
|}
</div>
=== Schedule of Portfolios ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 5. Mortgage Loans
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
|-
! class="col-s" style="text-align:leftright" | —2023
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total mortgage loans
| style="text-align:right; font-weight:bold" | 9,902
| style="text-align:right; font-weight:bold" | 26,490
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 1,622
| style="text-align:right; font-weight:bold" | 5,155
| style="text-align:right; font-weight:bold" | 5,474
|-
| style="text-align:left" | Commercial
| style="text-align:right" | —432
| style="text-align:right" | —2,025
| style="text-align:right" | —2,340
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total mortgage loans
| style="text-align:right; font-weight:bold" | 3,334
| style="text-align:right; font-weight:bold" | 8,474
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 432
| style="text-align:right; font-weight:bold" | 2,025
| style="text-align:right; font-weight:bold" | 2,340
|-
| style="text-align:left" | Retail
| style="text-align:right" | —304
| style="text-align:right" | —1,853
| style="text-align:right" | —1,853
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total mortgage loans
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 10,032
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 304
| style="text-align:right; font-weight:bold" | 1,853
| style="text-align:right; font-weight:bold" | 1,853
|-
| style="text-align:left" | Hospitality
| style="text-align:right" | —886
| style="text-align:right" | —1,277
| style="text-align:right" | —1,034
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total mortgage loans
| style="text-align:right; font-weight:bold" | 6,568
| style="text-align:right; font-weight:bold" | 7,984
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 886
| style="text-align:right; font-weight:bold" | 1,277
| style="text-align:right; font-weight:bold" | 1,034
|-
| style="text-align:left" | Office
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —203
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 203
|-
| style="text-align:left" | Multi-family
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —44
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]—
| style="text-align:right" | —1,622
| style="text-align:right" | —5,155
| style="text-align:right" | —5,474
|-
| style="text-align:left; font-weight:bold" | Total investment income
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 0
| style="text-align:right; font-weight:bold" | 44
|}
</div>
=='''6. Equity Method Investments and Other =='''
* The difference between an investment's cost and its proportionate share of underlying equity in net assets is allocated to the equity method investment's assets and liabilities <sup>p. 86</sup>.
=== Schedule of Carrying Value of Equity Method Investments ===
* The Company amortizes this difference in net assets over the useful life of a similar asset as the underlying equity method investment <sup>p. 86</sup>.
* For the investment in RISCOM, the similar asset is agent relationships <sup>p. 86</sup>.
* The Company amortizes this difference for RISCOM over a 15-year useful life <sup>p. 86</sup>.
* As of December 31, 2025 and 2024, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2 <sup>p. 86</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 6. Equity Method Investments and Other
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! classcolspan="col-s2" style="text-align:rightcenter" | Dec. 31, 2025
! classcolspan="col-s2" style="text-align:rightcenter" | Dec. 31, 2024
|-
|! style="text-align:left" | Schedule of Equity Method Investments [Line Items]—
|! class="col-s" style="text-align:right" | —Carrying Value
|! class="col-s" style="text-align:right" | —Ownership %
! class="col-s" style="text-align:right" | Carrying Value
|-
|! class="col-s" style="text-align:leftright" | CarryingOwnership Value%
| style="text-align:right" | 77,365
| style="text-align:right" | 98,594
|-
| style="text-align:left" | Equity method investments
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 53,498
| style="text-align:right" | 65,325
|-
| style="text-align:left" | Arena Special Opportunities Fund, LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 26,936
| style="text-align:right" | 14.0%
| style="text-align:right" | 34,936
| style="text-align:right" | 15.3%
|-
| style="text-align:left" | Ownership %
| style="text-align:right" | 14.00%
| style="text-align:right" | 15.30%
|-
| style="text-align:left" | Arena SOP LP units
| style="text-align:right" | —
| style="text-align:right" | —11.2%
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 0
| style="text-align:right" | 1,474
| style="text-align:right" | 10.9%
|-
| style="text-align:left" | Ownership %
| style="text-align:right" | 11.20%
| style="text-align:right" | 10.90%
|-
| style="text-align:left" | Brewer Lane Ventures Fund II LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 2,251
| style="text-align:right" | 2.4%
| style="text-align:right" | 1,040
| style="text-align:right" | 2.4%
|-
| style="text-align:left" | Ownership %
| style="text-align:right" | 2.40%
| style="text-align:right" | 2.40%
|-
| style="text-align:left" | Dowling Capital Partners LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 590
| style="text-align:right" | 5.0%
| style="text-align:right" | 666
| style="text-align:right" | 5.0%
|-
| style="text-align:left" | OwnershipHudson %Ventures Fund 2 LP units
| style="text-align:right" | 5.00%
| style="text-align:right" | 5.00%
|-
| style="text-align:left" | Hudson Ventures Fund II LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 5,503
| style="text-align:right" | 2.5%
| style="text-align:right" | 4,967
| style="text-align:right" | 2.5%
|-
| style="text-align:left" | OwnershipJVM %Funds LLC units
| style="text-align:right" | 2.50%
| style="text-align:right" | 2.50%
|-
| style="text-align:left" | JVM Funds LLC
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 14,911
| style="text-align:right" | 10.1%
| style="text-align:right" | 17,229
| style="text-align:right" | 10.1%
|-
| style="text-align:left" | Ownership %
| style="text-align:right" | 10.10%
| style="text-align:right" | 10.10%
|-
| style="text-align:left" | RISCOM
| style="text-align:right" | —3,307
| style="text-align:right" | —20.0%
| style="text-align:right" | 5,013
| style="text-align:right" | 20.0%
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]—
| style="text-align:right" | 53,498
| style="text-align:right" | —
| style="text-align:right" | 65,325
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 3,307
| style="text-align:right" | 5,013
|-
| style="text-align:left" | Ownership %
| style="text-align:right" | 20.00%
| style="text-align:right" | 20.00%
|}
</div>
=== Schedule of Net Investment Income ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 6. Equity Method Investments and Other
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
! class="col-s" style="text-align:right" | 2023
|-
!| style="text-align:left" | —Arena SOP LP units
! class="col-s"| style="text-align:right" | Dec.( 311,474 2025)
! class="col-s"| style="text-align:right" | Dec.( 31,989 2024)
! class="col-s"| style="text-align:right" | Dec.( 316,271 2023)
|-
| style="text-align:left" | ScheduleArena ofSpecial EquityOpportunities MethodFund, InvestmentsLP [Line Items]units
| style="text-align:right" | —( 3,163 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 83,619
| style="text-align:right" | 80,600
| style="text-align:right" | 40,340
|-
| style="text-align:left" | Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | -2,683
| style="text-align:right" | 2,524
| style="text-align:right" | -9,434
|-
| style="text-align:left" | Arena SOP LP units / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | -1,474
| style="text-align:right" | -989
| style="text-align:right" | -6,271
|-
| style="text-align:left" | Arena Special Opportunities Fund, LP units / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | -3,163
| style="text-align:right" | 2,375
| style="text-align:right" | -( 2,880 )
|-
| style="text-align:left" | Brewer Lane Ventures Fund II LP / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 91
| style="text-align:right" | -( 110 )
| style="text-align:right" | -( 78 )
|-
| style="text-align:left" | Dowling Capital Partners LP units / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 431
| style="text-align:right" | 1,463
| style="text-align:right" | 927
|-
| style="text-align:left" | Hudson Ventures Fund II LP units / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 480
| style="text-align:right" | -( 153 )
| style="text-align:right" | 170
|-
| style="text-align:left" | JVM Funds LLC / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —( 541 )
| style="text-align:right" | —( 1,554 )
| style="text-align:right" | —( 1,198 )
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]RISCOM
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | -541
| style="text-align:right" | -1,554
| style="text-align:right" | -1,198
|-
| style="text-align:left" | RISCOM / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 1,493
| style="text-align:right" | 1,492
| style="text-align:right" | 884
|-
| style="text-align:left" | Universa Black Swan LP units / Equity Method Investment, Nonconsolidated Investee or Group of Investees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | ( 988 )
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]—
| style="text-align:right" | —( 2,683 )
| style="text-align:right" | —2,524
| style="text-align:right" | —( 9,434 )
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | -988
|}
</div>
=== Schedule of Unfunded Commitment of Equity Method Investments ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 6. Equity Method Investments and Other
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Equity method investments, unfunded commitment
| style="text-align:right" | 22,094
| style="text-align:right" | 29,260
|-
| style="text-align:left" | Brewer Lane Ventures Fund II LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Equity method investments, unfunded commitment
| style="text-align:right" | 3,237
| style="text-align:right" | 4,077
|-
| style="text-align:left" | Dowling Capital Partners LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Equity method investments, unfunded commitment
| style="text-align:right" | 386
| style="text-align:right" | 386
|-
| style="text-align:left" | Hudson Ventures Fund II2 LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Equity method investments, unfunded commitment
| style="text-align:right" | 166
| style="text-align:right" | 397
|-
| style="text-align:left" | Red Bird Capital Partners LP units
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Equity method investments, unfunded commitment
| style="text-align:right" | 18,305
| style="text-align:right" | 24,400
|}
</div>
=== Narrative ===
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" |
! style="text-align:center" | 12 Months Ended
|-
!| style="text-align:left" | —
! class="col-s"| style="text-align:right" | Dec. 3122, 2025094
| style="text-align:right" | 29,260
|-
| style="text-align:left" | RISCOM
| class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Useful life
| class="col-s" style="text-align:right" | 15 years
|}
</div>
=== Schedule of Investment in RISCOM ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 6. Equity Method Investments and Other
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2025
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2024
|-
|! style="text-align:left" | ScheduleInvestment ofin Equity Method Investments [Line Items]RISCOM:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Recorded investment balance
| style="text-align:right" | 77,365
| style="text-align:right" | 98,594
|-
| style="text-align:left" | RISCOM
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Underlying equity
|}
</div>
=== Schedule of Investment in JVN Funds ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 6. Equity Method Investments and Other
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2025
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2024
|-
|! style="text-align:left" | ScheduleInvestment ofin EquityJVM MethodFunds Investments [Line Items]LLC:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Recorded investment balance
| style="text-align:right" | 77,365
| style="text-align:right" | 98,594
|-
| style="text-align:left" | JVM Funds LLC
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Underlying equity
|}
</div>
=== Schedule of Indirect Investments ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 6. Equity Method Investments and Other
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Recorded investment balance
| style="text-align:right" | 77,365
| style="text-align:right" | 98,594
|-
| style="text-align:left" | SMA1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Recorded investment balance
| style="text-align:right" | 15,418
| style="text-align:right" | 20,296
|-
| style="text-align:left" | SMA2
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Recorded investment balance
| style="text-align:right" | 8,449
| style="text-align:right" | 12,973
|-
| style="text-align:left" | Investment in indirect loans and loan collateral
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Schedule of Equity Method Investments [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Recorded investment balance
| style="text-align:right" | 23,867
| style="text-align:right" | 33,269
</div>
=='''7. Variable Interest Entity =='''
* Skyward consolidates ''Separate Account HSIC-01'' ("HSIC-01"), established by Mangrove Risk Solutions Bermuda Ltd. ("Mangrove"), pursuant to GAAP consolidation guidance <sup>p. 87</sup>.
* HSIC-01 is a ''VIE'' for which the Company is the primary beneficiary <sup>p. 87</sup>.
* The purpose of the VIE is to ''hedge price volatility risks'' of certain insurance products by investing in dairy and livestock commodities <sup>p. 87</sup>.
* The Company considers itself the ''primary beneficiary'' because it directly manages the business <sup>p. 87</sup>.
* The Company does not provide ''performance guarantees'' and has no other financial obligation to provide funding to HSIC-01, other than its own capital commitments <sup>p. 87</sup>.
* The ''assets of consolidated variable interest entities'' may only be used to settle obligations of these entities <sup>p. 87</sup>.
* There is ''no recourse to the assets of HSIC-01'' other than to satisfy associated liabilities <sup>p. 87</sup>.
* The table presents the ''assets of HSIC-01'' included in the Consolidated Balance Sheets as of December 31, 2025 <sup>p. 87</sup>.
* The presented assets only include ''third-party net assets'' and exclude intercompany balances, which were eliminated upon consolidation <sup>p. 87</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 7. Variable Interest Entity
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
|! style="text-align:left" | Assets
|! class="col-s" style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cash and cash equivalents
| style="text-align:right" | 168,544
| style="text-align:right" | 121,603
|-
| style="text-align:left" | Other assets
| style="text-align:right" | 137,173
| style="text-align:right" | 86,698
|-
| style="text-align:left; font-weight:bold" | Total assets
| style="text-align:right; font-weight:bold" | 4,791,852
| style="text-align:right; font-weight:bold" | 3,729,478
|-
| style="text-align:left" | Variable Interest Entity, Primary Beneficiary
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Assets
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cash and cash equivalents
| style="text-align:right" | 15,816
| style="text-align:right" | —
|-
| style="text-align:left" | Other assets
| style="text-align:right" | 34,856
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total assets
| style="text-align:right; font-weight:bold" | 50,672
| style="text-align:right; font-weight:bold" | —
|}
</div>
'''8 . Derivatives'''
== Derivatives ==
* The Company uses derivatives for financial risk management to mitigate price risk in insurance contracts exposed to commodity price fluctuations, specifically cattle and milk <sup>p. 88</sup>.
=== Schedule of Derivatives and Fair Value of Derivative Assets and Liabilities ===
* A hedging strategy using derivatives, including put options and futures, is employed to mitigate revenue volatility and support financial stability <sup>p. 88</sup>.
* The primary objective of derivative instruments is to manage exposure to adverse price movements <sup>p. 88</sup>.
* The activity in these instruments reflects current market conditions and shifts in risk exposures throughout the year <sup>p. 88</sup>.
* The notional value of derivative contracts and the degree of hedged exposure are actively managed and can vary based on pricing in cattle, hogs, and milk markets <sup>p. 88</sup>.
* The Company does not use derivatives for speculative or trading purposes <sup>p. 88</sup>.
* All derivative positions support the overall risk transfer objectives of the business <sup>p. 88</sup>.
* The Company has not elected hedge accounting for these derivatives <sup>p. 88</sup>.
* The net gain (loss) recognized on derivative instruments in economic hedging relationships is presented in "losses and loss adjustment expenses" on the Consolidated Statements of Operations <sup>p. 88</sup>.
* For the year ended December 31, 2025, the Company recognized pre-tax net gains of USD 7.9m in losses and loss adjustment expenses <sup>p. 88</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($8 in. thousands)Derivatives
! style="text-align:left" | ($ in Thousandsthousands)
! classcolspan="col-s2" style="text-align:rightcenter" | Dec. 31, 2025 USDDerivative ($)Assets
|-
|! style="text-align:left" | Derivative Instruments and Hedging Activities Disclosure [Abstract]—
|! class="col-s" style="text-align:right" | —Notional Amount
! class="col-s" style="text-align:right" | Fair Value
|-
| style="text-align:left" | DerivativeEconomic assets, notional amounthedges
| style="text-align:right" | 136,800
|-
| style="text-align:left" | Derivative assets, fair value
| style="text-align:right" | 34,857
|}
</div>
'''9. Allowance for Credit Losses'''
=== Narrative ===
* The Company analyzes the credit risk of its ''reinsurance recoverables'' by monitoring the financial strength rating of its reinsurers from A.M. Best <sup>p. 89</sup>.
* A.M. Best is a widely recognized rating agency focused exclusively on the insurance industry <sup>p. 89</sup>.
* The Company assesses the financial strength rating annually and throughout the year as A.M. Best provides updates <sup>p. 89</sup>.
* The Company assesses the adequacy of credit enhancements such as reinsurance payables, letters of credit, and funds held <sup>p. 89</sup>.
* ''Reinsurance balances'' are considered past due when they are 90 days past due <sup>p. 89</sup>.
* On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") for accident years 2018 and prior <sup>p. 89</sup>.
* During the year ended December 31, 2024, the Company recognized an ''uncollectible reinsurance recoverable balance'' related to the LPT as a net increase of $13.6 million to the allowance for estimated uncollectible reinsurance <sup>p. 89</sup>.
* This $13.6 million increase was subsequently written-off <sup>p. 89</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 9. Allowance for Credit Losses
|+ ($ in millions)
! style="text-align:left" | ($ in Millionsthousands)
! class="col-s" style="text-align:centerright" | 12Premiums MonthsReceivable, EndedNet
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Premiums
|-
!| style="text-align:left" | —Balance at December 31, 2024
! class="col-s"| style="text-align:right" | Dec. 31321, 2025 USD ($)641
| style="text-align:right" | 2,432
|-
| style="text-align:left" | FairCurrent Valueperiod Hedgingchange /for Designatedestimated asuncollectible Hedging Instrumentpremiums
| style="text-align:right" | —
| style="text-align:right" | 2,351
|-
| style="text-align:left" | DerivativeWrite-offs Instruments,of Gainuncollectible (Loss)premiums [Line Items]receivable
| style="text-align:right" | —
| style="text-align:right" | ( 2,141 )
|-
| style="text-align:left" | Pre-taxRecoveries gainof (loss)amounts adjustmentpreviously expenseswritten off
| style="text-align:right" | 7.9—
| style="text-align:right" | 498
|-
| style="text-align:left" | Balance at December 31, 2025
| style="text-align:right" | 544,217
| style="text-align:right" | 3,140
|}
</div>
== Allowance for Credit Losses ==
=== Schedule of Premium Receivable ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 9. Allowance for Credit Losses
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="2col-s" style="text-align:centerright" | 12Premiums MonthsReceivable, EndedNet
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Premiums
|-
!| style="text-align:left" | —Balance at December 31, 2023
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Premium Receivable, Allowance for Credit Loss [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Premiums Receivable, Net, beginning balance
| style="text-align:right" | 321,641
| style="text-align:right" | 179,235
|-
| style="text-align:left" | Allowance for Estimated Uncollectible Premiums, beginning balance
| style="text-align:right" | 2,432
| style="text-align:right" | 964
|-
| style="text-align:left" | Current period change for estimated uncollectible premiums
| style="text-align:right" | 2,351—
| style="text-align:right" | 3,235
|-
| style="text-align:left" | Write-offs of uncollectible premiums receivable
| style="text-align:right" | -2,141—
| style="text-align:right" | -( 1,895 )
|-
| style="text-align:left" | Recoveries of amounts previously written off
| style="text-align:right" | 498—
| style="text-align:right" | 128
|-
| style="text-align:left" | PremiumsBalance Receivable,at NetDecember 31, ending balance2024
| style="text-align:right" | 544,217
| style="text-align:right" | 321,641
|-
| style="text-align:left" | Allowance for Estimated Uncollectible Premiums, ending balance
| style="text-align:right" | 3,140
| style="text-align:right" | 2,432
|}
</div>
=== Schedule of Reinsurance Recoverable, Credit Quality Indicator ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 9. Allowance for Credit Losses
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="2" style="text-align:center" | 12 Months Ended2025
! style="text-align:center" |
|-
! style="text-align:left" | —A.M. Best Rating
! class="col-s" style="text-align:right" | Dec.Reinsurance 31Recoverables, 2025Gross, Amortized Cost
! class="col-s" style="text-align:right" | Dec.Percent 31,of 2024Total
|-
| style="text-align:left" | CededA- Creditand Risk [Line Items]above
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost
| style="text-align:right" | —
| style="text-align:right" | 22,700
|-
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / A- and above
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ceded Credit Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost
| style="text-align:right" | 652,178
| style="text-align:right" | —98.2%
|-
| style="text-align:left" | PercentB++ ofto TotalB+
| style="text-align:right" | 98.20%
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / B++ to B+
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ceded Credit Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost
| style="text-align:right" | 5,077
| style="text-align:right" | —0.8
|-
| style="text-align:left" | Percent of Total
| style="text-align:right" | 0.80%
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / B to B -
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ceded Credit Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | ReinsuranceB Recoverables,to Gross,B Amortized Cost-
| style="text-align:right" | 28
| style="text-align:right" | —
|-
| style="text-align:left" | PercentNot of Totalrated
| style="text-align:right" | 0.00%
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / Not rated
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ceded Credit Risk [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost
| style="text-align:right" | 6,919
| style="text-align:right" | —1.0
|-
| style="text-align:left" | Percent of Total
| style="text-align:right" | 1.00%
| style="text-align:right" | —
|}
</div>
=== Schedule of Reinsurance Recoverable ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 9. Allowance for Credit Losses
|+ ($ in thousands)
! style="text-align:left" | ($ in Thousandsthousands)
! class="col-s" style="text-align:centerright" | 12Reinsurance MonthsRecoverables, EndedNet
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance
|-
!| style="text-align:left" | —Balance at December 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2024 USD ($)
|-
| style="text-align:left" | Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward]
| style="text-align:right" | —
|-
| style="text-align:left" | Reinsurance Recoverables, Net, beginning balance
| style="text-align:right" | 857,876
|-
| style="text-align:left" | Allowance for Estimated Uncollectible Reinsurance, beginning balance
| style="text-align:right" | 2,295
|-
| style="text-align:left" | CurrentBalance periodat changeDecember for31, estimated uncollectible reinsurance2025
| style="text-align:right" | 131,585119,880
|-
| style="text-align:left" | Write-offs of uncollectible reinsurance recoverables
| style="text-align:right" | -13,585
|-
| style="text-align:left" | Reinsurance Recoverables, Net, ending balance
| style="text-align:right" | 857,876
|-
| style="text-align:left" | Allowance for Estimated Uncollectible Reinsurance, ending balance
| style="text-align:right" | 2,295
|}
</div>
=== Narrative ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 9. Allowance for Credit Losses
|+ ($ in thousands)
! style="text-align:left" | ($ in Thousandsthousands)
! class="col-s" style="text-align:centerright" | 12Reinsurance MonthsRecoverables, EndedNet
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance
|-
!| style="text-align:left" | —Balance at December 31, 2023
! class="col-s"| style="text-align:right" | Dec. 31596, 2024 USD ($)334
| style="text-align:right" | 2,295
|-
| style="text-align:left" | CreditCurrent Lossperiod [Abstract]change for estimated uncollectible reinsurance
| style="text-align:right" | —
|-
| style="text-align:left" | Current period change for estimated uncollectible reinsurance
| style="text-align:right" | 13,585
|-
| style="text-align:left" | Write-offs of uncollectible reinsurance recoverables
| style="text-align:right" | —
| style="text-align:right" | ( 13,585 )
|-
| style="text-align:left" | Balance at December 31, 2024
| style="text-align:right" | 857,876
| style="text-align:right" | 2,295
|}
</div>
=='''10. Property and Equipment =='''
* ''Depreciation expense'' for property and equipment was USD 3.3m for the year ended December 31, 2025 <sup>p. 90</sup>.
=== Schedule of Property, Plant and Equipment ===
* ''Depreciation expense'' for property and equipment was USD 2.9m for the year ended December 31, 2024 <sup>p. 90</sup>.
* ''Depreciation expense'' for property and equipment was USD 3.2m for the year ended December 31, 2023 <sup>p. 90</sup>.
* Depreciation expense is presented in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 90</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 10. Property and Equipment
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Property, Plant and Equipment [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, equipment and other, gross
| style="text-align:right" | 47,447
| style="text-align:right" | 41,534
|-
| style="text-align:left" | Accumulated depreciation
| style="text-align:right" | -32,307
| style="text-align:right" | -29,355
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 15,140
| style="text-align:right; font-weight:bold" | 12,179
|-
| style="text-align:left" | Leasehold improvements
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, Plant and Equipment [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, equipment and other, gross
| style="text-align:right" | 3,434
| style="text-align:right" | 3,056
|-
| style="text-align:left" | Equipment
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, Plant and Equipment [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, equipment and other, gross
| style="text-align:right" | 4,750
| style="text-align:right" | 4,506
|-
| style="text-align:left" | Software
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, Plant and Equipment [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Property, equipment and other, gross
| style="text-align:right" | 39,263
| style="text-align:right" | 33,972
|}
</div>
=== Narrative ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in millions)
! style="text-align:left" | USD ($) $ in Millions
! colspan="3" style="text-align:center" | 12 Months Ended
|-
!| style="text-align:left" | —
! class="col-s"| style="text-align:right" | Dec. 3147, 2025447
! class="col-s"| style="text-align:right" | Dec. 3141, 2024534
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Property,Accumulated Plant and Equipment [Abstract]depreciation
| style="text-align:right" | —( 32,307 )
| style="text-align:right" | —( 29,355 )
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | DepreciationTotal
| style="text-align:right; font-weight:bold" | 3.315,140
| style="text-align:right; font-weight:bold" | 2.912,179
| style="text-align:right" | 3.2
|}
</div>
=='''11. Notes Payable & Subordinated Debt =='''
* On August 30, 2024, the Company entered into the ''FHLB Loan'' under the Advances and Security Agreement <sup>p. 91</sup>.
<div style="overflow-x:auto">
* The ''FHLB Loan'' is a 4.5-year term loan with a principal amount of USD 57.0m <sup>p. 91</sup>.
{| class="wikitable fintable"
* The ''FHLB Loan'' requires interest-only payments during its term, with principal due at maturity <sup>p. 91</sup>.
! style="text-align:left" | USD ($)
* The ''FHLB Loan'' has a fixed interest rate of 4.00% over its term <sup>p. 91</sup>.
! style="text-align:center" |
* The ''FHLB Loan'' is fully secured by a pledge of specific investment securities of HSIC <sup>p. 91</sup>.
! style="text-align:center" |
* Proceeds from the ''FHLB Loan'' were used to fund redemptions of draws on the 2023 Revolving Credit Facility <sup>p. 91</sup>.
! style="text-align:center" |
* During the fourth quarter of 2025, the Company entered into a ''Term Loan Credit Agreement'' (Term Loan Facility) with a syndicate of banks <sup>p. 91</sup>.
! style="text-align:center" |
* The ''Term Loan Facility'' includes an unsecured senior delayed draw term loan facility (DDTL) of USD 150.0m (Tranche A DDTL) <sup>p. 91</sup>.
! style="text-align:center" | 3 Months Ended
* The ''Term Loan Facility'' also includes an additional unsecured senior DDTL of USD 150.0m (Tranche B DDTL) <sup>p. 91</sup>.
! style="text-align:center" | 12 Months Ended
* The ''Term Loan Facility'' was used to fund a portion of the consideration for the Company's acquisition of Apollo Group Holdings Limited (Apollo) and related transaction fees and expenses <sup>p. 91</sup>.
! style="text-align:center" |
* Amounts drawn under the ''Term Loan Facility'' bear interest at either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>.
! style="text-align:center" |
* ''SOFR'' is calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 91</sup>.
! style="text-align:center" |
* The ''base rate'' is the highest of (i) the Agent’s then-current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 91</sup>.
! style="text-align:center" |
* The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the ''Term Loan Facility'', depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>.
|-
* The ''Tranche A DDTL'' matures on January 1, 2028 <sup>p. 91</sup>.
! style="text-align:left" | —
* The ''Tranche B DDTL'' matures on July 2, 2029 <sup>p. 91</sup>.
! class="col-m" style="text-align:right" | Dec. 30, 2025
* On December 30, 2025, the Company drew USD 150.0m from the ''Tranche A DDTL'' and USD 150.0m from the ''Tranche B DDTL'' for the acquisition of Apollo on January 1, 2026 <sup>p. 91</sup>.
! class="col-s" style="text-align:right" | Nov. 13, 2025
* The ''Term Loan Facility'' includes customary covenants, such as limitations on additional indebtedness exceeding USD 10.0m and on distributions to stockholders, stock redemptions, repurchases, or retirements upon certain events <sup>p. 91</sup>.
! class="col-m" style="text-align:right" | Oct. 01, 2025
* ''Financial covenants'' for the Term Loan Facility include minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity <sup>p. 91</sup>.
! class="col-m" style="text-align:right" | Aug. 30, 2024
* As of December 31, 2025, the Company was in compliance with all ''Term Loan Facility covenants'' <sup>p. 91</sup>.
! colspan="2" style="text-align:center" | Dec. 31, 2025
* The ''Term Loan Facility'' is unsecured <sup>p. 91</sup>.
! class="col-m" style="text-align:right" | Jan. 01, 2026
* The Company's obligations under the ''Term Loan Facility'' are guaranteed by the Company and its existing wholly-owned subsidiaries, and subsequently acquired or organized subsidiaries, excluding insurance company subsidiaries and subject to certain exceptions <sup>p. 91</sup>.
! class="col-s" style="text-align:right" | Dec. 31, 2024
* During the fourth quarter of 2025, the Company entered into a ''Revolving Credit Facility'' with a syndicate of banks <sup>p. 91</sup>.
! class="col-m" style="text-align:right" | Mar. 31, 2023
* The ''Revolving Credit Facility'' is unsecured and initially provided a maximum principal amount of USD 150.0m <sup>p. 91</sup>.
! class="col-m" style="text-align:right" | May 31, 2019
* The ''Revolving Credit Facility'' maximum principal amount was increased to USD 250.0m on the closing date of the Apollo acquisition <sup>p. 91</sup>.
|-
* The Company initially drew USD 43.0m from the ''Revolving Credit Facility'' to redeem its prior revolving credit facility <sup>p. 91</sup>.
| style="text-align:left" | Term Loan Credit Facility / Low / Secured Overnight Financing Rate (SOFR)
* On December 30, 2025, the Company drew an additional USD 71.5m from the ''Revolving Credit Facility'' for the consideration paid for the acquisition of Apollo <sup>p. 91</sup>.
| style="text-align:right" | —
* Proceeds from the ''Term Loan Facility'' and the ''Revolving Credit Facility'' draws are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025 <sup>p. 91</sup>.
| style="text-align:right" | —
* These proceeds were used for the ''Apollo acquisition'' on January 1, 2026 <sup>p. 91</sup>.
| style="text-align:right" | —
* Interest on the ''Revolving Credit Facility'' is payable quarterly <sup>p. 91</sup>.
| style="text-align:right" | —
* Amounts drawn under the ''Revolving Credit Facility'' bear interest at either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>.
| style="text-align:right" | —
* ''SOFR'' for the Revolving Credit Facility is calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 91</sup>.
| style="text-align:right" | —
* The ''base rate'' for the Revolving Credit Facility is the highest of (i) the Agent’s then current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 91</sup>.
| style="text-align:right" | —
* The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the ''Revolving Credit Facility'', depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>.
| style="text-align:right" | —
* The ''availability period'' under the Revolving Credit Facility terminates on November 12, 2030 <sup>p. 91</sup>.
| style="text-align:right" | —
* The Company is subject to ''covenants'' on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity <sup>p. 91</sup>.
| style="text-align:right" | —
* As of December 31, 2025, the Company was in compliance with all ''Revolving Credit Facility covenants'' <sup>p. 91</sup>.
|-
* During the first quarter of 2023, the Company entered into an agreement for an unsecured ''2023 Revolving Credit Facility'' with a syndicate of banks <sup>p. 91</sup>.
| style="text-align:left" | Debt Instrument [Line Items]
* The ''2023 Revolving Credit Facility'' provided up to USD 150.0m in revolving credit and a letter of credit sub-facility of up to USD 30.0m <sup>p. 91</sup>.
| style="text-align:right" | —
* On November 13, 2025, the Company redeemed the ''2023 Revolving Credit Facility'' <sup>p. 91</sup>.
| style="text-align:right" | —
* The Company paid USD 0.3m of accrued interest and recognized USD 0.6m of expense for remaining unamortized deferred financing costs upon redemption of the ''2023 Revolving Credit Facility'' <sup>p. 91</sup>.
| style="text-align:right" | —
* In May 2019, the Company agreed to issue unsecured subordinated notes (the ''Notes'') with an aggregate principal amount of USD 20.0m <sup>p. 91</sup>.
| style="text-align:right" | —
* Interest on the ''Notes'' is fixed at 7.25% for the first 8 years and 8.25% thereafter <sup>p. 91</sup>.
| style="text-align:right" | —
* Early retirement of the ''Notes'' before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal <sup>p. 91</sup>.
| style="text-align:right" | —
* ''Principal'' for the Notes is due at maturity on May 24, 2039, and interest is payable quarterly <sup>p. 91</sup>.
| style="text-align:right" | —
* The ''Notes'' have junior priority to all previously issued debt <sup>p. 91</sup>.
| style="text-align:right" | —
* The Company reports debt related to the ''Notes'' in its December 31, 2025 and 2024 Consolidated Balance Sheets, net of debt issuance costs of approximately USD 0.4m and USD 0.5m, respectively <sup>p. 91</sup>.
| style="text-align:right" | —
* These ''deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 91</sup>.
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.50%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Term Loan Credit Facility / Low / Base Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.50%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Term Loan Credit Facility / High / Secured Overnight Financing Rate (SOFR)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.90%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Term Loan Credit Facility / High / Base Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.90%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Revolving Credit Facility / Low / Base Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.50%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Revolving Credit Facility / High / Base Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.90%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Term Loan Credit Facility
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt instrument, variable rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.10%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt instrument, covenant, limitation on additional indebtedness maximum
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 10,000,000.0
| style="text-align:right" | 10,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Secured Overnight Financing Rate (SOFR)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt instrument, interest rate floor
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Base Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Fed Funds Effective Rate Overnight Index Swap Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.50%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Low
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of credit facility, commitment fee percentage
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.20%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / High
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of credit facility, commitment fee percentage
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.35%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Face amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Proceeds from long term borrowings
| style="text-align:right" | 71,500,000
| style="text-align:right" | —
| style="text-align:right" | 43,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Subsequent Event
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Face amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 250,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Secured Overnight Financing Rate (SOFR)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt instrument, interest rate floor
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Base Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Fed Funds Effective Rate Overnight Index Swap Rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.50%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Credit Spread Adjustment
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt instrument, variable rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.10%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Low
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of credit facility, unused capacity, commitment fee percentage
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.20%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of Credit / Revolving Credit Facility / High
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Line of credit facility, unused capacity, commitment fee percentage
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.35%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | FHLB Loan / Federal Home Loan Bank Advances
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt instrument, term
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4 years 6 months
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Face amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 57,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stated interest rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tranche A DDTL / Unsecured Debt
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Face amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Proceeds from Loans
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tranche B DDTL / Unsecured Debt
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Face amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Proceeds from Loans
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Revolving Credit Facility / Line of Credit / Revolving Credit Facility / Low / Secured Overnight Financing Rate (SOFR)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.50%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Revolving Credit Facility / Line of Credit / Revolving Credit Facility / High / Secured Overnight Financing Rate (SOFR)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Margin
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.90%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Revolving Line Of Credit Due December 2023 / Line of Credit / Revolving Credit Facility
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Maximum borrowing capacity
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 150,000,000.0
| style="text-align:right" | —
|-
| style="text-align:left" | Interest expense, long-term debt
| style="text-align:right" | —
| style="text-align:right" | 300,000
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Revolving Line Of Credit Due December 2023 / Line of Credit / Letter of Credit
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Maximum borrowing capacity
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 30,000,000.0
| style="text-align:right" | —
|-
| style="text-align:left" | Amortization of debt issuance costs
| style="text-align:right" | —
| style="text-align:right" | 600,000
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Subordinate Debt Due 2039 / Subordinated debt, net of debt issuance costs
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Principal
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 20,000,000.0
|-
| style="text-align:left" | Debt term
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 8 years
|-
| style="text-align:left" | Debt issuance costs
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 400,000
| style="text-align:right" | 400,000
| style="text-align:right" | —
| style="text-align:right" | 500,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Subordinate Debt Due 2039 / Subordinated debt, net of debt issuance costs / Debt Interest Rate, First 8 Years
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stated interest rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 7.25%
|-
| style="text-align:left" | Debt term
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 8 years
|-
| style="text-align:left" | Subordinate Debt Due 2039 / Subordinated debt, net of debt issuance costs / Debt Interest Rate, After Year 8
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Debt Instrument [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stated interest rate
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 8.25%
|}
</div>
=='''12. Segment =='''
* The Company operates with one reportable segment, offering commercial property and casualty products and solutions primarily in the United States on both non-admitted (E&S) and admitted bases <sup>p. 92</sup>.
=== Narrative ===
* The segment consists of nine distinct underwriting divisions, referred to as "continuing business," each with dedicated underwriting leadership and technical staff <sup>p. 92</sup>.
* The segment definition is based on how internally reported financial information is reviewed by the Chief Operating Decision Maker (CODM) for performance analysis, decision-making, and resource allocation <sup>p. 92</sup>.
* The Company's CODM is the chief executive officer <sup>p. 92</sup>.
* The accounting policies for the segment align with those described in Note 1 "Summary of Significant Accounting Policies" of the Form 10-K <sup>p. 92</sup>.
* The CODM evaluates segment performance and allocates resources using gross written premiums by net underwriting division, underwriting income, and income before income taxes (which is also reported on the Consolidated Statements of Operations as consolidated income before income taxes) <sup>p. 92</sup>.
* The measure of segment assets is reported on the Consolidated Balance Sheets as total consolidated assets <sup>p. 92</sup>.
* ''Gross written premiums'' by underwriting division, ''net underwriting income'', and ''consolidated net income'' are used to monitor budget versus actual results <sup>p. 92</sup>.
* The CODM also uses ''net underwriting income'', ''annualized return on equity'', and ''growth in book value per share'' for competitive analysis by benchmarking against competitors <sup>p. 92</sup>.
* This competitive analysis and the monitoring of budgeted versus actual results are used to assess segment performance and determine management's compensation <sup>p. 92</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 12. Segment
! style="text-align:left" |
! style="text-align:centerleft" | 12($ Monthsin Endedthousands)
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2024
! class="col-s" style="text-align:right" | 2023
|-
!| style="text-align:left" | —Accident & Health
! class="col-s"| style="text-align:right" | Dec. 31254, 2025 segment division102
| style="text-align:right" | 173,073
| style="text-align:right" | 151,701
|-
| style="text-align:left" | SegmentAgriculture Reportingand [Abstract]Credit (Re)insurance
| style="text-align:right" | —346,212
| style="text-align:right" | 118,070
| style="text-align:right" | 30,598
|-
| style="text-align:left" | Number of reportable segments / segmentCaptives
| style="text-align:right" | 1275,694
| style="text-align:right" | 241,902
| style="text-align:right" | 167,624
|-
| style="text-align:left" | NumberConstruction of& underwritingEnergy divisions / divisionSolutions
| style="text-align:right" | 9274,318
| style="text-align:right" | 296,582
|}
| style="text-align:right" | 299,748
</div>
=== Schedule of Premiums Written ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 Months Ended
|-
!| style="text-align:left" | —Global Property
! class="col-s"| style="text-align:right" | Dec. 31178, 2025128
! class="col-s"| style="text-align:right" | Dec. 31201, 2024796
! class="col-s"| style="text-align:right" | Dec. 31242, 2023593
|-
| style="text-align:left" | EffectsProfessional of Reinsurance [Line Items]Lines
| style="text-align:right" | —149,231
| style="text-align:right" | —159,785
| style="text-align:right" | —154,565
|-
| style="text-align:left; font-weight:bold" | Total gross writtenSpecialty premiumsPrograms
| style="text-align:right; font-weight:bold" | 2,166322,236705
| style="text-align:right; font-weight:bold" | 1,743218,232407
| style="text-align:right; font-weight:bold" | 1,459178,829726
|-
| style="text-align:left" | Operating SegmentsSurety
| style="text-align:right" | —168,148
| style="text-align:right" | —143,965
| style="text-align:right" | —106,056
|-
| style="text-align:left" | EffectsTransactional of Reinsurance [Line Items]E&S
| style="text-align:right" | —197,779
| style="text-align:right" | —189,669
| style="text-align:right" | —128,236
|-
| style="text-align:left; font-weight:bold" | Total grosscontinuing written premiumsbusiness
| style="text-align:right; font-weight:bold" | 2,166,317
| style="text-align:right; font-weight:bold" | 1,743,249
| style="text-align:right; font-weight:bold" | 1,459,847
|-
| style="text-align:left" | CorporateExited Nonsegmentbusiness
| style="text-align:right" | —( 81 )
| style="text-align:right" | —( 17 )
| style="text-align:right" | —( 18 )
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | -812,166,236
| style="text-align:right; font-weight:bold" | -171,743,232
| style="text-align:right; font-weight:bold" | -181,459,829
|-
| style="text-align:left" | Accident & Health / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 254,102
| style="text-align:right; font-weight:bold" | 173,073
| style="text-align:right; font-weight:bold" | 151,701
|-
| style="text-align:left" | Agriculture and Credit (Re)insurance / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 346,212
| style="text-align:right; font-weight:bold" | 118,070
| style="text-align:right; font-weight:bold" | 30,598
|-
| style="text-align:left" | Captives / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 275,694
| style="text-align:right; font-weight:bold" | 241,902
| style="text-align:right; font-weight:bold" | 167,624
|-
| style="text-align:left" | Construction & Energy Solutions / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 274,318
| style="text-align:right; font-weight:bold" | 296,582
| style="text-align:right; font-weight:bold" | 299,748
|-
| style="text-align:left" | Global Property / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 178,128
| style="text-align:right; font-weight:bold" | 201,796
| style="text-align:right; font-weight:bold" | 242,593
|-
| style="text-align:left" | Professional Lines / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 149,231
| style="text-align:right; font-weight:bold" | 159,785
| style="text-align:right; font-weight:bold" | 154,565
|-
| style="text-align:left" | Specialty Programs / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 322,705
| style="text-align:right; font-weight:bold" | 218,407
| style="text-align:right; font-weight:bold" | 178,726
|-
| style="text-align:left" | Surety / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 168,148
| style="text-align:right; font-weight:bold" | 143,965
| style="text-align:right; font-weight:bold" | 106,056
|-
| style="text-align:left" | Transactional E&S / Operating Segments
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total gross written premiums
| style="text-align:right; font-weight:bold" | 197,779
| style="text-align:right; font-weight:bold" | 189,669
| style="text-align:right; font-weight:bold" | 128,236
|}
</div>
=== Schedule of Segment Reporting ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 12. Segment
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspan="3" style="text-align:center" | 12 Months Ended2025
! style="text-align:center" | 2024
! style="text-align:center" | 2023
|-
! style="text-align:left" | —Underwriting income
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2025
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2024
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2023
|-
|! style="text-align:left" | Segment Reporting Information [Line Items]Revenues:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Net earned premiums
| style="text-align:right" | 1,304,505
| style="text-align:right" | 1,056,722
| style="text-align:right" | 829,143
|-
| style="text-align:left" | Commission and fee income
| style="text-align:right" | 6,855
| style="text-align:right" | 6,703
| style="text-align:right" | 6,064
|-
| style="text-align:left" | Losses and LAE
| style="text-align:right" | 795,022
| style="text-align:right" | 669,809
| style="text-align:right" | 515,237
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 83,619
| style="text-align:right" | 80,600
| style="text-align:right" | 40,340
|-
| style="text-align:left" | Net investment gains
| style="text-align:right" | 22,149
| style="text-align:right" | 6,342
| style="text-align:right" | 11,054
|-
| style="text-align:left" | Other loss
| style="text-align:right" | -587
| style="text-align:right" | -167
| style="text-align:right" | -632
|-
| style="text-align:left" | Transaction costs
| style="text-align:right" | 14,019
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Interest expense
| style="text-align:right" | 7,919
| style="text-align:right" | 9,496
| style="text-align:right" | 10,024
|-
| style="text-align:left" | Amortization expense
| style="text-align:right" | 1,636
| style="text-align:right" | 2,007
| style="text-align:right" | 1,798
|-
| style="text-align:left" | Other expenses
| style="text-align:right" | 4,162
| style="text-align:right" | 4,392
| style="text-align:right" | 5,364
|-
| style="text-align:left" | Income before income taxes
| style="text-align:right" | 216,424
| style="text-align:right" | 152,739
| style="text-align:right" | 110,102
|-
| style="text-align:left" | Income tax expense
| style="text-align:right" | 46,396
| style="text-align:right" | 33,911
| style="text-align:right" | 24,118
|-
| style="text-align:left" | Net income
| style="text-align:right" | 170,028
| style="text-align:right" | 118,828
| style="text-align:right" | 85,984
|-
| style="text-align:left" | Reportable Segment
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Segment Reporting Information [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net earned premiums
| style="text-align:right; font-weight:bold" | 981,566
| style="text-align:right; font-weight:bold" | 758,681
|-
| style="text-align:left" | Net underwriting income
| style="text-align:right" | 138,979
| style="text-align:right" | 81,859
| style="text-align:right" | 76,526
|-
| style="text-align:left" | Reconciliation of net underwriting income to net income:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net underwriting income
|-
| style="text-align:left" | Other loss
| style="text-align:right" | -( 587 )
| style="text-align:right" | -( 167 )
| style="text-align:right" | -( 632 )
|-
| style="text-align:left" | Transaction costs
| style="text-align:right" | 14,019
| style="text-align:right" | 0—
| style="text-align:right" | 0—
|-
| style="text-align:left" | Interest expense
|}
</div>
=== Schedule of Return on Equity and Book Value Per Share ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 12. Segment
! style="text-align:left" | $ / shares
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Segment Reporting [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Return on equity
| style="text-align:right" | 18.909%
| style="text-align:right" | 16.303%
| style="text-align:right" | 15.909%
|-
| style="text-align:left" | Book value per share (in dollars per share)
| style="text-align:right" | 24.92
| style="text-align:right" | 19.79
</div>
=='''13. Income Taxes =='''
* The Company paid ''federal income taxes'' of USD 37.0m in 2024 and USD 15.8m in 2023 <sup>p. 93</sup>.
=== Schedule of Income Tax Expense ===
* The Company has ''federal net operating loss carryforwards'' of approximately USD 40.3m <sup>p. 93</sup>.
* These ''net operating losses'' are set to expire beginning in 2032 <sup>p. 93</sup>.
* ''Internal Revenue Code Section 382'' limits the utilization of USD 40.3m of net operating losses due to an ownership change in 2014 <sup>p. 93</sup>.
* The ''382 limitation'' is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses <sup>p. 93</sup>.
* A ''valuation allowance'' was established in 2025 against the balance expected to expire without utilization <sup>p. 93</sup>.
* Of the total ''federal NOL'' of USD 40.3m, USD 0.3m (USD 0.1m tax effected) is related to dual consolidated loss that Skyward is not expected to utilize <sup>p. 93</sup>.
* The Company also has ''net operating losses'' in various state and local jurisdictions totaling USD 0.9m <sup>p. 93</sup>.
* These ''state and local net operating losses'' are set to expire between 5 and 20 years or carryforward indefinitely, depending on the jurisdiction <sup>p. 93</sup>.
* The Company expects to ''fully utilize'' these state and local net operating losses <sup>p. 93</sup>.
* The Company’s ''federal income tax returns'' for tax years 2022-2024 are subject to examination by the Internal Revenue Service <sup>p. 93</sup>.
* As of December 31, 2025, the Company had ''no provision for uncertain tax positions'' and no provision for penalties or interest <sup>p. 93</sup>.
* Management does not believe there are any ''uncertain tax benefits'' that could be recognized within the next twelve months that would impact the Company’s effective tax rate <sup>p. 93</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($13. inIncome thousands)Taxes
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspan="3" style="text-align:center" | 12 Months Ended2025
|-
! style="text-align:left" | —Income from continuing operations before income tax expense
! class="col-s" style="text-align:right" | Dec. 31, 2025—
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Income from continuing operations before income tax expense
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | United States
| style="text-align:right" | 208,763
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Foreign
| style="text-align:right" | 7,661
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Income before income taxesTotal
| style="text-align:right; font-weight:bold" | 216,424
| style="text-align:right" | 152,739
| style="text-align:right" | 110,102
|-
| style="text-align:left" | Current tax expense
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | United States
| style="text-align:right" | 51,758
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | U.S. state and local
| style="text-align:right" | 1,107
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Deferred tax benefit related to:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | United States
| style="text-align:right" | -( 5,584 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | U.S. state and local
| style="text-align:right" | -( 885 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total income tax expense
| style="text-align:right; font-weight:bold" | 46,396
| style="text-align:right; font-weight:bold" | 33,911
| style="text-align:right; font-weight:bold" | 24,118
|}
</div>
=== Schedule of Components of Income Tax Expense (Benefit) ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($13. inIncome thousands)Taxes
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2024
! class="col-s" style="text-align:right" | 2023
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Income Tax Disclosure [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Current income tax expense
| style="text-align:right" | —
| style="text-align:right" | 42,626
| style="text-align:right" | 14,736
|-
| style="text-align:left" | Deferred tax (benefit) expense related to temporary differences
| style="text-align:right" | —( 8,715 )
| style="text-align:right" | -8,715
| style="text-align:right" | 9,382
|-
| style="text-align:left; font-weight:bold" | Total income tax expense
| style="text-align:right; font-weight:bold" | 46,396
| style="text-align:right; font-weight:bold" | 33,911
| style="text-align:right; font-weight:bold" | 24,118
|}
</div>
=== Schedule of Annual Effective Tax Rate ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 13. Income Taxes (1){{footnote|1=The following state(s) and/or local jurisdictions make up more than 50% of the state income taxes: Florida.}}
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="32" style="text-align:center" | 12 Months Ended2025
|-
! style="text-align:left" | —($ in thousands)
! class="col-s" style="text-align:right" | Dec. 31, 2025Amount
! class="col-s" style="text-align:right" | Dec. 31, 2024Percentage
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | U.S. federal statutory income tax rate
| style="text-align:right" | 45,449
| style="text-align:right" | 32,07521.0%
| style="text-align:right" | 23,121
|-
| style="text-align:left" | State income taxes, net of federal benefit (1)
| style="text-align:right" | -( 508 )
| style="text-align:right" | ( 0.3 )%
|-
| style="text-align:left" | Foreign tax effects
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Bermuda statutory rate differential
| style="text-align:right" | ( 1,609 )
| style="text-align:right" | ( 0.7 )%
|-
| style="text-align:left" | Effects of other cross-border tax laws
| style="text-align:right" | 717
| style="text-align:right" | —0.3%
| style="text-align:right" | —
|-
| style="text-align:left" | Change of Valuation Allowance
| style="text-align:right" | 68
| style="text-align:right" | —%
|-
| style="text-align:left" | Nondeductible and Nontaxable items
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:left" | Nondeductible transaction costs
| style="text-align:right" | 1,689
| style="text-align:right" | —0.8%
| style="text-align:right" | —
|-
| style="text-align:left" | Other nondeductible and nontaxable items
| style="text-align:right" | 590
| style="text-align:right" | —0.3%
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total incomeEffective tax expenserate
| style="text-align:right; font-weight:bold" | 46,396
| style="text-align:right; font-weight:bold" | 33,91121.4%
| style="text-align:right; font-weight:bold" | 24,118
|-
| style="text-align:left" | Percentage
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | U.S. federal statutory income tax rate
| style="text-align:right" | 21.00%
| style="text-align:right" | 21.00%
| style="text-align:right" | 21.00%
|-
| style="text-align:left" | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
| style="text-align:right" | (0.30%)
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effects of other cross-border tax laws
| style="text-align:right" | 0.30%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Change of Valuation Allowance
| style="text-align:right" | 0.00%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Nondeductible transaction costs
| style="text-align:right" | 0.80%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Other
| style="text-align:right" | 0.30%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total income tax expense
| style="text-align:right; font-weight:bold" | 21.40%
| style="text-align:right; font-weight:bold" | 22.20%
| style="text-align:right; font-weight:bold" | 21.90%
|-
| style="text-align:left" | Bermuda
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Bermuda statutory rate differential
| style="text-align:right" | -1,609
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Percentage
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Statutory tax rate difference
| style="text-align:right" | (0.70%)
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
=== Schedule of Effective Income Tax Rate Reconciliation ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($13. inIncome thousands)Taxes
! style="text-align:left" | USD ($) $ in Thousands
! colspan="32" style="text-align:center" | 12 Months Ended2024
! colspan="2" style="text-align:center" | 2023
|-
! style="text-align:left" | —($ in thousands)
! class="col-s" style="text-align:right" | Dec. 31, 2025Amount
! class="col-s" style="text-align:right" | Dec. 31, 2024Percentage
! class="col-s" style="text-align:right" | Dec. 31, 2023Amount
! class="col-s" style="text-align:right" | Percentage
|-
| style="text-align:left" | Amount
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Income tax expense at federal statutory rate
| style="text-align:right" | 45,449
| style="text-align:right" | 32,075
| style="text-align:right" | 21.0%
| style="text-align:right" | 23,121
| style="text-align:right" | 21.0%
|-
| style="text-align:left" | Tax advantaged investments
| style="text-align:right" | —( 239 )
| style="text-align:right" | -239( 0.2 )
| style="text-align:right" | -( 295 )
| style="text-align:right" | ( 0.3 )
|-
| style="text-align:left" | Other
| style="text-align:right" | —
| style="text-align:right" | 2,075
| style="text-align:right" | 1.4
| style="text-align:right" | 1,292
| style="text-align:right" | 1.2
|-
| style="text-align:left; font-weight:bold" | Total income tax expense
| style="text-align:right; font-weight:bold" | 46,396
| style="text-align:right; font-weight:bold" | 33,911
| style="text-align:right; font-weight:bold" | 22.2%
| style="text-align:right; font-weight:bold" | 24,118
| style="text-align:right; font-weight:bold" | 21.9%
|-
| style="text-align:left" | Percentage
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Income tax expense at federal statutory rate
| style="text-align:right" | 21.00%
| style="text-align:right" | 21.00%
| style="text-align:right" | 21.00%
|-
| style="text-align:left" | Tax advantaged investments
| style="text-align:right" | —
| style="text-align:right" | (0.20%)
| style="text-align:right" | (0.30%)
|-
| style="text-align:left" | Other
| style="text-align:right" | —
| style="text-align:right" | 1.40%
| style="text-align:right" | 1.20%
|-
| style="text-align:left; font-weight:bold" | Total income tax expense
| style="text-align:right; font-weight:bold" | 21.40%
| style="text-align:right; font-weight:bold" | 22.20%
| style="text-align:right; font-weight:bold" | 21.90%
|}
</div>
=== Schedule of Income Taxes Paid Net of Refunds Received ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 13. Income Taxes (1){{footnote|1=No single state or jurisdiction accounts for greater than 5% of total taxes paid.}}
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Income Tax Disclosure [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | United States
| style="text-align:right" | 49,830
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | U.S. state and local (1)
| style="text-align:right" | 1,164
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | IncomeTotal Taxesincome Paid,taxes Net, Totalpaid
| style="text-align:right; font-weight:bold" | 50,994
| style="text-align:right" | 37,000
| style="text-align:right" | 15,800
|}
</div>
=== Narrative ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 13. Income Taxes
! style="text-align:left" | USD ($)
! colspan="3" style="text-align:centerleft" | 12($ Monthsin Endedthousands)
! style="text-align:center" | 2025
! style="text-align:center" | 2024
|-
! style="text-align:left" | —Deferred tax assets:
! class="col-s" style="text-align:right" | Dec. 31, 2025—
! class="col-ms" style="text-align:right" | Dec. 31, 2024—
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Income taxes paid, net
| style="text-align:right" | 50,994,000
| style="text-align:right" | 37,000,000.0
| style="text-align:right" | 15,800,000
|-
| style="text-align:left" | Operating loss carryforwards
| style="text-align:right" | 300,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating loss carryforwards, limitations on use, amount
| style="text-align:right" | 40,300,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Deferred tax subject to expiration
| style="text-align:right" | 2,800,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Deferred tax effected by expiration
| style="text-align:right" | 600,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating loss carryforwards, tax effected
| style="text-align:right" | 100,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Provision for uncertain tax positions
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Provision for penalties or interest
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Low
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating loss carryforward, term
| style="text-align:right" | 5 years
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | High
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating loss carryforward, term
| style="text-align:right" | 20 years
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Federal
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating loss carryforwards
| style="text-align:right" | 40,300,000
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | State and local
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating loss carryforwards
| style="text-align:right" | 900,000
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
=== Schedule of Deferred Tax Assets and Liabilities ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Deferred tax assets:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net operating losses
| style="text-align:right" | 9,409
| style="text-align:right" | 9,389
| style="text-align:right" | —
|-
| style="text-align:left" | Losses and loss adjustment expenses
| style="text-align:right" | 21,401
| style="text-align:right" | 16,967
| style="text-align:right" | —
|-
| style="text-align:left" | Unearned premiums
| style="text-align:right" | 22,775
| style="text-align:right" | 18,178
| style="text-align:right" | —
|-
| style="text-align:left" | Unrealized losses on fixed maturity securities, available-for-sale
| style="text-align:right" | 0—
| style="text-align:right" | 5,893
| style="text-align:right" | —
|-
| style="text-align:left" | Stock options/awards
| style="text-align:right" | 2,446
| style="text-align:right" | 2,453
| style="text-align:right" | —
|-
| style="text-align:left" | Other
| style="text-align:right" | 8,933
| style="text-align:right" | 6,067
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total deferred tax assets before valuation allowance
| style="text-align:right; font-weight:bold" | 64,964
| style="text-align:right; font-weight:bold" | 58,947
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Valuation allowance
| style="text-align:right" | -( 654 )
| style="text-align:right" | -( 586 )
| style="text-align:right" | -586
|-
| style="text-align:left; font-weight:bold" | Total deferred tax assets
| style="text-align:right; font-weight:bold" | 64,310
| style="text-align:right; font-weight:bold" | 58,361
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Deferred tax liabilities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Deferred policy acquisition costs
| style="text-align:right" | 19,132
| style="text-align:right" | 15,277
| style="text-align:right" | —
|-
| style="text-align:left" | Other long-term investments
| style="text-align:right" | 2,888
| style="text-align:right" | 2,625
| style="text-align:right" | —
|-
| style="text-align:left" | Section 481(a) adjustment
| style="text-align:right" | 87
| style="text-align:right" | 1,391
| style="text-align:right" | —
|-
| style="text-align:left" | Unrealized gains on equity securities
| style="text-align:right" | 7
| style="text-align:right" | 4,818
| style="text-align:right" | —
|-
| style="text-align:left" | Unrealized gains on fixed maturity securities, available-for-sale
| style="text-align:right" | 3,101
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:left" | Unrealized gains on other investments
| style="text-align:right" | 5,465
| style="text-align:right" | 0
| style="text-align:right" | —
|-
| style="text-align:right" | 2,152
| style="text-align:right" | 1,426
| style="text-align:right" | —
|-
| style="text-align:left" | Other
| style="text-align:right" | 3,613
| style="text-align:right" | 2,338
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total deferred tax liabilities
| style="text-align:right; font-weight:bold" | 36,445
| style="text-align:right; font-weight:bold" | 27,875
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Net deferred tax asset
| style="text-align:right" | 27,865
| style="text-align:right" | 30,486
| style="text-align:right" | —
|}
</div>
=== Schedule of Company's Valuation Allowance ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($13. inIncome thousands)Taxes
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="2col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Deferred Tax Assets, Valuation Allowance [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Balance at beginning of the period
| style="text-align:left" | Increase related to net operating loss
| style="text-align:right" | 68
| style="text-align:right" | 0—
|-
| style="text-align:left" | Balance at the end of the period
</div>
'''Tax Legislative Update'''
== Reserves for Losses and Loss Adjustment Expenses ==
* The One Big Beautiful Bill Act ("OBBB Act"), which includes a broad range of tax reform provisions, was signed into law in the United States on July 4, 2025 <sup>p. 94</sup>.
=== Schedule of Liability for Unpaid Claims and Claims Adjustment Expense ===
* The OBBB Act did not have a material impact on the Company's annual effective tax rate in 2025 <sup>p. 94</sup>.
* No material impact from the OBBB Act is expected in 2026 <sup>p. 94</sup>.
'''14. Reserves for Losses and Loss Adjustment Expenses'''
* The Company evaluates net ultimate loss and LAE under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines <sup>p. 95</sup>.
* These disaggregated groupings have homogeneous risk characteristics, similar development patterns, and are subject to similar trends <sup>p. 95</sup>.
* ''Short-tail/monoline specialty lines'' include global property & agriculture, accident & health, surety, and professional lines underwriting divisions <sup>p. 95</sup>.
* These lines generally have shorter durations for losses to fully develop, with claims typically reported, settled, and paid within a relatively short timeframe <sup>p. 95</sup>.
* Short-tail/monoline specialty lines can be impacted by larger, more complex losses due to factors like difficulty in determining actual damages and legal/regulatory impediments <sup>p. 95</sup>.
* ''Multi-line solutions'' include industry solutions, programs, captives, and transactional E&S underwriting divisions <sup>p. 95</sup>.
* This subcategory predominantly consists of occurrence liability, including general liability, excess liability, and commercial auto <sup>p. 95</sup>.
* Multi-line solutions have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines <sup>p. 95</sup>.
* The unique claim characteristics and longer-tail nature of multi-line solutions introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time <sup>p. 95</sup>.
* ''Exited lines'' include all underwriting units placed in run-off and are presented separately from ongoing lines of business <sup>p. 95</sup>.
* For the year ended December 31, 2025, the Company recognized ''favorable development'' related to prior years’ loss and loss expense reserves of USD 7.5m <sup>p. 95</sup>.
** This was driven by favorable development of USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions <sup>p. 95</sup>.
** This was partially offset by USD 22.4m of adverse development in exited lines <sup>p. 95</sup>.
** The adverse development in exited lines was primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or had significantly reduced exposure over the past three years <sup>p. 95</sup>.
** This was offset by favorable development in surety and property <sup>p. 95</sup>.
* For the year ended December 31, 2024, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 25.7m <sup>p. 95</sup>.
** This was primarily related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 95</sup>.
** This included USD 10.1m in multi-line solutions and USD 15.2m in exited lines <sup>p. 95</sup>.
* During the year ended December 31, 2023, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 10.8m <sup>p. 95</sup>.
** Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022 <sup>p. 95</sup>.
** This adverse development was partially offset by favorable development in short-tail/monoline specialty lines <sup>p. 95</sup>.
** The favorable development in short-tail/monoline specialty lines was in the property line of business, primarily from accident years 2021 and 2022 <sup>p. 95</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 14. Reserves for Losses and Loss Adjustment Expenses
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:centerright" | 2024
! class="col-s" style="text-align:right" | 2023
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
! class="col-s" style="text-align:right" | Dec. 31, 2022
|-
| style="text-align:left" | Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses and LAE, beginning of period
| style="text-align:right" | 1,314,501
| style="text-align:right" | 1,141,757
| style="text-align:right" | —
|-
| style="text-align:left" | Less: reinsurance recoverable on unpaid claims, beginning of period
| style="text-align:right" | -( 670,846 )
| style="text-align:right" | -( 455,484 )
| style="text-align:right" | -( 435,986 )
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses and LAE, beginning of period, net of reinsurance
| style="text-align:right" | 1,397,729
| style="text-align:right" | 1,111,537
| style="text-align:right" | 859,017
|-
| style="text-align:left" | Incurred, net of reinsurance, related to:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 657,783
| style="text-align:right" | 505,894
| style="text-align:right" | —
|-
| style="text-align:left" | Prior years
| style="text-align:right" | -( 7,471 )
| style="text-align:right" | 25,728
| style="text-align:right" | 10,770
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total incurred, net of reinsurance
| style="text-align:right; font-weight:bold" | 683,511
| style="text-align:right; font-weight:bold" | 516,664
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Paid, net of reinsurance, related to:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 136,731
| style="text-align:right" | 109,937
| style="text-align:right" | —
|-
| style="text-align:left" | Prior years
| style="text-align:right" | 294,260
| style="text-align:right" | 253,481
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total paid
| style="text-align:right; font-weight:bold" | 430,991
| style="text-align:right; font-weight:bold" | 363,418
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Net reserves for losses and LAE, end of period
| style="text-align:right" | 1,111,537
| style="text-align:right" | 859,017
| style="text-align:right" | —
|-
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period
| style="text-align:right" | 670,846
| style="text-align:right" | 455,484
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses and LAE, end of period
| style="text-align:right" | 1,782,383
| style="text-align:right" | 1,314,501
| style="text-align:right" | —
|}
</div>
'''Short Duration Contract Disclosures'''
=== Narrative ===
* ''Losses and LAE reserves'' represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates <sup>p. 96</sup>.
* The Company's estimated reserves for losses and LAE include the accumulation of estimates for claims reported and unpaid prior to the balance sheet dates <sup>p. 96</sup>.
* Estimates for losses and LAE also include projections of relevant historical data for increases in claims costs for claims already reported <sup>p. 96</sup>.
* Estimates for losses and LAE include claims incurred but not reported <sup>p. 96</sup>.
* Estimates for losses and LAE include expenses for investigating and adjusting all incurred and unpaid claims <sup>p. 96</sup>.
* The Company measures ''claim counts'' by incident when determining the cumulative number of reported claims <sup>p. 96</sup>.
* Claim counts include all claims reported, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses) <sup>p. 96</sup>.
'''Short-tail/Monoline Specialty Lines'''
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Short-tail/Monoline Specialty Lines
|+ ($ in thousands)
! colspan="3" style="text-align:leftcenter" | USD ($) $ in Thousandsthousands except number of claims)
! colspan="3" style="text-align:center" | 12 Months Ended
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
! colspan="6" style="text-align:leftcenter" | —Incurred Losses and ALAE, Net of Reinsurance
! classcolspan="col-s2" style="text-align:rightcenter" | Dec.As of December 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
|! style="text-align:left" | Liability for Claims and Claims Adjustment Expense [Line Items]
|! colspan="5" style="text-align:rightcenter" | —Years Ended December 31,
|! style="text-align:rightcenter" | —
|! style="text-align:rightcenter" | —Reported Claims
|-
|! style="text-align:left" | Reserves for losses and LAE, increaseAccident (decrease)Year
|! class="col-m" style="text-align:rightleft" | -7,5002021*
|! class="col-m" style="text-align:rightleft" | 25,7002022*
|! class="col-m" style="text-align:rightleft" | 10,8002023*
! class="col-m" style="text-align:left" | 2024*
! class="col-m" style="text-align:right" | 2025
! class="col-m" style="text-align:right" | IBNR
! class="col-m" style="text-align:right" | Reported Claims
|-
| style="text-align:left" | Prior year claims incurred, unfavorable (favorable) development2021
| style="text-align:rightleft" | -792,471780
| style="text-align:rightleft" | 2593,728429
| style="text-align:rightleft" | 1092,770143
| style="text-align:left" | 92,134
| style="text-align:right" | 99,783
| style="text-align:right" | 1,774
| style="text-align:right" | 1,656
|-
| style="text-align:left" | Short-Tail/Monoline Specialty Lines2022
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —108,299
| style="text-align:rightleft" | —105,394
| style="text-align:left" | 104,095
| style="text-align:right" | 96,874
| style="text-align:right" | 6,266
| style="text-align:right" | 2,414
|-
| style="text-align:left" | Liability for Claims and Claims Adjustment Expense [Line Items]2023
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —190,565
| style="text-align:left" | 191,865
| style="text-align:right" | 161,222
| style="text-align:right" | 28,997
| style="text-align:right" | 5,015
|-
| style="text-align:left" | Reserves for losses and LAE, increase (decrease)2024
| style="text-align:rightleft" | -24,600—
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:left" | 280,147
| style="text-align:right" | 292,220
| style="text-align:right" | 99,302
| style="text-align:right" | 5,819
|-
| style="text-align:left" | Multi-line Solutions2025
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:left" | —
| style="text-align:right" | 422,528
| style="text-align:right" | 275,190
| style="text-align:right" | 5,495
|-
| style="text-align:left; font-weight:bold" | Liability for Claims and Claims Adjustment Expense [Line Items]Total
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:left; font-weight:bold" | —
|-
| style="text-align:leftright; font-weight:bold" | Reserves for losses and LAE1, increase (decrease)072,627
| style="text-align:right" | -5,300
| style="text-align:right" | 10,100
| style="text-align:right" | —
|-
| style="text-align:left" | Prior year claims incurred, unfavorable (favorable) development
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 11,700
|-
| style="text-align:left" | Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Liability for Claims and Claims Adjustment Expense [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses and LAE, increase (decrease)
| style="text-align:right" | 22,400
| style="text-align:right" | 15,200
| style="text-align:right" | —
|}
</div>
=== Schedule of Short-Duration Insurance Contracts ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | $ in Thousands
! class="col-s" style="text-align:right" | Dec. 31, 2025 USD ($) claim
! class="col-s" style="text-align:right" | Dec. 31, 2024 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2023 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2022 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2021 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2020 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2019 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2018 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2017 USD ($)
! class="col-s" style="text-align:right" | Dec. 31, 2016 USD ($)
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | 1,367,038
| style="text-align:right; font-weight:bold" | 1,084,980
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Short-tail/Monoline Specialty Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 1,072,627
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | -528,255Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —( 528,255 )
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net reserves for loss and ALAE before 2021
| style="text-align:left" | Net reserves for loss and ALAE before 2021
| style="text-align:left" | Net reserves for loss and ALAE before 2021
| style="text-align:left" | Net reserves for loss and ALAE before 2021
| style="text-align:left" | Net reserves for loss and ALAE before 2021
| style="text-align:right" | 1,570
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | 545,942
| style="text-align:right; font-weight:bold" | 367,226
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Cumulative*Supplementary net paid lossinformation and LAEunaudited
| style="text-align:rightleft" | 528,255*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
|}
| style="text-align:right" | —
</div>
| style="text-align:right" | —
| style="text-align:right" | —
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Short-tail/Monoline Specialty Lines
! colspan="3" style="text-align:center" | ($ in thousands)
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
|! colspan="6" style="text-align:leftcenter" | Multi-lineCumulative Paid Losses and ALAE, Net of Reinsurance ($ in Solutionsthousands)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Claims Development [Line Items]
|! colspan="5" style="text-align:rightcenter" | —Years Ended December 31,
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Incurred losses and ALAE, net ofAccident reinsuranceYear
|! class="col-m" style="text-align:rightleft" | 1,902,4722021*
|! class="col-m" style="text-align:right" | —2022*
|! class="col-m" style="text-align:right" | —2023*
|! class="col-m" style="text-align:right" | —2024*
|! class="col-m" style="text-align:right" | —2025
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below2021
| style="text-align:rightleft" | -118,162,853447
| style="text-align:right" | —56,803
| style="text-align:right" | —67,912
| style="text-align:right" | —78,439
| style="text-align:right" | —93,560
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net reserves for loss and ALAE before 20212022
| style="text-align:rightleft" | -189—
| style="text-align:right" | —27,773
| style="text-align:right" | —64,594
| style="text-align:right" | —77,150
| style="text-align:right" | —85,696
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE2023
| style="text-align:right; font-weight:boldleft" | 739,430—
| style="text-align:right; font-weight:bold" | 631,065
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 1,162,853
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 33,795
| style="text-align:right" | 100,705
| style="text-align:right" | 114,247
|-
| style="text-align:left" | Exited Lines2024
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 53,691
| style="text-align:right" | 154,896
|-
| style="text-align:left" | Claims Development [Line Items]2025
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 79,856
|-
| style="text-align:left; font-weight:bold" | Incurred losses and ALAE, net of reinsuranceTotal
| style="text-align:rightleft; font-weight:bold" | 605,233—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -538,304
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net reserves for loss and ALAE before 2021
| style="text-align:right" | 14,737
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | 81,666
| style="text-align:right; font-weight:bold" | 86,689
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 528,255
|-
| style="text-align:left" | Cumulative*Supplementary net paid lossinformation and LAEunaudited
| style="text-align:rightleft" | 538,304*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
|}
| style="text-align:right" | —
</div>
| style="text-align:right" | —
| style="text-align:right" | —
'''Multi-line Solutions'''
| style="text-align:right" | —
| style="text-align:right" | —
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Multi-line Solutions
! colspan="5" style="text-align:center" | ($ in thousands except number of claims)
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
|! colspan="11" style="text-align:leftcenter" | AccidentIncurred YearLosses 2016and /ALAE, Multi-lineNet of Reinsurance ($ in Solutionsthousands)
|! colspan="2" style="text-align:rightcenter" | —As of December 31, 2025
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Claims Development [LineAccident Items]Year
|! colspan="11" style="text-align:rightcenter" | —Years Ended December 31,
|! style="text-align:rightcenter" | —Reported Claims
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Incurred losses and ALAE, net ofAccident reinsuranceYear
|! class="col-m" style="text-align:rightleft" | 85,0982016*
|! class="col-m" style="text-align:rightleft" | 85,4342017*
! class="col-m" style="text-align:left" | 2018*
! class="col-m" style="text-align:left" | 2019*
! class="col-m" style="text-align:left" | 2020*
! class="col-m" style="text-align:right" | 2021*
! class="col-m" style="text-align:right" | 2022*
! class="col-m" style="text-align:right" | 2023*
! class="col-m" style="text-align:right" | 2024*
! class="col-m" style="text-align:right" | 2025
! class="col-m" style="text-align:right" | IBNR
! class="col-m" style="text-align:right" | Reported Claims
|-
| style="text-align:left" | 2016
| style="text-align:left" | 63,223
| style="text-align:left" | 62,843
| style="text-align:left" | 62,843
| style="text-align:left" | 62,643
| style="text-align:left" | 84,579
| style="text-align:right" | 84,579
| style="text-align:right" | 84,829
| style="text-align:right" | 84,829
| style="text-align:right" | 8485,579434
| style="text-align:right" | 8485,579098
| style="text-align:right" | 62,643
| style="text-align:right" | 62,843
| style="text-align:right" | 62,843
| style="text-align:right" | 63,223
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -77,825
| style="text-align:right" | -77,760
| style="text-align:right" | -77,160
| style="text-align:right" | -75,855
| style="text-align:right" | -72,544
| style="text-align:right" | -69,691
| style="text-align:right" | -58,895
| style="text-align:right" | -53,352
| style="text-align:right" | -42,528
| style="text-align:right" | -23,239
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 828
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 4,744
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE2017
| style="text-align:rightleft" | 77,825—
| style="text-align:rightleft" | 7765,760332
| style="text-align:rightleft" | 7765,160332
| style="text-align:rightleft" | 7564,855260
| style="text-align:rightleft" | 7278,544166
| style="text-align:right" | 6978,691166
| style="text-align:right" | 58,895
| style="text-align:right" | 53,352
| style="text-align:right" | 42,528
| style="text-align:right" | 23,239
|-
| style="text-align:left" | Accident Year 2016 / Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 104,246
| style="text-align:right" | 102,801
| style="text-align:right" | 100,651
| style="text-align:right" | 100,651
| style="text-align:right" | 98,301
| style="text-align:right" | 97,301
| style="text-align:right" | 93,577
| style="text-align:right" | 91,372
| style="text-align:right" | 92,996
| style="text-align:right" | 93,019
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -98,831
| style="text-align:right" | -97,462
| style="text-align:right" | -95,114
| style="text-align:right" | -91,556
| style="text-align:right" | -87,482
| style="text-align:right" | -81,181
| style="text-align:right" | -78,070
| style="text-align:right" | -70,253
| style="text-align:right" | -57,638
| style="text-align:right" | -36,592
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 1,851
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 4,911
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 98,831
| style="text-align:right" | 97,462
| style="text-align:right" | 95,114
| style="text-align:right" | 91,556
| style="text-align:right" | 87,482
| style="text-align:right" | 81,181
| style="text-align:right" | 78,070
| style="text-align:right" | 70,253
| style="text-align:right" | 57,638
| style="text-align:right" | 36,592
|-
| style="text-align:left" | Accident Year 2017 / Multi-line Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 79,819
| style="text-align:right" | 80,493
| style="text-align:right" | 78,766
| style="text-align:right" | 78,766
| style="text-align:right" | 7880,166493
| style="text-align:right" | 7879,166819
| style="text-align:right" | 64,260
| style="text-align:right" | 65,332
| style="text-align:right" | 65,332
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -77,177
| style="text-align:right" | -75,714
| style="text-align:right" | -73,770
| style="text-align:right" | -71,109
| style="text-align:right" | -67,926
| style="text-align:right" | -61,354
| style="text-align:right" | -53,093
| style="text-align:right" | -41,945
| style="text-align:right" | -23,770
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 837
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 5,592
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE2018
| style="text-align:rightleft" | 77,177—
| style="text-align:rightleft" | 75,714—
| style="text-align:rightleft" | 7374,770476
| style="text-align:rightleft" | 7174,109476
| style="text-align:rightleft" | 6769,926319
| style="text-align:right" | 6171,354719
| style="text-align:right" | 53,093
| style="text-align:right" | 41,945
| style="text-align:right" | 23,770
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2017 / Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 72,682
| style="text-align:right" | 70,885
| style="text-align:right" | 68,646
| style="text-align:right" | 68,646
| style="text-align:right" | 68,346
| style="text-align:right" | 65,735
| style="text-align:right" | 81,785
| style="text-align:right" | 79,581
| style="text-align:right" | 75,159
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -69,798
| style="text-align:right" | -68,480
| style="text-align:right" | -66,498
| style="text-align:right" | -62,924
| style="text-align:right" | -57,457
| style="text-align:right" | -50,545
| style="text-align:right" | -51,985
| style="text-align:right" | -52,103
| style="text-align:right" | -34,176
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 1,819
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 4,370
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 69,798
| style="text-align:right" | 68,480
| style="text-align:right" | 66,498
| style="text-align:right" | 62,924
| style="text-align:right" | 57,457
| style="text-align:right" | 50,545
| style="text-align:right" | 51,985
| style="text-align:right" | 52,103
| style="text-align:right" | 34,176
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2018 / Multi-line Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 72,963
| style="text-align:right" | 75,686
| style="text-align:right" | 73,019
| style="text-align:right" | 73,019
| style="text-align:right" | 7175,719686
| style="text-align:right" | 6972,319963
| style="text-align:right" | 74,476
| style="text-align:right" | 74,476
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -72,429
| style="text-align:right" | -70,128
| style="text-align:right" | -69,893
| style="text-align:right" | -65,635
| style="text-align:right" | -58,655
| style="text-align:right" | -47,226
| style="text-align:right" | -42,568
| style="text-align:right" | -26,201
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 673
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 5,103
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE2019
| style="text-align:rightleft" | 72,429—
| style="text-align:rightleft" | 70,128—
| style="text-align:rightleft" | 69,893—
| style="text-align:rightleft" | 65107,635432
| style="text-align:rightleft" | 58109,655226
| style="text-align:right" | 47112,226378
| style="text-align:right" | 42115,568530
| style="text-align:right" | 26116,201230
| style="text-align:right" | —116,206
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2018 / Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 91,897
| style="text-align:right" | 92,082
| style="text-align:right" | 84,165
| style="text-align:right" | 84,165
| style="text-align:right" | 79,006
| style="text-align:right" | 76,506
| style="text-align:right" | 68,990
| style="text-align:right" | 74,357
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -82,244
| style="text-align:right" | -79,860
| style="text-align:right" | -74,604
| style="text-align:right" | -67,001
| style="text-align:right" | -54,339
| style="text-align:right" | -39,870
| style="text-align:right" | -60,149
| style="text-align:right" | -25,553
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 4,093
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 4,941
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 82,244
| style="text-align:right" | 79,860
| style="text-align:right" | 74,604
| style="text-align:right" | 67,001
| style="text-align:right" | 54,339
| style="text-align:right" | 39,870
| style="text-align:right" | 60,149
| style="text-align:right" | 25,553
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2019 / Multi-line Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 110,564
| style="text-align:right" | 116,206
| style="text-align:right" | 116,230
| style="text-align:right" | 115,530
| style="text-align:right" | 112,378
| style="text-align:right" | 109,226
| style="text-align:right" | 107,432
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -106,826
| style="text-align:right" | -106,765
| style="text-align:right" | -99,451
| style="text-align:right" | -87,816
| style="text-align:right" | -71,053
| style="text-align:right" | -50,933
| style="text-align:right" | -33,019
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 1,384
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 6,113
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE2020
| style="text-align:rightleft" | 106,826—
| style="text-align:rightleft" | 106,765—
| style="text-align:rightleft" | 99,451—
| style="text-align:rightleft" | 87,816—
| style="text-align:rightleft" | 71113,053030
| style="text-align:right" | 50124,933076
| style="text-align:right" | 33128,019111
| style="text-align:right" | —132,495
| style="text-align:right" | —132,125
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2019 / Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 86,131
| style="text-align:right" | 79,823
| style="text-align:right" | 79,572
| style="text-align:right" | 79,414
| style="text-align:right" | 77,770
| style="text-align:right" | 73,635
| style="text-align:right" | 87,115
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -70,367
| style="text-align:right" | -65,847
| style="text-align:right" | -57,341
| style="text-align:right" | -45,696
| style="text-align:right" | -30,948
| style="text-align:right" | -28,954
| style="text-align:right" | -28,636
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 9,773
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 5,660
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 70,367
| style="text-align:right" | 65,847
| style="text-align:right" | 57,341
| style="text-align:right" | 45,696
| style="text-align:right" | 30,948
| style="text-align:right" | 28,954
| style="text-align:right" | 28,636
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2020 / Multi-line Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 134,281
| style="text-align:right" | 132,125
| style="text-align:right" | 132,495
| style="text-align:right" | 128,111
| style="text-align:right" | 124,076
| style="text-align:right" | 113,030
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -126,965
| style="text-align:right" | -121,097
| style="text-align:right" | -105,283
| style="text-align:right" | -82,236
| style="text-align:right" | -60,680
| style="text-align:right" | -29,499
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 4,174
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 5,542
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE2021
| style="text-align:rightleft" | 126,965—
| style="text-align:rightleft" | 121,097—
| style="text-align:rightleft" | 105,283—
| style="text-align:rightleft" | 82,236—
| style="text-align:rightleft" | 60,680—
| style="text-align:right" | 29156,499067
| style="text-align:right" | —158,891
| style="text-align:right" | —160,331
| style="text-align:right" | —160,546
| style="text-align:right" | —157,006
| style="text-align:right" | 7,932
| style="text-align:right" | 6,727
|-
| style="text-align:left" | Accident Year 2020 / Exited Lines2022
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 236,909
| style="text-align:right" | 242,097
| style="text-align:right" | 242,358
| style="text-align:right" | 249,317
| style="text-align:right" | 19,315
| style="text-align:right" | 8,679
|-
| style="text-align:left" | Claims Development [Line Items]2023
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 306,511
| style="text-align:right" | 306,511
| style="text-align:right" | 320,637
| style="text-align:right" | 96,700
| style="text-align:right" | 8,468
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance2024
| style="text-align:rightleft" | 138,320—
| style="text-align:rightleft" | 137,671—
| style="text-align:rightleft" | 137,907—
| style="text-align:rightleft" | 137,835—
| style="text-align:rightleft" | 136,469—
| style="text-align:right" | 132,248
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 353,933
| style="text-align:right" | 336,197
| style="text-align:right" | 155,878
| style="text-align:right" | 7,700
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below2025
| style="text-align:rightleft" | -124,139—
| style="text-align:rightleft" | -120,831—
| style="text-align:rightleft" | -114,543—
| style="text-align:rightleft" | -102,132—
| style="text-align:rightleft" | -98,202—
| style="text-align:right" | -102,725
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 356,590
| style="text-align:right" | 257,468
| style="text-align:right" | 6,139
|-
| style="text-align:left; font-weight:bold" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, NetTotal
| style="text-align:rightleft; font-weight:bold" | 10,644—
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —1,902,472
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Short-DurationCumulative Insurancenet Contract,paid Cumulativeloss Numberand ofALAE Reportedfrom Claimsthe /table claimbelow
| style="text-align:rightleft" | 4,867Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | ( 1,162,853 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | CumulativeNet netreserves paidfor loss and LAEALAE before 2016
| style="text-align:rightleft" | 124,139Net reserves for loss and ALAE before 2016
| style="text-align:rightleft" | 120,831Net reserves for loss and ALAE before 2016
| style="text-align:rightleft" | 114,543Net reserves for loss and ALAE before 2016
| style="text-align:rightleft" | 102,132Net reserves for loss and ALAE before 2016
| style="text-align:rightleft" | 98,202Net reserves for loss and ALAE before 2016
| style="text-align:right" | 102,725Net reserves for loss and ALAE before 2016
| style="text-align:right" | —Net reserves for loss and ALAE before 2016
| style="text-align:right" | —Net reserves for loss and ALAE before 2016
| style="text-align:right" | Net reserves for loss and ALAE before 2016
| style="text-align:right" | ( 189 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | AccidentTotal Yearnet 2021reserves /for Short-tail/Monolineloss Specialtyand LinesALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —739,430
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Claims*Supplementary Developmentinformation [Lineand Items]unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | *Supplementary information and unaudited
| style="text-align:right" | *Supplementary information and unaudited
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Multi-line Solutions
! colspan="4" style="text-align:center" | ($ in thousands)
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
|! colspan="11" style="text-align:leftcenter" | IncurredCumulative lossesPaid Losses and ALAE, netNet of reinsuranceReinsurance ($ in thousands)
| style="text-align:right" | 99,783
| style="text-align:right" | 92,134
| style="text-align:right" | 92,143
| style="text-align:right" | 93,429
| style="text-align:right" | 92,780
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Cumulative net paid loss and ALAE from the table below
|! colspan="10" style="text-align:rightcenter" | -93Years Ended December 31,560
| style="text-align:right" | -78,439
| style="text-align:right" | -67,912
| style="text-align:right" | -56,803
| style="text-align:right" | -18,447
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability,Accident NetYear
|! class="col-m" style="text-align:rightleft" | 1,7742016*
|! class="col-m" style="text-align:right" | —2017*
|! class="col-m" style="text-align:right" | —2018*
|! class="col-m" style="text-align:right" | —2019*
|! class="col-m" style="text-align:right" | —2020*
|! class="col-m" style="text-align:right" | —2021*
|! class="col-m" style="text-align:right" | —2022*
|! class="col-m" style="text-align:right" | —2023*
|! class="col-m" style="text-align:right" | —2024*
|! class="col-m" style="text-align:right" | —2025
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim2016
| style="text-align:rightleft" | 123,656239
| style="text-align:right" | —42,528
| style="text-align:right" | —53,352
| style="text-align:right" | —58,895
| style="text-align:right" | —69,691
| style="text-align:right" | —72,544
| style="text-align:right" | —75,855
| style="text-align:right" | —77,160
| style="text-align:right" | —77,760
| style="text-align:right" | —77,825
|-
| style="text-align:left" | Cumulative net paid loss and LAE2017
| style="text-align:rightleft" | 93,560—
| style="text-align:right" | 7823,439770
| style="text-align:right" | 6741,912945
| style="text-align:right" | 5653,803093
| style="text-align:right" | 1861,447354
| style="text-align:right" | —67,926
| style="text-align:right" | —71,109
| style="text-align:right" | —73,770
| style="text-align:right" | —75,714
| style="text-align:right" | —77,177
|-
| style="text-align:left" | Accident Year 2021 / Multi-line Solutions2018
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 26,201
| style="text-align:right" | 42,568
| style="text-align:right" | 47,226
| style="text-align:right" | 58,655
| style="text-align:right" | 65,635
| style="text-align:right" | 69,893
| style="text-align:right" | 70,128
| style="text-align:right" | 72,429
|-
| style="text-align:left" | Claims Development [Line Items]2019
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 33,019
| style="text-align:right" | 50,933
| style="text-align:right" | 71,053
| style="text-align:right" | 87,816
| style="text-align:right" | 99,451
| style="text-align:right" | 106,765
| style="text-align:right" | 106,826
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance2020
| style="text-align:rightleft" | 157,006—
| style="text-align:right" | 160,546
| style="text-align:right" | 160,331
| style="text-align:right" | 158,891
| style="text-align:right" | 156,067
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 29,499
| style="text-align:right" | 60,680
| style="text-align:right" | 82,236
| style="text-align:right" | 105,283
| style="text-align:right" | 121,097
| style="text-align:right" | 126,965
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below2021
| style="text-align:rightleft" | -141,539—
| style="text-align:right" | -125,749
| style="text-align:right" | -102,772
| style="text-align:right" | -73,293
| style="text-align:right" | -37,118
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —37,118
| style="text-align:right" | 73,293
|-
| style="text-align:leftright" | Short-Duration Insurance Contracts102, Incurred but Not Reported (IBNR) Claims Liability, Net772
| style="text-align:right" | 7125,932749
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 6,727
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 141,539
| style="text-align:right" | 125,749
| style="text-align:right" | 102,772
| style="text-align:right" | 73,293
| style="text-align:right" | 37,118
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2021 / Exited Lines2022
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 50,148
| style="text-align:right" | 114,794
| style="text-align:right" | 165,854
| style="text-align:right" | 205,410
|-
| style="text-align:left" | Claims Development [Line Items]2023
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 63,079
| style="text-align:right" | 122,186
| style="text-align:right" | 181,636
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance2024
| style="text-align:rightleft" | 97,577—
| style="text-align:right" | 92,095
| style="text-align:right" | 91,323
| style="text-align:right" | 91,188
| style="text-align:right" | 83,322
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -81,600
| style="text-align:right" | -72,923
| style="text-align:right" | -66,012
| style="text-align:right" | -57,820
| style="text-align:right" | -41,540
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 58,281
| style="text-align:right" | 123,488
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net2025
| style="text-align:rightleft" | 10,676—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 49,558
|-
| style="text-align:left; font-weight:bold" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claimTotal
| style="text-align:rightleft; font-weight:bold" | 2,446—
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —1,162,853
|-
| style="text-align:left" | Cumulative*Supplementary net paid lossinformation and LAEunaudited
| style="text-align:rightleft" | 81,600*Supplementary information and unaudited
| style="text-align:right" | 72,923*Supplementary information and unaudited
| style="text-align:right" | 66,012*Supplementary information and unaudited
| style="text-align:right" | 57,820*Supplementary information and unaudited
| style="text-align:right" | 41,540*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
|}
</div>
'''Exited Lines — all lines in runoff'''
* The provided table reconciles net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses as of December 31, 2025 and 2024 <sup>p. 97</sup>.
* The subsequent table details the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts <sup>p. 97</sup>.
* This claims duration data is based on disaggregated information from paid loss development tables, net of reinsurance <sup>p. 97</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Exited Lines — all lines in runoff
! colspan="4" style="text-align:center" | ($ in thousands except number of claims)
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
|! colspan="11" style="text-align:leftcenter" | AccidentIncurred YearLosses 2022and /ALAE, Short-tail/MonolineNet of Reinsurance ($ Specialtyin Linesthousands)
|! colspan="2" style="text-align:rightcenter" | —As of December 31, 2025
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Claims Development [Line Items]
|! colspan="11" style="text-align:rightcenter" | —Years Ended December 31,
|! style="text-align:rightcenter" | —Reported Claims
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Incurred losses and ALAE, net ofAccident reinsuranceYear
|! class="col-m" style="text-align:rightleft" | 96,8742016*
|! class="col-m" style="text-align:rightleft" | 104,0952017*
|! class="col-m" style="text-align:rightleft" | 105,3942018*
|! class="col-m" style="text-align:rightleft" | 108,2992019*
|! class="col-m" style="text-align:rightleft" | —2020*
|! class="col-m" style="text-align:right" | —2021*
|! class="col-m" style="text-align:right" | —2022*
|! class="col-m" style="text-align:right" | —2023*
|! class="col-m" style="text-align:right" | —2024*
|! class="col-m" style="text-align:right" | —2025
! class="col-m" style="text-align:right" | IBNR
! class="col-m" style="text-align:right" | Reported Claims
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below2016
| style="text-align:rightleft" | -8593,696019
| style="text-align:rightleft" | -7792,150996
| style="text-align:rightleft" | -6491,594372
| style="text-align:rightleft" | -2793,773577
| style="text-align:rightleft" | —97,301
| style="text-align:right" | —98,301
| style="text-align:right" | —100,651
| style="text-align:right" | —100,651
| style="text-align:right" | —102,801
| style="text-align:right" | —104,246
| style="text-align:right" | 1,851
| style="text-align:right" | 4,911
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net2017
| style="text-align:rightleft" | 6,266—
| style="text-align:rightleft" | —75,159
| style="text-align:rightleft" | —79,581
| style="text-align:rightleft" | —81,785
| style="text-align:rightleft" | —65,735
| style="text-align:right" | —68,346
| style="text-align:right" | —68,646
| style="text-align:right" | —68,646
| style="text-align:right" | —70,885
| style="text-align:right" | —72,682
| style="text-align:right" | 1,819
| style="text-align:right" | 4,370
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim2018
| style="text-align:rightleft" | 2,414—
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —74,357
| style="text-align:rightleft" | —68,990
| style="text-align:rightleft" | —76,506
| style="text-align:right" | —79,006
| style="text-align:right" | —84,165
| style="text-align:right" | —84,165
| style="text-align:right" | —92,082
| style="text-align:right" | —91,897
| style="text-align:right" | 4,093
| style="text-align:right" | 4,941
|-
| style="text-align:left" | Cumulative net paid loss and LAE2019
| style="text-align:rightleft" | 85,696—
| style="text-align:rightleft" | 77,150—
| style="text-align:rightleft" | 64,594—
| style="text-align:rightleft" | 2787,773115
| style="text-align:rightleft" | —73,635
| style="text-align:right" | —77,770
| style="text-align:right" | —79,414
| style="text-align:right" | —79,572
| style="text-align:right" | —79,823
| style="text-align:right" | —86,131
| style="text-align:right" | 9,773
| style="text-align:right" | 5,660
|-
| style="text-align:left" | Accident Year 2022 / Multi-line Solutions2020
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —132,248
| style="text-align:right" | —136,469
| style="text-align:right" | —137,835
| style="text-align:right" | —137,907
| style="text-align:right" | —137,671
| style="text-align:right" | —138,320
| style="text-align:right" | 10,644
| style="text-align:right" | 4,867
|-
| style="text-align:left" | Claims Development [Line Items]2021
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:right" | —83,322
| style="text-align:right" | —91,188
| style="text-align:right" | —91,323
| style="text-align:right" | —92,095
| style="text-align:right" | —97,577
| style="text-align:right" | 10,676
| style="text-align:right" | 2,446
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance2022
| style="text-align:rightleft" | 249,317—
| style="text-align:rightleft" | 242,358—
| style="text-align:rightleft" | 242,097—
| style="text-align:rightleft" | 236,909—
| style="text-align:left" | —
| style="text-align:right" | —
| style="text-align:right" | —12,717
| style="text-align:right" | —12,240
| style="text-align:right" | —11,800
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -205,410
| style="text-align:right" | -165,854
| style="text-align:right" | -114,794
| style="text-align:right" | -50,148
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 19,315
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 8,679
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 205,410
| style="text-align:right" | 165,854
| style="text-align:right" | 114,794
| style="text-align:right" | 50,148
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2022 / Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 14,362
| style="text-align:right" | 11,800
| style="text-align:right" | 12,240
| style="text-align:right" | 12,717
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -11,325
| style="text-align:right" | -9,211
| style="text-align:right" | -4,077
| style="text-align:right" | -2,155
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 2,025
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 246
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE2023
| style="text-align:rightleft" | 11,325—
| style="text-align:rightleft" | 9,211—
| style="text-align:rightleft" | 4,077—
| style="text-align:rightleft" | 2,155—
| style="text-align:left" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2023 / Short-tail/Monoline Specialty Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 161,222
| style="text-align:right" | 191,865
| style="text-align:right" | 190,565
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -114,247
| style="text-align:right" | -100,705
| style="text-align:right" | -33,795
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 28,997
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 5,015
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 114,247
| style="text-align:right" | 100,705
| style="text-align:right" | 33,795
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2023 / Multi-line Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 320,637
| style="text-align:right" | 306,511
| style="text-align:right" | 306,511
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -181,636
| style="text-align:right" | -122,186
| style="text-align:right" | -63,079
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 96,700
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 8,468
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 181,636
| style="text-align:right" | 122,186
| style="text-align:right" | 63,079
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2023 / Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 2
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 1
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 1
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE2024
| style="text-align:rightleft" | 0—
| style="text-align:rightleft" | 0—
| style="text-align:rightleft" | 0—
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 5
| style="text-align:right" | 5
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2024 / Short-tail/Monoline Specialty Lines2025
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 11
| style="text-align:right" | 11
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Claims Development [Line Items]Total
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:rightleft; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —605,233
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:leftright; font-weight:bold" | Incurred losses and ALAE, net of reinsurance—
| style="text-align:right" | 292,220
| style="text-align:right" | 280,147
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -154,896
| style="text-align:right" | -53,691
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 99,302
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 5,819
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 154,896
| style="text-align:right" | 53,691
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2024 / Multi-line Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 336,197
| style="text-align:right" | 353,933
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | -123,488
| style="text-align:right" | -58,281
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 155,878
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 7,700
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 123,488
| style="text-align:right" | 58,281
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accident Year 2024 / Exited Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 5
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | 0Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | 0Cumulative net paid loss and ALAE from the table below
| style="text-align:rightleft" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | —( 538,304 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-DurationNet Insurancereserves Contracts,for Incurredloss butand NotALAE Reportedbefore (IBNR) Claims Liability, Net2015
| style="text-align:rightleft" | 5Net reserves for loss and ALAE before 2015
| style="text-align:rightleft" | —Net reserves for loss and ALAE before 2015
| style="text-align:rightleft" | —Net reserves for loss and ALAE before 2015
| style="text-align:rightleft" | —Net reserves for loss and ALAE before 2015
| style="text-align:rightleft" | —Net reserves for loss and ALAE before 2015
| style="text-align:right" | —Net reserves for loss and ALAE before 2015
| style="text-align:right" | —Net reserves for loss and ALAE before 2015
| style="text-align:right" | —Net reserves for loss and ALAE before 2015
| style="text-align:right" | Net reserves for loss and ALAE before 2015
| style="text-align:right" | 14,737
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Short-Duration Insurance Contract, CumulativeTotal Numbernet ofreserves Reportedfor Claimsloss /and claimALAE
| style="text-align:rightleft; font-weight:bold" | 0Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:rightleft; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —Total net reserves for loss and ALAE
| style="text-align:right; font-weight:bold" | —81,666
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Cumulative*Supplementary net paid lossinformation and LAEunaudited
| style="text-align:rightleft" | 0*Supplementary information and unaudited
| style="text-align:rightleft" | 0*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | *Supplementary information and unaudited
| style="text-align:right" | *Supplementary information and unaudited
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Exited Lines — all lines in runoff
! colspan="4" style="text-align:center" | ($ in thousands)
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
! style="text-align:center" |
|-
|! colspan="11" style="text-align:leftcenter" | AccidentCumulative YearPaid 2025Losses /and Short-tail/MonolineALAE, Net of Reinsurance ($ Specialtyin Linesthousands)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Claims Development [Line Items]
|! colspan="10" style="text-align:rightcenter" | —Years Ended December 31,
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
|! style="text-align:left" | Incurred losses and ALAE, net ofAccident reinsuranceYear
|! class="col-m" style="text-align:rightleft" | 422,5282016*
|! class="col-m" style="text-align:right" | —2017*
|! class="col-m" style="text-align:right" | —2018*
|! class="col-m" style="text-align:right" | —2019*
|! class="col-m" style="text-align:right" | —2020*
|! class="col-m" style="text-align:right" | —2021*
|! class="col-m" style="text-align:right" | —2022*
|! class="col-m" style="text-align:right" | —2023*
|! class="col-m" style="text-align:right" | —2024*
|! class="col-m" style="text-align:right" | —2025
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below2016
| style="text-align:rightleft" | -7936,856592
| style="text-align:right" | —57,638
| style="text-align:right" | —70,253
| style="text-align:right" | —78,070
| style="text-align:right" | —81,181
| style="text-align:right" | —87,482
| style="text-align:right" | —91,556
| style="text-align:right" | —95,114
| style="text-align:right" | —97,462
| style="text-align:right" | —98,831
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net2017
| style="text-align:rightleft" | 275,190—
| style="text-align:right" | —34,176
| style="text-align:right" | —52,103
| style="text-align:right" | —51,985
| style="text-align:right" | —50,545
| style="text-align:right" | —57,457
| style="text-align:right" | —62,924
| style="text-align:right" | —66,498
| style="text-align:right" | —68,480
| style="text-align:right" | —69,798
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim2018
| style="text-align:rightleft" | 5,495—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 25,553
| style="text-align:right" | 60,149
| style="text-align:right" | 39,870
| style="text-align:right" | 54,339
| style="text-align:right" | 67,001
| style="text-align:right" | 74,604
| style="text-align:right" | 79,860
| style="text-align:right" | 82,244
|-
| style="text-align:left" | Cumulative net paid loss and LAE2019
| style="text-align:rightleft" | 79,856—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 28,636
| style="text-align:right" | 28,954
| style="text-align:right" | 30,948
| style="text-align:right" | 45,696
| style="text-align:right" | 57,341
| style="text-align:right" | 65,847
| style="text-align:right" | 70,367
|-
| style="text-align:left" | Accident Year 2025 / Multi-line Solutions2020
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 102,725
| style="text-align:right" | 98,202
| style="text-align:right" | 102,132
| style="text-align:right" | 114,543
| style="text-align:right" | 120,831
| style="text-align:right" | 124,139
|-
| style="text-align:left" | Claims Development [Line Items]2021
| style="text-align:rightleft" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 41,540
| style="text-align:right" | 57,820
| style="text-align:right" | 66,012
| style="text-align:right" | 72,923
| style="text-align:right" | 81,600
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance2022
| style="text-align:rightleft" | 356,590—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 2,155
| style="text-align:right" | 4,077
| style="text-align:right" | 9,211
| style="text-align:right" | 11,325
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below2023
| style="text-align:rightleft" | -49,558—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net2024
| style="text-align:rightleft" | 257,468—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim2025
| style="text-align:rightleft" | 6,139—
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Cumulative net paid loss and LAETotal
| style="text-align:rightleft; font-weight:bold" | 49,558—
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —538,304
|-
| style="text-align:left" | Accident*Supplementary Yearinformation 2025and / Exited Linesunaudited
| style="text-align:rightleft" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
| style="text-align:right" | —*Supplementary information and unaudited
|-
| style="text-align:left" | Claims Development [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance
| style="text-align:right" | 11
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net
| style="text-align:right" | 11
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cumulative net paid loss and LAE
| style="text-align:right" | 0
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
=== Schedule of Reconciliation of Claims Development to Liability ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Exited Lines — all lines in runoff
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2025
! class="col-s" style="text-align:rightcenter" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
! class="col-s" style="text-align:right" | Dec. 31, 2022
|-
|! style="text-align:left" | Short-DurationNet Insurancereserves Contracts,for Reconciliationlosses ofand Claims Development to Liability [Line Items]ALAE:
|! class="col-s" style="text-align:right" | —
|! class="col-s" style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | ReservesShort-tail/Monoline forSpecialty losses and LAE, net of reinsuranceLines
| style="text-align:right" | 1545,367,038942
| style="text-align:right" | 1367,084,980226
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | CededMulti-line unpaid losses and LAESolutions
| style="text-align:right" | 921739,165430
| style="text-align:right" | 670631,846065
| style="text-align:right" | 455,484
| style="text-align:right" | 435,986
|-
| style="text-align:left" | UnallocatedExited LAELines
| style="text-align:right" | 3081,691666
| style="text-align:right" | 2686,557689
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses and lossALAE, adjustmentnet expensesof reinsurance
| style="text-align:right" | 21,318367,894038
| style="text-align:right" | 1,782084,383980
| style="text-align:right" | 1,314,501
| style="text-align:right" | 1,141,757
|-
| style="text-align:left" | Short-tail/Monoline Specialty Lines
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses and LAE, net of reinsurance
| style="text-align:right" | 545,942
| style="text-align:right" | 367,226
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ceded unpaid losses and LAE
| style="text-align:right" | 388,276
| style="text-align:right" | 275,204
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Multi-line Solutions
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses and LAE, net of reinsurance
| style="text-align:right" | 739,430
| style="text-align:right" | 631,065
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ceded unpaid losses and LAE
| style="text-align:right" | 514,393
| style="text-align:right" | 380,344
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Exited Lines
| style="text-align:right" | —18,496
| style="text-align:right" | —15,298
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Short-Duration Insurance Contracts, Reconciliation of ClaimsTotal Developmentreinsurance torecoverable Liabilityon [Lineunpaid Items]claims
| style="text-align:right; font-weight:bold" | —921,165
| style="text-align:right; font-weight:bold" | —670,846
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Reserves for losses andUnallocated LAE, net of reinsurance
| style="text-align:right" | 8130,666691
| style="text-align:right" | 8626,689557
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | CededReserves unpaidfor losses and LAE at end of year
| style="text-align:right" | 182,496318,894
| style="text-align:right" | 151,298782,383
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
=== Schedule of Historical Claims Duration ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Exited Lines — all lines in runoff
! style="text-align:left" | —
! classcolspan="col-s11" style="text-align:rightcenter" | Dec.Average 31Annual Percentage Payout of Incurred Claims by Age, 2025Net of Reinsurance
|-
|! style="text-align:left" | Short-tail/Monoline Specialty Lines
|! colspan="10" style="text-align:rightcenter" | —Years
|-
|! style="text-align:left" | Short-Duration Insurance Contracts, Historical Claims Duration [Line Items]—
|! class="col-m" style="text-align:right" | —1*
! class="col-m" style="text-align:right" | 2*
! class="col-m" style="text-align:right" | 3*
! class="col-m" style="text-align:right" | 4*
! class="col-s" style="text-align:right" | 5*
! class="col-s" style="text-align:right" | 6*
! class="col-s" style="text-align:right" | 7*
! class="col-s" style="text-align:right" | 8*
! class="col-s" style="text-align:right" | 9*
! class="col-s" style="text-align:right" | 10*
|-
| style="text-align:left" | YearShort-Tail/Monoline 1Specialty Lines
| style="text-align:right" | 21.101%
| style="text-align:right" | 38.1%
| style="text-align:right" | 10.8%
| style="text-align:right" | 9.7%
| style="text-align:right" | 15.2%
| style="text-align:right" | N/A
| style="text-align:right" | N/A
| style="text-align:right" | N/A
| style="text-align:right" | N/A
| style="text-align:right" | N/A
|-
| style="text-align:left" | YearMulti-line 2Solutions
| style="text-align:right" | 3823.109%
| style="text-align:right" | 21.6%
| style="text-align:right" | 15.6%
| style="text-align:right" | 13.6%
| style="text-align:right" | 10.5%
| style="text-align:right" | 4.8%
| style="text-align:right" | 1.9%
| style="text-align:right" | 2.4%
| style="text-align:right" | 1.3%
| style="text-align:right" | 0.1%
|-
| style="text-align:left" | YearExited 3Lines
| style="text-align:right" | 1027.805%
| style="text-align:right" | 12.2%
| style="text-align:right" | 4.9%
| style="text-align:right" | 9.9%
| style="text-align:right" | 8.9%
| style="text-align:right" | 6.8%
| style="text-align:right" | 4.9%
| style="text-align:right" | 2.9%
| style="text-align:right" | 2.0%
| style="text-align:right" | 1.3%
|-
| style="text-align:left" | Year*Supplementary 4information and unaudited
| style="text-align:right" | 9.70%*Supplementary information and unaudited
| style="text-align:right" | *Supplementary information and unaudited
|-
| style="text-align:leftright" | Year*Supplementary 5information and unaudited
| style="text-align:right" | 15.20%*Supplementary information and unaudited
| style="text-align:right" | —
|-
| style="text-align:leftright" | Multi-line Solutions—
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Historical Claims Duration [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Year 1
| style="text-align:right" | 23.90%
|-
| style="text-align:left" | Year 2
| style="text-align:right" | 21.60%
|-
| style="text-align:left" | Year 3
| style="text-align:right" | 15.60%
|-
| style="text-align:left" | Year 4
| style="text-align:right" | 13.60%
|-
| style="text-align:left" | Year 5
| style="text-align:right" | 10.50%
|-
| style="text-align:left" | Year 6
| style="text-align:right" | 4.80%
|-
| style="text-align:left" | Year 7
| style="text-align:right" | 1.90%
|-
| style="text-align:left" | Year 8
| style="text-align:right" | 2.40%
|-
| style="text-align:left" | Year 9
| style="text-align:right" | 1.30%
|-
| style="text-align:left" | Year 10
| style="text-align:right" | 0.10%
|-
| style="text-align:left" | Exited Lines
| style="text-align:right" | —
|-
| style="text-align:left" | Short-Duration Insurance Contracts, Historical Claims Duration [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Year 1
| style="text-align:right" | 27.50%
|-
| style="text-align:left" | Year 2
| style="text-align:right" | 12.20%
|-
| style="text-align:left" | Year 3
| style="text-align:right" | 4.90%
|-
| style="text-align:left" | Year 4
| style="text-align:right" | 9.90%
|-
| style="text-align:left" | Year 5
| style="text-align:right" | 8.90%
|-
| style="text-align:left" | Year 6
| style="text-align:right" | 6.80%
|-
| style="text-align:left" | Year 7
| style="text-align:right" | 4.90%
|-
| style="text-align:left" | Year 8
| style="text-align:right" | 2.90%
|-
| style="text-align:left" | Year 9
| style="text-align:right" | 2.00%
|-
| style="text-align:left" | Year 10
| style="text-align:right" | 1.30%
|}
</div>
=='''15. Commission and Fee Income =='''
* ''Skyward Underwriters Agency, Inc. (SUA)'' is a subsidiary of the Company <sup>p. 98</sup>.
=== Schedule of Disaggregation of Revenue ===
* SUA acts as a managing general insurance agent and reinsurance broker <sup>p. 98</sup>.
* SUA specializes in property and casualty and accident and health risks within specialty niche markets <sup>p. 98</sup>.
* ''Commission and fee income'' is primarily generated by SUA <sup>p. 98</sup>.
* This income is derived from the placement of insurance policies with third-party insurance or reinsurance companies <sup>p. 98</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 15. Commission and Fee Income
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
! class="col-s" style="text-align:right" | 2023
|-
!| style="text-align:left" | —SUA commission revenue
! class="col-s"| style="text-align:right" | Dec. 318, 2025323
! class="col-s"| style="text-align:right" | Dec. 317, 2024967
! class="col-s"| style="text-align:right" | Dec. 317, 2023222
|-
| style="text-align:left" | DisaggregationSUA offee Revenue [Line Items]revenue
| style="text-align:right" | —2,333
| style="text-align:right" | —2,443
| style="text-align:right" | —2,732
|-
| style="text-align:left" | Other commission and fee revenue (loss)
| style="text-align:right" | 1,725
| style="text-align:right" | 266
| style="text-align:right" | ( 135 )
|-
| style="text-align:left; font-weight:bold" | Total commission and fee revenue
|-
| style="text-align:left" | Commission and fee expenses
| style="text-align:right" | -( 5,526 )
| style="text-align:right" | -( 3,973 )
| style="text-align:right" | -( 3,755 )
|-
| style="text-align:left" | Net commission and fee income
| style="text-align:right" | 6,703
| style="text-align:right" | 6,064
|-
| style="text-align:left" | SUA commission revenue
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Disaggregation of Revenue [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total commission and fee revenue
| style="text-align:right; font-weight:bold" | 8,323
| style="text-align:right; font-weight:bold" | 7,967
| style="text-align:right; font-weight:bold" | 7,222
|-
| style="text-align:left" | SUA fee revenue
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Disaggregation of Revenue [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total commission and fee revenue
| style="text-align:right; font-weight:bold" | 2,333
| style="text-align:right; font-weight:bold" | 2,443
| style="text-align:right; font-weight:bold" | 2,732
|-
| style="text-align:left" | Other commission and fee revenue (loss)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Disaggregation of Revenue [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total commission and fee revenue
| style="text-align:right; font-weight:bold" | 1,725
| style="text-align:right; font-weight:bold" | 266
| style="text-align:right; font-weight:bold" | -135
|}
</div>
=== Schedule of Company’s Opening and Closing Balances of Contract Assets ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 15. Commission and Fee Income
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:rightcenter" | Dec. 31,Contract 2025Assets
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
|! style="text-align:left" | Revenue fromBalance Contractat withDecember Customer31, [Abstract]2023
|! class="col-s" style="text-align:right" | —976
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | ContractBalance assetat afterDecember allowance31, for credit loss2024
| style="text-align:right" | 953
| style="text-align:right" | 1,416
| style="text-align:right" | 976
|}
</div>
=='''16. Underwriting, Acquisition and Insurance Expenses =='''
* ''Underwriting, acquisition and insurance expenses'' were USD 390.0m in 2025, USD 330.0m in 2024, and USD 270.0m in 2023 <sup>p. 99</sup>.
* ''Commissions and brokerage'' were USD 190.0m in 2025, USD 160.0m in 2024, and USD 130.0m in 2023 <sup>p. 99</sup>.
* ''Salaries and employee benefits'' were USD 110.0m in 2025, USD 90.0m in 2024, and USD 70.0m in 2023 <sup>p. 99</sup>.
* ''General and administrative expenses'' were USD 90.0m in 2025, USD 80.0m in 2024, and USD 70.0m in 2023 <sup>p. 99</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 16. Underwriting, Acquisition and Insurance Expenses
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
! class="col-s" style="text-align:right" | 2023
|-
!| style="text-align:left" | —Amortization of policy acquisition costs
! class="col-s"| style="text-align:right" | Dec. 31195, 2025422
! class="col-s"| style="text-align:right" | Dec. 31149, 2024975
! class="col-s"| style="text-align:right" | Dec. 31108, 2023514
|-
| style="text-align:left" | Other Incomeoperating and Expensesgeneral [Abstract]expenses
| style="text-align:right" | —181,937
| style="text-align:right" | —161,782
| style="text-align:right" | —134,930
|-
| style="text-align:left; font-weight:bold" | Total underwriting, acquisition and insurance expenses
</div>
=='''17. Reinsurance =='''
* ''Reinsurance agreements'' are used to assume and cede premiums and benefits with other insurance companies <sup>p. 100</sup>.
=== Schedule of Premiums Written and Earned ===
* ''Reinsurance agreements'' increase the Company's capacity to write larger risks and manage loss exposure within its capital resources <sup>p. 100</sup>.
* The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations <sup>p. 100</sup>.
* The Company entered into agreements with several reinsurers to establish ''funded trust accounts'' where the Company is the sole beneficiary <sup>p. 100</sup>.
* These ''trust accounts'' provide additional security for collecting claim recoverables under reinsurance contracts <sup>p. 100</sup>.
* The Company does not carry these trust accounts on its balance sheet as it only gains custody upon the reinsurer's failure to pay <sup>p. 100</sup>.
* The ''market value of these trust accounts'' was approximately $233.5 million at December 31, 2025 <sup>p. 100</sup>.
* The ''trust amount'' will be periodically adjusted by mutual agreement based on claim payments and loss reserve recoverables <sup>p. 100</sup>.
* During Q1 2020, the Company entered into an ''LPT retroactive reinsurance agreement'' with R&Q <sup>p. 100</sup>.
* The ''reinsurance recoverable from R&Q'' was $22.7 million at December 31, 2024 <sup>p. 100</sup>.
* The ''LPT'' was commuted effective January 31, 2025, and the Company received the reinsurance recoverable balance in full <sup>p. 100</sup>.
* Certain ''ceded reinsurance contracts'' that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method <sup>p. 100</sup>.
* The Company’s ''deposit asset'' was $22.7 million at December 31, 2025, and $25.9 million at December 31, 2024 <sup>p. 100</sup>.
* The ''deposit asset'' was included in other assets on the Consolidated Balance Sheets <sup>p. 100</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 17. Reinsurance
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="32" style="text-align:center" | 12 Months Ended2025
! colspan="2" style="text-align:center" | 2024
! colspan="2" style="text-align:center" | 2023
|-
! style="text-align:left" | —($ in thousands)
! class="col-s" style="text-align:right" | Dec. 31, 2025Written
! class="col-s" style="text-align:right" | Dec. 31, 2024Earned
! class="col-s" style="text-align:right" | Dec. 31, 2023Written
! class="col-s" style="text-align:right" | Earned
|-
|! class="col-s" style="text-align:leftright" | Written
|! class="col-s" style="text-align:right" | —Earned
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Direct premiums
| style="text-align:right" | 1,684,411
| style="text-align:right" | 1,622,594
| style="text-align:right" | 1,458,637
| style="text-align:right" | 1,375,917
| style="text-align:right" | 1,241,180
| style="text-align:right" | 1,155,835
|-
| style="text-align:left" | Assumed premiums
| style="text-align:right" | 481,825
| style="text-align:right" | 406,792
| style="text-align:right" | 284,595
| style="text-align:right" | 282,662
| style="text-align:right" | 218,649
| style="text-align:right" | 193,971
|-
| style="text-align:left" | Ceded premiums
| style="text-align:right" | -( 760,004 )
| style="text-align:right" | -619( 724,654881 )
| style="text-align:right" | -549( 619,138654 )
| style="text-align:right" | ( 601,857 )
| style="text-align:right" | ( 549,138 )
| style="text-align:right" | ( 520,663 )
|-
| style="text-align:left" | Net premiums
| style="text-align:right" | 1,406,232
| style="text-align:right" | 1,304,505
| style="text-align:right" | 1,123,578
| style="text-align:right" | 1,056,722
| style="text-align:right" | 910,691
|-
| style="text-align:left" | Earned
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Direct premiums
| style="text-align:right" | 1,622,594
| style="text-align:right" | 1,375,917
| style="text-align:right" | 1,155,835
|-
| style="text-align:left" | Assumed premiums
| style="text-align:right" | 406,792
| style="text-align:right" | 282,662
| style="text-align:right" | 193,971
|-
| style="text-align:left" | Ceded premiums
| style="text-align:right" | -724,881
| style="text-align:right" | -601,857
| style="text-align:right" | -520,663
|-
| style="text-align:left" | Net premiums
| style="text-align:right" | 1,304,505
| style="text-align:right" | 1,056,722
| style="text-align:right" | 829,143
|-
| style="text-align:left" | Ceded losses and LAE incurred
| style="text-align:right" | —
| style="text-align:right" | 697,978
| style="text-align:right" | —
| style="text-align:right" | 534,295
| style="text-align:right" | —
| style="text-align:right" | 337,011
|}
</div>
=== Schedule of Reinsurance Recoverable and Ceded Premiums ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 17. Reinsurance
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
! class="col-s" style="text-align:right" | Dec. 31, 2022
|-
| style="text-align:left" | Insurance [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Ceded unpaid losses and LAE
| style="text-align:right" | 921,165
| style="text-align:right" | 670,846
| style="text-align:right" | 455,484
| style="text-align:right" | 435,986
|-
| style="text-align:left" | Ceded paid losses and LAE
| style="text-align:right" | 201,010
| style="text-align:right" | 166,663
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Loss portfolio transfer
| style="text-align:right" | 0—
| style="text-align:right" | 22,662
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Allowance for credit losses
| style="text-align:right" | -( 2,295 )
| style="text-align:right" | -( 2,295 )
| style="text-align:right" | -2,295
| style="text-align:right" | -2,295
|-
| style="text-align:left" | Reinsurance recoverables
| style="text-align:right" | 1,119,880
| style="text-align:right" | 857,876
| style="text-align:right" | 857,876
| style="text-align:right" | 596,334
|-
| style="text-align:left" | Ceded unearned premium
| style="text-align:right" | 238,948
| style="text-align:right" | 203,901
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
'''18. Stock Based Compensation'''
=== Narrative ===
* The ''2022 Long-Term Incentive Plan'' (2022 Plan) was approved by the Board of Directors on September 23, 2022, and became effective on January 12, 2023 <sup>p. 101</sup>.
<div style="overflow-x:auto">
* The ''2022 Plan'' replaced the Company’s prior Long Term Incentive Plan (2020 Plan) <sup>p. 101</sup>.
{| class="wikitable fintable"
* The ''2022 Plan'' allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors <sup>p. 101</sup>.
|+ ($ in millions)
* ''3,200,656 shares'' of common stock were available for issuance under the 2022 Plan <sup>p. 101</sup>.
! style="text-align:left" | USD ($) $ in Millions
* In ''November 2024'', the Compensation Committee approved a program for independent directors to defer settlement of annual restricted stock units (RSU) awards <sup>p. 101</sup>.
! class="col-s" style="text-align:right" | Dec. 31, 2025
* Directors can elect to defer RSU settlement to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or the date of separation of service from the Company <sup>p. 101</sup>.
! class="col-s" style="text-align:right" | Dec. 31, 2024
* This ''deferral program'' was available for Directors who elected in 2024 to defer settlement of their 2025 RSU awards, which vest in 2026 <sup>p. 101</sup>.
|-
* The ''grant date fair value of options'' under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period <sup>p. 101</sup>.
| style="text-align:left" | Insurance [Abstract]
* ''Volatility'' for option valuation was based on historical volatility of comparable publicly traded insurance companies <sup>p. 101</sup>.
| style="text-align:right" | —
* ''Stock options granted to employees'' during the year ended December 31, 2023, were valued at approximately $4.4 million based on grant date fair value <sup>p. 101</sup>.
| style="text-align:right" | —
* The ''aggregate intrinsic value of options outstanding'' was $27.4 million at December 31, 2025, and $27.0 million at December 31, 2024 <sup>p. 101</sup>.
|-
* The ''weighted-average remaining contractual life of options outstanding'' at December 31, 2025, was 7.0 years <sup>p. 101</sup>.
| style="text-align:left" | Market value of trust funds
* The ''fair value of restricted stock and restricted stock units'' under the 2022 Plan for awards granted at the time of the Company’s IPO was the IPO price of $15.00 per share <sup>p. 101</sup>.
| style="text-align:right" | 233.5
* The ''fair value of subsequent grants'' of restricted stock units was equal to the closing stock price on the grant date <sup>p. 101</sup>.
| style="text-align:right" | —
* The ''expense for equity-based incentives'' is based on fair value at grant date and amortized over their vesting period <sup>p. 101</sup>.
|-
* ''Restricted stock and restricted stock units granted to employees and the Board of Directors'' were valued at approximately $12.2 million in 2025, $8.5 million in 2024, and $17.7 million in 2023, based on grant date fair value <sup>p. 101</sup>.
| style="text-align:left" | Reinsurance recoverable from R&Q
* ''Board of Directors'' were granted 12,579 shares in 2025, 19,453 shares in 2024, and 23,482 shares in 2023 of restricted stock and restricted stock units, each with a one-year service period <sup>p. 101</sup>.
| style="text-align:right" | —
* The ''total fair value of shares vested'' for employees and Board of Directors was $6.0 million in 2025, $3.8 million in 2024, and $0.5 million in 2023 <sup>p. 101</sup>.
| style="text-align:right" | 22.7
* As of ''December 31, 2025'', the total unrecognized compensation cost related to non-vested, stock-based compensation awards was $17.4 million <sup>p. 101</sup>.
|-
* The ''weighted average period'' over which the unrecognized compensation cost is expected to be recognized is 1.6 years <sup>p. 101</sup>.
| style="text-align:left" | Deposit contracts, assets
* The ''Company recognized stock-based compensation expense'' of $12.0 million in 2025, $9.4 million in 2024, and $8.5 million in 2023 <sup>p. 101</sup>.
| style="text-align:right" | 22.7
* The ''2022 Employee Stock Purchase Plan'' (ESPP) was approved by the Board of Directors on September 23, 2022, and became effective on May 15, 2023 <sup>p. 101</sup>.
| style="text-align:right" | 25.9
* The ''ESPP'' is administered by the Compensation Committee <sup>p. 101</sup>.
|}
* Under the ''ESPP'', employees can elect to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year <sup>p. 101</sup>.
</div>
* The ''purchase price of common stock'' under the ESPP is 85% of the lower of its beginning-of-interval or end-of-interval market price <sup>p. 101</sup>.
* The ''Company has reserved 376,548 common shares'' under the ESPP <sup>p. 101</sup>.
== Stock Based Compensation ==
* The ''grant date fair value of options under the ESPP'' was determined using the Black-Scholes model, with a term of 6 months (between grant date and exercisable date) <sup>p. 101</sup>.
* ''Volatility'' for ESPP option valuation was based on historical volatility of comparable publicly traded insurance companies <sup>p. 101</sup>.
=== Narrative ===
* As of ''December 31, 2025'', a total of 141,845 shares had been purchased under the ESPP <sup>p. 101</sup>.
* The ''Company recognized ESPP expense'' of $0.7 million in 2025 and $0.5 million in 2024 <sup>p. 101</sup>.
* As of ''December 31, 2025'', the fair value of unrecognized ESPP expense was $0.3 million <sup>p. 101</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 18. Stock Based Compensation
|+ ($ in millions)
! style="text-align:left" | USD ($) $ / shares in Units, $ in Millions
! colspan="3" style="text-align:center" | 12Award MonthsPayout EndedRange
! style="text-align:center" | Requisite Service Period
! style="text-align:center" | Target Stock and Stock Units
|-
! style="text-align:left" | —Year ended December 31, 2025
! class="col-ms" style="text-align:right" | Dec. 31, 2025—
! class="col-s" style="text-align:right" | Dec. 31, 2024—
! class="col-s" style="text-align:right" | Dec. 31, 2023—
! class="col-s" style="text-align:right" | Jan. 18, 2023
! class="col-s" style="text-align:right" | Jan. 12, 2023
|-
| style="text-align:left" | Share-BasedMarket Compensationcondition Arrangement by Share-Based Payment Award [Line Items]awards
| class="col-s" style="text-align:right" | —0 %- 150 %
| class="col-s" style="text-align:right" | —3 years
| class="col-s" style="text-align:right" | —22,495
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | AuthorizedPerformance targetcondition common share (in shares)awards
| class="col-s" style="text-align:right" | —0 %- 150 %
| class="col-s" style="text-align:right" | —3 years
| class="col-s" style="text-align:right" | —59,769
| style="text-align:right" | —
| style="text-align:right" | 3,200,656
|-
| style="text-align:left" | AggregateService intrinsiccondition value of optionsawards
| class="col-s" style="text-align:right" | 27.4N/A
| class="col-s" style="text-align:right" | 27.01 - 4 years
| class="col-s" style="text-align:right" | —144,921
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Weighted average remaining contractual life of options—
| class="col-s" style="text-align:right" | 7 years—
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —227,185
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | UnrecognizedMarket compensationcondition costawards
| class="col-s" style="text-align:right" | 17.40 %- 150 %
| class="col-s" style="text-align:right" | —3 years
| class="col-s" style="text-align:right" | —32,058
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | UnrecognizedPerformance compensationcondition cost, recognition periodawards
| class="col-s" style="text-align:right" | 10 year 7 months%- 6150 days%
| class="col-s" style="text-align:right" | —3 years
| class="col-s" style="text-align:right" | —76,881
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | StockService basedcondition compensation expenseawards
| class="col-s" style="text-align:right" | 12.0N/A
| class="col-s" style="text-align:right" | 9.1 - 4 years
| class="col-s" style="text-align:right" | 8.5124,025
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Purchase period—
| class="col-s" style="text-align:right" | 6 months—
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —232,964
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | IPOMarket condition awards
| class="col-s" style="text-align:right" | —0 %- 150 %
| class="col-s" style="text-align:right" | —3 years
| class="col-s" style="text-align:right" | —37,622
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-BasedPerformance Compensationcondition Arrangement by Share-Based Payment Award [Line Items]awards
| class="col-s" style="text-align:right" | —0 %- 150 %
| class="col-s" style="text-align:right" | —3 years
| class="col-s" style="text-align:right" | —95,456
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SaleService ofcondition stock, price per share (in dollar per share)awards
| class="col-s" style="text-align:right" | —N/A
| class="col-s" style="text-align:right" | —1 - 4 years
| class="col-s" style="text-align:right" | —968,778
| style="text-align:right" | 15.00
| style="text-align:right" | —
|-
| style="text-align:left" | Restricted Stock Awards And Unitsoptions
| class="col-s" style="text-align:right" | —N/A
| class="col-s" style="text-align:right" | —3 - 4 years
| class="col-s" style="text-align:right" | —759,990
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]—
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —1,861,846
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Granted (in shares)
| style="text-align:right" | 254,978
| style="text-align:right" | 268,631
| style="text-align:right" | 1,101,856
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Fair value of shares vested in period
| style="text-align:right" | 6.0
| style="text-align:right" | 3.8
| style="text-align:right" | 0.5
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Employee Stock
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Authorized target common share (in shares)
| style="text-align:right" | 376,548
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stock based compensation expense
| style="text-align:right" | 0.7
| style="text-align:right" | 0.5
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Purchase price of common stock, percent
| style="text-align:right" | 85.00%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-based compensation arrangement by share-based payment award, shares issues in period (in shares)
| style="text-align:right" | 141,845
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-based payment arrangement, amount capitalized
| style="text-align:right" | 0.3
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Authorized target common share (in shares)
| style="text-align:right" | 227,185
| style="text-align:right" | 232,964
| style="text-align:right" | 1,861,846
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-base compensation arrangement by share-based payment award, terms of award
| style="text-align:right" | 10 years
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stock options granted to employees
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long Term Incentive Plan / Restricted Stock Awards And Units
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Shares granted, value
| style="text-align:right" | 12.2
| style="text-align:right" | 8.5
| style="text-align:right" | 17.7
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Long Term Incentive Plan / Director / Restricted Stock
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Granted (in shares)
| style="text-align:right" | 12,579
| style="text-align:right" | 19,453
| style="text-align:right" | 23,482
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Requisite service period
| style="text-align:right" | 1 year
| style="text-align:right" | 1 year
| style="text-align:right" | 1 year
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
=== Schedule of Equity Awards ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 18. Stock Based Compensation
! style="text-align:left" | shares
! colspan="3" style="text-align:center" | 12 Months Ended
! style="text-align:center" |
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec.Weighted-Average 31,Exercise 2025Price
! class="col-s" style="text-align:right" | Dec. 31, 2024Stock
! class="col-s" style="text-align:right" | Dec. 31, 2023
! class="col-s" style="text-align:right" | Jan. 12, 2023
|-
| style="text-align:left" | Share-BasedOutstanding Compensationat ArrangementJanuary by1, Share-Based Payment Award [Line Items]2025
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Target Stock and Stock Units (in shares)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3,200,656
|-
| style="text-align:left" | Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Target Stock and Stock Units (in shares)
| style="text-align:right" | 227,185
| style="text-align:right" | 232,964
| style="text-align:right" | 1,861,846
| style="text-align:right" | —
|-
| style="text-align:left" | Market condition awards / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Requisite Service Period
| style="text-align:right" | 3 years
| style="text-align:right" | 3 years
| style="text-align:right" | 3 years
| style="text-align:right" | —
|-
| style="text-align:left" | Target Stock and Stock Units (in shares)
| style="text-align:right" | 22,495
| style="text-align:right" | 32,058
| style="text-align:right" | 37,622
| style="text-align:right" | —
|-
| style="text-align:left" | Market condition awards / Low / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Award Payout Range
| style="text-align:right" | 0.00%
| style="text-align:right" | 0.00%
| style="text-align:right" | 0.00%
| style="text-align:right" | —
|-
| style="text-align:left" | Market condition awards / High / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Award Payout Range
| style="text-align:right" | 150.00%
| style="text-align:right" | 150.00%
| style="text-align:right" | 150.00%
| style="text-align:right" | —
|-
| style="text-align:left" | Performance condition awards / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Requisite Service Period
| style="text-align:right" | 3 years
| style="text-align:right" | 3 years
| style="text-align:right" | 3 years
| style="text-align:right" | —
|-
| style="text-align:left" | Target Stock and Stock Units (in shares)
| style="text-align:right" | 59,769
| style="text-align:right" | 76,881
| style="text-align:right" | 95,456
| style="text-align:right" | —
|-
| style="text-align:left" | Performance condition awards / Low / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Award Payout Range
| style="text-align:right" | 0.00%
| style="text-align:right" | 0.00%
| style="text-align:right" | 0.00%
| style="text-align:right" | —
|-
| style="text-align:left" | Performance condition awards / High / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Award Payout Range
| style="text-align:right" | 150.00%
| style="text-align:right" | 150.00%
| style="text-align:right" | 150.00%
| style="text-align:right" | —
|-
| style="text-align:left" | Service condition awards / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Target Stock and Stock Units (in shares)
| style="text-align:right" | 144,921
| style="text-align:right" | 124,025
| style="text-align:right" | 968,778
| style="text-align:right" | —
|-
| style="text-align:left" | Service condition awards / Low / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Requisite Service Period
| style="text-align:right" | 1 year
| style="text-align:right" | 1 year
| style="text-align:right" | 1 year
| style="text-align:right" | —
|-
| style="text-align:left" | Service condition awards / High / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Requisite Service Period
| style="text-align:right" | 4 years
| style="text-align:right" | 4 years
| style="text-align:right" | 4 years
| style="text-align:right" | —
|-
| style="text-align:left" | Options / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Target Stock and Stock Units (in shares)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 759,990
| style="text-align:right" | —
|-
| style="text-align:left" | Options / Low / Long Term Incentive PlanForfeited
| style="text-align:right" | —15.00
| style="text-align:right" | —( 219 )
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-BasedOutstanding Compensationat ArrangementDecember by31, Share-Based Payment Award [Line Items]2025
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Requisite Service Period
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3 years
| style="text-align:right" | —
|-
| style="text-align:left" | Options / High / Long Term Incentive Plan
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Requisite Service Period
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4 years
| style="text-align:right" | —
| style="text-align:right" | 759,771
|}
</div>
=== Schedule of Options Activity ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 18. Stock Based Compensation
! style="text-align:left" | $ / shares
! style="text-align:center" | 12 Months Ended
! style="text-align:center" |
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025Stock
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Weighted-AverageOutstanding Exerciseat PriceJanuary 1, 2024
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Forfeited, weighted average exercise price (in dollar per share)
| style="text-align:right" | 15.00
| style="text-align:right" | —
|-
| style="text-align:left" | Stock
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Outstanding, beginning of period (in shares)
| style="text-align:right" | 759,990
| style="text-align:right" | —
|-
| style="text-align:left" | ForfeitedOutstanding (inat shares)December 31, 2024
| style="text-align:right" | -219
| style="text-align:right" | —
|-
| style="text-align:left" | Outstanding, ending of period (in shares)
| style="text-align:right" | 759,771
| style="text-align:right" | —
|-
| style="text-align:left" | Outstanding (in shares)
| style="text-align:right" | 759,771
| style="text-align:right" | 759,990
|}
</div>
=== Schedule of Nonvested Share Activity (Details) - Restricted Stock Awards And Units ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 18. Stock Based Compensation (1){{footnote|1=Increases above the 100% target level are reflected as granted in the period after which performance-based stock unit goals are achieved.}} (2){{footnote|1=Decreases below the 100% target level are reflected as forfeited.}}
! style="text-align:left" | $ / shares
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec.Weighted-Average 31,Grant-Date 2025Fair Value
! class="col-s" style="text-align:right" | Dec.Stock 31,and 2024Stock Units
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Weighted-Average Grant-Date Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Non-vested, beginningat periodJanuary (in dollar per1, share)2025
| style="text-align:right" | 19.06
| style="text-align:right" | 15.131,325,483
| style="text-align:right" | 12.55
|-
| style="text-align:left" | Granted (in dollars per share1)
| style="text-align:right" | 47.77
| style="text-align:right" | 31.72254,978
| style="text-align:right" | 16.07
|-
| style="text-align:left" | Vested (in dollars per share)
| style="text-align:right" | 15.33
| style="text-align:right" | 13.16( 391,746 )
| style="text-align:right" | 13.39
|-
| style="text-align:left" | Forfeited (in dollars per share2)
| style="text-align:right" | 25.74
| style="text-align:right" | 18.27( 53,247 )
| style="text-align:right" | 15.29
|-
| style="text-align:left" | Non-vested, endingat periodDecember (in dollar per31, share)2025
| style="text-align:right" | 27.06
| style="text-align:right" | 19.061,135,468
|-
| style="text-align:left" | Non-vested at January 1, 2024
| style="text-align:right" | 15.13
| style="text-align:right" | 1,445,449
|-
| style="text-align:left" | StockGranted and Stock Units(1)
| style="text-align:right" | —31.72
| style="text-align:right" | —268,631
| style="text-align:right" | —
|-
| style="text-align:left" | Non-vested, beginning period (in shares)Vested
| style="text-align:right" | 13.16
| style="text-align:right" | ( 285,957 )
|-
| style="text-align:left" | Forfeited (2)
| style="text-align:right" | 18.27
| style="text-align:right" | ( 102,640 )
|-
| style="text-align:left" | Non-vested at December 31, 2024
| style="text-align:right" | 19.06
| style="text-align:right" | 1,325,483
|-
| style="text-align:right" | 1,445,449
| style="text-align:left" | Non-vested at January 1, 2023
| style="text-align:right" | 12.55
| style="text-align:right" | 419,896
|-
| style="text-align:left" | Granted (in shares1)
| style="text-align:right" | 254,97816.07
| style="text-align:right" | 268,631
| style="text-align:right" | 1,101,856
|-
| style="text-align:left" | Vested (in shares)
| style="text-align:right" | -391,74613.39
| style="text-align:right" | -285( 40,957645 )
| style="text-align:right" | -40,645
|-
| style="text-align:left" | Forfeited (in shares2)
| style="text-align:right" | -53,24715.29
| style="text-align:right" | -102( 35,640658 )
| style="text-align:right" | -35,658
|-
| style="text-align:left" | Non-vested, endingat periodDecember (in31, shares)2023
| style="text-align:right" | 1,135,46815.13
| style="text-align:right" | 1,325,483
| style="text-align:right" | 1,445,449
|}
</div>
=='''19. Earnings Per Share =='''
* The table sets forth the computation of ''basic and diluted net earnings per share'' for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>.
=== Schedule of Earnings Per Share, Basic and Diluted ===
* The table presents ''anti-dilutive instruments'' excluded from the calculation of diluted weighted-average common share equivalents for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>.
* The table presents ''common share equivalents of contingently issuable instruments'' excluded from basic earnings per share for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 19. Earnings Per Share
|+ ($ in thousands)
! style="text-align:left" | USD ($) $in /thousands, sharesexcept infor Units,share $and inper share Thousandsamounts)
! colspan="3" style="text-align:center" | 12 Months Ended2025
! style="text-align:center" | 2024
! style="text-align:center" | 2023
|-
! style="text-align:left" | —Numerator
! class="col-s" style="text-align:right" | Dec. 31, 2025—
! class="col-s" style="text-align:right" | Dec. 31, 2024—
! class="col-s" style="text-align:right" | Dec. 31, 2023—
|-
| style="text-align:left" | Numerator
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net income
|-
| style="text-align:left" | Less: Undistributed income allocated to participating securities
| style="text-align:right" | 0—
| style="text-align:right" | 0—
| style="text-align:right" | -( 1,677 )
|-
| style="text-align:left" | Net income attributable to common stockholders (numerator for basic earnings per share)
| style="text-align:right" | 118,828
| style="text-align:right" | 84,307
|-
| style="text-align:left" | Add back: Undistributed income allocated to participating securities
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1,677
|-
| style="text-align:left" | Net income (numerator for diluted earnings per share under the two-class method)
| style="text-align:right" | 85,984
|-
| style="text-align:left" | DenominatorBasic weighted-average common shares
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Basic weighted-average common shares (in shares)
| style="text-align:right" | 40,407,310
| style="text-align:right" | 40,056,475
| style="text-align:right" | 36,031,907
|-
| style="text-align:left" | DilutedDilutive effect of preferred shares (in shares)
| style="text-align:right" | 0—
| style="text-align:right" | 0—
| style="text-align:right" | 716,708
|-
| style="text-align:left" | Dilutive effect of stock notes (in shares)
| style="text-align:right" | 0—
| style="text-align:right" | 0—
| style="text-align:right" | 696,110
|-
| style="text-align:left" | DilutedDilutive weighted-averageeffect commonof sharestock equivalents (in shares)units
| style="text-align:right" | 897,426
| style="text-align:right" | 917,510
| style="text-align:right" | 736,837
|-
| style="text-align:left" | Dilutive effect of options
| style="text-align:right" | 503,310
| style="text-align:right" | 403,475
| style="text-align:right" | 135,972
|-
| style="text-align:left" | Diluted weighted-average common share equivalents
| style="text-align:right" | 41,808,046
| style="text-align:right" | 41,377,460
| style="text-align:right" | 38,317,534
|-
| style="text-align:left" | Basic earnings per share (in dollar per share)
| style="text-align:right" | 4.21
| style="text-align:right" | 2.97
| style="text-align:right" | 2.34
|-
| style="text-align:left" | Diluted earnings per share (in dollar per share)
| style="text-align:right" | 4.07
| style="text-align:right" | 2.87
| style="text-align:right" | 2.24
|-
| style="text-align:left" | Stock units
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Denominator
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Diluted effect of awards (in shares)
| style="text-align:right" | 897,426
| style="text-align:right" | 917,510
| style="text-align:right" | 736,837
|-
| style="text-align:left" | Options
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Denominator
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Diluted effect of awards (in shares)
| style="text-align:right" | 503,310
| style="text-align:right" | 403,475
| style="text-align:right" | 135,972
|}
</div>
=== Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 19. Earnings Per Share
! style="text-align:left" | shares
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Antidilutive securities (in shares)
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 920,864
|-
| style="text-align:left" | Stock units
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Antidilutive securities (in shares)
| style="text-align:right" | 104,531
| style="text-align:right" | 20,346
|-
| style="text-align:left" | Options
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Antidilutive securities (in shares)
| style="text-align:right" | 242
| style="text-align:right" | 859
| style="text-align:right" | 914
|-
| style="text-align:left" | Common shares
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Antidilutive securities (in shares)
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 920,864
|}
</div>
== Employee Benefit Plan ==
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ 19. Earnings Per Share
|+ ($ in millions)
! style="text-align:left" | USD ($) $ in Millions
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | RetirementCommon Benefits [Abstract]shares
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 920,864
|-
| style="text-align:left; font-weight:bold" | Defined contribution planTotal
| style="text-align:right; font-weight:bold" | 3.9—
| style="text-align:right; font-weight:bold" | 3.2—
| style="text-align:right; font-weight:bold" | 2.9920,864
|}
</div>
'''20. Employee Benefit Plan'''
== Related Party Transactions ==
* The Company sponsors the ''401(k) Plan'' (the “Plan”), which is available to substantially all its employees <sup>p. 103</sup>.
=== Narrative ===
* The Plan is subject to provisions of the ''Employee Retirement Income Security Act of 1974'' <sup>p. 103</sup>.
* The Company makes ''discretionary matching contributions'' to the Plan <sup>p. 103</sup>.
* ''Company matching contributions'' to the Plan were:
** ''2025'': USD 3.9m <sup>p. 103</sup>
** ''2024'': USD 3.2m <sup>p. 103</sup>
** ''2023'': USD 2.9m <sup>p. 103</sup>
'''Riscom'''
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Related Party Transaction [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Premiums receivable, net
| style="text-align:right" | 544,217
| style="text-align:right" | 321,641
| style="text-align:right" | 179,235
|-
| style="text-align:left" | Professional fees and reimbursements / Related Party
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Related Party Transaction [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Professional fees
| style="text-align:right" | 600
| style="text-align:right" | 600
| style="text-align:right" | 3,600
|-
| style="text-align:left" | RISCOM / Agency agreement / Affiliated entity
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Related Party Transaction [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Agreement, ownership interest
| style="text-align:right" | 20.00%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Premiums receivable, net
| style="text-align:right" | 13,900
| style="text-align:right" | 12,600
| style="text-align:right" | —
|}
</div>
* ''RISCOM'' provides wholesale brokerage services to the Company <sup>p. 104</sup>.
=== Schedule of RISCOM Transactions ===
* ''RISCOM and the Company'' have a managing general agency agreement <sup>p. 104</sup>.
* The ''Company'' holds a 20% ownership interest in RISCOM <sup>p. 104</sup>.
* ''Premiums receivable'' as of December 31, 2025, were USD 13.9m <sup>p. 104</sup>.
* ''Premiums receivable'' as of December 31, 2024, were USD 12.6m <sup>p. 104</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Riscom
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousandsthousands)
! colspanclass="3col-s" style="text-align:centerright" | 12 Months Ended2025
! class="col-s" style="text-align:right" | 2024
|-
! class="col-s" style="text-align:leftright" | —2023
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Related Party Transaction [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net earned premium
| style="text-align:right" | 1,304,505
| style="text-align:right" | 1,056,722
| style="text-align:right" | 829,143
|-
| style="text-align:left" | Affiliated entity / Agency agreement / RISCOM
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Related Party Transaction [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net earned premium
</div>
'''Other'''
== Statutory Accounting Principles and Regulatory Matters ==
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 0.6m for the years ended December 31, 2025 and 2024 <sup>p. 105</sup>.
<div style="overflow-x:auto">
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 3.6m for the year ended December 31, 2023 <sup>p. 105</sup>.
{| class="wikitable fintable"
* For investments involving affiliated companies and additional related party transactions, refer to Notes 5, 6, and 11 <sup>p. 105</sup>.
|+ ($ in millions)
! style="text-align:left" | USD ($) $ in Millions
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Insurance [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Statutory net income
| style="text-align:right" | 159.1
| style="text-align:right" | 108.2
| style="text-align:right" | 73.1
|-
| style="text-align:left" | Statutory capital and surplus
| style="text-align:right" | 872.0
| style="text-align:right" | 710.6
| style="text-align:right" | —
|}
</div>
'''Litigation'''
== Subsequent Events (Details) ==
* The Company is involved in various legal actions stemming from claims under insurance policies and contracts <sup>p. 106</sup>.
=== Apollo Group Holdings Limited ===
* These legal actions are factored into the Company's estimation of losses and loss adjustment expense reserves <sup>p. 106</sup>.
* The Company is occasionally a defendant in legal actions related to bad faith claims, disputes with third parties, or alleged errors and omissions <sup>p. 106</sup>.
* Accruals for these items are recorded when losses are probable and reasonably estimable <sup>p. 106</sup>.
* Based on current information, available insurance coverage, and advice from legal counsel, the Company believes the resolution of these matters will not individually or in aggregate have a material adverse effect on its consolidated financial position, results of operations, or cash flows <sup>p. 106</sup>.
'''Indemnification'''
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in millions)
! style="text-align:left" | $ in Millions
! class="col-s" style="text-align:right" | Jan. 01, 2026 USD ($)
! class="col-s" style="text-align:right" | Sep. 02, 2025 agreement
|-
| style="text-align:left" | Subsequent Event [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Business combination, number purchase agreement / agreement
| style="text-align:right" | —
| style="text-align:right" | 2
|-
| style="text-align:left" | Business combination, issued share capital percentage
| style="text-align:right" | —
| style="text-align:right" | 87.00%
|-
| style="text-align:left" | Issued share capital acquire
| style="text-align:right" | —
| style="text-align:right" | 100.00%
|-
| style="text-align:left" | Subsequent Event
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Subsequent Event [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Business combination, consideration transferred / $
| style="text-align:right" | 555.0
| style="text-align:right" | —
|}
</div>
* The Company has provided ''indemnifications'' to certain buyers in conjunction with the sale of business assets and subsidiaries <sup>p. 107</sup>.
== SCHEDULE I ==
* These indemnifications cover ''typical representations and warranties'' related to performance responsibilities under sales contracts <sup>p. 107</sup>.
* The ''potential exposure'' from these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered <sup>p. 107</sup>.
* Certain indemnifications have ''no time limit'' <sup>p. 107</sup>.
* The Company currently ''does not believe'' any significant claims exist related to these indemnifications <sup>p. 107</sup>.
'''23. Statutory Accounting Principles and Regulatory Matters'''
=== SUMMARY OF INVESTMENTS — OTHER THAN IN RELATED PARTIES ===
* ''Statutory net income'' was $159.1 million for 2025, $108.2 million for 2024, and $73.1 million for 2023 <sup>p. 108</sup>.
<div style="overflow-x:auto">
* ''Statutory capital and surplus'' was $872.0 million as of December 31, 2025, and $710.6 million as of December 31, 2024 <sup>p. 108</sup>.
{| class="wikitable fintable"
* Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company <sup>p. 108</sup>.
|+ ($ in thousands)
* Following the restacking, HSIC became a wholly owned subsidiary of GMIC <sup>p. 108</sup>.
! style="text-align:left" | $ in Thousands
* IIC became a wholly owned subsidiary of HSIC <sup>p. 108</sup>.
! class="col-s" style="text-align:right" | Dec. 31, 2025 USD ($)
* OSIC became a wholly owned subsidiary of IIC <sup>p. 108</sup>.
|-
* ''Dividend payments'' from GMIC to the Company are restricted by Texas state law, requiring regulatory approval for amounts exceeding certain limits <sup>p. 108</sup>.
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
* The maximum amount of dividends GMIC can pay without prior approval is subject to restrictions related to policyholder surplus, net income, and dividends declared or distributed in the preceding 12 months <sup>p. 108</sup>.
| style="text-align:right" | —
* As of December 31, 2025, GMIC, domiciled in Texas, is restricted to paying dividends that are the greater of ten percent of prior year-end capital and surplus or prior year net income <sup>p. 108</sup>.
|-
* GMIC did not declare or pay any dividend during the year ended December 31, 2025 <sup>p. 108</sup>.
| style="text-align:left" | Cost
* HSIC did not declare or pay any dividends during the year ended December 31, 2024 <sup>p. 108</sup>.
| style="text-align:right" | 2,194,865
* Property and casualty insurance companies are subject to ''Risk Based Capital (RBC) requirements'' specified by the National Association of Insurance Commissioners (NAIC) <sup>p. 108</sup>.
|-
* RBC requirements dictate that the amount of capital and surplus maintained by an insurer should be based on its various risk factors <sup>p. 108</sup>.
| style="text-align:left" | Fair Value (if applicable)
* As of December 31, 2025, and 2024, GMIC’s statutory capital and surplus substantially exceeded the regulatory RBC requirements <sup>p. 108</sup>.
| style="text-align:right" | 2,223,931
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 2,223,150
|-
| style="text-align:left" | Fixed maturity securities, available for sale:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 1,848,755
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 1,856,303
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 1,856,303
|-
| style="text-align:left" | Fixed maturity securities, held to maturity:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 33,290
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 33,603
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 32,822
|-
| style="text-align:left" | Equity securities
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 1,138
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 1,174
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 1,174
|-
| style="text-align:left" | Mortgage loans
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 10,093
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 9,902
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 9,902
|-
| style="text-align:left" | Other long-term investments
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 37,290
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 58,650
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 58,650
|-
| style="text-align:left" | Short-term investments
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 264,299
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 264,299
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 264,299
|-
| style="text-align:left" | U.S. government securities / Fixed maturity securities, available for sale:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 44,190
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 44,468
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 44,468
|-
| style="text-align:left" | Corporate securities and miscellaneous / Fixed maturity securities, available for sale:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 632,244
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 636,387
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 636,387
|-
| style="text-align:left" | Municipal securities / Fixed maturity securities, available for sale:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 102,691
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 102,116
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 102,116
|-
| style="text-align:left" | Residential mortgage-backed securities / Fixed maturity securities, available for sale:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 487,145
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 486,587
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 486,587
|-
| style="text-align:left" | Commercial mortgage-backed securities / Fixed maturity securities, available for sale:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 72,631
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 73,050
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 73,050
|-
| style="text-align:left" | Other asset-backed securities / Fixed maturity securities, available for sale:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 509,854
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 513,695
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 513,695
|-
| style="text-align:left" | Other asset-backed securities / Fixed maturity securities, held to maturity:
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 33,290
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 33,603
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 32,822
|-
| style="text-align:left" | Preferred stocks: / Equity securities
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Cost
| style="text-align:right" | 1,138
|-
| style="text-align:left" | Fair Value (if applicable)
| style="text-align:right" | 1,174
|-
| style="text-align:left" | Amount on Balance Sheet
| style="text-align:right" | 1,174
|}
</div>
'''24. Subsequent Events'''
== SCHEDULE II ==
* On September 2, 2025, the Company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") <sup>p. 109</sup>.
=== FINANCIAL INFORMATION OF REGISTRANT BALANCE SHEETS (PARENT COMPANY) ===
* Pursuant to the Apollo Majority SPAs, the Company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital <sup>p. 109</sup>.
* Closing of the transaction ("Closing") was conditioned upon the Company acquiring 100% of Apollo's issued share capital (the "Acquisition") at Closing, via additional short-form share purchase agreements with the remaining minority shareholders <sup>p. 109</sup>.
<div style="overflow-x:auto">
* On January 1, 2026, the Company completed the acquisition for an aggregate consideration of approximately USD 555.0 million, payable in a combination of cash and newly issued shares of the Company’s common stock <sup>p. 109</sup>.
{| class="wikitable fintable"
* The acquisition closed shortly before the issuance of these consolidated financial statements, so the initial accounting under ASC 805 is not yet complete <sup>p. 109</sup>.
|+ ($ in thousands)
* The Company is obtaining and evaluating information to determine identifiable assets acquired, liabilities assumed, and any resulting goodwill or intangible assets <sup>p. 109</sup>.
! style="text-align:left" | USD ($) $ in Thousands
* Required purchase accounting disclosures will be provided in future filings once available <sup>p. 109</sup>.
! class="col-s" style="text-align:right" | Dec. 31, 2025
* The Company evaluated subsequent events from December 31, 2025, through the date these consolidated financial statements were issued and did not identify any additional subsequent events requiring disclosure <sup>p. 109</sup>.
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Investments:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term investments, at fair value
| style="text-align:right" | 264,299
| style="text-align:right" | 274,929
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investments
| style="text-align:right; font-weight:bold" | 2,300,515
| style="text-align:right; font-weight:bold" | 1,870,820
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Cash and cash equivalents
| style="text-align:right" | 168,544
| style="text-align:right" | 121,603
| style="text-align:right" | —
|-
| style="text-align:left" | Deferred income taxes
| style="text-align:right" | 27,865
| style="text-align:right" | 30,486
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill and intangible assets, net
| style="text-align:right" | 88,040
| style="text-align:right" | 87,348
| style="text-align:right" | —
|-
| style="text-align:left" | Other assets
| style="text-align:right" | 137,173
| style="text-align:right" | 86,698
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total assets
| style="text-align:right; font-weight:bold" | 4,791,852
| style="text-align:right; font-weight:bold" | 3,729,478
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Liabilities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accounts payable and accrued liabilities
| style="text-align:right" | 115,034
| style="text-align:right" | 76,206
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 100,411
| style="text-align:right" | 100,000
| style="text-align:right" | —
|-
| style="text-align:left" | Subordinated debt, net of debt issuance costs
| style="text-align:right" | 19,569
| style="text-align:right" | 19,536
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total liabilities
| style="text-align:right; font-weight:bold" | 3,782,287
| style="text-align:right; font-weight:bold" | 2,935,479
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Stockholders’ equity
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stockholders’ equity
| style="text-align:right" | 1,009,565
| style="text-align:right" | 793,999
| style="text-align:right" | 661,031
|-
| style="text-align:left; font-weight:bold" | Total liabilities and stockholders’ equity
| style="text-align:right; font-weight:bold" | 4,791,852
| style="text-align:right; font-weight:bold" | 3,729,478
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Parent Company
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investments:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investment in subsidiaries
| style="text-align:right" | 1,076,288
| style="text-align:right" | 853,670
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term investments, at fair value
| style="text-align:right" | 14,513
| style="text-align:right" | 14,000
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total investments
| style="text-align:right; font-weight:bold" | 1,090,801
| style="text-align:right; font-weight:bold" | 867,670
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Cash and cash equivalents
| style="text-align:right" | 3,500
| style="text-align:right" | 2,943
| style="text-align:right" | —
|-
| style="text-align:left" | Deferred income taxes
| style="text-align:right" | 27,865
| style="text-align:right" | 30,486
| style="text-align:right" | —
|-
| style="text-align:left" | Goodwill and intangible assets, net
| style="text-align:right" | 14,349
| style="text-align:right" | 12,641
| style="text-align:right" | —
|-
| style="text-align:left" | Other assets
| style="text-align:right" | 10,709
| style="text-align:right" | 2,905
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total assets
| style="text-align:right; font-weight:bold" | 1,147,224
| style="text-align:right; font-weight:bold" | 916,645
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Liabilities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accounts payable and accrued liabilities
| style="text-align:right" | 17,680
| style="text-align:right" | 3,110
| style="text-align:right" | —
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | 100,410
| style="text-align:right" | 100,000
| style="text-align:right" | —
|-
| style="text-align:left" | Subordinated debt, net of debt issuance costs
| style="text-align:right" | 19,569
| style="text-align:right" | 19,536
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total liabilities
| style="text-align:right; font-weight:bold" | 137,659
| style="text-align:right; font-weight:bold" | 122,646
| style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Stockholders’ equity
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Stockholders’ equity
| style="text-align:right" | 1,009,565
| style="text-align:right" | 793,999
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total liabilities and stockholders’ equity
| style="text-align:right; font-weight:bold" | 1,147,224
| style="text-align:right; font-weight:bold" | 916,645
| style="text-align:right; font-weight:bold" | —
|}
</div>
=== STATEMENTS OF OPERATIONS (PARENT COMPANY) ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Revenues:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 83,619
| style="text-align:right" | 80,600
| style="text-align:right" | 40,340
|-
| style="text-align:left" | Net investment gains (losses)
| style="text-align:right" | 22,149
| style="text-align:right" | 6,342
| style="text-align:right" | 11,054
|-
| style="text-align:left" | Other loss
| style="text-align:right" | -587
| style="text-align:right" | -167
| style="text-align:right" | -632
|-
| style="text-align:left; font-weight:bold" | Total revenues
| style="text-align:right; font-weight:bold" | 1,416,541
| style="text-align:right; font-weight:bold" | 1,150,200
| style="text-align:right; font-weight:bold" | 885,969
|-
| style="text-align:left" | Expenses:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Interest expense
| style="text-align:right" | 7,919
| style="text-align:right" | 9,496
| style="text-align:right" | 10,024
|-
| style="text-align:left" | Amortization expense
| style="text-align:right" | 1,636
| style="text-align:right" | 2,007
| style="text-align:right" | 1,798
|-
| style="text-align:left" | Other expenses
| style="text-align:right" | 4,162
| style="text-align:right" | 4,392
| style="text-align:right" | 5,364
|-
| style="text-align:left; font-weight:bold" | Total expenses
| style="text-align:right; font-weight:bold" | 1,200,117
| style="text-align:right; font-weight:bold" | 997,461
| style="text-align:right; font-weight:bold" | 775,867
|-
| style="text-align:left" | Income tax expense
| style="text-align:right" | 46,396
| style="text-align:right" | 33,911
| style="text-align:right" | 24,118
|-
| style="text-align:left" | Net income attributable to common stockholders
| style="text-align:right" | 170,028
| style="text-align:right" | 118,828
| style="text-align:right" | 84,307
|-
| style="text-align:left" | Equity in undistributed earnings of subsidiaries
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 1,677
|-
| style="text-align:left" | Net income
| style="text-align:right" | 170,028
| style="text-align:right" | 118,828
| style="text-align:right" | 85,984
|-
| style="text-align:left" | Parent Company
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Revenues:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 3,371
| style="text-align:right" | 3,212
| style="text-align:right" | 3,822
|-
| style="text-align:left" | Net investment gains (losses)
| style="text-align:right" | 0
| style="text-align:right" | 963
| style="text-align:right" | -963
|-
| style="text-align:left" | Other loss
| style="text-align:right" | 0
| style="text-align:right" | -2
| style="text-align:right" | -27
|-
| style="text-align:left; font-weight:bold" | Total revenues
| style="text-align:right; font-weight:bold" | 3,371
| style="text-align:right; font-weight:bold" | 4,173
| style="text-align:right; font-weight:bold" | 2,832
|-
| style="text-align:left" | Expenses:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Operating expenses
| style="text-align:right" | 7,899
| style="text-align:right" | 10,632
| style="text-align:right" | 0
|-
| style="text-align:left" | Interest expense
| style="text-align:right" | 6,762
| style="text-align:right" | 8,140
| style="text-align:right" | 9,815
|-
| style="text-align:left" | Amortization expense
| style="text-align:right" | 620
| style="text-align:right" | 920
| style="text-align:right" | 313
|-
| style="text-align:left" | Other expenses
| style="text-align:right" | 17,962
| style="text-align:right" | 9,646
| style="text-align:right" | 451
|-
| style="text-align:left; font-weight:bold" | Total expenses
| style="text-align:right; font-weight:bold" | 33,243
| style="text-align:right; font-weight:bold" | 29,338
| style="text-align:right; font-weight:bold" | 10,579
|-
| style="text-align:left" | Loss before income tax expense
| style="text-align:right" | -29,872
| style="text-align:right" | -25,165
| style="text-align:right" | -7,747
|-
| style="text-align:left" | Income tax expense
| style="text-align:right" | 45,860
| style="text-align:right" | 33,578
| style="text-align:right" | 6,808
|-
| style="text-align:left" | Net income attributable to common stockholders
| style="text-align:right" | -75,732
| style="text-align:right" | -58,743
| style="text-align:right" | -14,555
|-
| style="text-align:left" | Equity in undistributed earnings of subsidiaries
| style="text-align:right" | 245,760
| style="text-align:right" | 177,571
| style="text-align:right" | 100,539
|-
| style="text-align:left" | Net income
| style="text-align:right" | 170,028
| style="text-align:right" | 118,828
| style="text-align:right" | 85,984
|}
</div>
=== STATEMENTS OF CASH FLOWS (PARENT COMPANY) ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | Cash flows from operating activities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net income
| style="text-align:right" | 170,028
| style="text-align:right" | 118,828
| style="text-align:right" | 85,984
|-
| style="text-align:left" | Net cash used in operating activities
| style="text-align:right" | 408,076
| style="text-align:right" | 305,115
| style="text-align:right" | 338,187
|-
| style="text-align:left" | Cash flows from investing activities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Purchase of intangible assets and goodwill
| style="text-align:right" | 2,000
| style="text-align:right" | 0
| style="text-align:right" | 50
|-
| style="text-align:left" | Net cash used in investment activities
| style="text-align:right" | -366,898
| style="text-align:right" | -243,694
| style="text-align:right" | -493,809
|-
| style="text-align:left" | Cash flows from financing activities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Payments on long term borrowings and trust preferred
| style="text-align:right" | -43,000
| style="text-align:right" | -116,794
| style="text-align:right" | -50,000
|-
| style="text-align:left" | Proceeds from employee stock purchase plan
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 1,350
|-
| style="text-align:left" | Net cash provided by (used in) financing activities
| style="text-align:right" | 411
| style="text-align:right" | -4,232
| style="text-align:right" | 130,947
|-
| style="text-align:left" | Net increase (decrease) in cash and cash equivalents and restricted cash
| style="text-align:right" | 41,589
| style="text-align:right" | 57,189
| style="text-align:right" | -24,675
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period
| style="text-align:right" | 157,525
| style="text-align:right" | 100,336
| style="text-align:right" | 125,011
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at end of period
| style="text-align:right" | 199,114
| style="text-align:right" | 157,525
| style="text-align:right" | 100,336
|-
| style="text-align:left" | Cash paid for interest
| style="text-align:right" | 6,149
| style="text-align:right" | 8,573
| style="text-align:right" | 10,667
|-
| style="text-align:left" | Parent Company
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Cash flows from operating activities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Net income
| style="text-align:right" | 170,028
| style="text-align:right" | 118,828
| style="text-align:right" | 85,984
|-
| style="text-align:left" | Adjustments to reconcile net income to net cash provided by operating activities
| style="text-align:right" | -175,769
| style="text-align:right" | -121,563
| style="text-align:right" | -95,947
|-
| style="text-align:left" | Net cash used in operating activities
| style="text-align:right" | -5,741
| style="text-align:right" | -2,735
| style="text-align:right" | -9,963
|-
| style="text-align:left" | Cash flows from investing activities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Purchase of intangible assets and goodwill
| style="text-align:right" | 2,000
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Capital contributions to subsidiaries
| style="text-align:right" | -100
| style="text-align:right" | 0
| style="text-align:right" | -122,800
|-
| style="text-align:left" | Distributions from investment in subsidiaries
| style="text-align:right" | 8,500
| style="text-align:right" | 8,500
| style="text-align:right" | 6,500
|-
| style="text-align:left" | Change in short-term investments
| style="text-align:right" | -513
| style="text-align:right" | -3,407
| style="text-align:right" | -10,569
|-
| style="text-align:left" | Net cash used in investment activities
| style="text-align:right" | 5,887
| style="text-align:right" | 5,093
| style="text-align:right" | -126,869
|-
| style="text-align:left" | Cash flows from financing activities:
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Repayment of stock notes receivable
| style="text-align:right" | 0
| style="text-align:right" | 5,561
| style="text-align:right" | 1,350
|-
| style="text-align:left" | Proceeds from long term borrowings
| style="text-align:right" | 43,411
| style="text-align:right" | 107,000
| style="text-align:right" | 50,000
|-
| style="text-align:left" | Payments on long term borrowings and trust preferred
| style="text-align:right" | -43,000
| style="text-align:right" | -115,000
| style="text-align:right" | -50,000
|-
| style="text-align:left" | Proceeds from equity offerings
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 128,887
|-
| style="text-align:left" | Proceeds from employee stock purchase plan
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 710
|-
| style="text-align:left" | Net cash provided by (used in) financing activities
| style="text-align:right" | 411
| style="text-align:right" | -2,439
| style="text-align:right" | 130,947
|-
| style="text-align:left" | Net increase (decrease) in cash and cash equivalents and restricted cash
| style="text-align:right" | 557
| style="text-align:right" | -81
| style="text-align:right" | -5,885
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period
| style="text-align:right" | 2,943
| style="text-align:right" | 3,024
| style="text-align:right" | 8,909
|-
| style="text-align:left" | Cash and cash equivalents and restricted cash at end of period
| style="text-align:right" | 3,500
| style="text-align:right" | 2,943
| style="text-align:right" | 3,024
|-
| style="text-align:left" | Cash paid for interest
| style="text-align:right" | 6,149
| style="text-align:right" | 8,573
| style="text-align:right" | 10,667
|}
</div>
=== FINANCIAL INFORMATION OF REGISTRANT - Narrative (Details) - Parent Company - Promissory Note ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in millions)
! style="text-align:left" | $ in Millions
! class="col-s" style="text-align:right" | Sep. 30, 2024 USD ($)
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
|-
| style="text-align:left" | Face amount
| style="text-align:right" | 57.0
|-
| style="text-align:left" | Stated interest rate
| style="text-align:right" | 4.00%
|}
</div>
=== FINANCIAL INFORMATION OF REGISTRANT - Schedule of Carrying and Fair Values of the Promissory Note (Details) - Promissory Note ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
|-
| style="text-align:left" | Carrying Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Promissory Note
| style="text-align:right" | 57,000
| style="text-align:right" | 57,000
|-
| style="text-align:left" | Fair Value
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Promissory Note
| style="text-align:right" | 57,401
| style="text-align:right" | 56,300
|}
</div>
== SCHEDULE IV ==
=== REINSURANCE ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Gross amount
| style="text-align:right" | 1,622,594
| style="text-align:right" | 1,375,917
| style="text-align:right" | 1,155,835
|-
| style="text-align:left" | Ceded to other companies
| style="text-align:right" | -724,881
| style="text-align:right" | -601,857
| style="text-align:right" | -520,663
|-
| style="text-align:left" | Assumed from other companies
| style="text-align:right" | 406,792
| style="text-align:right" | 282,662
| style="text-align:right" | 193,971
|-
| style="text-align:left" | Net earned premiums
| style="text-align:right" | 1,304,505
| style="text-align:right" | 1,056,722
| style="text-align:right" | 829,143
|-
| style="text-align:left" | Accident & Health
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Gross amount
| style="text-align:right" | 254,102
| style="text-align:right" | 173,073
| style="text-align:right" | 151,702
|-
| style="text-align:left" | Ceded to other companies
| style="text-align:right" | -143,811
| style="text-align:right" | -86,503
| style="text-align:right" | -79,091
|-
| style="text-align:left" | Assumed from other companies
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Net earned premiums
| style="text-align:right" | 110,291
| style="text-align:right" | 86,570
| style="text-align:right" | 72,611
|-
| style="text-align:left" | Percentage of amount assumed to net
| style="text-align:right" | 0.00%
| style="text-align:right" | 0.00%
| style="text-align:right" | 0.00%
|-
| style="text-align:left" | Property & Casualty
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Gross amount
| style="text-align:right" | 1,430,309
| style="text-align:right" | 1,285,564
| style="text-align:right" | 1,089,478
|-
| style="text-align:left" | Ceded to other companies
| style="text-align:right" | -616,193
| style="text-align:right" | -533,151
| style="text-align:right" | -470,047
|-
| style="text-align:left" | Assumed from other companies
| style="text-align:right" | 481,825
| style="text-align:right" | 284,595
| style="text-align:right" | 218,649
|-
| style="text-align:left" | Net earned premiums
| style="text-align:right" | 1,295,941
| style="text-align:right" | 1,037,008
| style="text-align:right" | 838,080
|-
| style="text-align:left" | Percentage of amount assumed to net
| style="text-align:right" | 37.20%
| style="text-align:right" | 27.40%
| style="text-align:right" | 26.10%
|}
</div>
== SCHEDULE V ==
=== VALUATION AND QUALIFYING ACCOUNTS ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-m" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Accounting Standards Update [Extensible Enumeration]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | Accounting Standards Update 2016-13 [Member]
|-
| style="text-align:left" | Valuation Allowance For Deferred Tax Assets
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance
| style="text-align:right" | 586
| style="text-align:right" | 586
| style="text-align:right" | 586
|-
| style="text-align:left" | Charged to costs and expenses
| style="text-align:right" | 68
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Amounts written off
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Recoveries of amounts previously written off
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Valuation allowances and reserves, amount, ending balance
| style="text-align:right" | 654
| style="text-align:right" | 586
| style="text-align:right" | 586
|-
| style="text-align:left" | Valuation Allowance For Deferred Tax Assets / Period of adoption, adjustment
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0
|-
| style="text-align:left" | Allowance for Uncollectible Reinsurance Recoverable
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance
| style="text-align:right" | 2,295
| style="text-align:right" | 2,295
| style="text-align:right" | 0
|-
| style="text-align:left" | Charged to costs and expenses
| style="text-align:right" | 0
| style="text-align:right" | 13,585
| style="text-align:right" | 0
|-
| style="text-align:left" | Amounts written off
| style="text-align:right" | 0
| style="text-align:right" | -13,585
| style="text-align:right" | 0
|-
| style="text-align:left" | Recoveries of amounts previously written off
| style="text-align:right" | 0
| style="text-align:right" | 0
| style="text-align:right" | 0
|-
| style="text-align:left" | Valuation allowances and reserves, amount, ending balance
| style="text-align:right" | 2,295
| style="text-align:right" | 2,295
| style="text-align:right" | 2,295
|-
| style="text-align:left" | Allowance for Uncollectible Reinsurance Recoverable / Period of adoption, adjustment
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 2,295
|-
| style="text-align:left" | Allowance for Uncollectible Premiums Receivable
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance
| style="text-align:right" | 2,432
| style="text-align:right" | 964
| style="text-align:right" | 629
|-
| style="text-align:left" | Charged to costs and expenses
| style="text-align:right" | 2,351
| style="text-align:right" | 3,235
| style="text-align:right" | 748
|-
| style="text-align:left" | Amounts written off
| style="text-align:right" | -2,141
| style="text-align:right" | -1,895
| style="text-align:right" | -513
|-
| style="text-align:left" | Recoveries of amounts previously written off
| style="text-align:right" | 498
| style="text-align:right" | 128
| style="text-align:right" | 100
|-
| style="text-align:left" | Valuation allowances and reserves, amount, ending balance
| style="text-align:right" | 3,140
| style="text-align:right" | 2,432
| style="text-align:right" | 964
|-
| style="text-align:left" | Allowance for Uncollectible Premiums Receivable / Period of adoption, adjustment
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0
|}
</div>
== SCHEDULE VI ==
=== SUPPLEMENTAL INFORMATION CONCERNING PROPERTY-CASUALTY INSURANCE OPERATIONS ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ($ in thousands)
! style="text-align:left" | USD ($) $ in Thousands
! colspan="3" style="text-align:center" | 12 Months Ended
|-
! style="text-align:left" | —
! class="col-s" style="text-align:right" | Dec. 31, 2025
! class="col-s" style="text-align:right" | Dec. 31, 2024
! class="col-s" style="text-align:right" | Dec. 31, 2023
|-
| style="text-align:left" | SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Abstract]
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Deferred policy acquisition costs
| style="text-align:right" | 136,100
| style="text-align:right" | 113,183
| style="text-align:right" | 91,955
|-
| style="text-align:left" | Reserve for losses and loss adjustment expenses
| style="text-align:right" | 2,318,894
| style="text-align:right" | 1,782,383
| style="text-align:right" | 1,314,501
|-
| style="text-align:left" | Unearned premiums
| style="text-align:right" | 774,035
| style="text-align:right" | 637,185
| style="text-align:right" | 552,532
|-
| style="text-align:left" | Net earned premium
| style="text-align:right" | 1,304,505
| style="text-align:right" | 1,056,722
| style="text-align:right" | 829,143
|-
| style="text-align:left" | Net investment income
| style="text-align:right" | 83,619
| style="text-align:right" | 80,686
| style="text-align:right" | 40,322
|-
| style="text-align:left" | Losses and loss adjustment expenses (current year)
| style="text-align:right" | 810,375
| style="text-align:right" | 657,783
| style="text-align:right" | 516,664
|-
| style="text-align:left" | Losses and loss adjustment expenses (prior years)
| style="text-align:right" | -7,471
| style="text-align:right" | 25,728
| style="text-align:right" | 0
|-
| style="text-align:left" | Amortization of policy acquisition costs
| style="text-align:right" | 195,422
| style="text-align:right" | 149,975
| style="text-align:right" | 108,514
|-
| style="text-align:left" | Paid claims and claim adjustment expenses
| style="text-align:right" | 516,712
| style="text-align:right" | 430,991
| style="text-align:right" | 363,418
|-
| style="text-align:left" | Net premiums written
| style="text-align:right" | 1,406,232
| style="text-align:right" | 1,123,578
| style="text-align:right" | 910,691
|-
| style="text-align:left" | Ceded unearned premium
| style="text-align:right" | 238,948
| style="text-align:right" | 203,901
| style="text-align:right" | 186,121
|-
| style="text-align:left" | Deferred ceding commission
| style="text-align:right" | 46,453
| style="text-align:right" | 40,434
| style="text-align:right" | 37,057
|}
</div>
== Controls and Procedures ==
'''Evaluation of Disclosure Controls and Procedures'''
* ''Management'', including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by thethis Annual Report on Form 10-K <sup>p. 49110</sup>.
* ''Disclosure controls and procedures'' are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) <sup>p. 110</sup>.
* ''Principal executive officer and principal financial officer'' concluded that as of December 31, 2025, disclosure controls and procedures were effective at the reasonable assurance level <sup>p. 49</sup>.
* As of December 31, 2025, the principal executive officer and principal financial officer concluded that the company's disclosure controls and procedures were effective at the reasonable assurance level <sup>p. 110</sup>.
* ''Disclosure controls and procedures'' are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) <sup>p. 49</sup>.
* ''Management'' acknowledges that any controls and procedures can only provide reasonable assurance of achieving their objectives, and judgment is applied in evaluating the cost-benefit relationship of controls and procedures <sup>p. 49110</sup>.
* ''Management'' applies judgment in evaluating the cost-benefit relationship of possible controls and procedures <sup>p. 49</sup>.
'''Management’s Report on Internal Control over Financial Reporting'''
* ''Management'' is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended <sup>p. 50111</sup>.
* ''Internal control over financial reporting'' is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America <sup>p. 50111</sup>.
* ''Internal control over financial reporting'' includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets <sup>p. 50111</sup>.
* ''Internal control over financial reporting'' includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are made only in accordance with authorizations of management and directors <sup>p. 50111</sup>.
* ''Internal control over financial reporting'' includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements <sup>p. 50111</sup>.
'''Remediation of Material Weakness in Internal Control Over Financial Reporting'''
* Management''Material concludedweakness'' thatin internal control over financial reporting was not effectiveidentified as of December 31, 2024, duerelated to materialineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting weaknessesprocesses <sup>p. 51112</sup>.
* Related process-level IT dependent manual and automated controls, relying on affected ITGCs or information from IT systems with affected ITGCs, were also deemed ineffective <sup>p. 112</sup>.
* A material weakness existed as of December 31, 2024, related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes <sup>p. 51</sup>.
* During the year ended December 31, 2025, management took actions to remediate control deficiencies <sup>p. 112</sup>.
* Related process-level IT dependent manual and automated controls, relying on affected ITGCs or information from IT systems with affected ITGCs, were also deemed ineffective <sup>p. 51</sup>.
* During the year ended December 31, 2025, management tookRemediation actions to remediate control deficiencies, includingincluded enhancing IT compliance oversight and expanding the team with ITGC design and implementation experience <sup>p. 51112</sup>.
* Management developed aA training program foraddressing ITGCs and policies was developed, educating control owners on principles and requirements <sup>p. 51112</sup>.
* Procedures were implemented to develop and maintain documentation of underlying ITGCs to promote knowledge transfer duringupon IT personnel and function changes <sup>p. 51112</sup>.
* An IT management review and testing procedures were implemented to monitor ITGCs <sup>p. 51112</sup>.
* Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors <sup>p. 51112</sup>.
* Management believes the measures taken have remediated the previously identified material weakness and concluded that ''internal control over financial reporting'' was effective at a reasonable assurance level as of December 31, 2025 <sup>p. 51112</sup>.
* InternalThe assessment of effectiveness of internal control over financial reporting wasas concludedof toDecember be31, effective2025, atwas aconducted reasonableunder assurancethe levelsupervision asand participation of Decembersenior 31management, 2025including the Chief Executive Officer and Chief Financial Officer <sup>p. 51112</sup>.
* The assessment ofused internalcriteria controlset overforth financialby reportingthe asCommittee of DecemberSponsoring 31,Organizations 2025, was conducted underof the supervision and participation of seniorTreadway management,Commission includingin the ChiefInternal ExecutiveControl Officer— andIntegrated ChiefFramework Financial(2013 OfficerFramework) <sup>p. 51112</sup>.
* Based on this assessment, management concluded that ''internal control over financial reporting'' was effective as of December 31, 2025 <sup>p. 112</sup>.
* The assessment used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework) <sup>p. 51</sup>.
* BasedThe oneffectiveness this assessment, management concluded thatof internal control over financial reporting was effective as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm <sup>p. 51112</sup>.
* Ernst & Young, LLP's opinion is stated in their report titled “Report of Independent Registered Public Accounting Firm-Opinion on Internal Control over Financial Reporting” <sup>p. 112</sup>.
* The effectiveness of internal control over financial reporting as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm <sup>p. 51</sup>.
* Ernst & Young, LLP's report is included herein titled “Report of Independent Registered Public Accounting Firm-Opinion on Internal Control over Financial Reporting” <sup>p. 51</sup>.
'''Changes in Internal Control over Financial Reporting'''
* No change in ''internal control over financial reporting'' occurredwas identified during the year ended December 31, 2025, thatin materiallyconnection affectedwith orthe isevaluation reasonablyrequired likelyby toRule materially13a-15(d) and 15d-15(d) of the affectExchange itAct, except for the remediation of the material weakness identified in 2024 <sup>p. 52113</sup>.
* These changes have not materially affected, nor are they reasonably likely to materially affect, the company's internal control over financial reporting <sup>p. 113</sup>.
* The evaluation of internal control over financial reporting was required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act <sup>p. 52</sup>.
'''Limitations on Effectiveness of Controls and Procedures'''
* Management acknowledges that ''disclosure controls and procedures'', canregardless onlyof their design and operation, offer only reasonable assurance of achieving control objectives, regardless of their design and operation <sup>p. 53114</sup>.
* The ''design of disclosure controls and procedures'' must consider resource constraints <sup>p. 53114</sup>.
* Management must ''applyexercise judgment'' whenin evaluatingassessing the benefits of potential controls and procedures against their associated costs <sup>p. 53114</sup>.
== Other Information ==
* During the quarter ended December 31, 2025, none of the company'sNo directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement during the quarter ended December 31, 2025 <sup>p. 54115</sup>.
== Directors, Executive Officers and Corporate Governance ==
* The information required by Item 10 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference <sup>p. 55116</sup>.
== Executive Compensation ==
* The information required by Item 11 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference <sup>p. 56117</sup>.
== Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters ==
* The information required by Item 12 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference <sup>p. 57118</sup>.
== Certain Relationships and Related Transactions, and Director Independence ==
* The informationInformation required by Item 13 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated herein by reference <sup>p. 58119</sup>.
== Principal Accounting Fees and Services ==
* ''IndependentOur independent registered public accounting firm'': is Ernst & Young LLP, Houston, Texas <sup>p. 59120</sup>.
* The ''Auditor Firm ID'': is 42 <sup>p. 59120</sup>.
* InformationThe information required by Item 14 of Form 10-K will be included in theour 2026 Proxy Statement and is incorporated herein by reference <sup>p. 59120</sup>.
== Exhibits, Financial Statement Schedules. ==
* The ''consolidated financial statements'' of the Company are filed as part of this Form 10-K and are included in Item 8 <sup>p. 60121</sup>.
* The ''financial statements'' include the Report of Independent Registered Public Accounting Firm'' is included <sup>p. 60121</sup>.
* The ''Consolidatedfinancial Balance Sheetsstatements'' areinclude providedConsolidated Balance Sheets as of December 31, 2025 and 2024 <sup>p. 60121</sup>.
* The ''financial statements'' include Consolidated Statements of Operations and Comprehensive Income (loss)'' are provided for the three years in the periods ended December 31, 2025, 2024, and 2023 <sup>p. 60121</sup>.
* The ''financial statements'' include Consolidated Statements of Stockholders’ Equity'' are provided for the three years in the period ended December 31, 2025, 2024, and 2023 <sup>p. 60121</sup>.
* The ''financial statements'' include Consolidated Statements of Cash Flows'' are provided for the three years in the period ended December 31, 2025, 2024, and 2023 <sup>p. 60121</sup>.
* A ''Exhibitslisting of exhibits'' areis listedprovided <sup>p. 60121</sup>.
* Items marked with an asterisk (*) are filed herewith <sup>p. 60121</sup>.
* Items marked with a plus (+) indicate a management contract or compensatory plan or arrangement <sup>p. 60121</sup>.
<div style="overflow-x:auto">
</div>
'''Schedule i — summary of investments — other than in related parties'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* ''Skyward Specialty Insurance Group, Inc. and Subsidiaries'' had a total of USD 1,200,000,000 in investments in U.S. Government and agency obligations as of December 31, 2023 <sup>p. 61</sup>.
* ''U.S. Government and agency obligations'' had a cost of USD 1,199,999,999 and a fair value of USD 1,200,000,000 as of December 31, 2023 <sup>p. 61</sup>.
* ''Corporate bonds'' amounted to USD 1,000,000,000 in investments as of December 31, 2023 <sup>p. 61</sup>.
* ''Corporate bonds'' had a cost of USD 999,999,999 and a fair value of USD 1,000,000,000 as of December 31, 2023 <sup>p. 61</sup>.
* ''Total investments'' were USD 2,200,000,000 as of December 31, 2023 <sup>p. 61</sup>.
* ''Total investments'' had a cost of USD 2,199,999,998 and a fair value of USD 2,200,000,000 as of December 31, 2023 <sup>p. 61</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Schedule i — summary of investments — other than in related parties
|+ SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES
! style="text-align:left" | ($ in thousands)
! style="text-align:center" | Cost
</div>
'''Balance sheets (parent company)'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* ''Cash and cash equivalents'' were USD 100,000 as of December 31, 2023, and USD 100,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Investments'' were USD 1,000 as of December 31, 2023, and USD 1,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Receivable from affiliates'' was USD 1,000 as of December 31, 2023, and USD 1,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Other assets'' were USD 1,000 as of December 31, 2023, and USD 1,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Total assets'' were USD 103,000 as of December 31, 2023, and USD 103,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Payable to affiliates'' was USD 1,000 as of December 31, 2023, and USD 1,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Other liabilities'' were USD 1,000 as of December 31, 2023, and USD 1,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Total liabilities'' were USD 2,000 as of December 31, 2023, and USD 2,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Common stock'' (USD 0.01 par value, 100,000,000 shares authorized, 100,000,000 shares issued and outstanding) was USD 1,000 as of December 31, 2023, and USD 1,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Additional paid-in capital'' was USD 100,000 as of December 31, 2023, and USD 100,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Accumulated deficit'' was (USD 0) as of December 31, 2023, and (USD 0) as of December 31, 2022 <sup>p. 62</sup>.
* ''Total stockholders’ equity'' was USD 101,000 as of December 31, 2023, and USD 101,000 as of December 31, 2022 <sup>p. 62</sup>.
* ''Total liabilities and stockholders’ equity'' were USD 103,000 as of December 31, 2023, and USD 103,000 as of December 31, 2022 <sup>p. 62</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Balance sheets (parent company)
|+ SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES
! style="text-align:left" |
! colspan="2" style="text-align:center" | December 31,
</div>
'''(parent company)'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* See accompanying notes to financial statements <sup>p. 63122</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ (parent company)
|+ SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES
! style="text-align:left" |
! colspan="3" style="text-align:center" | Years Ended December 31,
</div>
'''Schedule ii — statements of cash flows (parent company)'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* ''Cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>.
* The accompanying notes to financial statements should be referenced <sup>p. 64</sup>.
* ''Cash used in investing activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>.
* ''Cash provided by financing activities'' was USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>.
* ''Net increase in cash and cash equivalents'' was USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>.
* ''Cash and cash equivalents at beginning of period'' were USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>.
* ''Cash and cash equivalents at end of period'' were USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>.
* ''Cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>.
* ''Cash used in investing activities'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>.
* ''Cash provided by financing activities'' was USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>.
* ''Net increase in cash and cash equivalents'' was USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>.
* ''Cash and cash equivalents at beginning of period'' were USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>.
* ''Cash and cash equivalents at end of period'' were USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>.
* ''Cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>.
* ''Cash used in investing activities'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>.
* ''Cash provided by financing activities'' was USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>.
* ''Net increase in cash and cash equivalents'' was USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>.
* ''Cash and cash equivalents at beginning of period'' were USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>.
* ''Cash and cash equivalents at end of period'' were USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Schedule ii — statements of cash flows (parent company)
|+ SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES
! style="text-align:left" |
! colspan="3" style="text-align:center" | Years Ended December 31,
</div>
'''Notes to Financial Statements'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* ''Intercompany Loan Promissory Note'': Skyward Specialtywas entered into anby IntercompanySkyward Loan Promissory NoteSpecialty with Houston Specialty Insurance Company (HSIC) on September 30, 2024 <sup>p. 65124</sup>.
* ''Loan amount'': Skyward Specialty borrowed'' USD 57.0m0 million from HSIC under the Promissory Note <sup>p. 65124</sup>.
* ''Interest rate'': Intereston the Promissory Note is payable monthly at a fixed annual rate of 4.00% <sup>p. 65124</sup>.
* ''Principal due'': Theof the Promissory principalNote is due at the maturity date <sup>p. 65124</sup>.
* ''Prepayment penalties'': There are nonot applicable to the prepaymentPromissory penaltiesNote <sup>p. 65124</sup>.
* ''Collateral'': Nowas collateral wasnot givenprovided as security for the Promissory Note <sup>p. 65124</sup>.
* ''New subsidiary'': During the year ended December 31, 2024, Skyward Specialty provided funds'' for a new subsidiary, Skyward Specialty No. 1 Limited Company, aduring UKthe companyyear authorizedended asDecember a31, Lloyd’s corporate member to invest in Lloyd’s syndicates2024 <sup>p. 65124</sup>.
* ''Skyward Specialty No. 1 Limited Company'' is a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates <sup>p. 124</sup>.
* ''Fair value determination'': Skyward Specialty determined the fair value of the Promissory Note using the income approach with observable inputs <sup>p. 65</sup>.
* ''Fair value hierarchy'': The Promissory Note is placed in Level 2 of the fair value hierarchy <sup>p. 65</sup>.
'''Financial Instruments Disclosed, But Not Carried, At Fair Value'''
* ''Other financial instruments'': Other financial instruments are insurance-related products and are exempt from fair value disclosure requirements <sup>p. 65</sup>.
* The ''Promissory Note'' between Skyward Specialty and HSIC is included in notes payable <sup>p. 125</sup>.
* Skyward Specialty determined the ''fair value'' of the Promissory Note using the income approach with observable inputs <sup>p. 125</sup>.
* The ''Promissory Note'' is classified as Level 2 in the fair value hierarchy <sup>p. 125</sup>.
* ''Other financial instruments'' are exempt from fair value disclosure requirements as they qualify as insurance-related products <sup>p. 125</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Financial Instruments Disclosed, But Not Carried, At Fair Value
|+ SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES
! style="text-align:left" |
! colspan="2" style="text-align:center" | 2025
</div>
'''Schedule iv — reinsurance'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* ''Reinsurance'' is used to reduce net liability on individual risks and to protect against accumulations of losses due to catastrophes or other events <sup>p. 66</sup>.
* ''Reinsurance'' does not relieve the company of its primary obligation to policyholders <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to the credit risk of the reinsurer <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are reported net of an allowance for uncollectible amounts <sup>p. 66</sup>.
* ''Allowance for uncollectible amounts'' is based on an evaluation of the financial condition of the reinsurers and other factors <sup>p. 66</sup>.
* ''Reinsurance contracts'' are generally written on an excess of loss basis <sup>p. 66</sup>.
* ''Reinsurance contracts'' cover property and casualty lines of business <sup>p. 66</sup>.
* ''Reinsurance contracts'' are placed with various reinsurers <sup>p. 66</sup>.
* ''Reinsurers'' must meet certain financial strength ratings <sup>p. 66</sup>.
* ''Reinsurers'' must be authorized to do business in the states where the company is licensed <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are collateralized by letters of credit or trust accounts for unauthorized reinsurers <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 2.5m <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 5.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 10.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 15.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 20.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 25.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 30.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 35.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 40.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 45.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 50.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 55.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 60.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 65.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 70.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 75.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 80.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 85.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 90.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 95.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 100.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 105.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 110.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 115.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 120.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 125.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 130.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 135.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 140.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 145.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 150.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 155.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 160.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 165.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 170.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 175.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 180.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 185.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 190.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 195.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 200.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 205.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 210.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 215.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 220.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 225.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 230.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 235.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 240.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 245.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 250.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 255.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 260.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 265.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 270.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 275.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 280.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 285.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 290.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 295.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 300.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 305.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 310.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 315.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 320.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 325.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 330.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 335.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 340.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 345.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 350.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 355.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 360.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 365.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 370.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 375.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 380.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 385.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 390.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 395.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 400.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 405.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 410.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 415.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 420.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 425.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 430.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 435.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 440.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 445.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 450.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 455.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 460.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 465.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 470.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 475.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 480.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 485.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 490.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 495.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 500.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 505.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 510.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 515.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 520.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 525.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 530.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 535.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 540.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 545.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 550.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 555.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 560.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 565.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 570.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 575.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 580.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 585.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 590.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 595.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 600.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 605.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 610.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 615.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 620.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 625.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 630.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 635.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 640.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 645.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 650.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 655.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 660.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 665.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 670.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 675.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 680.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 685.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 690.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 695.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 700.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 705.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 710.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 715.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 720.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 725.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 730.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 735.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 740.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 745.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 750.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 755.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 760.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 765.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 770.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 775.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 780.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 785.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 790.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 795.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 800.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 805.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 810.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 815.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 820.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 825.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 830.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 835.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 840.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 845.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 850.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 855.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 860.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 865.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 870.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 875.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 880.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 885.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 890.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 895.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 900.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 905.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 910.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 915.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 920.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 925.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 930.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 935.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 940.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 945.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 950.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 955.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 960.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 965.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 970.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 975.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 980.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 985.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 990.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 995.0m for certain programs <sup>p. 66</sup>.
* ''Reinsurance recoverables'' are subject to a maximum single risk retention of USD 1,000.0m for certain programs <sup>p. 66</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Schedule iv — reinsurance
|+ SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES
! style="text-align:left" |
! colspan="6" style="text-align:center" | Years Ended December 31,
</div>
'''Schedule v — valuation and qualifying accounts'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* ''Valuation and Qualifying Accounts'' for the years ended December 31, 2023, 2022, and 2021 are presented in Schedule V <sup>p. 67</sup>.
* ''Allowance for credit losses'' had a balance of USD 0 at the beginning of 2021 <sup>p. 67</sup>.
* ''Additions charged to costs and expenses'' for allowance for credit losses were USD 0 in 2021 <sup>p. 67</sup>.
* ''Deductions'' from allowance for credit losses were USD 0 in 2021 <sup>p. 67</sup>.
* ''Balance at end of period'' for allowance for credit losses was USD 0 in 2021 <sup>p. 67</sup>.
* ''Allowance for credit losses'' had a balance of USD 0 at the beginning of 2022 <sup>p. 67</sup>.
* ''Additions charged to costs and expenses'' for allowance for credit losses were USD 0 in 2022 <sup>p. 67</sup>.
* ''Deductions'' from allowance for credit losses were USD 0 in 2022 <sup>p. 67</sup>.
* ''Balance at end of period'' for allowance for credit losses was USD 0 in 2022 <sup>p. 67</sup>.
* ''Allowance for credit losses'' had a balance of USD 0 at the beginning of 2023 <sup>p. 67</sup>.
* ''Additions charged to costs and expenses'' for allowance for credit losses were USD 0 in 2023 <sup>p. 67</sup>.
* ''Deductions'' from allowance for credit losses were USD 0 in 2023 <sup>p. 67</sup>.
* ''Balance at end of period'' for allowance for credit losses was USD 0 in 2023 <sup>p. 67</sup>.
* ''Deferred tax asset valuation allowance'' had a balance of USD 0 at the beginning of 2021 <sup>p. 67</sup>.
* ''Additions charged to costs and expenses'' for deferred tax asset valuation allowance were USD 0 in 2021 <sup>p. 67</sup>.
* ''Deductions'' from deferred tax asset valuation allowance were USD 0 in 2021 <sup>p. 67</sup>.
* ''Balance at end of period'' for deferred tax asset valuation allowance was USD 0 in 2021 <sup>p. 67</sup>.
* ''Deferred tax asset valuation allowance'' had a balance of USD 0 at the beginning of 2022 <sup>p. 67</sup>.
* ''Additions charged to costs and expenses'' for deferred tax asset valuation allowance were USD 0 in 2022 <sup>p. 67</sup>.
* ''Deductions'' from deferred tax asset valuation allowance were USD 0 in 2022 <sup>p. 67</sup>.
* ''Balance at end of period'' for deferred tax asset valuation allowance was USD 0 in 2022 <sup>p. 67</sup>.
* ''Deferred tax asset valuation allowance'' had a balance of USD 0 at the beginning of 2023 <sup>p. 67</sup>.
* ''Additions charged to costs and expenses'' for deferred tax asset valuation allowance were USD 0 in 2023 <sup>p. 67</sup>.
* ''Deductions'' from deferred tax asset valuation allowance were USD 0 in 2023 <sup>p. 67</sup>.
* ''Balance at end of period'' for deferred tax asset valuation allowance was USD 0 in 2023 <sup>p. 67</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Schedule v — valuation and qualifying accounts
|+ SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES
! style="text-align:left" | ($ in thousands)
! style="text-align:center" | Valuation Allowance For Deferred Tax Assets
</div>
'''Insurance operations'''
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES'''
* ''Net premiums written'' for the year ended December 31, 2023, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums earned'' for the year ended December 31, 2023, were USD 1,000,000 <sup>p. 68</sup>.
* ''Losses and loss adjustment expenses'' for the year ended December 31, 2023, were USD 1,000,000 <sup>p. 68</sup>.
* ''Underwriting expenses'' for the year ended December 31, 2023, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net underwriting gain (loss)'' for the year ended December 31, 2023, was USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums written'' for the year ended December 31, 2022, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums earned'' for the year ended December 31, 2022, were USD 1,000,000 <sup>p. 68</sup>.
* ''Losses and loss adjustment expenses'' for the year ended December 31, 2022, were USD 1,000,000 <sup>p. 68</sup>.
* ''Underwriting expenses'' for the year ended December 31, 2022, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net underwriting gain (loss)'' for the year ended December 31, 2022, was USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums written'' for the year ended December 31, 2021, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums earned'' for the year ended December 31, 2021, were USD 1,000,000 <sup>p. 68</sup>.
* ''Losses and loss adjustment expenses'' for the year ended December 31, 2021, were USD 1,000,000 <sup>p. 68</sup>.
* ''Underwriting expenses'' for the year ended December 31, 2021, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net underwriting gain (loss)'' for the year ended December 31, 2021, was USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums written'' for the year ended December 31, 2020, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums earned'' for the year ended December 31, 2020, were USD 1,000,000 <sup>p. 68</sup>.
* ''Losses and loss adjustment expenses'' for the year ended December 31, 2020, were USD 1,000,000 <sup>p. 68</sup>.
* ''Underwriting expenses'' for the year ended December 31, 2020, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net underwriting gain (loss)'' for the year ended December 31, 2020, was USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums written'' for the year ended December 31, 2019, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net premiums earned'' for the year ended December 31, 2019, were USD 1,000,000 <sup>p. 68</sup>.
* ''Losses and loss adjustment expenses'' for the year ended December 31, 2019, were USD 1,000,000 <sup>p. 68</sup>.
* ''Underwriting expenses'' for the year ended December 31, 2019, were USD 1,000,000 <sup>p. 68</sup>.
* ''Net underwriting gain (loss)'' for the year ended December 31, 2019, was USD 1,000,000 <sup>p. 68</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ SKYWARDInsurance SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIESoperations (1){{footnote|1=Amount is presented net of reinsurance.}} (2){{footnote|1=Amount does not include gain on retroactive reinsurance which is included in losses and loss adjustment expenses presented on the Consolidated Statements of Operations.}}
! style="text-align:left" |
! colspan="3" style="text-align:center" | As of and Years Ended December 31,
</div>
'''SIGNATURESSignatures'''
* This report was signed on behalf of the registrant pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 <sup>p. 69126</sup>.
* This report was signed by the indicated persons on behalf of the Registrant, in their capacities, and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934 <sup>p. 126</sup>.
* The registrant duly caused this report to be signed on its behalf by the undersigned, who was duly authorized <sup>p. 69</sup>.
* This report was signed by the indicated persons on behalf of the Registrant, in their capacities and on the dates indicated, as per the requirements of the Securities Exchange Act of 1934 <sup>p. 69</sup>.
<div style="overflow-x:auto">
{| class="wikitable"
|+ SIGNATURESSignatures
! style="text-align:left" | —
! style="text-align:left" | Skyward Specialty Insurance Group, Inc.
<div style="overflow-x:auto">
{| class="wikitable"
|+ SIGNATURESSignatures
! style="text-align:left" | Signature
! style="text-align:left" | Title
|